id	sid	tid	token	lemma	pos
aiua-9669	1	1	cop+ed+fisse	cop+ed+fisse	NOUN
aiua-9669	1	2	2006	2006	NUM
aiua-9669	1	3	archivio	archivio	NOUN
aiua-9669	1	4	italiano	italiano	X
aiua-9669	1	5	di	di	X
aiua-9669	1	6	urologia	urologia	PROPN
aiua-9669	1	7	e	e	PROPN
aiua-9669	1	8	andrologia	andrologia	NOUN
aiua-9669	1	9	2021	2021	NUM
aiua-9669	1	10	;	;	PUNCT
aiua-9669	1	11	93	93	NUM
aiua-9669	1	12	,	,	PUNCT
aiua-9669	1	13	192	192	NUM
aiua-9669	1	14	review	review	VERB
aiua-9669	1	15	no	no	DET
aiua-9669	1	16	conflict	conflict	NOUN
aiua-9669	1	17	of	of	ADP
aiua-9669	1	18	interest	interest	NOUN
aiua-9669	1	19	declared	declare	VERB
aiua-9669	1	20	.	.	PUNCT
aiua-9669	2	1	doi	doi	NOUN
aiua-9669	2	2	:	:	PUNCT
aiua-9669	2	3	10.4081	10.4081	NUM
aiua-9669	2	4	/	/	SYM
aiua-9669	2	5	aiua.2021.1.92	aiua.2021.1.92	PROPN
aiua-9669	2	6	dence	dence	NOUN
aiua-9669	2	7	of	of	ADP
aiua-9669	2	8	those	those	DET
aiua-9669	2	9	significant	significant	ADJ
aiua-9669	2	10	pca	pca	NOUN
aiua-9669	2	11	undetected	undetecte	VERB
aiua-9669	2	12	in	in	ADP
aiua-9669	2	13	screening	screen	VERB
aiua-9669	2	14	trials	trial	NOUN
aiua-9669	2	15	that	that	PRON
aiua-9669	2	16	are	be	AUX
aiua-9669	2	17	even	even	ADV
aiua-9669	2	18	now	now	ADV
aiua-9669	2	19	responsible	responsible	ADJ
aiua-9669	2	20	of	of	ADP
aiua-9669	2	21	specific	specific	ADJ
aiua-9669	2	22	mortality	mortality	NOUN
aiua-9669	2	23	and	and	CCONJ
aiua-9669	2	24	are	be	AUX
aiua-9669	2	25	called	call	VERB
aiua-9669	2	26	“	"	PUNCT
aiua-9669	2	27	escapes	escape	VERB
aiua-9669	2	28	cancers	cancer	NOUN
aiua-9669	2	29	”	"	PUNCT
aiua-9669	2	30	.	.	PUNCT
aiua-9669	3	1	the	the	DET
aiua-9669	3	2	occurrence	occurrence	NOUN
aiua-9669	3	3	of	of	ADP
aiua-9669	3	4	one	one	NUM
aiua-9669	3	5	of	of	ADP
aiua-9669	3	6	the	the	DET
aiua-9669	3	7	above	above	ADJ
aiua-9669	3	8	scenarios	scenario	NOUN
aiua-9669	3	9	is	be	AUX
aiua-9669	3	10	overwhelming	overwhelming	ADJ
aiua-9669	3	11	for	for	ADP
aiua-9669	3	12	the	the	DET
aiua-9669	3	13	patients	patient	NOUN
aiua-9669	3	14	and	and	CCONJ
aiua-9669	3	15	unpredicted	unpredicte	VERB
aiua-9669	3	16	for	for	ADP
aiua-9669	3	17	the	the	DET
aiua-9669	3	18	physician	physician	NOUN
aiua-9669	3	19	.	.	PUNCT
aiua-9669	4	1	then	then	ADV
aiua-9669	4	2	we	we	PRON
aiua-9669	4	3	addressed	address	VERB
aiua-9669	4	4	limitations	limitation	NOUN
aiua-9669	4	5	and	and	CCONJ
aiua-9669	4	6	reasons	reason	NOUN
aiua-9669	4	7	to	to	PART
aiua-9669	4	8	understand	understand	VERB
aiua-9669	4	9	why	why	SCONJ
aiua-9669	4	10	early	early	ADJ
aiua-9669	4	11	significant	significant	ADJ
aiua-9669	4	12	cancer	cancer	NOUN
aiua-9669	4	13	may	may	AUX
aiua-9669	4	14	be	be	AUX
aiua-9669	4	15	still	still	ADV
aiua-9669	4	16	missed	miss	VERB
aiua-9669	4	17	nowadays	nowadays	ADV
aiua-9669	4	18	.	.	PUNCT
aiua-9669	5	1	these	these	DET
aiua-9669	5	2	issues	issue	NOUN
aiua-9669	5	3	of	of	ADP
aiua-9669	5	4	multidisciplinary	multidisciplinary	ADJ
aiua-9669	5	5	interest	interest	NOUN
aiua-9669	5	6	had	have	AUX
aiua-9669	5	7	been	be	AUX
aiua-9669	5	8	subdivided	subdivide	VERB
aiua-9669	5	9	and	and	CCONJ
aiua-9669	5	10	deepened	deepen	VERB
aiua-9669	5	11	under	under	ADP
aiua-9669	5	12	four	four	NUM
aiua-9669	5	13	main	main	ADJ
aiua-9669	5	14	arguments	argument	NOUN
aiua-9669	5	15	:	:	PUNCT
aiua-9669	5	16	the	the	DET
aiua-9669	5	17	radiological	radiological	ADJ
aiua-9669	5	18	point	point	NOUN
aiua-9669	5	19	of	of	ADP
aiua-9669	5	20	view	view	NOUN
aiua-9669	5	21	,	,	PUNCT
aiua-9669	5	22	biochemical	biochemical	ADJ
aiua-9669	5	23	and	and	CCONJ
aiua-9669	5	24	clinical	clinical	ADJ
aiua-9669	5	25	point	point	NOUN
aiua-9669	5	26	of	of	ADP
aiua-9669	5	27	view	view	NOUN
aiua-9669	5	28	,	,	PUNCT
aiua-9669	5	29	pathological	pathological	ADJ
aiua-9669	5	30	point	point	NOUN
aiua-9669	5	31	of	of	ADP
aiua-9669	5	32	view	view	NOUN
aiua-9669	5	33	and	and	CCONJ
aiua-9669	5	34	focus	focus	VERB
aiua-9669	5	35	on	on	ADP
aiua-9669	5	36	pi	pi	NOUN
aiua-9669	5	37	-	-	PUNCT
aiua-9669	5	38	rads	rad	NOUN
aiua-9669	5	39	3	3	NUM
aiua-9669	5	40	lesions	lesion	NOUN
aiua-9669	5	41	:	:	PUNCT
aiua-9669	5	42	transition	transition	NOUN
aiua-9669	5	43	zone	zone	NOUN
aiua-9669	5	44	(	(	PUNCT
aiua-9669	5	45	tz	tz	PROPN
aiua-9669	5	46	)	)	PUNCT
aiua-9669	5	47	vs	vs	ADP
aiua-9669	5	48	peripheral	peripheral	ADJ
aiua-9669	5	49	zone	zone	NOUN
aiua-9669	5	50	(	(	PUNCT
aiua-9669	5	51	pz	pz	NOUN
aiua-9669	5	52	)	)	PUNCT
aiua-9669	5	53	.	.	PUNCT
aiua-9669	6	1	biochemical	biochemical	ADJ
aiua-9669	6	2	and	and	CCONJ
aiua-9669	6	3	clinical	clinical	ADJ
aiua-9669	6	4	point	point	NOUN
aiua-9669	6	5	of	of	ADP
aiua-9669	6	6	view	view	NOUN
aiua-9669	6	7	evaluate	evaluate	VERB
aiua-9669	6	8	the	the	DET
aiua-9669	6	9	presence	presence	NOUN
aiua-9669	6	10	of	of	ADP
aiua-9669	6	11	pca	pca	PROPN
aiua-9669	6	12	in	in	ADP
aiua-9669	6	13	case	case	NOUN
aiua-9669	6	14	of	of	ADP
aiua-9669	6	15	men	man	NOUN
aiua-9669	6	16	with	with	ADP
aiua-9669	6	17	low	low	ADJ
aiua-9669	6	18	psa	psa	NOUN
aiua-9669	6	19	level	level	NOUN
aiua-9669	6	20	is	be	AUX
aiua-9669	6	21	a	a	DET
aiua-9669	6	22	new	new	ADJ
aiua-9669	6	23	challenge	challenge	NOUN
aiua-9669	6	24	to	to	PART
aiua-9669	6	25	reduce	reduce	VERB
aiua-9669	6	26	the	the	DET
aiua-9669	6	27	mortality	mortality	NOUN
aiua-9669	6	28	due	due	ADP
aiua-9669	6	29	to	to	ADP
aiua-9669	6	30	pca	pca	NOUN
aiua-9669	6	31	and	and	CCONJ
aiua-9669	6	32	increase	increase	VERB
aiua-9669	6	33	the	the	DET
aiua-9669	6	34	detection	detection	NOUN
aiua-9669	6	35	in	in	ADP
aiua-9669	6	36	case	case	NOUN
aiua-9669	6	37	of	of	ADP
aiua-9669	6	38	disease	disease	NOUN
aiua-9669	6	39	risk	risk	NOUN
aiua-9669	6	40	.	.	PUNCT
aiua-9669	7	1	the	the	DET
aiua-9669	7	2	national	national	ADJ
aiua-9669	7	3	comprehensive	comprehensive	ADJ
aiua-9669	7	4	cancer	cancer	NOUN
aiua-9669	7	5	network	network	NOUN
aiua-9669	7	6	(	(	PUNCT
aiua-9669	7	7	nccn	nccn	PROPN
aiua-9669	7	8	)	)	PUNCT
aiua-9669	7	9	(	(	PUNCT
aiua-9669	7	10	version	version	NOUN
aiua-9669	7	11	2020.1	2020.1	NUM
aiua-9669	7	12	)	)	PUNCT
aiua-9669	7	13	described	describe	VERB
aiua-9669	7	14	the	the	DET
aiua-9669	7	15	low	low	ADJ
aiua-9669	7	16	level	level	NOUN
aiua-9669	7	17	of	of	ADP
aiua-9669	7	18	psa	psa	NOUN
aiua-9669	7	19	as	as	ADP
aiua-9669	7	20	the	the	DET
aiua-9669	7	21	presence	presence	NOUN
aiua-9669	7	22	of	of	ADP
aiua-9669	7	23	a	a	DET
aiua-9669	7	24	serum	serum	NOUN
aiua-9669	7	25	psa	psa	NOUN
aiua-9669	7	26	<	<	X
aiua-9669	7	27	3	3	NUM
aiua-9669	7	28	ng	ng	NOUN
aiua-9669	7	29	/	/	SYM
aiua-9669	7	30	ml	ml	NOUN
aiua-9669	7	31	according	accord	VERB
aiua-9669	7	32	to	to	ADP
aiua-9669	7	33	beckman	beckman	PROPN
aiua-9669	7	34	standard	standard	PROPN
aiua-9669	7	35	,	,	PUNCT
aiua-9669	7	36	which	which	PRON
aiua-9669	7	37	cut	cut	NOUN
aiua-9669	7	38	-	-	PUNCT
aiua-9669	7	39	off	off	NOUN
aiua-9669	7	40	is	be	AUX
aiua-9669	7	41	4.0	4.0	NUM
aiua-9669	7	42	ng	ng	NOUN
aiua-9669	7	43	/	/	SYM
aiua-9669	7	44	ml	ml	PROPN
aiua-9669	7	45	.	.	PUNCT
aiua-9669	8	1	this	this	DET
aiua-9669	8	2	value	value	NOUN
aiua-9669	8	3	translated	translate	VERB
aiua-9669	8	4	to	to	ADP
aiua-9669	8	5	who	who	PRON
aiua-9669	8	6	is	be	AUX
aiua-9669	8	7	3.0	3.0	NUM
aiua-9669	8	8	ng	ng	NOUN
aiua-9669	8	9	/	/	SYM
aiua-9669	8	10	ml	ml	PROPN
aiua-9669	8	11	.	.	PUNCT
aiua-9669	9	1	over	over	ADP
aiua-9669	9	2	time	time	NOUN
aiua-9669	9	3	the	the	DET
aiua-9669	9	4	international	international	ADJ
aiua-9669	9	5	guidelines	guideline	NOUN
aiua-9669	9	6	changed	change	VERB
aiua-9669	9	7	dramatically	dramatically	ADV
aiua-9669	9	8	based	base	VERB
aiua-9669	9	9	on	on	ADP
aiua-9669	9	10	results	result	NOUN
aiua-9669	9	11	of	of	ADP
aiua-9669	9	12	milestone	milestone	NOUN
aiua-9669	9	13	studies	study	NOUN
aiua-9669	9	14	by	by	ADP
aiua-9669	9	15	thompson	thompson	PROPN
aiua-9669	9	16	et	et	PROPN
aiua-9669	9	17	al	al	PROPN
aiua-9669	9	18	.	.	PROPN
aiua-9669	10	1	(	(	PUNCT
aiua-9669	10	2	4	4	NUM
aiua-9669	10	3	)	)	PUNCT
aiua-9669	10	4	.	.	PUNCT
aiua-9669	11	1	they	they	PRON
aiua-9669	11	2	presented	present	VERB
aiua-9669	11	3	a	a	DET
aiua-9669	11	4	clinical	clinical	ADJ
aiua-9669	11	5	trial	trial	NOUN
aiua-9669	11	6	in	in	ADP
aiua-9669	11	7	which	which	PRON
aiua-9669	11	8	9459	9459	NUM
aiua-9669	11	9	men	man	NOUN
aiua-9669	11	10	were	be	AUX
aiua-9669	11	11	analysed	analyse	VERB
aiua-9669	11	12	for	for	ADP
aiua-9669	11	13	a	a	DET
aiua-9669	11	14	pca	pca	PROPN
aiua-9669	11	15	prevention	prevention	NOUN
aiua-9669	11	16	trial	trial	NOUN
aiua-9669	11	17	(	(	PUNCT
aiua-9669	11	18	pcpt	pcpt	NOUN
aiua-9669	11	19	):	):	PUNCT
aiua-9669	11	20	2950	2950	NUM
aiua-9669	11	21	men	man	NOUN
aiua-9669	11	22	presented	present	VERB
aiua-9669	11	23	a	a	DET
aiua-9669	11	24	psa	psa	NOUN
aiua-9669	11	25	level	level	NOUN
aiua-9669	11	26	<	<	X
aiua-9669	11	27	4.0	4.0	NUM
aiua-9669	11	28	ng	ng	NOUN
aiua-9669	11	29	/	/	SYM
aiua-9669	11	30	ml	ml	PROPN
aiua-9669	11	31	and	and	CCONJ
aiua-9669	11	32	negative	negative	ADJ
aiua-9669	11	33	dre	dre	NOUN
aiua-9669	11	34	.	.	PUNCT
aiua-9669	12	1	all	all	DET
aiua-9669	12	2	the	the	DET
aiua-9669	12	3	population	population	NOUN
aiua-9669	12	4	received	receive	VERB
aiua-9669	12	5	biopsy	biopsy	NOUN
aiua-9669	12	6	at	at	ADP
aiua-9669	12	7	the	the	DET
aiua-9669	12	8	end	end	NOUN
aiua-9669	12	9	study	study	NOUN
aiua-9669	12	10	per	per	ADP
aiua-9669	12	11	protocol	protocol	NOUN
aiua-9669	12	12	.	.	PUNCT
aiua-9669	13	1	the	the	DET
aiua-9669	13	2	prevalence	prevalence	NOUN
aiua-9669	13	3	of	of	ADP
aiua-9669	13	4	pca	pca	PROPN
aiua-9669	13	5	was	be	AUX
aiua-9669	13	6	15.2	15.2	NUM
aiua-9669	13	7	%	%	NOUN
aiua-9669	13	8	in	in	ADP
aiua-9669	13	9	the	the	DET
aiua-9669	13	10	group	group	NOUN
aiua-9669	13	11	with	with	ADP
aiua-9669	13	12	low	low	ADJ
aiua-9669	13	13	psa	psa	NOUN
aiua-9669	13	14	level	level	NOUN
aiua-9669	13	15	and	and	CCONJ
aiua-9669	13	16	the	the	DET
aiua-9669	13	17	incidence	incidence	NOUN
aiua-9669	13	18	of	of	ADP
aiua-9669	13	19	cspca	cspca	NOUN
aiua-9669	13	20	is	be	AUX
aiua-9669	13	21	summarized	summarize	VERB
aiua-9669	13	22	in	in	ADP
aiua-9669	13	23	table	table	NOUN
aiua-9669	13	24	1	1	NUM
aiua-9669	13	25	.	.	PUNCT
aiua-9669	14	1	that	that	PRON
aiua-9669	14	2	means	mean	VERB
aiua-9669	14	3	that	that	SCONJ
aiua-9669	14	4	there	there	PRON
aiua-9669	14	5	is	be	VERB
aiua-9669	14	6	a	a	DET
aiua-9669	14	7	cspca	cspca	NOUN
aiua-9669	14	8	also	also	ADV
aiua-9669	14	9	in	in	ADP
aiua-9669	14	10	patients	patient	NOUN
aiua-9669	14	11	with	with	ADP
aiua-9669	14	12	low	low	ADJ
aiua-9669	14	13	psa	psa	NOUN
aiua-9669	14	14	level	level	NOUN
aiua-9669	14	15	.	.	PUNCT
aiua-9669	15	1	to	to	PART
aiua-9669	15	2	limit	limit	VERB
aiua-9669	15	3	the	the	DET
aiua-9669	15	4	number	number	NOUN
aiua-9669	15	5	of	of	ADP
aiua-9669	15	6	patients	patient	NOUN
aiua-9669	15	7	to	to	PART
aiua-9669	15	8	undergo	undergo	VERB
aiua-9669	15	9	prostate	prostate	NOUN
aiua-9669	15	10	biopsy	biopsy	NOUN
aiua-9669	15	11	other	other	ADJ
aiua-9669	15	12	clinical	clinical	ADJ
aiua-9669	15	13	evaluations	evaluation	NOUN
aiua-9669	15	14	need	need	VERB
aiua-9669	15	15	to	to	PART
aiua-9669	15	16	be	be	AUX
aiua-9669	15	17	considered	consider	VERB
aiua-9669	15	18	:	:	PUNCT
aiua-9669	15	19	dre	dre	NOUN
aiua-9669	15	20	,	,	PUNCT
aiua-9669	15	21	imaging	imaging	NOUN
aiua-9669	15	22	,	,	PUNCT
aiua-9669	15	23	prostate	prostate	NOUN
aiua-9669	15	24	volume	volume	NOUN
aiua-9669	15	25	,	,	PUNCT
aiua-9669	15	26	age	age	NOUN
aiua-9669	15	27	and	and	CCONJ
aiua-9669	15	28	genetic	genetic	ADJ
aiua-9669	15	29	risk	risk	NOUN
aiua-9669	15	30	.	.	PUNCT
aiua-9669	16	1	advantage	advantage	NOUN
aiua-9669	16	2	must	must	AUX
aiua-9669	16	3	be	be	AUX
aiua-9669	16	4	balanced	balance	VERB
aiua-9669	16	5	to	to	ADP
aiua-9669	16	6	probability	probability	NOUN
aiua-9669	16	7	of	of	ADP
aiua-9669	16	8	prostate	prostate	NOUN
aiua-9669	16	9	biopsy	biopsy	NOUN
aiua-9669	16	10	complications	complication	NOUN
aiua-9669	16	11	(	(	PUNCT
aiua-9669	16	12	5	5	NUM
aiua-9669	16	13	)	)	PUNCT
aiua-9669	16	14	.	.	PUNCT
aiua-9669	17	1	digital	digital	ADJ
aiua-9669	17	2	rectal	rectal	ADJ
aiua-9669	17	3	examination	examination	NOUN
aiua-9669	17	4	and	and	CCONJ
aiua-9669	17	5	psa	psa	VERB
aiua-9669	17	6	the	the	DET
aiua-9669	17	7	decision	decision	NOUN
aiua-9669	17	8	to	to	PART
aiua-9669	17	9	do	do	AUX
aiua-9669	17	10	a	a	DET
aiua-9669	17	11	prostate	prostate	NOUN
aiua-9669	17	12	biopsy	biopsy	NOUN
aiua-9669	17	13	can	can	AUX
aiua-9669	17	14	change	change	VERB
aiua-9669	17	15	after	after	ADP
aiua-9669	17	16	the	the	DET
aiua-9669	17	17	dre	dre	PROPN
aiua-9669	17	18	.	.	PUNCT
aiua-9669	18	1	based	base	VERB
aiua-9669	18	2	on	on	ADP
aiua-9669	18	3	this	this	DET
aiua-9669	18	4	fact	fact	NOUN
aiua-9669	18	5	,	,	PUNCT
aiua-9669	18	6	halpern	halpern	PROPN
aiua-9669	18	7	et	et	PROPN
aiua-9669	18	8	al	al	PROPN
aiua-9669	18	9	.	.	PROPN
aiua-9669	18	10	analysed	analyse	VERB
aiua-9669	18	11	the	the	DET
aiua-9669	18	12	dre	dre	NOUN
aiua-9669	18	13	of	of	ADP
aiua-9669	18	14	35,350	35,350	NUM
aiua-9669	18	15	men	man	NOUN
aiua-9669	18	16	and	and	CCONJ
aiua-9669	18	17	stratified	stratify	VERB
aiua-9669	18	18	the	the	DET
aiua-9669	18	19	results	result	NOUN
aiua-9669	18	20	by	by	ADP
aiua-9669	18	21	psa	psa	NOUN
aiua-9669	18	22	level	level	NOUN
aiua-9669	18	23	and	and	CCONJ
aiua-9669	18	24	reasons	reason	NOUN
aiua-9669	18	25	why	why	SCONJ
aiua-9669	18	26	significant	significant	ADJ
aiua-9669	18	27	prostate	prostate	NOUN
aiua-9669	18	28	cancer	cancer	NOUN
aiua-9669	18	29	is	be	AUX
aiua-9669	18	30	still	still	ADV
aiua-9669	18	31	missed	miss	VERB
aiua-9669	18	32	in	in	ADP
aiua-9669	18	33	early	early	ADJ
aiua-9669	18	34	stage	stage	NOUN
aiua-9669	18	35	were	be	AUX
aiua-9669	18	36	investigated	investigate	VERB
aiua-9669	18	37	at	at	ADP
aiua-9669	18	38	the	the	DET
aiua-9669	18	39	22nd	22nd	ADJ
aiua-9669	18	40	national	national	ADJ
aiua-9669	18	41	sieun	sieun	NOUN
aiua-9669	18	42	(	(	PUNCT
aiua-9669	18	43	italian	italian	ADJ
aiua-9669	18	44	society	society	NOUN
aiua-9669	18	45	of	of	ADP
aiua-9669	18	46	integrated	integrate	VERB
aiua-9669	18	47	diagnostic	diagnostic	ADJ
aiua-9669	18	48	in	in	ADP
aiua-9669	18	49	urology	urology	NOUN
aiua-9669	18	50	,	,	PUNCT
aiua-9669	18	51	andrology	andrology	NOUN
aiua-9669	18	52	,	,	PUNCT
aiua-9669	18	53	nephrology	nephrology	NOUN
aiua-9669	18	54	)	)	PUNCT
aiua-9669	18	55	congress	congress	PROPN
aiua-9669	18	56	took	take	VERB
aiua-9669	18	57	place	place	NOUN
aiua-9669	18	58	from	from	ADP
aiua-9669	18	59	30th	30th	ADJ
aiua-9669	18	60	november	november	PROPN
aiua-9669	18	61	to	to	ADP
aiua-9669	18	62	1st	1st	ADJ
aiua-9669	18	63	december	december	PROPN
aiua-9669	18	64	2020	2020	NUM
aiua-9669	18	65	,	,	PUNCT
aiua-9669	18	66	in	in	ADP
aiua-9669	18	67	virtual	virtual	ADJ
aiua-9669	18	68	modality	modality	NOUN
aiua-9669	18	69	.	.	PUNCT
aiua-9669	19	1	even	even	ADV
aiua-9669	19	2	if	if	SCONJ
aiua-9669	19	3	multiparametric	multiparametric	ADJ
aiua-9669	19	4	magnetic	magnetic	ADJ
aiua-9669	19	5	resonance	resonance	NOUN
aiua-9669	19	6	(	(	PUNCT
aiua-9669	19	7	mr	mr	PROPN
aiua-9669	19	8	)	)	PUNCT
aiua-9669	19	9	has	have	AUX
aiua-9669	19	10	been	be	AUX
aiua-9669	19	11	introduced	introduce	VERB
aiua-9669	19	12	in	in	ADP
aiua-9669	19	13	the	the	DET
aiua-9669	19	14	clinical	clinical	ADJ
aiua-9669	19	15	practice	practice	NOUN
aiua-9669	19	16	several	several	ADJ
aiua-9669	19	17	,	,	PUNCT
aiua-9669	19	18	limitations	limitation	NOUN
aiua-9669	19	19	are	be	AUX
aiua-9669	19	20	emerging	emerge	VERB
aiua-9669	19	21	in	in	ADP
aiua-9669	19	22	patient	patient	NOUN
aiua-9669	19	23	with	with	ADP
aiua-9669	19	24	regular	regular	ADJ
aiua-9669	19	25	digital	digital	ADJ
aiua-9669	19	26	rectal	rectal	ADJ
aiua-9669	19	27	examination	examination	NOUN
aiua-9669	19	28	(	(	PUNCT
aiua-9669	19	29	dre	dre	PROPN
aiua-9669	19	30	)	)	PUNCT
aiua-9669	19	31	and	and	CCONJ
aiua-9669	19	32	serum	serum	NOUN
aiua-9669	19	33	prostate	prostate	NOUN
aiua-9669	19	34	specific	specific	ADJ
aiua-9669	19	35	antigen	antigen	NOUN
aiua-9669	19	36	(	(	PUNCT
aiua-9669	19	37	psa	psa	NOUN
aiua-9669	19	38	)	)	PUNCT
aiua-9669	19	39	levels	level	NOUN
aiua-9669	19	40	approaching	approach	VERB
aiua-9669	19	41	the	the	DET
aiua-9669	19	42	normal	normal	ADJ
aiua-9669	19	43	limits	limit	NOUN
aiua-9669	19	44	.	.	PUNCT
aiua-9669	20	1	the	the	DET
aiua-9669	20	2	present	present	ADJ
aiua-9669	20	3	paper	paper	NOUN
aiua-9669	20	4	summarizes	summarize	NOUN
aiua-9669	20	5	highlights	highlight	NOUN
aiua-9669	20	6	observed	observe	VERB
aiua-9669	20	7	in	in	ADP
aiua-9669	20	8	those	those	DET
aiua-9669	20	9	cases	case	NOUN
aiua-9669	20	10	where	where	SCONJ
aiua-9669	20	11	significant	significant	ADJ
aiua-9669	20	12	prostate	prostate	NOUN
aiua-9669	20	13	cancer	cancer	NOUN
aiua-9669	20	14	may	may	AUX
aiua-9669	20	15	be	be	AUX
aiua-9669	20	16	missed	miss	VERB
aiua-9669	20	17	by	by	ADP
aiua-9669	20	18	psa	psa	NOUN
aiua-9669	20	19	or	or	CCONJ
aiua-9669	20	20	imaging	imaging	NOUN
aiua-9669	20	21	and	and	CCONJ
aiua-9669	20	22	dre	dre	PROPN
aiua-9669	20	23	.	.	PUNCT
aiua-9669	21	1	the	the	DET
aiua-9669	21	2	issue	issue	NOUN
aiua-9669	21	3	of	of	ADP
aiua-9669	21	4	multidisciplinary	multidisciplinary	ADJ
aiua-9669	21	5	interest	interest	NOUN
aiua-9669	21	6	had	have	AUX
aiua-9669	21	7	been	be	AUX
aiua-9669	21	8	subdivided	subdivide	VERB
aiua-9669	21	9	and	and	CCONJ
aiua-9669	21	10	deepened	deepen	VERB
aiua-9669	21	11	under	under	ADP
aiua-9669	21	12	four	four	NUM
aiua-9669	21	13	main	main	ADJ
aiua-9669	21	14	topics	topic	NOUN
aiua-9669	21	15	:	:	PUNCT
aiua-9669	21	16	biochemical	biochemical	ADJ
aiua-9669	21	17	,	,	PUNCT
aiua-9669	21	18	clinical	clinical	ADJ
aiua-9669	21	19	,	,	PUNCT
aiua-9669	21	20	pathological	pathological	ADJ
aiua-9669	21	21	and	and	CCONJ
aiua-9669	21	22	radiological	radiological	ADJ
aiua-9669	21	23	point	point	NOUN
aiua-9669	21	24	of	of	ADP
aiua-9669	21	25	view	view	NOUN
aiua-9669	21	26	with	with	ADP
aiua-9669	21	27	a	a	DET
aiua-9669	21	28	focus	focus	NOUN
aiua-9669	21	29	on	on	ADP
aiua-9669	21	30	pi	pi	NOUN
aiua-9669	21	31	-	-	PUNCT
aiua-9669	21	32	rads	rad	NOUN
aiua-9669	21	33	3	3	NUM
aiua-9669	21	34	lesions	lesion	NOUN
aiua-9669	21	35	.	.	PUNCT
aiua-9669	22	1	key	key	ADJ
aiua-9669	22	2	words	word	NOUN
aiua-9669	22	3	:	:	PUNCT
aiua-9669	22	4	prostate	prostate	NOUN
aiua-9669	22	5	cancer	cancer	NOUN
aiua-9669	22	6	;	;	PUNCT
aiua-9669	22	7	prostate	prostate	NOUN
aiua-9669	22	8	needle	needle	NOUN
aiua-9669	22	9	biopsy	biopsy	NOUN
aiua-9669	22	10	;	;	PUNCT
aiua-9669	22	11	radical	radical	ADJ
aiua-9669	22	12	prostatectomy	prostatectomy	NOUN
aiua-9669	22	13	;	;	PUNCT
aiua-9669	22	14	diagnosis	diagnosis	NOUN
aiua-9669	22	15	;	;	PUNCT
aiua-9669	22	16	magnetic	magnetic	ADJ
aiua-9669	22	17	resonance	resonance	NOUN
aiua-9669	22	18	imaging	imaging	NOUN
aiua-9669	22	19	.	.	PUNCT
aiua-9669	22	20	submitted	submit	VERB
aiua-9669	22	21	9	9	NUM
aiua-9669	22	22	january	january	NOUN
aiua-9669	22	23	2021	2021	NUM
aiua-9669	22	24	;	;	PUNCT
aiua-9669	22	25	accepted	accept	VERB
aiua-9669	22	26	21	21	NUM
aiua-9669	22	27	january	january	PROPN
aiua-9669	22	28	2021	2021	NUM
aiua-9669	22	29	introduction	introduction	NOUN
aiua-9669	22	30	the	the	DET
aiua-9669	22	31	present	present	ADJ
aiua-9669	22	32	paper	paper	NOUN
aiua-9669	22	33	summarizes	summarize	NOUN
aiua-9669	22	34	highlights	highlight	NOUN
aiua-9669	22	35	in	in	ADP
aiua-9669	22	36	the	the	DET
aiua-9669	22	37	field	field	NOUN
aiua-9669	22	38	of	of	ADP
aiua-9669	22	39	prostate	prostate	NOUN
aiua-9669	22	40	cancer	cancer	NOUN
aiua-9669	22	41	(	(	PUNCT
aiua-9669	22	42	pca	pca	PROPN
aiua-9669	22	43	)	)	PUNCT
aiua-9669	22	44	focusing	focus	VERB
aiua-9669	22	45	on	on	ADP
aiua-9669	22	46	significant	significant	ADJ
aiua-9669	22	47	types	type	NOUN
aiua-9669	22	48	that	that	PRON
aiua-9669	22	49	do	do	AUX
aiua-9669	22	50	not	not	PART
aiua-9669	22	51	rise	rise	VERB
aiua-9669	22	52	serum	serum	NOUN
aiua-9669	22	53	psa	psa	NOUN
aiua-9669	22	54	,	,	PUNCT
aiua-9669	22	55	those	those	PRON
aiua-9669	22	56	that	that	PRON
aiua-9669	22	57	are	be	AUX
aiua-9669	22	58	undetected	undetecte	VERB
aiua-9669	22	59	by	by	ADP
aiua-9669	22	60	imaging	imaging	NOUN
aiua-9669	22	61	or	or	CCONJ
aiua-9669	22	62	those	those	PRON
aiua-9669	22	63	that	that	PRON
aiua-9669	22	64	are	be	AUX
aiua-9669	22	65	unpalpable	unpalpable	ADJ
aiua-9669	22	66	.	.	PUNCT
aiua-9669	23	1	this	this	DET
aiua-9669	23	2	issue	issue	NOUN
aiua-9669	23	3	rises	rise	VERB
aiua-9669	23	4	several	several	ADJ
aiua-9669	23	5	implications	implication	NOUN
aiua-9669	23	6	such	such	ADJ
aiua-9669	23	7	as	as	ADP
aiua-9669	23	8	development	development	NOUN
aiua-9669	23	9	of	of	ADP
aiua-9669	23	10	early	early	ADJ
aiua-9669	23	11	pca	pca	NOUN
aiua-9669	23	12	and	and	CCONJ
aiua-9669	23	13	limitations	limitation	NOUN
aiua-9669	23	14	in	in	ADP
aiua-9669	23	15	cancer	cancer	NOUN
aiua-9669	23	16	detection	detection	NOUN
aiua-9669	23	17	using	use	VERB
aiua-9669	23	18	updated	update	VERB
aiua-9669	23	19	technologies	technology	NOUN
aiua-9669	23	20	(	(	PUNCT
aiua-9669	23	21	1	1	NUM
aiua-9669	23	22	,	,	PUNCT
aiua-9669	23	23	2	2	NUM
aiua-9669	23	24	)	)	PUNCT
aiua-9669	23	25	.	.	PUNCT
aiua-9669	24	1	the	the	DET
aiua-9669	24	2	knowledge	knowledge	NOUN
aiua-9669	24	3	is	be	AUX
aiua-9669	24	4	useful	useful	ADJ
aiua-9669	24	5	for	for	ADP
aiua-9669	24	6	patient	patient	NOUN
aiua-9669	24	7	and	and	CCONJ
aiua-9669	24	8	physician	physician	NOUN
aiua-9669	24	9	information	information	NOUN
aiua-9669	24	10	before	before	ADP
aiua-9669	24	11	any	any	DET
aiua-9669	24	12	further	further	ADJ
aiua-9669	24	13	invasive	invasive	ADJ
aiua-9669	24	14	diagnostic	diagnostic	ADJ
aiua-9669	24	15	procedure	procedure	NOUN
aiua-9669	24	16	such	such	ADJ
aiua-9669	24	17	as	as	ADP
aiua-9669	24	18	biopsy	biopsy	NOUN
aiua-9669	24	19	or	or	CCONJ
aiua-9669	24	20	before	before	ADP
aiua-9669	24	21	any	any	DET
aiua-9669	24	22	therapy	therapy	NOUN
aiua-9669	24	23	of	of	ADP
aiua-9669	24	24	concurrent	concurrent	ADJ
aiua-9669	24	25	benign	benign	ADJ
aiua-9669	24	26	prostatic	prostatic	ADJ
aiua-9669	24	27	hyperplasie	hyperplasie	NOUN
aiua-9669	24	28	(	(	PUNCT
aiua-9669	24	29	bph	bph	NOUN
aiua-9669	24	30	)	)	PUNCT
aiua-9669	24	31	(	(	PUNCT
aiua-9669	24	32	3	3	NUM
aiua-9669	24	33	)	)	PUNCT
aiua-9669	24	34	.	.	PUNCT
aiua-9669	25	1	the	the	DET
aiua-9669	25	2	believes	belief	NOUN
aiua-9669	25	3	of	of	ADP
aiua-9669	25	4	most	most	ADJ
aiua-9669	25	5	men	man	NOUN
aiua-9669	25	6	is	be	AUX
aiua-9669	25	7	that	that	SCONJ
aiua-9669	25	8	every	every	DET
aiua-9669	25	9	cancer	cancer	NOUN
aiua-9669	25	10	is	be	AUX
aiua-9669	25	11	detected	detect	VERB
aiua-9669	25	12	if	if	SCONJ
aiua-9669	25	13	we	we	PRON
aiua-9669	25	14	use	use	VERB
aiua-9669	25	15	magnetic	magnetic	ADJ
aiua-9669	25	16	resonance	resonance	NOUN
aiua-9669	25	17	given	give	VERB
aiua-9669	25	18	that	that	DET
aiua-9669	25	19	prostatic	prostatic	ADJ
aiua-9669	25	20	specific	specific	ADJ
aiua-9669	25	21	antigen	antigen	NOUN
aiua-9669	25	22	(	(	PUNCT
aiua-9669	25	23	psa	psa	NOUN
aiua-9669	25	24	)	)	PUNCT
aiua-9669	25	25	and	and	CCONJ
aiua-9669	25	26	digital	digital	ADJ
aiua-9669	25	27	rectal	rectal	ADJ
aiua-9669	25	28	examination	examination	NOUN
aiua-9669	25	29	(	(	PUNCT
aiua-9669	25	30	dre	dre	PROPN
aiua-9669	25	31	)	)	PUNCT
aiua-9669	25	32	may	may	AUX
aiua-9669	25	33	miss	miss	VERB
aiua-9669	25	34	sometimes	sometimes	ADV
aiua-9669	25	35	early	early	ADJ
aiua-9669	25	36	cancer	cancer	NOUN
aiua-9669	25	37	,	,	PUNCT
aiua-9669	25	38	therefore	therefore	ADV
aiua-9669	25	39	prostate	prostate	NOUN
aiua-9669	25	40	mpmr	mpmr	NOUN
aiua-9669	25	41	(	(	PUNCT
aiua-9669	25	42	magnetic	magnetic	ADJ
aiua-9669	25	43	resonance	resonance	NOUN
aiua-9669	25	44	)	)	PUNCT
aiua-9669	25	45	imaging	imaging	NOUN
aiua-9669	25	46	is	be	AUX
aiua-9669	25	47	extremely	extremely	ADV
aiua-9669	25	48	required	require	VERB
aiua-9669	25	49	even	even	ADV
aiua-9669	25	50	if	if	SCONJ
aiua-9669	25	51	is	be	AUX
aiua-9669	25	52	not	not	PART
aiua-9669	25	53	clinically	clinically	ADV
aiua-9669	25	54	indicated	indicate	VERB
aiua-9669	25	55	.	.	PUNCT
aiua-9669	26	1	as	as	ADP
aiua-9669	26	2	examples	example	NOUN
aiua-9669	26	3	of	of	ADP
aiua-9669	26	4	this	this	PRON
aiua-9669	26	5	we	we	PRON
aiua-9669	26	6	refer	refer	VERB
aiua-9669	26	7	to	to	ADP
aiua-9669	26	8	two	two	NUM
aiua-9669	26	9	clinical	clinical	ADJ
aiua-9669	26	10	scenarios	scenario	NOUN
aiua-9669	26	11	commonly	commonly	ADV
aiua-9669	26	12	observed	observe	VERB
aiua-9669	26	13	in	in	ADP
aiua-9669	26	14	clinical	clinical	ADJ
aiua-9669	26	15	practice	practice	NOUN
aiua-9669	26	16	:	:	PUNCT
aiua-9669	26	17	the	the	DET
aiua-9669	26	18	first	first	ADJ
aiua-9669	26	19	,	,	PUNCT
aiua-9669	26	20	is	be	AUX
aiua-9669	26	21	t1b	t1b	PROPN
aiua-9669	26	22	pca	pca	PROPN
aiua-9669	26	23	detected	detect	VERB
aiua-9669	26	24	after	after	ADP
aiua-9669	26	25	bph	bph	NOUN
aiua-9669	26	26	surgery	surgery	NOUN
aiua-9669	26	27	in	in	ADP
aiua-9669	26	28	patients	patient	NOUN
aiua-9669	26	29	with	with	ADP
aiua-9669	26	30	in	in	ADP
aiua-9669	26	31	-	-	PUNCT
aiua-9669	26	32	range	range	NOUN
aiua-9669	26	33	psa	psa	NOUN
aiua-9669	26	34	and	and	CCONJ
aiua-9669	26	35	normal	normal	ADJ
aiua-9669	26	36	dre	dre	NOUN
aiua-9669	26	37	,	,	PUNCT
aiua-9669	26	38	the	the	DET
aiua-9669	26	39	second	second	ADJ
aiua-9669	26	40	,	,	PUNCT
aiua-9669	26	41	the	the	DET
aiua-9669	26	42	incidetection	incidetection	NOUN
aiua-9669	26	43	limits	limit	NOUN
aiua-9669	26	44	of	of	ADP
aiua-9669	26	45	significant	significant	ADJ
aiua-9669	26	46	prostate	prostate	NOUN
aiua-9669	26	47	cancer	cancer	NOUN
aiua-9669	26	48	using	use	VERB
aiua-9669	26	49	multiparametric	multiparametric	ADJ
aiua-9669	26	50	mr	mr	PROPN
aiua-9669	26	51	and	and	CCONJ
aiua-9669	26	52	digital	digital	ADJ
aiua-9669	26	53	rectal	rectal	ADJ
aiua-9669	26	54	examination	examination	NOUN
aiua-9669	26	55	in	in	ADP
aiua-9669	26	56	men	man	NOUN
aiua-9669	26	57	with	with	ADP
aiua-9669	26	58	low	low	ADJ
aiua-9669	26	59	serum	serum	NOUN
aiua-9669	26	60	psa	psa	NOUN
aiua-9669	26	61	:	:	PUNCT
aiua-9669	26	62	up	up	ADP
aiua-9669	26	63	-	-	PUNCT
aiua-9669	26	64	date	date	NOUN
aiua-9669	26	65	of	of	ADP
aiua-9669	26	66	the	the	DET
aiua-9669	26	67	italian	italian	ADJ
aiua-9669	26	68	society	society	NOUN
aiua-9669	26	69	of	of	ADP
aiua-9669	26	70	integrated	integrate	VERB
aiua-9669	26	71	diagnostic	diagnostic	ADJ
aiua-9669	26	72	in	in	ADP
aiua-9669	26	73	urology	urology	NOUN
aiua-9669	26	74	summary	summary	NOUN
aiua-9669	26	75	andrea	andrea	PROPN
aiua-9669	26	76	b.	b.	PROPN
aiua-9669	26	77	galosi	galosi	PROPN
aiua-9669	26	78	1	1	NUM
aiua-9669	26	79	,	,	PUNCT
aiua-9669	26	80	erika	erika	PROPN
aiua-9669	26	81	palagonia	palagonia	PROPN
aiua-9669	26	82	1	1	NUM
aiua-9669	26	83	,	,	PUNCT
aiua-9669	26	84	simone	simone	NOUN
aiua-9669	26	85	scarcella	scarcella	PROPN
aiua-9669	26	86	1	1	NUM
aiua-9669	26	87	,	,	PUNCT
aiua-9669	26	88	alessia	alessia	PROPN
aiua-9669	26	89	cimadamore	cimadamore	PROPN
aiua-9669	26	90	2	2	NUM
aiua-9669	26	91	,	,	PUNCT
aiua-9669	26	92	vito	vito	PROPN
aiua-9669	26	93	lacetera	lacetera	NOUN
aiua-9669	26	94	3	3	NUM
aiua-9669	26	95	,	,	PUNCT
aiua-9669	26	96	rocco	rocco	PROPN
aiua-9669	26	97	f.	f.	PROPN
aiua-9669	26	98	delle	delle	PROPN
aiua-9669	26	99	fave	fave	PROPN
aiua-9669	26	100	1	1	NUM
aiua-9669	26	101	,	,	PUNCT
aiua-9669	26	102	angelo	angelo	PROPN
aiua-9669	26	103	antezza	antezza	PROPN
aiua-9669	26	104	1	1	NUM
aiua-9669	26	105	,	,	PUNCT
aiua-9669	26	106	lucio	lucio	PROPN
aiua-9669	26	107	dell’atti	dell’atti	VERB
aiua-9669	26	108	1	1	NUM
aiua-9669	26	109	1	1	NUM
aiua-9669	26	110	division	division	NOUN
aiua-9669	26	111	of	of	ADP
aiua-9669	26	112	urology	urology	NOUN
aiua-9669	26	113	,	,	PUNCT
aiua-9669	26	114	school	school	NOUN
aiua-9669	26	115	of	of	ADP
aiua-9669	26	116	medicine	medicine	NOUN
aiua-9669	26	117	,	,	PUNCT
aiua-9669	26	118	università	università	PROPN
aiua-9669	26	119	politecnica	politecnica	PROPN
aiua-9669	26	120	delle	delle	PROPN
aiua-9669	26	121	marche	marche	PROPN
aiua-9669	26	122	,	,	PUNCT
aiua-9669	26	123	ancona	ancona	PROPN
aiua-9669	26	124	,	,	PUNCT
aiua-9669	26	125	italy	italy	PROPN
aiua-9669	26	126	;	;	PUNCT
aiua-9669	26	127	2	2	NUM
aiua-9669	26	128	division	division	NOUN
aiua-9669	26	129	of	of	ADP
aiua-9669	26	130	pathology	pathology	NOUN
aiua-9669	26	131	,	,	PUNCT
aiua-9669	26	132	school	school	NOUN
aiua-9669	26	133	of	of	ADP
aiua-9669	26	134	medicine	medicine	NOUN
aiua-9669	26	135	,	,	PUNCT
aiua-9669	26	136	università	università	PROPN
aiua-9669	26	137	politecnica	politecnica	PROPN
aiua-9669	26	138	delle	delle	PROPN
aiua-9669	26	139	marche	marche	PROPN
aiua-9669	26	140	,	,	PUNCT
aiua-9669	26	141	ancona	ancona	PROPN
aiua-9669	26	142	,	,	PUNCT
aiua-9669	26	143	italy	italy	PROPN
aiua-9669	26	144	;	;	PUNCT
aiua-9669	26	145	3	3	NUM
aiua-9669	26	146	division	division	NOUN
aiua-9669	26	147	of	of	ADP
aiua-9669	26	148	urology	urology	NOUN
aiua-9669	26	149	,	,	PUNCT
aiua-9669	26	150	azienda	azienda	PROPN
aiua-9669	26	151	ospedaliera	ospedaliera	NOUN
aiua-9669	26	152	marche	marche	PROPN
aiua-9669	26	153	nord	nord	PROPN
aiua-9669	26	154	,	,	PUNCT
aiua-9669	26	155	pesaro	pesaro	PROPN
aiua-9669	26	156	,	,	PUNCT
aiua-9669	26	157	italy	italy	PROPN
aiua-9669	26	158	.	.	PROPN
aiua-9669	27	1	presented	present	VERB
aiua-9669	27	2	at	at	ADP
aiua-9669	27	3	the	the	DET
aiua-9669	27	4	sieun	sieun	PROPN
aiua-9669	27	5	congress	congress	PROPN
aiua-9669	27	6	ancona	ancona	PROPN
aiua-9669	27	7	30	30	NUM
aiua-9669	27	8	november	november	PROPN
aiua-9669	27	9	1	1	NUM
aiua-9669	27	10	december	december	PROPN
aiua-9669	27	11	2020	2020	NUM
aiua-9669	27	12	93archivio	93archivio	NUM
aiua-9669	27	13	italiano	italiano	NOUN
aiua-9669	27	14	di	di	X
aiua-9669	27	15	urologia	urologia	PROPN
aiua-9669	27	16	e	e	PROPN
aiua-9669	27	17	andrologia	andrologia	NOUN
aiua-9669	27	18	2021	2021	NUM
aiua-9669	27	19	;	;	PUNCT
aiua-9669	27	20	93	93	NUM
aiua-9669	27	21	,	,	PUNCT
aiua-9669	27	22	1	1	NUM
aiua-9669	27	23	significant	significant	ADJ
aiua-9669	27	24	prostate	prostate	NOUN
aiua-9669	27	25	cancer	cancer	NOUN
aiua-9669	27	26	with	with	ADP
aiua-9669	27	27	low	low	ADJ
aiua-9669	27	28	psa	psa	PROPN
aiua-9669	27	29	dre	dre	PROPN
aiua-9669	27	30	positivity	positivity	NOUN
aiua-9669	27	31	(	(	PUNCT
aiua-9669	27	32	6	6	NUM
aiua-9669	27	33	)	)	PUNCT
aiua-9669	27	34	.	.	PUNCT
aiua-9669	28	1	overall	overall	ADV
aiua-9669	28	2	,	,	PUNCT
aiua-9669	28	3	the	the	DET
aiua-9669	28	4	incidence	incidence	NOUN
aiua-9669	28	5	of	of	ADP
aiua-9669	28	6	clinically	clinically	ADV
aiua-9669	28	7	significant	significant	ADJ
aiua-9669	28	8	pca	pca	NOUN
aiua-9669	28	9	was	be	AUX
aiua-9669	28	10	higher	high	ADJ
aiua-9669	28	11	in	in	ADP
aiua-9669	28	12	men	man	NOUN
aiua-9669	28	13	with	with	ADP
aiua-9669	28	14	suspicious	suspicious	ADJ
aiua-9669	28	15	dre	dre	NOUN
aiua-9669	28	16	independently	independently	ADV
aiua-9669	28	17	of	of	ADP
aiua-9669	28	18	the	the	DET
aiua-9669	28	19	psa	psa	NOUN
aiua-9669	28	20	level	level	NOUN
aiua-9669	28	21	.	.	PUNCT
aiua-9669	29	1	furthermore	furthermore	ADV
aiua-9669	29	2	,	,	PUNCT
aiua-9669	29	3	the	the	DET
aiua-9669	29	4	results	result	NOUN
aiua-9669	29	5	highlight	highlight	VERB
aiua-9669	29	6	that	that	SCONJ
aiua-9669	29	7	in	in	ADP
aiua-9669	29	8	patients	patient	NOUN
aiua-9669	29	9	with	with	ADP
aiua-9669	29	10	psa	psa	NOUN
aiua-9669	29	11	level	level	NOUN
aiua-9669	29	12	between	between	ADP
aiua-9669	29	13	3	3	NUM
aiua-9669	29	14	-	-	SYM
aiua-9669	29	15	4.9	4.9	NUM
aiua-9669	29	16	ng	ng	NOUN
aiua-9669	29	17	/	/	SYM
aiua-9669	29	18	ml	ml	ADP
aiua-9669	29	19	the	the	DET
aiua-9669	29	20	positivity	positivity	NOUN
aiua-9669	29	21	of	of	ADP
aiua-9669	29	22	dre	dre	PROPN
aiua-9669	29	23	increased	increase	VERB
aiua-9669	29	24	the	the	DET
aiua-9669	29	25	risk	risk	NOUN
aiua-9669	29	26	of	of	ADP
aiua-9669	29	27	clinically	clinically	ADV
aiua-9669	29	28	significant	significant	ADJ
aiua-9669	29	29	pca	pca	NOUN
aiua-9669	29	30	from	from	ADP
aiua-9669	29	31	9.2	9.2	NUM
aiua-9669	29	32	%	%	NOUN
aiua-9669	29	33	to	to	ADP
aiua-9669	29	34	15.7	15.7	NUM
aiua-9669	29	35	%	%	NOUN
aiua-9669	29	36	;	;	PUNCT
aiua-9669	29	37	in	in	ADP
aiua-9669	29	38	patients	patient	NOUN
aiua-9669	29	39	with	with	ADP
aiua-9669	29	40	a	a	DET
aiua-9669	29	41	level	level	NOUN
aiua-9669	29	42	between	between	ADP
aiua-9669	29	43	2	2	NUM
aiua-9669	29	44	-	-	SYM
aiua-9669	29	45	2.9	2.9	NUM
aiua-9669	29	46	from	from	ADP
aiua-9669	29	47	3.5	3.5	NUM
aiua-9669	29	48	%	%	NOUN
aiua-9669	29	49	to	to	ADP
aiua-9669	29	50	6.5	6.5	NUM
aiua-9669	29	51	%	%	NOUN
aiua-9669	29	52	;	;	PUNCT
aiua-9669	29	53	between	between	ADP
aiua-9669	29	54	1	1	NUM
aiua-9669	29	55	-	-	SYM
aiua-9669	29	56	1.9	1.9	NUM
aiua-9669	29	57	ng	ng	PROPN
aiua-9669	29	58	/	/	SYM
aiua-9669	29	59	ml	ml	PROPN
aiua-9669	29	60	from	from	ADP
aiua-9669	29	61	1.2	1.2	NUM
aiua-9669	29	62	%	%	NOUN
aiua-9669	29	63	to	to	ADP
aiua-9669	29	64	2.3	2.3	NUM
aiua-9669	29	65	%	%	NOUN
aiua-9669	29	66	and	and	CCONJ
aiua-9669	29	67	in	in	ADP
aiua-9669	29	68	patients	patient	NOUN
aiua-9669	29	69	with	with	ADP
aiua-9669	29	70	a	a	DET
aiua-9669	29	71	psa	psa	NOUN
aiua-9669	29	72	<	<	X
aiua-9669	29	73	1	1	NUM
aiua-9669	29	74	ng	ng	PROPN
aiua-9669	29	75	/	/	SYM
aiua-9669	29	76	ml	ml	NOUN
aiua-9669	29	77	from	from	ADP
aiua-9669	29	78	0.2	0.2	NUM
aiua-9669	29	79	%	%	NOUN
aiua-9669	29	80	to	to	ADP
aiua-9669	29	81	0.7	0.7	NUM
aiua-9669	29	82	%	%	NOUN
aiua-9669	29	83	.	.	PUNCT
aiua-9669	30	1	positive	positive	ADJ
aiua-9669	30	2	dre	dre	PROPN
aiua-9669	30	3	is	be	AUX
aiua-9669	30	4	correlated	correlate	VERB
aiua-9669	30	5	with	with	ADP
aiua-9669	30	6	cancer	cancer	NOUN
aiua-9669	30	7	even	even	ADV
aiua-9669	30	8	at	at	ADP
aiua-9669	30	9	low	low	ADJ
aiua-9669	30	10	level	level	NOUN
aiua-9669	30	11	of	of	ADP
aiua-9669	30	12	psa	psa	NOUN
aiua-9669	30	13	.	.	PUNCT
aiua-9669	30	14	age	age	NOUN
aiua-9669	30	15	and	and	CCONJ
aiua-9669	30	16	psa	psa	VERB
aiua-9669	30	17	another	another	DET
aiua-9669	30	18	important	important	ADJ
aiua-9669	30	19	aspect	aspect	NOUN
aiua-9669	30	20	is	be	AUX
aiua-9669	30	21	the	the	DET
aiua-9669	30	22	age	age	NOUN
aiua-9669	30	23	of	of	ADP
aiua-9669	30	24	this	this	DET
aiua-9669	30	25	men	man	NOUN
aiua-9669	30	26	and	and	CCONJ
aiua-9669	30	27	how	how	SCONJ
aiua-9669	30	28	the	the	DET
aiua-9669	30	29	time	time	NOUN
aiua-9669	30	30	could	could	AUX
aiua-9669	30	31	influence	influence	VERB
aiua-9669	30	32	the	the	DET
aiua-9669	30	33	probability	probability	NOUN
aiua-9669	30	34	of	of	ADP
aiua-9669	30	35	develop	develop	VERB
aiua-9669	30	36	pca	pca	PROPN
aiua-9669	30	37	.	.	PUNCT
aiua-9669	31	1	in	in	ADP
aiua-9669	31	2	particular	particular	ADJ
aiua-9669	31	3	,	,	PUNCT
aiua-9669	31	4	a	a	DET
aiua-9669	31	5	study	study	NOUN
aiua-9669	31	6	analysed	analyse	VERB
aiua-9669	31	7	the	the	DET
aiua-9669	31	8	probability	probability	NOUN
aiua-9669	31	9	of	of	ADP
aiua-9669	31	10	men	man	NOUN
aiua-9669	31	11	to	to	PART
aiua-9669	31	12	develop	develop	VERB
aiua-9669	31	13	a	a	DET
aiua-9669	31	14	pca	pca	NOUN
aiua-9669	31	15	after	after	ADP
aiua-9669	31	16	25	25	NUM
aiua-9669	31	17	years	year	NOUN
aiua-9669	31	18	from	from	ADP
aiua-9669	31	19	the	the	DET
aiua-9669	31	20	first	first	ADJ
aiua-9669	31	21	assessment	assessment	NOUN
aiua-9669	31	22	(	(	PUNCT
aiua-9669	31	23	7	7	NUM
aiua-9669	31	24	)	)	PUNCT
aiua-9669	31	25	.	.	PUNCT
aiua-9669	32	1	in	in	ADP
aiua-9669	32	2	the	the	DET
aiua-9669	32	3	range	range	NOUN
aiua-9669	32	4	from	from	ADP
aiua-9669	32	5	37	37	NUM
aiua-9669	32	6	to	to	PART
aiua-9669	32	7	42	42	NUM
aiua-9669	32	8	years	year	NOUN
aiua-9669	32	9	of	of	ADP
aiua-9669	32	10	age	age	NOUN
aiua-9669	32	11	with	with	ADP
aiua-9669	32	12	a	a	DET
aiua-9669	32	13	low	low	ADJ
aiua-9669	32	14	psa	psa	NOUN
aiua-9669	32	15	level	level	NOUN
aiua-9669	32	16	the	the	DET
aiua-9669	32	17	risk	risk	NOUN
aiua-9669	32	18	to	to	PART
aiua-9669	32	19	have	have	AUX
aiua-9669	32	20	a	a	DET
aiua-9669	32	21	pca	pca	NOUN
aiua-9669	32	22	metastasis	metastasis	NOUN
aiua-9669	32	23	after	after	SCONJ
aiua-9669	32	24	25	25	NUM
aiua-9669	32	25	years	year	NOUN
aiua-9669	32	26	increased	increase	VERB
aiua-9669	32	27	with	with	ADP
aiua-9669	32	28	concentrations	concentration	NOUN
aiua-9669	32	29	in	in	ADP
aiua-9669	32	30	the	the	DET
aiua-9669	32	31	highest	high	ADJ
aiua-9669	32	32	10th	10th	NOUN
aiua-9669	32	33	of	of	ADP
aiua-9669	32	34	psa	psa	PROPN
aiua-9669	32	35	(	(	PUNCT
aiua-9669	32	36	≥	≥	NUM
aiua-9669	32	37	1.3	1.3	NUM
aiua-9669	32	38	ng	ng	NOUN
aiua-9669	32	39	/	/	SYM
aiua-9669	32	40	ml	ml	PROPN
aiua-9669	32	41	)	)	PUNCT
aiua-9669	32	42	and	and	CCONJ
aiua-9669	32	43	the	the	DET
aiua-9669	32	44	highest	high	ADJ
aiua-9669	32	45	quarter	quarter	NOUN
aiua-9669	32	46	of	of	ADP
aiua-9669	32	47	psa	psa	PROPN
aiua-9669	32	48	(	(	PUNCT
aiua-9669	32	49	≥	≥	NUM
aiua-9669	32	50	0.9	0.9	NUM
aiua-9669	32	51	ng	ng	PROPN
aiua-9669	32	52	/	/	SYM
aiua-9669	32	53	ml	ml	PROPN
aiua-9669	32	54	)	)	PUNCT
aiua-9669	32	55	.	.	PUNCT
aiua-9669	33	1	in	in	ADP
aiua-9669	33	2	the	the	DET
aiua-9669	33	3	range	range	NOUN
aiua-9669	33	4	of	of	ADP
aiua-9669	33	5	45	45	NUM
aiua-9669	33	6	to	to	PART
aiua-9669	33	7	49	49	NUM
aiua-9669	33	8	years	year	NOUN
aiua-9669	33	9	of	of	ADP
aiua-9669	33	10	age	age	NOUN
aiua-9669	33	11	the	the	DET
aiua-9669	33	12	risk	risk	NOUN
aiua-9669	33	13	to	to	PART
aiua-9669	33	14	develop	develop	VERB
aiua-9669	33	15	cancer	cancer	NOUN
aiua-9669	33	16	metastasis	metastasis	NOUN
aiua-9669	33	17	or	or	CCONJ
aiua-9669	33	18	to	to	PART
aiua-9669	33	19	die	die	VERB
aiua-9669	33	20	for	for	ADP
aiua-9669	33	21	pca	pca	PROPN
aiua-9669	33	22	increased	increase	VERB
aiua-9669	33	23	in	in	ADP
aiua-9669	33	24	patients	patient	NOUN
aiua-9669	33	25	with	with	ADP
aiua-9669	33	26	a	a	DET
aiua-9669	33	27	psa	psa	NOUN
aiua-9669	33	28	level	level	NOUN
aiua-9669	33	29	in	in	ADP
aiua-9669	33	30	the	the	DET
aiua-9669	33	31	highest	high	ADJ
aiua-9669	33	32	decile	decile	NOUN
aiua-9669	33	33	(	(	PUNCT
aiua-9669	33	34	≥	≥	NUM
aiua-9669	33	35	1.6	1.6	NUM
aiua-9669	33	36	ng	ng	PROPN
aiua-9669	33	37	/	/	SYM
aiua-9669	33	38	ml	ml	PROPN
aiua-9669	33	39	)	)	PUNCT
aiua-9669	33	40	and	and	CCONJ
aiua-9669	33	41	the	the	DET
aiua-9669	33	42	highest	high	ADJ
aiua-9669	33	43	quarter	quarter	NOUN
aiua-9669	33	44	of	of	ADP
aiua-9669	33	45	psa	psa	VERB
aiua-9669	33	46	≥	≥	PROPN
aiua-9669	33	47	1.1	1.1	NUM
aiua-9669	33	48	ng	ng	PROPN
aiua-9669	33	49	/	/	SYM
aiua-9669	33	50	ml	ml	PROPN
aiua-9669	33	51	.	.	PUNCT
aiua-9669	34	1	psa	psa	VERB
aiua-9669	34	2	velocity	velocity	NOUN
aiua-9669	34	3	lifelong	lifelong	ADJ
aiua-9669	34	4	psa	psa	NOUN
aiua-9669	34	5	trend	trend	NOUN
aiua-9669	34	6	can	can	AUX
aiua-9669	34	7	help	help	VERB
aiua-9669	34	8	for	for	ADP
aiua-9669	34	9	rigorous	rigorous	ADJ
aiua-9669	34	10	follow	follow	NOUN
aiua-9669	34	11	-	-	PUNCT
aiua-9669	34	12	up	up	NOUN
aiua-9669	34	13	of	of	ADP
aiua-9669	34	14	young	young	ADJ
aiua-9669	34	15	men	man	NOUN
aiua-9669	34	16	.	.	PUNCT
aiua-9669	35	1	this	this	DET
aiua-9669	35	2	evaluation	evaluation	NOUN
aiua-9669	35	3	is	be	AUX
aiua-9669	35	4	called	call	VERB
aiua-9669	35	5	psa	psa	NOUN
aiua-9669	35	6	velocity	velocity	NOUN
aiua-9669	35	7	(	(	PUNCT
aiua-9669	35	8	psav	psav	NOUN
aiua-9669	35	9	)	)	PUNCT
aiua-9669	35	10	and	and	CCONJ
aiua-9669	35	11	calculates	calculate	VERB
aiua-9669	35	12	how	how	SCONJ
aiua-9669	35	13	quickly	quickly	ADV
aiua-9669	35	14	psa	psa	VERB
aiua-9669	35	15	rises	rise	NOUN
aiua-9669	35	16	over	over	ADP
aiua-9669	35	17	time	time	NOUN
aiua-9669	35	18	.	.	PUNCT
aiua-9669	36	1	the	the	DET
aiua-9669	36	2	increase	increase	NOUN
aiua-9669	36	3	in	in	ADP
aiua-9669	36	4	psa	psa	NOUN
aiua-9669	36	5	is	be	AUX
aiua-9669	36	6	greater	great	ADJ
aiua-9669	36	7	in	in	ADP
aiua-9669	36	8	patients	patient	NOUN
aiua-9669	36	9	who	who	PRON
aiua-9669	36	10	have	have	VERB
aiua-9669	36	11	a	a	DET
aiua-9669	36	12	higher	high	ADJ
aiua-9669	36	13	risk	risk	NOUN
aiua-9669	36	14	of	of	ADP
aiua-9669	36	15	developing	develop	VERB
aiua-9669	36	16	a	a	DET
aiua-9669	36	17	lethal	lethal	ADJ
aiua-9669	36	18	pca	pca	NOUN
aiua-9669	36	19	(	(	PUNCT
aiua-9669	36	20	8)	8)	NUM
aiua-9669	36	21	.	.	PUNCT
aiua-9669	37	1	there	there	PRON
aiua-9669	37	2	is	be	VERB
aiua-9669	37	3	a	a	DET
aiua-9669	37	4	cut	cut	VERB
aiua-9669	37	5	-	-	PUNCT
aiua-9669	37	6	off	off	ADP
aiua-9669	37	7	level	level	NOUN
aiua-9669	37	8	of	of	ADP
aiua-9669	37	9	0.35	0.35	NUM
aiua-9669	37	10	ng	ng	NOUN
aiua-9669	37	11	/	/	SYM
aiua-9669	37	12	ml	ml	X
aiua-9669	37	13	per	per	ADP
aiua-9669	37	14	year	year	NOUN
aiua-9669	37	15	of	of	ADP
aiua-9669	37	16	psav	psav	NOUN
aiua-9669	37	17	which	which	PRON
aiua-9669	37	18	could	could	AUX
aiua-9669	37	19	individualize	individualize	VERB
aiua-9669	37	20	patients	patient	NOUN
aiua-9669	37	21	with	with	ADP
aiua-9669	37	22	the	the	DET
aiua-9669	37	23	risk	risk	NOUN
aiua-9669	37	24	of	of	ADP
aiua-9669	37	25	death	death	NOUN
aiua-9669	37	26	from	from	ADP
aiua-9669	37	27	pca	pca	PROPN
aiua-9669	37	28	.	.	PUNCT
aiua-9669	38	1	men	man	NOUN
aiua-9669	38	2	having	have	VERB
aiua-9669	38	3	a	a	DET
aiua-9669	38	4	psav	psav	NOUN
aiua-9669	38	5	above	above	ADP
aiua-9669	38	6	0.35	0.35	NUM
aiua-9669	38	7	5	5	NUM
aiua-9669	39	1	to10	to10	PROPN
aiua-9669	39	2	years	year	NOUN
aiua-9669	39	3	before	before	ADP
aiua-9669	39	4	the	the	DET
aiua-9669	39	5	diagnosis	diagnosis	NOUN
aiua-9669	39	6	of	of	ADP
aiua-9669	39	7	the	the	DET
aiua-9669	39	8	tumor	tumor	NOUN
aiua-9669	39	9	,	,	PUNCT
aiua-9669	39	10	had	have	VERB
aiua-9669	39	11	a	a	DET
aiua-9669	39	12	relative	relative	ADJ
aiua-9669	39	13	risk	risk	NOUN
aiua-9669	39	14	of	of	ADP
aiua-9669	39	15	pca	pca	PROPN
aiua-9669	39	16	death	death	NOUN
aiua-9669	39	17	of	of	ADP
aiua-9669	39	18	10.7	10.7	NUM
aiua-9669	39	19	compared	compare	VERB
aiua-9669	39	20	to	to	ADP
aiua-9669	39	21	men	man	NOUN
aiua-9669	39	22	with	with	ADP
aiua-9669	39	23	a	a	DET
aiua-9669	39	24	lower	low	ADJ
aiua-9669	39	25	psav	psav	NOUN
aiua-9669	39	26	.	.	PUNCT
aiua-9669	40	1	these	these	DET
aiua-9669	40	2	results	result	NOUN
aiua-9669	40	3	were	be	AUX
aiua-9669	40	4	confirmed	confirm	VERB
aiua-9669	40	5	extending	extend	VERB
aiua-9669	40	6	the	the	DET
aiua-9669	40	7	retrospective	retrospective	ADJ
aiua-9669	40	8	analysis	analysis	NOUN
aiua-9669	40	9	to	to	ADP
aiua-9669	40	10	15	15	NUM
aiua-9669	40	11	years	year	NOUN
aiua-9669	40	12	,	,	PUNCT
aiua-9669	40	13	with	with	ADP
aiua-9669	40	14	a	a	DET
aiua-9669	40	15	relative	relative	ADJ
aiua-9669	40	16	risk	risk	NOUN
aiua-9669	40	17	of	of	ADP
aiua-9669	40	18	4.7	4.7	NUM
aiua-9669	40	19	.	.	PUNCT
aiua-9669	41	1	moreover	moreover	ADV
aiua-9669	41	2	,	,	PUNCT
aiua-9669	41	3	vickers	vickers	PROPN
aiua-9669	41	4	et	et	PROPN
aiua-9669	41	5	al	al	PROPN
aiua-9669	41	6	.	.	PROPN
aiua-9669	41	7	assessed	assess	VERB
aiua-9669	41	8	that	that	SCONJ
aiua-9669	41	9	only	only	ADV
aiua-9669	41	10	8	8	NUM
aiua-9669	41	11	%	%	NOUN
aiua-9669	41	12	of	of	ADP
aiua-9669	41	13	men	man	NOUN
aiua-9669	41	14	with	with	ADP
aiua-9669	41	15	a	a	DET
aiua-9669	41	16	psa	psa	NOUN
aiua-9669	41	17	<	<	X
aiua-9669	41	18	2.5	2.5	NUM
aiua-9669	41	19	ng	ng	PROPN
aiua-9669	41	20	/	/	SYM
aiua-9669	41	21	ml	ml	PROPN
aiua-9669	41	22	and	and	CCONJ
aiua-9669	41	23	negative	negative	ADJ
aiua-9669	41	24	dre	dre	PROPN
aiua-9669	41	25	had	have	VERB
aiua-9669	41	26	a	a	DET
aiua-9669	41	27	psav	psav	NOUN
aiua-9669	41	28	over	over	ADP
aiua-9669	41	29	0.35	0.35	NUM
aiua-9669	41	30	ng	ng	PROPN
aiua-9669	41	31	/	/	SYM
aiua-9669	41	32	ml	ml	NOUN
aiua-9669	41	33	/	/	SYM
aiua-9669	41	34	year	year	NOUN
aiua-9669	41	35	and	and	CCONJ
aiua-9669	41	36	that	that	SCONJ
aiua-9669	41	37	in	in	ADP
aiua-9669	41	38	this	this	DET
aiua-9669	41	39	population	population	NOUN
aiua-9669	41	40	the	the	DET
aiua-9669	41	41	risk	risk	NOUN
aiua-9669	41	42	to	to	PART
aiua-9669	41	43	develop	develop	VERB
aiua-9669	41	44	a	a	DET
aiua-9669	41	45	pca	pca	NOUN
aiua-9669	41	46	was	be	AUX
aiua-9669	41	47	18	18	NUM
aiua-9669	41	48	%	%	NOUN
aiua-9669	41	49	while	while	SCONJ
aiua-9669	41	50	in	in	ADP
aiua-9669	41	51	a	a	DET
aiua-9669	41	52	population	population	NOUN
aiua-9669	41	53	with	with	ADP
aiua-9669	41	54	a	a	DET
aiua-9669	41	55	lower	low	ADJ
aiua-9669	41	56	psav	psav	NOUN
aiua-9669	41	57	the	the	DET
aiua-9669	41	58	risk	risk	NOUN
aiua-9669	41	59	was	be	AUX
aiua-9669	41	60	14	14	NUM
aiua-9669	41	61	%	%	NOUN
aiua-9669	41	62	(	(	PUNCT
aiua-9669	41	63	9	9	NUM
aiua-9669	41	64	)	)	PUNCT
aiua-9669	41	65	.	.	PUNCT
aiua-9669	42	1	however	however	ADV
aiua-9669	42	2	,	,	PUNCT
aiua-9669	42	3	the	the	DET
aiua-9669	42	4	risk	risk	NOUN
aiua-9669	42	5	of	of	ADP
aiua-9669	42	6	cspca	cspca	NOUN
aiua-9669	42	7	is	be	AUX
aiua-9669	42	8	not	not	PART
aiua-9669	42	9	high	high	ADJ
aiua-9669	42	10	in	in	ADP
aiua-9669	42	11	both	both	CCONJ
aiua-9669	42	12	the	the	DET
aiua-9669	42	13	two	two	NUM
aiua-9669	42	14	groups	group	NOUN
aiua-9669	42	15	.	.	PUNCT
aiua-9669	43	1	these	these	DET
aiua-9669	43	2	considerations	consideration	NOUN
aiua-9669	43	3	can	can	AUX
aiua-9669	43	4	help	help	VERB
aiua-9669	43	5	us	we	PRON
aiua-9669	43	6	to	to	PART
aiua-9669	43	7	better	well	ADV
aiua-9669	43	8	evaluate	evaluate	VERB
aiua-9669	43	9	and	and	CCONJ
aiua-9669	43	10	follow	follow	VERB
aiua-9669	43	11	certain	certain	ADJ
aiua-9669	43	12	young	young	ADJ
aiua-9669	43	13	patients	patient	NOUN
aiua-9669	43	14	with	with	ADP
aiua-9669	43	15	normal	normal	ADJ
aiua-9669	43	16	psa	psa	NOUN
aiua-9669	43	17	and	and	CCONJ
aiua-9669	43	18	negative	negative	ADJ
aiua-9669	43	19	dre	dre	PROPN
aiua-9669	43	20	.	.	PUNCT
aiua-9669	44	1	psa	psa	VERB
aiua-9669	44	2	density	density	NOUN
aiua-9669	44	3	and	and	CCONJ
aiua-9669	44	4	mpmr	mpmr	NOUN
aiua-9669	44	5	psa	psa	VERB
aiua-9669	44	6	densisty	densisty	NOUN
aiua-9669	44	7	(	(	PUNCT
aiua-9669	44	8	psad	psad	ADJ
aiua-9669	44	9	)	)	PUNCT
aiua-9669	44	10	is	be	AUX
aiua-9669	44	11	obtained	obtain	VERB
aiua-9669	44	12	dividing	divide	VERB
aiua-9669	44	13	serum	serum	NOUN
aiua-9669	44	14	total	total	ADJ
aiua-9669	44	15	psa	psa	NOUN
aiua-9669	44	16	value	value	NOUN
aiua-9669	44	17	by	by	ADP
aiua-9669	44	18	prostate	prostate	NOUN
aiua-9669	44	19	volume	volume	NOUN
aiua-9669	44	20	calculated	calculate	VERB
aiua-9669	44	21	by	by	ADP
aiua-9669	44	22	imaging	imaging	NOUN
aiua-9669	44	23	(	(	PUNCT
aiua-9669	44	24	transrectal	transrectal	ADJ
aiua-9669	44	25	ultrasound	ultrasound	NOUN
aiua-9669	44	26	or	or	CCONJ
aiua-9669	44	27	mpmr	mpmr	NOUN
aiua-9669	44	28	)	)	PUNCT
aiua-9669	44	29	(	(	PUNCT
aiua-9669	44	30	10	10	NUM
aiua-9669	44	31	)	)	PUNCT
aiua-9669	44	32	.	.	PUNCT
aiua-9669	45	1	since	since	SCONJ
aiua-9669	45	2	1990	1990	NUM
aiua-9669	45	3	,	,	PUNCT
aiua-9669	45	4	the	the	DET
aiua-9669	45	5	psad	psad	NOUN
aiua-9669	45	6	enhanced	enhance	VERB
aiua-9669	45	7	the	the	DET
aiua-9669	45	8	specificity	specificity	NOUN
aiua-9669	45	9	of	of	ADP
aiua-9669	45	10	cancer	cancer	NOUN
aiua-9669	45	11	detection	detection	NOUN
aiua-9669	45	12	in	in	ADP
aiua-9669	45	13	men	man	NOUN
aiua-9669	45	14	with	with	ADP
aiua-9669	45	15	a	a	DET
aiua-9669	45	16	normal	normal	ADJ
aiua-9669	45	17	dre	dre	NOUN
aiua-9669	45	18	and	and	CCONJ
aiua-9669	45	19	an	an	DET
aiua-9669	45	20	intermediate	intermediate	ADJ
aiua-9669	45	21	psa	psa	NOUN
aiua-9669	45	22	level	level	NOUN
aiua-9669	45	23	(	(	PUNCT
aiua-9669	45	24	11	11	NUM
aiua-9669	45	25	)	)	PUNCT
aiua-9669	45	26	.	.	PUNCT
aiua-9669	46	1	recently	recently	ADV
aiua-9669	46	2	,	,	PUNCT
aiua-9669	46	3	several	several	ADJ
aiua-9669	46	4	studies	study	NOUN
aiua-9669	46	5	demonstrated	demonstrate	VERB
aiua-9669	46	6	that	that	SCONJ
aiua-9669	46	7	the	the	DET
aiua-9669	46	8	combination	combination	NOUN
aiua-9669	46	9	of	of	ADP
aiua-9669	46	10	psad	psad	ADJ
aiua-9669	46	11	and	and	CCONJ
aiua-9669	46	12	mpmri	mpmri	PROPN
aiua-9669	46	13	findings	finding	NOUN
aiua-9669	46	14	allows	allow	VERB
aiua-9669	46	15	the	the	DET
aiua-9669	46	16	better	well	ADJ
aiua-9669	46	17	risk	risk	NOUN
aiua-9669	46	18	stratification	stratification	NOUN
aiua-9669	46	19	in	in	ADP
aiua-9669	46	20	a	a	DET
aiua-9669	46	21	cohort	cohort	NOUN
aiua-9669	46	22	of	of	ADP
aiua-9669	46	23	biopsy	biopsy	NOUN
aiua-9669	46	24	-	-	PUNCT
aiua-9669	46	25	naive	naive	ADJ
aiua-9669	46	26	and	and	CCONJ
aiua-9669	46	27	previously	previously	ADV
aiua-9669	46	28	negative	negative	ADJ
aiua-9669	46	29	biopsy	biopsy	NOUN
aiua-9669	46	30	patients	patient	NOUN
aiua-9669	46	31	.	.	PUNCT
aiua-9669	47	1	pagniez	pagniez	NOUN
aiua-9669	47	2	et	et	PROPN
aiua-9669	47	3	al	al	PROPN
aiua-9669	47	4	.	.	PROPN
aiua-9669	47	5	increased	increase	VERB
aiua-9669	47	6	the	the	DET
aiua-9669	47	7	negative	negative	ADJ
aiua-9669	47	8	predictive	predictive	ADJ
aiua-9669	47	9	value	value	NOUN
aiua-9669	47	10	of	of	ADP
aiua-9669	47	11	mpmri	mpmri	PROPN
aiua-9669	47	12	from	from	ADP
aiua-9669	47	13	84.4	84.4	NUM
aiua-9669	47	14	%	%	NOUN
aiua-9669	47	15	to	to	ADP
aiua-9669	47	16	90.4	90.4	NUM
aiua-9669	47	17	%	%	NOUN
aiua-9669	47	18	by	by	ADP
aiua-9669	47	19	using	use	VERB
aiua-9669	47	20	the	the	DET
aiua-9669	47	21	psad	psad	NOUN
aiua-9669	47	22	with	with	ADP
aiua-9669	47	23	a	a	DET
aiua-9669	47	24	cut	cut	NOUN
aiua-9669	47	25	off	off	ADP
aiua-9669	47	26	of	of	ADP
aiua-9669	47	27	0.15	0.15	NUM
aiua-9669	47	28	ng	ng	NOUN
aiua-9669	47	29	/	/	SYM
aiua-9669	47	30	ml	ml	PROPN
aiua-9669	47	31	/	/	SYM
aiua-9669	47	32	cc	cc	NOUN
aiua-9669	47	33	(	(	PUNCT
aiua-9669	47	34	12	12	NUM
aiua-9669	47	35	)	)	PUNCT
aiua-9669	47	36	.	.	PUNCT
aiua-9669	48	1	even	even	ADV
aiua-9669	48	2	in	in	ADP
aiua-9669	48	3	cancer	cancer	NOUN
aiua-9669	48	4	active	active	ADJ
aiua-9669	48	5	surveillance	surveillance	NOUN
aiua-9669	48	6	an	an	DET
aiua-9669	48	7	emerging	emerge	VERB
aiua-9669	48	8	body	body	NOUN
aiua-9669	48	9	of	of	ADP
aiua-9669	48	10	evidence	evidence	NOUN
aiua-9669	48	11	is	be	AUX
aiua-9669	48	12	growing	grow	VERB
aiua-9669	48	13	.	.	PUNCT
aiua-9669	49	1	roscigno	roscigno	NOUN
aiua-9669	49	2	et	et	PROPN
aiua-9669	49	3	al	al	PROPN
aiua-9669	49	4	.	.	PROPN
aiua-9669	49	5	evaluated	evaluate	VERB
aiua-9669	49	6	the	the	DET
aiua-9669	49	7	role	role	NOUN
aiua-9669	49	8	of	of	ADP
aiua-9669	49	9	psad	psad	ADJ
aiua-9669	49	10	in	in	ADP
aiua-9669	49	11	identifying	identify	VERB
aiua-9669	49	12	patients	patient	NOUN
aiua-9669	49	13	presenting	present	VERB
aiua-9669	49	14	a	a	DET
aiua-9669	49	15	different	different	ADJ
aiua-9669	49	16	risk	risk	NOUN
aiua-9669	49	17	of	of	ADP
aiua-9669	49	18	reclassification	reclassification	NOUN
aiua-9669	49	19	at	at	ADP
aiua-9669	49	20	confirmatory	confirmatory	NOUN
aiua-9669	49	21	or	or	CCONJ
aiua-9669	49	22	follow	follow	VERB
aiua-9669	49	23	-	-	PUNCT
aiua-9669	49	24	up	up	ADP
aiua-9669	49	25	biopsy	biopsy	NOUN
aiua-9669	49	26	:	:	PUNCT
aiua-9669	49	27	higher	high	ADJ
aiua-9669	49	28	psad	psad	ADJ
aiua-9669	49	29	was	be	AUX
aiua-9669	49	30	associated	associate	VERB
aiua-9669	49	31	with	with	ADP
aiua-9669	49	32	higher	high	ADJ
aiua-9669	49	33	risk	risk	NOUN
aiua-9669	49	34	of	of	ADP
aiua-9669	49	35	reclassification	reclassification	NOUN
aiua-9669	49	36	for	for	ADP
aiua-9669	49	37	all	all	DET
aiua-9669	49	38	pi	pi	ADJ
aiua-9669	49	39	-	-	PUNCT
aiua-9669	49	40	rads	rad	NOUN
aiua-9669	49	41	lesions	lesion	NOUN
aiua-9669	49	42	(	(	PUNCT
aiua-9669	49	43	13	13	NUM
aiua-9669	49	44	)	)	PUNCT
aiua-9669	49	45	.	.	PUNCT
aiua-9669	50	1	psad	psad	PROPN
aiua-9669	50	2	was	be	AUX
aiua-9669	50	3	an	an	DET
aiua-9669	50	4	independent	independent	ADJ
aiua-9669	50	5	predictor	predictor	NOUN
aiua-9669	50	6	of	of	ADP
aiua-9669	50	7	reclassification	reclassification	NOUN
aiua-9669	50	8	using	use	VERB
aiua-9669	50	9	0.20	0.20	NUM
aiua-9669	50	10	as	as	ADP
aiua-9669	50	11	cut	cut	NOUN
aiua-9669	50	12	-	-	PUNCT
aiua-9669	50	13	off	off	NOUN
aiua-9669	50	14	.	.	PUNCT
aiua-9669	51	1	furthermore	furthermore	ADV
aiua-9669	51	2	,	,	PUNCT
aiua-9669	51	3	bhat	bhat	PROPN
aiua-9669	51	4	et	et	PROPN
aiua-9669	51	5	al	al	PROPN
aiua-9669	51	6	.	.	PROPN
aiua-9669	51	7	showed	show	VERB
aiua-9669	51	8	that	that	SCONJ
aiua-9669	51	9	none	none	NOUN
aiua-9669	51	10	of	of	ADP
aiua-9669	51	11	the	the	DET
aiua-9669	51	12	patients	patient	NOUN
aiua-9669	51	13	in	in	ADP
aiua-9669	51	14	active	active	ADJ
aiua-9669	51	15	surveillance	surveillance	NOUN
aiua-9669	51	16	presented	present	VERB
aiua-9669	51	17	a	a	DET
aiua-9669	51	18	risk	risk	NOUN
aiua-9669	51	19	of	of	ADP
aiua-9669	51	20	disease	disease	NOUN
aiua-9669	51	21	reclassification	reclassification	NOUN
aiua-9669	51	22	in	in	ADP
aiua-9669	51	23	case	case	NOUN
aiua-9669	51	24	of	of	ADP
aiua-9669	51	25	pi	pi	NOUN
aiua-9669	51	26	-	-	PUNCT
aiua-9669	51	27	rads	rad	NOUN
aiua-9669	51	28	scores	score	NOUN
aiua-9669	51	29	of	of	ADP
aiua-9669	51	30	1	1	NUM
aiua-9669	51	31	to	to	PART
aiua-9669	51	32	3	3	NUM
aiua-9669	51	33	and	and	CCONJ
aiua-9669	51	34	psad	psad	VERB
aiua-9669	51	35	0.15	0.15	NUM
aiua-9669	51	36	ng	ng	NOUN
aiua-9669	51	37	/	/	SYM
aiua-9669	51	38	ml	ml	PROPN
aiua-9669	51	39	/	/	SYM
aiua-9669	51	40	cc	cc	PROPN
aiua-9669	51	41	as	as	ADP
aiua-9669	51	42	upper	upper	ADJ
aiua-9669	51	43	limit	limit	NOUN
aiua-9669	51	44	(	(	PUNCT
aiua-9669	51	45	14	14	NUM
aiua-9669	51	46	)	)	PUNCT
aiua-9669	51	47	.	.	PUNCT
aiua-9669	52	1	psad	psad	PROPN
aiua-9669	52	2	might	might	AUX
aiua-9669	52	3	spare	spare	VERB
aiua-9669	52	4	some	some	DET
aiua-9669	52	5	men	man	NOUN
aiua-9669	52	6	from	from	ADP
aiua-9669	52	7	the	the	DET
aiua-9669	52	8	morbidity	morbidity	NOUN
aiua-9669	52	9	associated	associate	VERB
aiua-9669	52	10	with	with	ADP
aiua-9669	52	11	a	a	DET
aiua-9669	52	12	prostate	prostate	NOUN
aiua-9669	52	13	biopsy	biopsy	NOUN
aiua-9669	52	14	and	and	CCONJ
aiua-9669	52	15	diagnosis	diagnosis	NOUN
aiua-9669	52	16	of	of	ADP
aiua-9669	52	17	low	low	ADJ
aiua-9669	52	18	-	-	PUNCT
aiua-9669	52	19	grade	grade	NOUN
aiua-9669	52	20	prostate	prostate	NOUN
aiua-9669	52	21	cancer	cancer	NOUN
aiua-9669	52	22	,	,	PUNCT
aiua-9669	52	23	therefore	therefore	ADV
aiua-9669	52	24	should	should	AUX
aiua-9669	52	25	be	be	AUX
aiua-9669	52	26	included	include	VERB
aiua-9669	52	27	in	in	ADP
aiua-9669	52	28	the	the	DET
aiua-9669	52	29	flow	flow	NOUN
aiua-9669	52	30	-	-	PUNCT
aiua-9669	52	31	chart	chart	NOUN
aiua-9669	52	32	of	of	ADP
aiua-9669	52	33	prostate	prostate	NOUN
aiua-9669	52	34	cancer	cancer	NOUN
aiua-9669	52	35	diagnosis	diagnosis	NOUN
aiua-9669	52	36	.	.	PUNCT
aiua-9669	53	1	low	low	ADJ
aiua-9669	53	2	or	or	CCONJ
aiua-9669	53	3	normal	normal	ADJ
aiua-9669	53	4	psa	psa	NOUN
aiua-9669	53	5	and	and	CCONJ
aiua-9669	53	6	mpmr	mpmr	NOUN
aiua-9669	53	7	the	the	DET
aiua-9669	53	8	negative	negative	ADJ
aiua-9669	53	9	predictive	predictive	ADJ
aiua-9669	53	10	value	value	NOUN
aiua-9669	53	11	(	(	PUNCT
aiua-9669	53	12	npv	npv	NOUN
aiua-9669	53	13	)	)	PUNCT
aiua-9669	53	14	of	of	ADP
aiua-9669	53	15	mpmr	mpmr	NOUN
aiua-9669	53	16	is	be	AUX
aiua-9669	53	17	variable	variable	ADJ
aiua-9669	53	18	:	:	PUNCT
aiua-9669	53	19	in	in	ADP
aiua-9669	53	20	literature	literature	NOUN
aiua-9669	53	21	there	there	PRON
aiua-9669	53	22	are	be	VERB
aiua-9669	53	23	many	many	ADJ
aiua-9669	53	24	studies	study	NOUN
aiua-9669	53	25	that	that	PRON
aiua-9669	53	26	report	report	VERB
aiua-9669	53	27	a	a	DET
aiua-9669	53	28	npv	npv	NOUN
aiua-9669	53	29	more	more	ADJ
aiua-9669	53	30	than	than	ADP
aiua-9669	53	31	80	80	NUM
aiua-9669	53	32	%	%	NOUN
aiua-9669	53	33	and	and	CCONJ
aiua-9669	53	34	others	other	NOUN
aiua-9669	53	35	that	that	PRON
aiua-9669	53	36	set	set	VERB
aiua-9669	53	37	this	this	DET
aiua-9669	53	38	value	value	NOUN
aiua-9669	53	39	around	around	ADV
aiua-9669	53	40	60	60	NUM
aiua-9669	53	41	%	%	NOUN
aiua-9669	53	42	(	(	PUNCT
aiua-9669	53	43	15	15	NUM
aiua-9669	53	44	)	)	PUNCT
aiua-9669	53	45	.	.	PUNCT
aiua-9669	54	1	the	the	DET
aiua-9669	54	2	main	main	ADJ
aiua-9669	54	3	variable	variable	NOUN
aiua-9669	54	4	to	to	PART
aiua-9669	54	5	set	set	VERB
aiua-9669	54	6	npv	npv	NOUN
aiua-9669	54	7	is	be	AUX
aiua-9669	54	8	the	the	DET
aiua-9669	54	9	type	type	NOUN
aiua-9669	54	10	of	of	ADP
aiua-9669	54	11	population	population	NOUN
aiua-9669	54	12	taken	take	VERB
aiua-9669	54	13	into	into	ADP
aiua-9669	54	14	account	account	NOUN
aiua-9669	54	15	for	for	ADP
aiua-9669	54	16	the	the	DET
aiua-9669	54	17	analysis	analysis	NOUN
aiua-9669	54	18	.	.	PUNCT
aiua-9669	55	1	if	if	SCONJ
aiua-9669	55	2	we	we	PRON
aiua-9669	55	3	considered	consider	VERB
aiua-9669	55	4	a	a	DET
aiua-9669	55	5	population	population	NOUN
aiua-9669	55	6	with	with	ADP
aiua-9669	55	7	a	a	DET
aiua-9669	55	8	low	low	ADJ
aiua-9669	55	9	risk	risk	NOUN
aiua-9669	55	10	of	of	ADP
aiua-9669	55	11	pca	pca	NOUN
aiua-9669	55	12	the	the	DET
aiua-9669	55	13	nvp	nvp	PROPN
aiua-9669	55	14	is	be	AUX
aiua-9669	55	15	50	50	NUM
aiua-9669	55	16	%	%	NOUN
aiua-9669	55	17	,	,	PUNCT
aiua-9669	55	18	this	this	PRON
aiua-9669	55	19	means	mean	VERB
aiua-9669	55	20	that	that	SCONJ
aiua-9669	55	21	a	a	DET
aiua-9669	55	22	negative	negative	ADJ
aiua-9669	55	23	mpmri	mpmri	NOUN
aiua-9669	55	24	in	in	ADP
aiua-9669	55	25	a	a	DET
aiua-9669	55	26	patient	patient	NOUN
aiua-9669	55	27	halves	halve	VERB
aiua-9669	55	28	the	the	DET
aiua-9669	55	29	risk	risk	NOUN
aiua-9669	55	30	of	of	ADP
aiua-9669	55	31	pca	pca	PROPN
aiua-9669	55	32	,	,	PUNCT
aiua-9669	55	33	but	but	CCONJ
aiua-9669	55	34	a	a	DET
aiua-9669	55	35	very	very	ADV
aiua-9669	55	36	high	high	ADJ
aiua-9669	55	37	residual	residual	ADJ
aiua-9669	55	38	risk	risk	NOUN
aiua-9669	55	39	remains	remain	VERB
aiua-9669	55	40	.	.	PUNCT
aiua-9669	56	1	on	on	ADP
aiua-9669	56	2	the	the	DET
aiua-9669	56	3	other	other	ADJ
aiua-9669	56	4	hand	hand	NOUN
aiua-9669	56	5	,	,	PUNCT
aiua-9669	56	6	in	in	ADP
aiua-9669	56	7	a	a	DET
aiua-9669	56	8	population	population	NOUN
aiua-9669	56	9	with	with	ADP
aiua-9669	56	10	a	a	DET
aiua-9669	56	11	high	high	ADJ
aiua-9669	56	12	risk	risk	NOUN
aiua-9669	56	13	of	of	ADP
aiua-9669	56	14	pca	pca	PROPN
aiua-9669	56	15	,	,	PUNCT
aiua-9669	56	16	the	the	DET
aiua-9669	56	17	mpmri	mpmri	PROPN
aiua-9669	56	18	can	can	AUX
aiua-9669	56	19	even	even	ADV
aiua-9669	56	20	reach	reach	VERB
aiua-9669	56	21	a	a	DET
aiua-9669	56	22	npv	npv	NOUN
aiua-9669	56	23	of	of	ADP
aiua-9669	56	24	88	88	NUM
aiua-9669	56	25	%	%	NOUN
aiua-9669	56	26	.	.	PUNCT
aiua-9669	57	1	the	the	DET
aiua-9669	57	2	patient	patient	NOUN
aiua-9669	57	3	's	's	PART
aiua-9669	57	4	baseline	baseline	ADJ
aiua-9669	57	5	risk	risk	NOUN
aiua-9669	57	6	must	must	AUX
aiua-9669	57	7	be	be	AUX
aiua-9669	57	8	valuated	valuate	VERB
aiua-9669	57	9	and	and	CCONJ
aiua-9669	57	10	there	there	PRON
aiua-9669	57	11	are	be	VERB
aiua-9669	57	12	calculators	calculator	NOUN
aiua-9669	57	13	used	use	VERB
aiua-9669	57	14	to	to	PART
aiua-9669	57	15	determine	determine	VERB
aiua-9669	57	16	the	the	DET
aiua-9669	57	17	patient	patient	NOUN
aiua-9669	57	18	's	's	PART
aiua-9669	57	19	risk	risk	NOUN
aiua-9669	57	20	(	(	PUNCT
aiua-9669	57	21	by	by	ADP
aiua-9669	57	22	example	example	NOUN
aiua-9669	57	23	,	,	PUNCT
aiua-9669	57	24	prostate	prostate	NOUN
aiua-9669	57	25	cancer	cancer	NOUN
aiua-9669	57	26	risk	risk	NOUN
aiua-9669	57	27	calculators	calculator	NOUN
aiua-9669	57	28	)	)	PUNCT
aiua-9669	57	29	(	(	PUNCT
aiua-9669	57	30	16	16	NUM
aiua-9669	57	31	)	)	PUNCT
aiua-9669	57	32	.	.	PUNCT
aiua-9669	58	1	long	long	ADJ
aiua-9669	58	2	-	-	PUNCT
aiua-9669	58	3	term	term	NOUN
aiua-9669	58	4	npv	npv	NOUN
aiua-9669	58	5	has	have	AUX
aiua-9669	58	6	been	be	AUX
aiua-9669	58	7	addressed	address	VERB
aiua-9669	58	8	in	in	ADP
aiua-9669	58	9	a	a	DET
aiua-9669	58	10	recent	recent	ADJ
aiua-9669	58	11	study	study	NOUN
aiua-9669	58	12	:	:	PUNCT
aiua-9669	58	13	84	84	NUM
aiua-9669	58	14	%	%	NOUN
aiua-9669	58	15	of	of	ADP
aiua-9669	58	16	patients	patient	NOUN
aiua-9669	58	17	with	with	ADP
aiua-9669	58	18	negative	negative	ADJ
aiua-9669	58	19	mpmr	mpmr	NOUN
aiua-9669	58	20	were	be	AUX
aiua-9669	58	21	free	free	ADJ
aiua-9669	58	22	of	of	ADP
aiua-9669	58	23	cancer	cancer	NOUN
aiua-9669	58	24	even	even	ADV
aiua-9669	58	25	after	after	ADP
aiua-9669	58	26	4	4	NUM
aiua-9669	58	27	years	year	NOUN
aiua-9669	58	28	of	of	ADP
aiua-9669	58	29	follow	follow	NOUN
aiua-9669	58	30	-	-	PUNCT
aiua-9669	58	31	up	up	NOUN
aiua-9669	58	32	,	,	PUNCT
aiua-9669	58	33	whereas	whereas	SCONJ
aiua-9669	58	34	16	16	NUM
aiua-9669	58	35	%	%	NOUN
aiua-9669	58	36	developed	develop	VERB
aiua-9669	58	37	pca	pca	NOUN
aiua-9669	58	38	although	although	SCONJ
aiua-9669	58	39	only	only	ADV
aiua-9669	58	40	4	4	NUM
aiua-9669	58	41	%	%	NOUN
aiua-9669	58	42	developed	develop	VERB
aiua-9669	58	43	a	a	DET
aiua-9669	58	44	cspca	cspca	NOUN
aiua-9669	58	45	(	(	PUNCT
aiua-9669	58	46	17	17	NUM
aiua-9669	58	47	)	)	PUNCT
aiua-9669	58	48	.	.	PUNCT
aiua-9669	59	1	characterization	characterization	NOUN
aiua-9669	59	2	of	of	ADP
aiua-9669	59	3	the	the	DET
aiua-9669	59	4	familiar	familiar	ADJ
aiua-9669	59	5	history	history	NOUN
aiua-9669	59	6	and	and	CCONJ
aiua-9669	59	7	genetic	genetic	ADJ
aiua-9669	59	8	there	there	PRON
aiua-9669	59	9	are	be	VERB
aiua-9669	59	10	men	man	NOUN
aiua-9669	59	11	with	with	ADP
aiua-9669	59	12	low	low	ADJ
aiua-9669	59	13	psa	psa	NOUN
aiua-9669	59	14	level	level	NOUN
aiua-9669	59	15	,	,	PUNCT
aiua-9669	59	16	negative	negative	ADJ
aiua-9669	59	17	mpmri	mpmri	PROPN
aiua-9669	59	18	and	and	CCONJ
aiua-9669	59	19	unpalpable	unpalpable	ADJ
aiua-9669	59	20	disease	disease	NOUN
aiua-9669	59	21	with	with	ADP
aiua-9669	59	22	pca	pca	PROPN
aiua-9669	59	23	(	(	PUNCT
aiua-9669	59	24	18	18	NUM
aiua-9669	59	25	)	)	PUNCT
aiua-9669	59	26	.	.	PUNCT
aiua-9669	60	1	these	these	DET
aiua-9669	60	2	men	man	NOUN
aiua-9669	60	3	have	have	VERB
aiua-9669	60	4	usually	usually	ADV
aiua-9669	60	5	familiar	familiar	ADJ
aiua-9669	60	6	history	history	NOUN
aiua-9669	60	7	of	of	ADP
aiua-9669	60	8	pca	pca	PROPN
aiua-9669	60	9	and	and	CCONJ
aiua-9669	60	10	undergo	undergo	VERB
aiua-9669	60	11	premature	premature	ADJ
aiua-9669	60	12	serial	serial	ADJ
aiua-9669	60	13	psa	psa	NOUN
aiua-9669	60	14	exams	exam	NOUN
aiua-9669	60	15	,	,	PUNCT
aiua-9669	60	16	clinic	clinic	NOUN
aiua-9669	60	17	visits	visit	NOUN
aiua-9669	60	18	,	,	PUNCT
aiua-9669	60	19	and	and	CCONJ
aiua-9669	60	20	rectal	rectal	ADJ
aiua-9669	60	21	examination	examination	NOUN
aiua-9669	60	22	.	.	PUNCT
aiua-9669	61	1	the	the	DET
aiua-9669	61	2	genetic	genetic	ADJ
aiua-9669	61	3	tests	test	NOUN
aiua-9669	61	4	are	be	AUX
aiua-9669	61	5	suggested	suggest	VERB
aiua-9669	61	6	in	in	ADP
aiua-9669	61	7	men	man	NOUN
aiua-9669	61	8	with	with	ADP
aiua-9669	61	9	one	one	NUM
aiua-9669	61	10	brother	brother	NOUN
aiua-9669	61	11	or	or	CCONJ
aiua-9669	61	12	father	father	NOUN
aiua-9669	61	13	or	or	CCONJ
aiua-9669	61	14	two	two	NUM
aiua-9669	61	15	or	or	CCONJ
aiua-9669	61	16	more	more	ADJ
aiua-9669	61	17	male	male	ADJ
aiua-9669	61	18	relatives	relative	NOUN
aiua-9669	61	19	with	with	ADP
aiua-9669	61	20	one	one	NUM
aiua-9669	61	21	of	of	ADP
aiua-9669	61	22	the	the	DET
aiua-9669	61	23	following	following	NOUN
aiua-9669	61	24	:	:	PUNCT
aiua-9669	61	25	diagnosed	diagnose	VERB
aiua-9669	61	26	with	with	ADP
aiua-9669	61	27	pca	pca	PROPN
aiua-9669	61	28	at	at	ADP
aiua-9669	61	29	age	age	NOUN
aiua-9669	61	30	less	less	ADJ
aiua-9669	61	31	than	than	ADP
aiua-9669	61	32	60	60	NUM
aiua-9669	61	33	years	year	NOUN
aiua-9669	61	34	(	(	PUNCT
aiua-9669	61	35	recommended	recommend	VERB
aiua-9669	61	36	)	)	PUNCT
aiua-9669	61	37	,	,	PUNCT
aiua-9669	61	38	any	any	PRON
aiua-9669	61	39	of	of	ADP
aiua-9669	61	40	whom	whom	PRON
aiua-9669	61	41	died	die	VERB
aiua-9669	61	42	of	of	ADP
aiua-9669	61	43	pca	pca	NOUN
aiua-9669	61	44	(	(	PUNCT
aiua-9669	61	45	recommended	recommend	VERB
aiua-9669	61	46	)	)	PUNCT
aiua-9669	61	47	,	,	PUNCT
aiua-9669	61	48	any	any	PRON
aiua-9669	61	49	of	of	ADP
aiua-9669	61	50	whom	whom	PRON
aiua-9669	61	51	had	have	VERB
aiua-9669	61	52	metastatic	metastatic	ADJ
aiua-9669	61	53	pca	pca	NOUN
aiua-9669	61	54	(	(	PUNCT
aiua-9669	61	55	recommend	recommend	VERB
aiua-9669	61	56	)	)	PUNCT
aiua-9669	61	57	(	(	PUNCT
aiua-9669	61	58	19	19	NUM
aiua-9669	61	59	)	)	PUNCT
aiua-9669	61	60	.	.	PUNCT
aiua-9669	62	1	genetic	genetic	ADJ
aiua-9669	62	2	testing	testing	NOUN
aiua-9669	62	3	should	should	AUX
aiua-9669	62	4	be	be	AUX
aiua-9669	62	5	considered	consider	VERB
aiua-9669	62	6	in	in	ADP
aiua-9669	62	7	men	man	NOUN
aiua-9669	62	8	with	with	ADP
aiua-9669	62	9	family	family	NOUN
aiua-9669	62	10	history	history	NOUN
aiua-9669	62	11	of	of	ADP
aiua-9669	62	12	2	2	NUM
aiua-9669	62	13	or	or	CCONJ
aiua-9669	62	14	more	more	ADJ
aiua-9669	62	15	cancers	cancer	NOUN
aiua-9669	62	16	in	in	ADP
aiua-9669	62	17	hereditary	hereditary	ADJ
aiua-9669	62	18	breast	breast	NOUN
aiua-9669	62	19	and	and	CCONJ
aiua-9669	62	20	ovarian	ovarian	ADJ
aiua-9669	62	21	cancer	cancer	NOUN
aiua-9669	62	22	,	,	PUNCT
aiua-9669	62	23	or	or	CCONJ
aiua-9669	62	24	lynch	lynch	PROPN
aiua-9669	62	25	syndrome	syndrome	PROPN
aiua-9669	62	26	in	in	ADP
aiua-9669	62	27	any	any	DET
aiua-9669	62	28	relatives	relative	NOUN
aiua-9669	62	29	on	on	ADP
aiua-9669	62	30	the	the	DET
aiua-9669	62	31	same	same	ADJ
aiua-9669	62	32	of	of	ADP
aiua-9669	62	33	the	the	DET
aiua-9669	62	34	family	family	NOUN
aiua-9669	62	35	(	(	PUNCT
aiua-9669	62	36	especially	especially	ADV
aiua-9669	62	37	if	if	SCONJ
aiua-9669	62	38	diagnosed	diagnose	VERB
aiua-9669	62	39	at	at	ADP
aiua-9669	62	40	age	age	NOUN
aiua-9669	62	41	<	<	X
aiua-9669	62	42	50	50	NUM
aiua-9669	62	43	years	year	NOUN
aiua-9669	62	44	)	)	PUNCT
aiua-9669	62	45	(	(	PUNCT
aiua-9669	62	46	20	20	NUM
aiua-9669	62	47	)	)	PUNCT
aiua-9669	62	48	.	.	PUNCT
aiua-9669	63	1	the	the	DET
aiua-9669	63	2	brca2	brca2	PROPN
aiua-9669	63	3	mutation	mutation	NOUN
aiua-9669	63	4	leads	lead	VERB
aiua-9669	63	5	to	to	ADP
aiua-9669	63	6	a	a	DET
aiua-9669	63	7	three	three	NUM
aiua-9669	63	8	times	time	NOUN
aiua-9669	63	9	greater	great	ADJ
aiua-9669	63	10	risk	risk	NOUN
aiua-9669	63	11	of	of	ADP
aiua-9669	63	12	death	death	NOUN
aiua-9669	63	13	(	(	PUNCT
aiua-9669	63	14	21	21	NUM
aiua-9669	63	15	)	)	PUNCT
aiua-9669	63	16	.	.	PUNCT
aiua-9669	64	1	there	there	PRON
aiua-9669	64	2	are	be	VERB
aiua-9669	64	3	many	many	ADJ
aiua-9669	64	4	other	other	ADJ
aiua-9669	64	5	important	important	ADJ
aiua-9669	64	6	aspects	aspect	NOUN
aiua-9669	64	7	of	of	ADP
aiua-9669	64	8	genetics	genetic	NOUN
aiua-9669	64	9	that	that	PRON
aiua-9669	64	10	have	have	AUX
aiua-9669	64	11	been	be	AUX
aiua-9669	64	12	identified	identify	VERB
aiua-9669	64	13	over	over	ADP
aiua-9669	64	14	the	the	DET
aiua-9669	64	15	years	year	NOUN
aiua-9669	64	16	by	by	ADP
aiua-9669	64	17	numerous	numerous	ADJ
aiua-9669	64	18	studies	study	NOUN
aiua-9669	64	19	.	.	PUNCT
aiua-9669	65	1	first	first	ADV
aiua-9669	65	2	,	,	PUNCT
aiua-9669	65	3	carriers	carrier	NOUN
aiua-9669	65	4	of	of	ADP
aiua-9669	65	5	brca1	brca1	PROPN
aiua-9669	65	6	and	and	CCONJ
aiua-9669	65	7	mostly	mostly	ADV
aiua-9669	65	8	brca2	brca2	NOUN
aiua-9669	65	9	mutations	mutation	NOUN
aiua-9669	65	10	are	be	AUX
aiua-9669	65	11	at	at	ADP
aiua-9669	65	12	high	high	ADJ
aiua-9669	65	13	risk	risk	NOUN
aiua-9669	65	14	of	of	ADP
aiua-9669	65	15	developing	develop	VERB
aiua-9669	65	16	pca	pca	PROPN
aiua-9669	65	17	.	.	PUNCT
aiua-9669	66	1	germline	germline	NOUN
aiua-9669	66	2	mutations	mutation	NOUN
aiua-9669	66	3	in	in	ADP
aiua-9669	66	4	the	the	DET
aiua-9669	66	5	brca	brca	PROPN
aiua-9669	66	6	genes	gene	NOUN
aiua-9669	66	7	,	,	PUNCT
aiua-9669	66	8	mainly	mainly	ADV
aiua-9669	66	9	in	in	ADP
aiua-9669	66	10	brca2	brca2	PROPN
aiua-9669	66	11	,	,	PUNCT
aiua-9669	66	12	also	also	ADV
aiua-9669	66	13	have	have	VERB
aiua-9669	66	14	implications	implication	NOUN
aiua-9669	66	15	in	in	ADP
aiua-9669	66	16	the	the	DET
aiua-9669	66	17	prognosis	prognosis	NOUN
aiua-9669	66	18	and	and	CCONJ
aiua-9669	66	19	management	management	NOUN
aiua-9669	66	20	of	of	ADP
aiua-9669	66	21	the	the	DET
aiua-9669	66	22	disease	disease	NOUN
aiua-9669	66	23	,	,	PUNCT
aiua-9669	66	24	with	with	ADP
aiua-9669	66	25	meditable	meditable	ADJ
aiua-9669	66	26	1	1	NUM
aiua-9669	66	27	.	.	PUNCT
aiua-9669	66	28	correlation	correlation	NOUN
aiua-9669	66	29	of	of	ADP
aiua-9669	66	30	psa	psa	NOUN
aiua-9669	66	31	level	level	NOUN
aiua-9669	66	32	,	,	PUNCT
aiua-9669	66	33	prostate	prostate	NOUN
aiua-9669	66	34	cancer	cancer	NOUN
aiua-9669	66	35	(	(	PUNCT
aiua-9669	66	36	pca	pca	PROPN
aiua-9669	66	37	)	)	PUNCT
aiua-9669	66	38	and	and	CCONJ
aiua-9669	66	39	high	high	ADJ
aiua-9669	66	40	grade	grade	NOUN
aiua-9669	66	41	pca	pca	PROPN
aiua-9669	66	42	(	(	PUNCT
aiua-9669	66	43	gleason	gleason	PROPN
aiua-9669	66	44	score	score	VERB
aiua-9669	66	45	≥	≥	PROPN
aiua-9669	66	46	7	7	NUM
aiua-9669	66	47	)	)	PUNCT
aiua-9669	66	48	(	(	PUNCT
aiua-9669	66	49	from	from	ADP
aiua-9669	66	50	thompson	thompson	PROPN
aiua-9669	66	51	et	et	PROPN
aiua-9669	66	52	al	al	PROPN
aiua-9669	66	53	.	.	PROPN
aiua-9669	66	54	2004	2004	NUM
aiua-9669	66	55	)	)	PUNCT
aiua-9669	66	56	.	.	PUNCT
aiua-9669	67	1	psa	psa	PROPN
aiua-9669	67	2	level	level	PROPN
aiua-9669	67	3	ng	ng	PROPN
aiua-9669	67	4	/	/	SYM
aiua-9669	67	5	ml	ml	PROPN
aiua-9669	67	6	3.1	3.1	NUM
aiua-9669	67	7	-	-	SYM
aiua-9669	67	8	4	4	NUM
aiua-9669	67	9	2.1	2.1	NUM
aiua-9669	67	10	-	-	SYM
aiua-9669	67	11	3.0	3.0	NUM
aiua-9669	67	12	1.1	1.1	NUM
aiua-9669	67	13	-	-	SYM
aiua-9669	67	14	2.0	2.0	NUM
aiua-9669	67	15	0.6	0.6	NUM
aiua-9669	67	16	-	-	SYM
aiua-9669	67	17	1.0	1.0	NUM
aiua-9669	67	18	<	<	SYM
aiua-9669	67	19	0.5	0.5	NUM
aiua-9669	67	20	men	man	NOUN
aiua-9669	67	21	with	with	ADP
aiua-9669	67	22	pca	pca	PROPN
aiua-9669	67	23	(	(	PUNCT
aiua-9669	67	24	n	n	NOUN
aiua-9669	67	25	=	=	SYM
aiua-9669	67	26	449	449	NUM
aiua-9669	67	27	)	)	PUNCT
aiua-9669	67	28	26.9	26.9	NUM
aiua-9669	67	29	%	%	NOUN
aiua-9669	67	30	23.9	23.9	NUM
aiua-9669	67	31	%	%	NOUN
aiua-9669	67	32	17.0	17.0	NUM
aiua-9669	67	33	%	%	NOUN
aiua-9669	67	34	10.1	10.1	NUM
aiua-9669	67	35	%	%	NOUN
aiua-9669	67	36	6.6	6.6	NUM
aiua-9669	67	37	%	%	NOUN
aiua-9669	67	38	men	man	NOUN
aiua-9669	67	39	with	with	ADP
aiua-9669	67	40	high	high	ADJ
aiua-9669	67	41	grade	grade	NOUN
aiua-9669	67	42	pca	pca	NOUN
aiua-9669	67	43	(	(	PUNCT
aiua-9669	67	44	gleason	gleason	PROPN
aiua-9669	67	45	score	score	VERB
aiua-9669	67	46	≥	≥	PROPN
aiua-9669	67	47	7	7	NUM
aiua-9669	67	48	)	)	PUNCT
aiua-9669	67	49	(	(	PUNCT
aiua-9669	67	50	n	n	NOUN
aiua-9669	67	51	=	=	SYM
aiua-9669	67	52	67	67	NUM
aiua-9669	67	53	)	)	PUNCT
aiua-9669	67	54	25	25	NUM
aiua-9669	67	55	%	%	NOUN
aiua-9669	67	56	19.1	19.1	NUM
aiua-9669	67	57	%	%	NOUN
aiua-9669	67	58	11.8	11.8	NUM
aiua-9669	67	59	%	%	NOUN
aiua-9669	67	60	10	10	NUM
aiua-9669	67	61	%	%	NOUN
aiua-9669	67	62	12.5	12.5	NUM
aiua-9669	67	63	%	%	NOUN
aiua-9669	67	64	archivio	archivio	NOUN
aiua-9669	67	65	italiano	italiano	NOUN
aiua-9669	67	66	di	di	X
aiua-9669	67	67	urologia	urologia	PROPN
aiua-9669	67	68	e	e	PROPN
aiua-9669	67	69	andrologia	andrologia	NOUN
aiua-9669	67	70	2021	2021	NUM
aiua-9669	67	71	;	;	PUNCT
aiua-9669	67	72	93	93	NUM
aiua-9669	67	73	,	,	PUNCT
aiua-9669	67	74	1	1	NUM
aiua-9669	67	75	a.b	a.b	NOUN
aiua-9669	67	76	.	.	PROPN
aiua-9669	67	77	galosi	galosi	PROPN
aiua-9669	67	78	,	,	PUNCT
aiua-9669	67	79	e.	e.	PROPN
aiua-9669	67	80	palagonia	palagonia	PROPN
aiua-9669	67	81	,	,	PUNCT
aiua-9669	67	82	s.	s.	PROPN
aiua-9669	67	83	scarcella	scarcella	PROPN
aiua-9669	67	84	,	,	PUNCT
aiua-9669	67	85	a.	a.	NOUN
aiua-9669	67	86	cimadamore	cimadamore	PROPN
aiua-9669	67	87	,	,	PUNCT
aiua-9669	67	88	v.	v.	ADP
aiua-9669	67	89	lacetera	lacetera	PROPN
aiua-9669	67	90	,	,	PUNCT
aiua-9669	67	91	r.f	r.f	PROPN
aiua-9669	67	92	.	.	PROPN
aiua-9669	67	93	delle	delle	PROPN
aiua-9669	67	94	fave	fave	PROPN
aiua-9669	67	95	,	,	PUNCT
aiua-9669	67	96	a.	a.	NOUN
aiua-9669	67	97	antezza	antezza	PROPN
aiua-9669	67	98	,	,	PUNCT
aiua-9669	67	99	l.	l.	PROPN
aiua-9669	67	100	dell’atti	dell’atti	VERB
aiua-9669	67	101	94	94	NUM
aiua-9669	67	102	an	an	DET
aiua-9669	67	103	cause	cause	NOUN
aiua-9669	67	104	-	-	PUNCT
aiua-9669	67	105	specific	specific	ADJ
aiua-9669	67	106	survival	survival	NOUN
aiua-9669	67	107	(	(	PUNCT
aiua-9669	67	108	css	css	PROPN
aiua-9669	67	109	)	)	PUNCT
aiua-9669	67	110	for	for	ADP
aiua-9669	67	111	carriers	carrier	NOUN
aiua-9669	67	112	of	of	ADP
aiua-9669	67	113	2.1	2.1	NUM
aiua-9669	67	114	years	year	NOUN
aiua-9669	67	115	compared	compare	VERB
aiua-9669	67	116	with	with	ADP
aiua-9669	67	117	12.4	12.4	NUM
aiua-9669	67	118	years	year	NOUN
aiua-9669	67	119	for	for	ADP
aiua-9669	67	120	non	non	NOUN
aiua-9669	67	121	-	-	NOUN
aiua-9669	67	122	carriers	carrier	NOUN
aiua-9669	67	123	(	(	PUNCT
aiua-9669	67	124	22	22	NUM
aiua-9669	67	125	)	)	PUNCT
aiua-9669	67	126	.	.	PUNCT
aiua-9669	68	1	secondly	secondly	ADV
aiua-9669	68	2	,	,	PUNCT
aiua-9669	68	3	lynch	lynch	PROPN
aiua-9669	68	4	syndrome	syndrome	PROPN
aiua-9669	68	5	is	be	AUX
aiua-9669	68	6	a	a	DET
aiua-9669	68	7	type	type	NOUN
aiua-9669	68	8	of	of	ADP
aiua-9669	68	9	inherited	inherit	VERB
aiua-9669	68	10	cancer	cancer	NOUN
aiua-9669	68	11	syndrome	syndrome	NOUN
aiua-9669	68	12	associated	associate	VERB
aiua-9669	68	13	with	with	ADP
aiua-9669	68	14	germline	germline	NOUN
aiua-9669	68	15	mutations	mutation	NOUN
aiua-9669	68	16	mainly	mainly	ADV
aiua-9669	68	17	in	in	ADP
aiua-9669	68	18	the	the	DET
aiua-9669	68	19	msh2	msh2	NOUN
aiua-9669	68	20	and	and	CCONJ
aiua-9669	68	21	msh6	msh6	NOUN
aiua-9669	68	22	genes	gene	NOUN
aiua-9669	68	23	;	;	PUNCT
aiua-9669	68	24	affected	affect	VERB
aiua-9669	68	25	individuals	individual	NOUN
aiua-9669	68	26	are	be	AUX
aiua-9669	68	27	at	at	ADP
aiua-9669	68	28	an	an	DET
aiua-9669	68	29	increased	increase	VERB
aiua-9669	68	30	risk	risk	NOUN
aiua-9669	68	31	for	for	ADP
aiua-9669	68	32	colorectal	colorectal	ADJ
aiua-9669	68	33	cancer	cancer	NOUN
aiua-9669	68	34	but	but	CCONJ
aiua-9669	68	35	also	also	ADV
aiua-9669	68	36	for	for	ADP
aiua-9669	68	37	other	other	ADJ
aiua-9669	68	38	associated	associated	ADJ
aiua-9669	68	39	tumors	tumor	NOUN
aiua-9669	68	40	including	include	VERB
aiua-9669	68	41	utero	utero	ADJ
aiua-9669	68	42	and	and	CCONJ
aiua-9669	68	43	ovary	ovary	ADJ
aiua-9669	68	44	,	,	PUNCT
aiua-9669	68	45	stomach	stomach	NOUN
aiua-9669	68	46	and	and	CCONJ
aiua-9669	68	47	small	small	ADJ
aiua-9669	68	48	bowel	bowel	NOUN
aiua-9669	68	49	,	,	PUNCT
aiua-9669	68	50	pancreas	pancrea	NOUN
aiua-9669	68	51	,	,	PUNCT
aiua-9669	68	52	ureter	ureter	ADJ
aiua-9669	68	53	or	or	CCONJ
aiua-9669	68	54	renal	renal	ADJ
aiua-9669	68	55	pelvis	pelvis	NOUN
aiua-9669	68	56	,	,	PUNCT
aiua-9669	68	57	biliary	biliary	ADJ
aiua-9669	68	58	tract	tract	NOUN
aiua-9669	68	59	,	,	PUNCT
aiua-9669	68	60	brain	brain	NOUN
aiua-9669	68	61	and	and	CCONJ
aiua-9669	68	62	prostate	prostate	NOUN
aiua-9669	68	63	.	.	PUNCT
aiua-9669	69	1	the	the	DET
aiua-9669	69	2	risk	risk	NOUN
aiua-9669	69	3	of	of	ADP
aiua-9669	69	4	developing	develop	VERB
aiua-9669	69	5	pca	pca	NOUN
aiua-9669	69	6	in	in	ADP
aiua-9669	69	7	this	this	DET
aiua-9669	69	8	patients	patient	NOUN
aiua-9669	69	9	is	be	AUX
aiua-9669	69	10	twofold	twofold	ADV
aiua-9669	69	11	higher	high	ADJ
aiua-9669	69	12	than	than	ADP
aiua-9669	69	13	general	general	ADJ
aiua-9669	69	14	population	population	NOUN
aiua-9669	69	15	(	(	PUNCT
aiua-9669	69	16	23	23	NUM
aiua-9669	69	17	)	)	PUNCT
aiua-9669	69	18	.	.	PUNCT
aiua-9669	70	1	criteria	criterion	NOUN
aiua-9669	70	2	of	of	ADP
aiua-9669	70	3	hereditary	hereditary	ADJ
aiua-9669	70	4	pca	pca	PROPN
aiua-9669	70	5	from	from	ADP
aiua-9669	70	6	john	john	PROPN
aiua-9669	70	7	hopkins	hopkins	PROPN
aiua-9669	70	8	university	university	PROPN
aiua-9669	70	9	(	(	PUNCT
aiua-9669	70	10	jhu	jhu	PROPN
aiua-9669	70	11	)	)	PUNCT
aiua-9669	70	12	included	include	VERB
aiua-9669	70	13	at	at	ADP
aiua-9669	70	14	least	least	ADV
aiua-9669	70	15	3	3	NUM
aiua-9669	70	16	first	first	ADJ
aiua-9669	70	17	-	-	PUNCT
aiua-9669	70	18	line	line	NOUN
aiua-9669	70	19	relatives	relative	NOUN
aiua-9669	70	20	with	with	ADP
aiua-9669	70	21	pca	pca	NOUN
aiua-9669	70	22	or	or	CCONJ
aiua-9669	70	23	cases	case	NOUN
aiua-9669	70	24	of	of	ADP
aiua-9669	70	25	pca	pca	NOUN
aiua-9669	70	26	in	in	ADP
aiua-9669	70	27	three	three	NUM
aiua-9669	70	28	generations	generation	NOUN
aiua-9669	70	29	,	,	PUNCT
aiua-9669	70	30	as	as	ADV
aiua-9669	70	31	well	well	ADV
aiua-9669	70	32	as	as	ADP
aiua-9669	70	33	2	2	NUM
aiua-9669	70	34	relatives	relative	NOUN
aiua-9669	70	35	with	with	ADP
aiua-9669	70	36	pca	pca	PROPN
aiua-9669	70	37	<	<	X
aiua-9669	70	38	56	56	NUM
aiua-9669	70	39	years	year	NOUN
aiua-9669	70	40	of	of	ADP
aiua-9669	70	41	age	age	NOUN
aiua-9669	70	42	(	(	PUNCT
aiua-9669	70	43	24	24	NUM
aiua-9669	70	44	)	)	PUNCT
aiua-9669	70	45	.	.	PUNCT
aiua-9669	71	1	approximately	approximately	ADV
aiua-9669	71	2	8	8	NUM
aiua-9669	71	3	%	%	NOUN
aiua-9669	71	4	of	of	ADP
aiua-9669	71	5	young	young	ADJ
aiua-9669	71	6	pca	pca	NOUN
aiua-9669	71	7	patients	patient	NOUN
aiua-9669	71	8	have	have	VERB
aiua-9669	71	9	hereditary	hereditary	ADJ
aiua-9669	71	10	pca	pca	NOUN
aiua-9669	71	11	.	.	PUNCT
aiua-9669	72	1	the	the	DET
aiua-9669	72	2	recommendation	recommendation	NOUN
aiua-9669	72	3	of	of	ADP
aiua-9669	72	4	the	the	DET
aiua-9669	72	5	national	national	ADJ
aiua-9669	72	6	comprehensive	comprehensive	ADJ
aiua-9669	72	7	cancer	cancer	NOUN
aiua-9669	72	8	network	network	NOUN
aiua-9669	72	9	(	(	PUNCT
aiua-9669	72	10	nccn	nccn	PROPN
aiua-9669	72	11	)	)	PUNCT
aiua-9669	72	12	is	be	AUX
aiua-9669	72	13	to	to	PART
aiua-9669	72	14	use	use	VERB
aiua-9669	72	15	next	next	ADJ
aiua-9669	72	16	generation	generation	NOUN
aiua-9669	72	17	sequencing	sequence	VERB
aiua-9669	72	18	to	to	PART
aiua-9669	72	19	sequence	sequence	VERB
aiua-9669	72	20	the	the	DET
aiua-9669	72	21	multigene	multigene	ADJ
aiua-9669	72	22	panel	panel	NOUN
aiua-9669	72	23	,	,	PUNCT
aiua-9669	72	24	which	which	PRON
aiua-9669	72	25	includes	include	VERB
aiua-9669	72	26	at	at	ADP
aiua-9669	72	27	least	least	ADJ
aiua-9669	72	28	brca1	brca1	PROPN
aiua-9669	72	29	,	,	PUNCT
aiua-9669	72	30	brca2	brca2	PROPN
aiua-9669	72	31	,	,	PUNCT
aiua-9669	72	32	atm	atm	PROPN
aiua-9669	72	33	,	,	PUNCT
aiua-9669	72	34	brip1	brip1	PROPN
aiua-9669	72	35	,	,	PUNCT
aiua-9669	72	36	chek2	chek2	PROPN
aiua-9669	72	37	,	,	PUNCT
aiua-9669	72	38	nbn	nbn	PROPN
aiua-9669	72	39	,	,	PUNCT
aiua-9669	72	40	hoxb13	hoxb13	PROPN
aiua-9669	72	41	,	,	PUNCT
aiua-9669	72	42	mlh1	mlh1	PROPN
aiua-9669	72	43	,	,	PUNCT
aiua-9669	72	44	msh2	msh2	NOUN
aiua-9669	72	45	,	,	PUNCT
aiua-9669	72	46	msh6	msh6	NOUN
aiua-9669	72	47	and	and	CCONJ
aiua-9669	72	48	pms2	pms2	NOUN
aiua-9669	72	49	(	(	PUNCT
aiua-9669	72	50	25	25	NUM
aiua-9669	72	51	)	)	PUNCT
aiua-9669	72	52	.	.	PUNCT
aiua-9669	73	1	men	man	NOUN
aiua-9669	73	2	with	with	ADP
aiua-9669	73	3	age	age	NOUN
aiua-9669	73	4	between	between	ADP
aiua-9669	73	5	45	45	NUM
aiua-9669	73	6	-	-	SYM
aiua-9669	73	7	75	75	NUM
aiua-9669	73	8	years	year	NOUN
aiua-9669	73	9	with	with	ADP
aiua-9669	73	10	psa	psa	VERB
aiua-9669	73	11	<	<	X
aiua-9669	73	12	1	1	NUM
aiua-9669	73	13	ng	ng	PROPN
aiua-9669	73	14	/	/	SYM
aiua-9669	73	15	ml	ml	PROPN
aiua-9669	73	16	,	,	PUNCT
aiua-9669	73	17	dre	dre	X
aiua-9669	73	18	normal	normal	ADJ
aiua-9669	73	19	or	or	CCONJ
aiua-9669	73	20	psa	psa	VERB
aiua-9669	73	21	1	1	NUM
aiua-9669	73	22	-	-	SYM
aiua-9669	73	23	3	3	NUM
aiua-9669	73	24	ng	ng	PROPN
aiua-9669	73	25	/	/	SYM
aiua-9669	73	26	ml	ml	PROPN
aiua-9669	73	27	and	and	CCONJ
aiua-9669	73	28	dre	dre	PROPN
aiua-9669	73	29	normal	normal	ADJ
aiua-9669	73	30	are	be	AUX
aiua-9669	73	31	often	often	ADV
aiua-9669	73	32	underestimated	underestimate	VERB
aiua-9669	73	33	,	,	PUNCT
aiua-9669	73	34	this	this	PRON
aiua-9669	73	35	led	lead	VERB
aiua-9669	73	36	to	to	PART
aiua-9669	73	37	correctly	correctly	ADV
aiua-9669	73	38	frame	frame	VERB
aiua-9669	73	39	the	the	DET
aiua-9669	73	40	patient	patient	NOUN
aiua-9669	73	41	who	who	PRON
aiua-9669	73	42	needs	need	VERB
aiua-9669	73	43	annual	annual	ADJ
aiua-9669	73	44	checks	check	NOUN
aiua-9669	73	45	for	for	ADP
aiua-9669	73	46	pca	pca	PROPN
aiua-9669	73	47	early	early	ADJ
aiua-9669	73	48	detection	detection	NOUN
aiua-9669	73	49	.	.	PUNCT
aiua-9669	74	1	however	however	ADV
aiua-9669	74	2	,	,	PUNCT
aiua-9669	74	3	a	a	DET
aiua-9669	74	4	personalised	personalised	ADJ
aiua-9669	74	5	risk	risk	NOUN
aiua-9669	74	6	-	-	PUNCT
aiua-9669	74	7	adapter	adapter	NOUN
aiua-9669	74	8	strategy	strategy	NOUN
aiua-9669	74	9	for	for	ADP
aiua-9669	74	10	early	early	ADJ
aiua-9669	74	11	detection	detection	NOUN
aiua-9669	74	12	pca	pca	NOUN
aiua-9669	74	13	could	could	AUX
aiua-9669	74	14	be	be	AUX
aiua-9669	74	15	associated	associate	VERB
aiua-9669	74	16	with	with	ADP
aiua-9669	74	17	an	an	DET
aiua-9669	74	18	important	important	ADJ
aiua-9669	74	19	risk	risk	NOUN
aiua-9669	74	20	reduction	reduction	NOUN
aiua-9669	74	21	of	of	ADP
aiua-9669	74	22	over	over	ADP
aiua-9669	74	23	-	-	PUNCT
aiua-9669	74	24	diagnosis	diagnosis	NOUN
aiua-9669	74	25	and	and	CCONJ
aiua-9669	74	26	over	over	ADP
aiua-9669	74	27	-	-	PUNCT
aiua-9669	74	28	biopsy	biopsy	NOUN
aiua-9669	74	29	(	(	PUNCT
aiua-9669	74	30	26	26	NUM
aiua-9669	74	31	,	,	PUNCT
aiua-9669	74	32	27	27	NUM
aiua-9669	74	33	)	)	PUNCT
aiua-9669	74	34	.	.	PUNCT
aiua-9669	75	1	pathological	pathological	ADJ
aiua-9669	75	2	point	point	NOUN
aiua-9669	75	3	of	of	ADP
aiua-9669	75	4	view	view	NOUN
aiua-9669	75	5	:	:	PUNCT
aiua-9669	75	6	definition	definition	NOUN
aiua-9669	75	7	of	of	ADP
aiua-9669	75	8	cspca	cspca	PROPN
aiua-9669	75	9	although	although	SCONJ
aiua-9669	75	10	epstein	epstein	PROPN
aiua-9669	75	11	criteria	criterion	NOUN
aiua-9669	75	12	have	have	VERB
aiua-9669	75	13	a	a	DET
aiua-9669	75	14	suboptimal	suboptimal	ADJ
aiua-9669	75	15	accuracy	accuracy	NOUN
aiua-9669	75	16	for	for	ADP
aiua-9669	75	17	predicting	predict	VERB
aiua-9669	75	18	significant	significant	ADJ
aiua-9669	75	19	pca	pca	NOUN
aiua-9669	75	20	,	,	PUNCT
aiua-9669	75	21	the	the	DET
aiua-9669	75	22	pathological	pathological	ADJ
aiua-9669	75	23	concept	concept	NOUN
aiua-9669	75	24	of	of	ADP
aiua-9669	75	25	significant	significant	ADJ
aiua-9669	75	26	prostate	prostate	NOUN
aiua-9669	75	27	cancer	cancer	NOUN
aiua-9669	75	28	is	be	AUX
aiua-9669	75	29	a	a	DET
aiua-9669	75	30	lesion	lesion	NOUN
aiua-9669	75	31	with	with	ADP
aiua-9669	75	32	volume	volume	NOUN
aiua-9669	75	33	of	of	ADP
aiua-9669	75	34	>	>	X
aiua-9669	75	35	0.2	0.2	NUM
aiua-9669	75	36	ml	ml	NOUN
aiua-9669	75	37	,	,	PUNCT
aiua-9669	75	38	a	a	DET
aiua-9669	75	39	gleason	gleason	PROPN
aiua-9669	75	40	grade	grade	NOUN
aiua-9669	75	41	≥	≥	PROPN
aiua-9669	75	42	7	7	NUM
aiua-9669	75	43	or	or	CCONJ
aiua-9669	75	44	extraprostatic	extraprostatic	ADJ
aiua-9669	75	45	extension	extension	NOUN
aiua-9669	75	46	(	(	PUNCT
aiua-9669	75	47	28	28	NUM
aiua-9669	75	48	)	)	PUNCT
aiua-9669	75	49	,	,	PUNCT
aiua-9669	75	50	the	the	DET
aiua-9669	75	51	index	index	NOUN
aiua-9669	75	52	lesion	lesion	NOUN
aiua-9669	75	53	is	be	AUX
aiua-9669	75	54	defined	define	VERB
aiua-9669	75	55	as	as	ADP
aiua-9669	75	56	the	the	DET
aiua-9669	75	57	larger	large	ADJ
aiua-9669	75	58	and/or	and/or	CCONJ
aiua-9669	75	59	containing	contain	VERB
aiua-9669	75	60	high	high	ADJ
aiua-9669	75	61	grade	grade	NOUN
aiua-9669	75	62	tumor	tumor	NOUN
aiua-9669	75	63	(	(	PUNCT
aiua-9669	75	64	pattern	pattern	NOUN
aiua-9669	75	65	4	4	NUM
aiua-9669	75	66	or	or	CCONJ
aiua-9669	75	67	5	5	NUM
aiua-9669	75	68	)	)	PUNCT
aiua-9669	75	69	(	(	PUNCT
aiua-9669	75	70	29	29	NUM
aiua-9669	75	71	)	)	PUNCT
aiua-9669	75	72	.	.	PUNCT
aiua-9669	76	1	these	these	DET
aiua-9669	76	2	values	value	NOUN
aiua-9669	76	3	were	be	AUX
aiua-9669	76	4	defined	define	VERB
aiua-9669	76	5	assessing	assess	VERB
aiua-9669	76	6	185	185	NUM
aiua-9669	76	7	patients	patient	NOUN
aiua-9669	76	8	who	who	PRON
aiua-9669	76	9	underwent	undergo	VERB
aiua-9669	76	10	radical	radical	ADJ
aiua-9669	76	11	prostatectomy	prostatectomy	NOUN
aiua-9669	76	12	with	with	ADP
aiua-9669	76	13	a	a	DET
aiua-9669	76	14	median	median	NOUN
aiua-9669	76	15	of	of	ADP
aiua-9669	76	16	five	five	NUM
aiua-9669	76	17	years	year	NOUN
aiua-9669	76	18	follow	follow	NOUN
aiua-9669	76	19	-	-	PUNCT
aiua-9669	76	20	up	up	NOUN
aiua-9669	76	21	in	in	ADP
aiua-9669	76	22	which	which	PRON
aiua-9669	76	23	epstein	epstein	PROPN
aiua-9669	76	24	et	et	PROPN
aiua-9669	76	25	al	al	PROPN
aiua-9669	76	26	.	.	PROPN
aiua-9669	76	27	demonstrated	demonstrate	VERB
aiua-9669	76	28	that	that	SCONJ
aiua-9669	76	29	none	none	NOUN
aiua-9669	76	30	of	of	ADP
aiua-9669	76	31	the	the	DET
aiua-9669	76	32	patients	patient	NOUN
aiua-9669	76	33	with	with	ADP
aiua-9669	76	34	palpable	palpable	ADJ
aiua-9669	76	35	tumors	tumor	NOUN
aiua-9669	76	36	clinical	clinical	ADJ
aiua-9669	76	37	t2	t2	NOUN
aiua-9669	76	38	with	with	ADP
aiua-9669	76	39	a	a	DET
aiua-9669	76	40	volume	volume	NOUN
aiua-9669	76	41	<	<	X
aiua-9669	76	42	0.2	0.2	NUM
aiua-9669	76	43	cc	cc	NOUN
aiua-9669	76	44	had	have	VERB
aiua-9669	76	45	extra	extra	ADJ
aiua-9669	76	46	-	-	ADJ
aiua-9669	76	47	prostatic	prostatic	ADJ
aiua-9669	76	48	extension	extension	NOUN
aiua-9669	76	49	(	(	PUNCT
aiua-9669	76	50	epe	epe	PROPN
aiua-9669	76	51	)	)	PUNCT
aiua-9669	76	52	or	or	CCONJ
aiua-9669	76	53	biochemical	biochemical	ADJ
aiua-9669	76	54	recurrence	recurrence	NOUN
aiua-9669	76	55	(	(	PUNCT
aiua-9669	76	56	bcr	bcr	PROPN
aiua-9669	76	57	)	)	PUNCT
aiua-9669	76	58	(	(	PUNCT
aiua-9669	76	59	30	30	NUM
aiua-9669	76	60	)	)	PUNCT
aiua-9669	76	61	.	.	PUNCT
aiua-9669	77	1	however	however	ADV
aiua-9669	77	2	,	,	PUNCT
aiua-9669	77	3	there	there	PRON
aiua-9669	77	4	was	be	VERB
aiua-9669	77	5	a	a	DET
aiua-9669	77	6	high	high	ADJ
aiua-9669	77	7	incidence	incidence	NOUN
aiua-9669	77	8	of	of	ADP
aiua-9669	77	9	multifocal	multifocal	ADJ
aiua-9669	77	10	pca	pca	NOUN
aiua-9669	77	11	and	and	CCONJ
aiua-9669	77	12	consequently	consequently	ADV
aiua-9669	77	13	summing	sum	VERB
aiua-9669	77	14	the	the	DET
aiua-9669	77	15	volumes	volume	NOUN
aiua-9669	77	16	of	of	ADP
aiua-9669	77	17	many	many	ADJ
aiua-9669	77	18	small	small	ADJ
aiua-9669	77	19	prostate	prostate	NOUN
aiua-9669	77	20	tumors	tumor	NOUN
aiua-9669	77	21	would	would	AUX
aiua-9669	77	22	result	result	VERB
aiua-9669	77	23	in	in	ADP
aiua-9669	77	24	a	a	DET
aiua-9669	77	25	total	total	ADJ
aiua-9669	77	26	volume	volume	NOUN
aiua-9669	77	27	higher	high	ADJ
aiua-9669	77	28	than	than	ADP
aiua-9669	77	29	0.2	0.2	NUM
aiua-9669	77	30	ml	ml	NOUN
aiua-9669	77	31	,	,	PUNCT
aiua-9669	77	32	although	although	SCONJ
aiua-9669	77	33	actually	actually	ADV
aiua-9669	77	34	there	there	PRON
aiua-9669	77	35	is	be	VERB
aiua-9669	77	36	no	no	DET
aiua-9669	77	37	evidence	evidence	NOUN
aiua-9669	77	38	that	that	SCONJ
aiua-9669	77	39	these	these	DET
aiua-9669	77	40	smaller	small	ADJ
aiua-9669	77	41	multifocal	multifocal	ADJ
aiua-9669	77	42	tumors	tumor	NOUN
aiua-9669	77	43	impact	impact	NOUN
aiua-9669	77	44	on	on	ADP
aiua-9669	77	45	the	the	DET
aiua-9669	77	46	prognosis	prognosis	NOUN
aiua-9669	77	47	of	of	ADP
aiua-9669	77	48	the	the	DET
aiua-9669	77	49	index	index	NOUN
aiua-9669	77	50	tumor	tumor	NOUN
aiua-9669	77	51	(	(	PUNCT
aiua-9669	77	52	31	31	NUM
aiua-9669	77	53	)	)	PUNCT
aiua-9669	77	54	.	.	PUNCT
aiua-9669	78	1	in	in	ADP
aiua-9669	78	2	the	the	DET
aiua-9669	78	3	era	era	NOUN
aiua-9669	78	4	of	of	ADP
aiua-9669	78	5	cognitive	cognitive	ADJ
aiua-9669	78	6	guided	guide	VERB
aiua-9669	78	7	fusion	fusion	NOUN
aiua-9669	78	8	biopsies	biopsy	NOUN
aiua-9669	78	9	,	,	PUNCT
aiua-9669	78	10	in	in	ADP
aiua-9669	78	11	the	the	DET
aiua-9669	78	12	last	last	ADJ
aiua-9669	78	13	years	year	NOUN
aiua-9669	78	14	several	several	ADJ
aiua-9669	78	15	studies	study	NOUN
aiua-9669	78	16	showed	show	VERB
aiua-9669	78	17	that	that	SCONJ
aiua-9669	78	18	imaging	imaging	NOUN
aiua-9669	78	19	driven	drive	VERB
aiua-9669	78	20	biopsy	biopsy	NOUN
aiua-9669	78	21	help	help	NOUN
aiua-9669	78	22	to	to	PART
aiua-9669	78	23	target	target	VERB
aiua-9669	78	24	the	the	DET
aiua-9669	78	25	cancer	cancer	NOUN
aiua-9669	78	26	properly	properly	ADV
aiua-9669	78	27	increasing	increase	VERB
aiua-9669	78	28	the	the	DET
aiua-9669	78	29	grading	grade	VERB
aiua-9669	78	30	assessment	assessment	NOUN
aiua-9669	78	31	through	through	ADP
aiua-9669	78	32	biopsy	biopsy	NOUN
aiua-9669	78	33	(	(	PUNCT
aiua-9669	78	34	32	32	NUM
aiua-9669	78	35	,	,	PUNCT
aiua-9669	78	36	33	33	NUM
aiua-9669	78	37	)	)	PUNCT
aiua-9669	78	38	.	.	PUNCT
aiua-9669	79	1	pca	pca	PROPN
aiua-9669	79	2	is	be	AUX
aiua-9669	79	3	considered	consider	VERB
aiua-9669	79	4	a	a	DET
aiua-9669	79	5	paradigm	paradigm	NOUN
aiua-9669	79	6	of	of	ADP
aiua-9669	79	7	morphologic	morphologic	ADJ
aiua-9669	79	8	heterogeneity	heterogeneity	NOUN
aiua-9669	79	9	and	and	CCONJ
aiua-9669	79	10	the	the	DET
aiua-9669	79	11	role	role	NOUN
aiua-9669	79	12	of	of	ADP
aiua-9669	79	13	the	the	DET
aiua-9669	79	14	pathologist	pathologist	NOUN
aiua-9669	79	15	and	and	CCONJ
aiua-9669	79	16	of	of	ADP
aiua-9669	79	17	biopsy	biopsy	NOUN
aiua-9669	79	18	technique	technique	NOUN
aiua-9669	79	19	assumes	assume	VERB
aiua-9669	79	20	great	great	ADJ
aiua-9669	79	21	importance	importance	NOUN
aiua-9669	79	22	for	for	ADP
aiua-9669	79	23	the	the	DET
aiua-9669	79	24	choice	choice	NOUN
aiua-9669	79	25	of	of	ADP
aiua-9669	79	26	treatment	treatment	NOUN
aiua-9669	79	27	and	and	CCONJ
aiua-9669	79	28	appropriate	appropriate	ADJ
aiua-9669	79	29	follow	follow	NOUN
aiua-9669	79	30	-	-	PUNCT
aiua-9669	79	31	up	up	NOUN
aiua-9669	79	32	(	(	PUNCT
aiua-9669	79	33	26	26	NUM
aiua-9669	79	34	)	)	PUNCT
aiua-9669	79	35	.	.	PUNCT
aiua-9669	80	1	grade	grade	NOUN
aiua-9669	80	2	group	group	NOUN
aiua-9669	80	3	1	1	NUM
aiua-9669	80	4	(	(	PUNCT
aiua-9669	80	5	gleason	gleason	PROPN
aiua-9669	80	6	score	score	NOUN
aiua-9669	80	7	3	3	NUM
aiua-9669	80	8	+	+	SYM
aiua-9669	80	9	3	3	NUM
aiua-9669	80	10	=	=	SYM
aiua-9669	80	11	6	6	NUM
aiua-9669	80	12	)	)	PUNCT
aiua-9669	80	13	,	,	PUNCT
aiua-9669	80	14	pathologically	pathologically	ADV
aiua-9669	80	15	composed	compose	VERB
aiua-9669	80	16	of	of	ADP
aiua-9669	80	17	individual	individual	ADJ
aiua-9669	80	18	discrete	discrete	ADJ
aiua-9669	80	19	wellformed	wellforme	VERB
aiua-9669	80	20	separated	separate	VERB
aiua-9669	80	21	glands	gland	NOUN
aiua-9669	80	22	,	,	PUNCT
aiua-9669	80	23	is	be	AUX
aiua-9669	80	24	very	very	ADV
aiua-9669	80	25	homogeneous	homogeneous	ADJ
aiua-9669	80	26	with	with	ADP
aiua-9669	80	27	an	an	DET
aiua-9669	80	28	excellent	excellent	ADJ
aiua-9669	80	29	prognosis	prognosis	NOUN
aiua-9669	80	30	(	(	PUNCT
aiua-9669	80	31	34	34	NUM
aiua-9669	80	32	,	,	PUNCT
aiua-9669	80	33	35	35	NUM
aiua-9669	80	34	)	)	PUNCT
aiua-9669	80	35	.	.	PUNCT
aiua-9669	81	1	in	in	ADP
aiua-9669	81	2	a	a	DET
aiua-9669	81	3	population	population	NOUN
aiua-9669	81	4	of	of	ADP
aiua-9669	81	5	20845	20845	NUM
aiua-9669	81	6	men	man	NOUN
aiua-9669	81	7	with	with	ADP
aiua-9669	81	8	clinically	clinically	ADV
aiua-9669	81	9	localized	localize	VERB
aiua-9669	81	10	pca	pca	NOUN
aiua-9669	81	11	treated	treat	VERB
aiua-9669	81	12	by	by	ADP
aiua-9669	81	13	radical	radical	ADJ
aiua-9669	81	14	prostatectomy	prostatectomy	NOUN
aiua-9669	81	15	in	in	ADP
aiua-9669	81	16	four	four	NUM
aiua-9669	81	17	different	different	ADJ
aiua-9669	81	18	american	american	ADJ
aiua-9669	81	19	hospitals	hospital	NOUN
aiua-9669	81	20	,	,	PUNCT
aiua-9669	81	21	epstein	epstein	PROPN
aiua-9669	81	22	et	et	PROPN
aiua-9669	81	23	al	al	PROPN
aiua-9669	81	24	.	.	PROPN
aiua-9669	81	25	did	do	AUX
aiua-9669	81	26	not	not	PART
aiua-9669	81	27	observe	observe	VERB
aiua-9669	81	28	distant	distant	ADJ
aiua-9669	81	29	metastasis	metastasis	NOUN
aiua-9669	81	30	or	or	CCONJ
aiua-9669	81	31	cancer	cancer	NOUN
aiua-9669	81	32	-	-	PUNCT
aiua-9669	81	33	specific	specific	ADJ
aiua-9669	81	34	mortality	mortality	NOUN
aiua-9669	81	35	in	in	ADP
aiua-9669	81	36	a	a	DET
aiua-9669	81	37	subgroup	subgroup	NOUN
aiua-9669	81	38	of	of	ADP
aiua-9669	81	39	more	more	ADJ
aiua-9669	81	40	than	than	ADP
aiua-9669	81	41	6000	6000	NUM
aiua-9669	81	42	men	man	NOUN
aiua-9669	81	43	with	with	ADP
aiua-9669	81	44	organ	organ	NOUN
aiua-9669	81	45	-	-	PUNCT
aiua-9669	81	46	confined	confine	VERB
aiua-9669	81	47	and	and	CCONJ
aiua-9669	81	48	negative	negative	ADJ
aiua-9669	81	49	margins	margin	NOUN
aiua-9669	81	50	with	with	ADP
aiua-9669	81	51	pure	pure	ADJ
aiua-9669	81	52	gleason	gleason	PROPN
aiua-9669	81	53	score	score	NOUN
aiua-9669	81	54	6	6	NUM
aiua-9669	81	55	disease	disease	NOUN
aiua-9669	81	56	;	;	PUNCT
aiua-9669	81	57	the	the	DET
aiua-9669	81	58	risk	risk	NOUN
aiua-9669	81	59	of	of	ADP
aiua-9669	81	60	progression	progression	NOUN
aiua-9669	81	61	in	in	ADP
aiua-9669	81	62	this	this	DET
aiua-9669	81	63	group	group	NOUN
aiua-9669	81	64	is	be	AUX
aiua-9669	81	65	approaching	approach	VERB
aiua-9669	81	66	0	0	NUM
aiua-9669	81	67	%	%	NOUN
aiua-9669	81	68	(	(	PUNCT
aiua-9669	81	69	36	36	NUM
aiua-9669	81	70	)	)	PUNCT
aiua-9669	81	71	.	.	PUNCT
aiua-9669	82	1	despite	despite	SCONJ
aiua-9669	82	2	these	these	DET
aiua-9669	82	3	results	result	NOUN
aiua-9669	82	4	,	,	PUNCT
aiua-9669	82	5	we	we	PRON
aiua-9669	82	6	must	must	AUX
aiua-9669	82	7	consider	consider	VERB
aiua-9669	82	8	that	that	SCONJ
aiua-9669	82	9	not	not	PART
aiua-9669	82	10	all	all	DET
aiua-9669	82	11	tumors	tumor	NOUN
aiua-9669	82	12	that	that	SCONJ
aiua-9669	82	13	“	"	PUNCT
aiua-9669	82	14	look	look	VERB
aiua-9669	82	15	good	good	ADJ
aiua-9669	82	16	”	"	PUNCT
aiua-9669	82	17	from	from	ADP
aiua-9669	82	18	a	a	DET
aiua-9669	82	19	clinical	clinical	ADJ
aiua-9669	82	20	point	point	NOUN
aiua-9669	82	21	of	of	ADP
aiua-9669	82	22	view	view	NOUN
aiua-9669	82	23	(	(	PUNCT
aiua-9669	82	24	psa	psa	VERB
aiua-9669	82	25	<	<	X
aiua-9669	82	26	3	3	NUM
aiua-9669	82	27	ng	ng	PROPN
aiua-9669	82	28	/	/	SYM
aiua-9669	82	29	ml	ml	PROPN
aiua-9669	82	30	,	,	PUNCT
aiua-9669	82	31	negative	negative	ADJ
aiua-9669	82	32	dre	dre	PROPN
aiua-9669	82	33	,	,	PUNCT
aiua-9669	82	34	negative	negative	ADJ
aiua-9669	82	35	transrectal	transrectal	ADJ
aiua-9669	82	36	ultrasound	ultrasound	NOUN
aiua-9669	82	37	,	,	PUNCT
aiua-9669	82	38	pi	pi	NOUN
aiua-9669	82	39	-	-	PUNCT
aiua-9669	82	40	rads	rad	NOUN
aiua-9669	82	41	3	3	NUM
aiua-9669	82	42	at	at	ADP
aiua-9669	82	43	mpmr	mpmr	PROPN
aiua-9669	82	44	)	)	PUNCT
aiua-9669	82	45	are	be	AUX
aiua-9669	82	46	also	also	ADV
aiua-9669	82	47	good	good	ADJ
aiua-9669	82	48	from	from	ADP
aiua-9669	82	49	the	the	DET
aiua-9669	82	50	histological	histological	ADJ
aiua-9669	82	51	and	and	CCONJ
aiua-9669	82	52	molecular	molecular	ADJ
aiua-9669	82	53	point	point	NOUN
aiua-9669	82	54	of	of	ADP
aiua-9669	82	55	view	view	NOUN
aiua-9669	82	56	.	.	PUNCT
aiua-9669	83	1	kamoun	kamoun	NOUN
aiua-9669	83	2	et	et	PROPN
aiua-9669	83	3	al	al	PROPN
aiua-9669	83	4	.	.	PROPN
aiua-9669	84	1	subdivided	subdivide	VERB
aiua-9669	84	2	prostate	prostate	NOUN
aiua-9669	84	3	tumors	tumor	NOUN
aiua-9669	84	4	in	in	ADP
aiua-9669	84	5	three	three	NUM
aiua-9669	84	6	different	different	ADJ
aiua-9669	84	7	genetical	genetical	ADJ
aiua-9669	84	8	signatures	signature	NOUN
aiua-9669	84	9	profiled	profile	VERB
aiua-9669	84	10	on	on	ADP
aiua-9669	84	11	dna	dna	PROPN
aiua-9669	84	12	methylation	methylation	NOUN
aiua-9669	84	13	,	,	PUNCT
aiua-9669	84	14	snp	snp	NOUN
aiua-9669	84	15	arrays	array	NOUN
aiua-9669	84	16	and	and	CCONJ
aiua-9669	84	17	mrna	mrna	PROPN
aiua-9669	84	18	arrays	array	VERB
aiua-9669	84	19	.	.	PUNCT
aiua-9669	85	1	molecular	molecular	ADJ
aiua-9669	85	2	subtype	subtype	NOUN
aiua-9669	85	3	“	"	PUNCT
aiua-9669	85	4	s2	s2	NOUN
aiua-9669	85	5	”	"	PUNCT
aiua-9669	85	6	tumors	tumor	NOUN
aiua-9669	85	7	,	,	PUNCT
aiua-9669	85	8	which	which	PRON
aiua-9669	85	9	mainly	mainly	ADV
aiua-9669	85	10	included	include	VERB
aiua-9669	85	11	isup	isup	ADJ
aiua-9669	85	12	group	group	NOUN
aiua-9669	85	13	1	1	NUM
aiua-9669	85	14	and	and	CCONJ
aiua-9669	85	15	2	2	NUM
aiua-9669	85	16	,	,	PUNCT
aiua-9669	85	17	present	present	ADJ
aiua-9669	85	18	with	with	ADP
aiua-9669	85	19	tmprss2	tmprss2	NOUN
aiua-9669	85	20	-	-	PUNCT
aiua-9669	85	21	erg	erg	NOUN
aiua-9669	85	22	fusions	fusion	NOUN
aiua-9669	85	23	with	with	ADP
aiua-9669	85	24	constancy	constancy	NOUN
aiua-9669	85	25	in	in	ADP
aiua-9669	85	26	other	other	ADJ
aiua-9669	85	27	molecular	molecular	ADJ
aiua-9669	85	28	subgroups	subgroup	NOUN
aiua-9669	85	29	and	and	CCONJ
aiua-9669	85	30	were	be	AUX
aiua-9669	85	31	also	also	ADV
aiua-9669	85	32	characterized	characterize	VERB
aiua-9669	85	33	by	by	ADP
aiua-9669	85	34	an	an	DET
aiua-9669	85	35	almost	almost	ADV
aiua-9669	85	36	total	total	ADJ
aiua-9669	85	37	absence	absence	NOUN
aiua-9669	85	38	of	of	ADP
aiua-9669	85	39	mutations	mutation	NOUN
aiua-9669	85	40	in	in	ADP
aiua-9669	85	41	pten	pten	NOUN
aiua-9669	85	42	,	,	PUNCT
aiua-9669	85	43	in	in	ADP
aiua-9669	85	44	the	the	DET
aiua-9669	85	45	phosphoinositol	phosphoinositol	ADJ
aiua-9669	85	46	kinase	kinase	PROPN
aiua-9669	85	47	pathway	pathway	NOUN
aiua-9669	85	48	and	and	CCONJ
aiua-9669	85	49	in	in	ADP
aiua-9669	85	50	p53	p53	NOUN
aiua-9669	85	51	.	.	PUNCT
aiua-9669	86	1	however	however	ADV
aiua-9669	86	2	a	a	DET
aiua-9669	86	3	little	little	ADJ
aiua-9669	86	4	percentage	percentage	NOUN
aiua-9669	86	5	of	of	ADP
aiua-9669	86	6	isup	isup	NOUN
aiua-9669	86	7	3	3	NUM
aiua-9669	86	8	and	and	CCONJ
aiua-9669	86	9	4	4	NUM
aiua-9669	86	10	tumors	tumor	NOUN
aiua-9669	86	11	was	be	AUX
aiua-9669	86	12	represented	represent	VERB
aiua-9669	86	13	also	also	ADV
aiua-9669	86	14	in	in	ADP
aiua-9669	86	15	this	this	DET
aiua-9669	86	16	class	class	NOUN
aiua-9669	86	17	(	(	PUNCT
aiua-9669	86	18	37	37	NUM
aiua-9669	86	19	)	)	PUNCT
aiua-9669	86	20	.	.	PUNCT
aiua-9669	87	1	cribriform	cribriform	NOUN
aiua-9669	87	2	histology	histology	NOUN
aiua-9669	87	3	and	and	CCONJ
aiua-9669	87	4	intraductal	intraductal	ADJ
aiua-9669	87	5	carcinoma	carcinoma	NOUN
aiua-9669	87	6	while	while	SCONJ
aiua-9669	87	7	pure	pure	ADJ
aiua-9669	87	8	gleason	gleason	PROPN
aiua-9669	87	9	score	score	VERB
aiua-9669	87	10	6	6	NUM
aiua-9669	87	11	prostate	prostate	NOUN
aiua-9669	87	12	cancers	cancer	NOUN
aiua-9669	87	13	have	have	VERB
aiua-9669	87	14	an	an	DET
aiua-9669	87	15	excellent	excellent	ADJ
aiua-9669	87	16	outcome	outcome	NOUN
aiua-9669	87	17	in	in	ADP
aiua-9669	87	18	terms	term	NOUN
aiua-9669	87	19	of	of	ADP
aiua-9669	87	20	progression	progression	NOUN
aiua-9669	87	21	,	,	PUNCT
aiua-9669	87	22	absence	absence	NOUN
aiua-9669	87	23	of	of	ADP
aiua-9669	87	24	distant	distant	ADJ
aiua-9669	87	25	metastasis	metastasis	NOUN
aiua-9669	87	26	and	and	CCONJ
aiua-9669	87	27	disease	disease	NOUN
aiua-9669	87	28	-	-	PUNCT
aiua-9669	87	29	free	free	ADJ
aiua-9669	87	30	survival	survival	NOUN
aiua-9669	87	31	,	,	PUNCT
aiua-9669	87	32	areas	area	NOUN
aiua-9669	87	33	of	of	ADP
aiua-9669	87	34	cribriform	cribriform	NOUN
aiua-9669	87	35	pattern	pattern	NOUN
aiua-9669	87	36	4	4	NUM
aiua-9669	87	37	histology	histology	NOUN
aiua-9669	87	38	,	,	PUNCT
aiua-9669	87	39	intraductal	intraductal	ADJ
aiua-9669	87	40	carcinoma	carcinoma	NOUN
aiua-9669	87	41	and	and	CCONJ
aiua-9669	87	42	pca	pca	NOUN
aiua-9669	87	43	with	with	ADP
aiua-9669	87	44	reactive	reactive	ADJ
aiua-9669	87	45	stroma	stroma	NOUN
aiua-9669	87	46	are	be	AUX
aiua-9669	87	47	characterized	characterize	VERB
aiua-9669	87	48	by	by	ADP
aiua-9669	87	49	aggressive	aggressive	ADJ
aiua-9669	87	50	genetic	genetic	ADJ
aiua-9669	87	51	alterations	alteration	NOUN
aiua-9669	87	52	and	and	CCONJ
aiua-9669	87	53	worse	bad	ADJ
aiua-9669	87	54	oncological	oncological	ADJ
aiua-9669	87	55	outcomes	outcome	NOUN
aiua-9669	87	56	.	.	PUNCT
aiua-9669	88	1	presence	presence	NOUN
aiua-9669	88	2	of	of	ADP
aiua-9669	88	3	pattern	pattern	NOUN
aiua-9669	88	4	4	4	NUM
aiua-9669	88	5	with	with	ADP
aiua-9669	88	6	cribriform	cribriform	NOUN
aiua-9669	88	7	histology	histology	NOUN
aiua-9669	88	8	must	must	AUX
aiua-9669	88	9	be	be	AUX
aiua-9669	88	10	reported	report	VERB
aiua-9669	88	11	because	because	SCONJ
aiua-9669	88	12	its	its	PRON
aiua-9669	88	13	presence	presence	NOUN
aiua-9669	88	14	and	and	CCONJ
aiua-9669	88	15	its	its	PRON
aiua-9669	88	16	quantitative	quantitative	ADJ
aiua-9669	88	17	representation	representation	NOUN
aiua-9669	88	18	(	(	PUNCT
aiua-9669	88	19	in	in	ADP
aiua-9669	88	20	terms	term	NOUN
aiua-9669	88	21	of	of	ADP
aiua-9669	88	22	percentage	percentage	NOUN
aiua-9669	88	23	)	)	PUNCT
aiua-9669	88	24	aggravate	aggravate	VERB
aiua-9669	88	25	prognosis	prognosis	NOUN
aiua-9669	88	26	(	(	PUNCT
aiua-9669	88	27	38	38	NUM
aiua-9669	88	28	)	)	PUNCT
aiua-9669	88	29	.	.	PUNCT
aiua-9669	89	1	cribriform	cribriform	NOUN
aiua-9669	89	2	can	can	AUX
aiua-9669	89	3	be	be	AUX
aiua-9669	89	4	confused	confuse	VERB
aiua-9669	89	5	by	by	ADP
aiua-9669	89	6	an	an	DET
aiua-9669	89	7	inexperienced	inexperienced	ADJ
aiua-9669	89	8	pathologist	pathologist	NOUN
aiua-9669	89	9	with	with	ADP
aiua-9669	89	10	other	other	ADJ
aiua-9669	89	11	histotypes	histotype	NOUN
aiua-9669	89	12	like	like	ADP
aiua-9669	89	13	glomeruloid	glomeruloid	PROPN
aiua-9669	89	14	glands	gland	NOUN
aiua-9669	89	15	,	,	PUNCT
aiua-9669	89	16	fused	fuse	VERB
aiua-9669	89	17	glands	gland	NOUN
aiua-9669	89	18	and	and	CCONJ
aiua-9669	89	19	poorly	poorly	ADV
aiua-9669	89	20	formed	form	VERB
aiua-9669	89	21	glands	gland	NOUN
aiua-9669	89	22	.	.	PUNCT
aiua-9669	90	1	hollemans	holleman	NOUN
aiua-9669	90	2	et	et	PROPN
aiua-9669	90	3	al	al	PROPN
aiua-9669	90	4	.	.	PROPN
aiua-9669	91	1	distinguished	distinguished	ADJ
aiua-9669	91	2	cribriform	cribriform	NOUN
aiua-9669	91	3	type	type	NOUN
aiua-9669	91	4	into	into	ADP
aiua-9669	91	5	two	two	NUM
aiua-9669	91	6	groups	group	NOUN
aiua-9669	91	7	:	:	PUNCT
aiua-9669	91	8	small	small	ADJ
aiua-9669	91	9	cribriform	cribriform	NOUN
aiua-9669	91	10	(	(	PUNCT
aiua-9669	91	11	<	<	X
aiua-9669	91	12	12	12	NUM
aiua-9669	91	13	lumina	lumina	NOUN
aiua-9669	91	14	)	)	PUNCT
aiua-9669	91	15	and	and	CCONJ
aiua-9669	91	16	large	large	ADJ
aiua-9669	91	17	cribriform	cribriform	NOUN
aiua-9669	91	18	(	(	PUNCT
aiua-9669	91	19	>	>	X
aiua-9669	91	20	12	12	NUM
aiua-9669	91	21	lumina	lumina	NOUN
aiua-9669	91	22	):	):	PUNCT
aiua-9669	91	23	patients	patient	NOUN
aiua-9669	91	24	with	with	ADP
aiua-9669	91	25	large	large	ADJ
aiua-9669	91	26	invasive	invasive	ADJ
aiua-9669	91	27	cribriform	cribriform	NOUN
aiua-9669	91	28	growth	growth	NOUN
aiua-9669	91	29	belong	belong	VERB
aiua-9669	91	30	to	to	ADP
aiua-9669	91	31	a	a	DET
aiua-9669	91	32	more	more	ADV
aiua-9669	91	33	aggressive	aggressive	ADJ
aiua-9669	91	34	subgroup	subgroup	NOUN
aiua-9669	91	35	with	with	ADP
aiua-9669	91	36	an	an	DET
aiua-9669	91	37	increased	increase	VERB
aiua-9669	91	38	risk	risk	NOUN
aiua-9669	91	39	for	for	ADP
aiua-9669	91	40	biochemical	biochemical	ADJ
aiua-9669	91	41	recurrence	recurrence	NOUN
aiua-9669	91	42	and	and	CCONJ
aiua-9669	91	43	metastasis	metastasis	NOUN
aiua-9669	91	44	(	(	PUNCT
aiua-9669	91	45	39	39	NUM
aiua-9669	91	46	)	)	PUNCT
aiua-9669	91	47	.	.	PUNCT
aiua-9669	92	1	intraductal	intraductal	ADJ
aiua-9669	92	2	carcinoma	carcinoma	NOUN
aiua-9669	92	3	(	(	PUNCT
aiua-9669	92	4	idc	idc	PROPN
aiua-9669	92	5	-	-	PROPN
aiua-9669	92	6	p	p	NOUN
aiua-9669	92	7	)	)	PUNCT
aiua-9669	92	8	is	be	AUX
aiua-9669	92	9	pathologically	pathologically	ADV
aiua-9669	92	10	recognized	recognize	VERB
aiua-9669	92	11	by	by	ADP
aiua-9669	92	12	its	its	PRON
aiua-9669	92	13	cribriform	cribriform	NOUN
aiua-9669	92	14	or	or	CCONJ
aiua-9669	92	15	solid	solid	ADJ
aiua-9669	92	16	growth	growth	NOUN
aiua-9669	92	17	pattern	pattern	NOUN
aiua-9669	92	18	distending	distend	VERB
aiua-9669	92	19	preexistent	preexistent	NOUN
aiua-9669	92	20	acini	acinus	NOUN
aiua-9669	92	21	and	and	CCONJ
aiua-9669	92	22	prostatic	prostatic	ADJ
aiua-9669	92	23	ducts	duct	NOUN
aiua-9669	92	24	with	with	ADP
aiua-9669	92	25	preservation	preservation	NOUN
aiua-9669	92	26	of	of	ADP
aiua-9669	92	27	basal	basal	ADJ
aiua-9669	92	28	cells	cell	NOUN
aiua-9669	92	29	;	;	PUNCT
aiua-9669	92	30	in	in	ADP
aiua-9669	92	31	most	most	ADJ
aiua-9669	92	32	cases	case	NOUN
aiua-9669	92	33	idc	idc	PROPN
aiua-9669	92	34	-	-	PROPN
aiua-9669	92	35	p	p	PROPN
aiua-9669	92	36	is	be	AUX
aiua-9669	92	37	closed	close	VERB
aiua-9669	92	38	associated	associate	VERB
aiua-9669	92	39	to	to	ADP
aiua-9669	92	40	presence	presence	NOUN
aiua-9669	92	41	of	of	ADP
aiua-9669	92	42	high	high	ADJ
aiua-9669	92	43	grade	grade	NOUN
aiua-9669	92	44	pca	pca	NOUN
aiua-9669	92	45	and	and	CCONJ
aiua-9669	92	46	high	high	ADJ
aiua-9669	92	47	volume	volume	NOUN
aiua-9669	92	48	cancers	cancer	NOUN
aiua-9669	92	49	(	(	PUNCT
aiua-9669	92	50	40	40	NUM
aiua-9669	92	51	)	)	PUNCT
aiua-9669	92	52	.	.	PUNCT
aiua-9669	93	1	percentage	percentage	NOUN
aiua-9669	93	2	of	of	ADP
aiua-9669	93	3	grade	grade	NOUN
aiua-9669	93	4	4	4	NUM
aiua-9669	93	5	,	,	PUNCT
aiua-9669	93	6	grade	grade	NOUN
aiua-9669	93	7	4	4	NUM
aiua-9669	93	8	cribriform	cribriform	NOUN
aiua-9669	93	9	pattern	pattern	NOUN
aiua-9669	93	10	and	and	CCONJ
aiua-9669	93	11	the	the	DET
aiua-9669	93	12	presence	presence	NOUN
aiua-9669	93	13	of	of	ADP
aiua-9669	93	14	intraductal	intraductal	ADJ
aiua-9669	93	15	carcinoma	carcinoma	NOUN
aiua-9669	93	16	at	at	ADP
aiua-9669	93	17	biopsy	biopsy	NOUN
aiua-9669	93	18	have	have	VERB
aiua-9669	93	19	an	an	DET
aiua-9669	93	20	important	important	ADJ
aiua-9669	93	21	impact	impact	NOUN
aiua-9669	93	22	on	on	ADP
aiua-9669	93	23	the	the	DET
aiua-9669	93	24	prognosis	prognosis	NOUN
aiua-9669	93	25	.	.	PUNCT
aiua-9669	94	1	the	the	DET
aiua-9669	94	2	presence	presence	NOUN
aiua-9669	94	3	of	of	ADP
aiua-9669	94	4	intraductal	intraductal	ADJ
aiua-9669	94	5	growth	growth	NOUN
aiua-9669	94	6	or	or	CCONJ
aiua-9669	94	7	invasive	invasive	ADJ
aiua-9669	94	8	cribriform	cribriform	NOUN
aiua-9669	94	9	cancer	cancer	NOUN
aiua-9669	94	10	at	at	ADP
aiua-9669	94	11	biopsy	biopsy	NOUN
aiua-9669	94	12	outperforms	outperform	NOUN
aiua-9669	94	13	percentage	percentage	NOUN
aiua-9669	94	14	grade	grade	NOUN
aiua-9669	94	15	4	4	NUM
aiua-9669	94	16	in	in	ADP
aiua-9669	94	17	predicting	predict	VERB
aiua-9669	94	18	outcome	outcome	NOUN
aiua-9669	94	19	of	of	ADP
aiua-9669	94	20	gleason	gleason	PROPN
aiua-9669	94	21	score	score	VERB
aiua-9669	94	22	3	3	NUM
aiua-9669	94	23	+	+	SYM
aiua-9669	94	24	4	4	NUM
aiua-9669	94	25	=	=	SYM
aiua-9669	94	26	7	7	NUM
aiua-9669	94	27	pca	pca	NOUN
aiua-9669	94	28	:	:	PUNCT
aiua-9669	94	29	in	in	ADP
aiua-9669	94	30	370	370	NUM
aiua-9669	94	31	men	man	NOUN
aiua-9669	94	32	with	with	ADP
aiua-9669	94	33	gs	gs	PROPN
aiua-9669	94	34	3	3	NUM
aiua-9669	94	35	+	+	NOUN
aiua-9669	94	36	4	4	NUM
aiua-9669	94	37	=	=	SYM
aiua-9669	94	38	7	7	NUM
aiua-9669	94	39	prostatic	prostatic	ADJ
aiua-9669	94	40	cancer	cancer	NOUN
aiua-9669	94	41	was	be	AUX
aiua-9669	94	42	demonstrated	demonstrate	VERB
aiua-9669	94	43	that	that	SCONJ
aiua-9669	94	44	invasive	invasive	ADJ
aiua-9669	94	45	cribriform	cribriform	NOUN
aiua-9669	94	46	and/or	and/or	CCONJ
aiua-9669	94	47	intraductal	intraductal	ADJ
aiua-9669	94	48	carcinoma	carcinoma	NOUN
aiua-9669	94	49	are	be	AUX
aiua-9669	94	50	independent	independent	ADJ
aiua-9669	94	51	parameters	parameter	NOUN
aiua-9669	94	52	for	for	ADP
aiua-9669	94	53	bcr	bcr	NOUN
aiua-9669	94	54	after	after	ADP
aiua-9669	94	55	radical	radical	ADJ
aiua-9669	94	56	prostatectomy	prostatectomy	NOUN
aiua-9669	94	57	,	,	PUNCT
aiua-9669	94	58	while	while	SCONJ
aiua-9669	94	59	percentage	percentage	NOUN
aiua-9669	94	60	of	of	ADP
aiua-9669	94	61	gleason	gleason	PROPN
aiua-9669	94	62	group	group	PROPN
aiua-9669	94	63	4	4	NUM
aiua-9669	94	64	is	be	AUX
aiua-9669	94	65	not	not	PART
aiua-9669	94	66	.	.	PUNCT
aiua-9669	95	1	the	the	DET
aiua-9669	95	2	majority	majority	NOUN
aiua-9669	95	3	of	of	ADP
aiua-9669	95	4	idc	idc	PROPN
aiua-9669	95	5	-	-	PROPN
aiua-9669	95	6	p	p	PROPN
aiua-9669	95	7	derived	derive	VERB
aiua-9669	95	8	from	from	ADP
aiua-9669	95	9	adjacent	adjacent	ADJ
aiua-9669	95	10	highgrade	highgrade	NOUN
aiua-9669	95	11	invasive	invasive	ADJ
aiua-9669	95	12	carcinoma	carcinoma	NOUN
aiua-9669	95	13	via	via	ADP
aiua-9669	95	14	retrograde	retrograde	ADJ
aiua-9669	95	15	spreading	spread	VERB
aiua-9669	95	16	of	of	ADP
aiua-9669	95	17	cancer	cancer	NOUN
aiua-9669	95	18	cells	cell	NOUN
aiua-9669	95	19	along	along	ADP
aiua-9669	95	20	benign	benign	ADJ
aiua-9669	95	21	ducts	duct	NOUN
aiua-9669	95	22	and	and	CCONJ
aiua-9669	95	23	acini	acinus	NOUN
aiua-9669	95	24	;	;	PUNCT
aiua-9669	95	25	a	a	DET
aiua-9669	95	26	small	small	ADJ
aiua-9669	95	27	group	group	NOUN
aiua-9669	95	28	of	of	ADP
aiua-9669	95	29	idc	idc	PROPN
aiua-9669	95	30	-	-	PROPN
aiua-9669	95	31	p	p	PROPN
aiua-9669	95	32	may	may	AUX
aiua-9669	95	33	represent	represent	VERB
aiua-9669	95	34	the	the	DET
aiua-9669	95	35	transformation	transformation	NOUN
aiua-9669	95	36	of	of	ADP
aiua-9669	95	37	precancerous	precancerous	ADJ
aiua-9669	95	38	intraductal	intraductal	ADJ
aiua-9669	95	39	proliferation	proliferation	NOUN
aiua-9669	95	40	induced	induce	VERB
aiua-9669	95	41	by	by	ADP
aiua-9669	95	42	various	various	ADJ
aiua-9669	95	43	oncogenic	oncogenic	ADJ
aiua-9669	95	44	alterations	alteration	NOUN
aiua-9669	95	45	(	(	PUNCT
aiua-9669	95	46	41	41	NUM
aiua-9669	95	47	)	)	PUNCT
aiua-9669	95	48	.	.	PUNCT
aiua-9669	96	1	the	the	DET
aiua-9669	96	2	prevalence	prevalence	NOUN
aiua-9669	96	3	of	of	ADP
aiua-9669	96	4	idc	idc	PROPN
aiua-9669	96	5	-	-	PROPN
aiua-9669	96	6	p	p	PROPN
aiua-9669	96	7	increased	increase	VERB
aiua-9669	96	8	significantly	significantly	ADV
aiua-9669	96	9	from	from	ADP
aiua-9669	96	10	2.1	2.1	NUM
aiua-9669	96	11	%	%	NOUN
aiua-9669	96	12	in	in	ADP
aiua-9669	96	13	low	low	ADJ
aiua-9669	96	14	-	-	PUNCT
aiua-9669	96	15	risk	risk	NOUN
aiua-9669	96	16	patient	patient	NOUN
aiua-9669	96	17	up	up	ADP
aiua-9669	96	18	to	to	PART
aiua-9669	96	19	56.0	56.0	NUM
aiua-9669	96	20	%	%	NOUN
aiua-9669	96	21	in	in	ADP
aiua-9669	96	22	metastatic	metastatic	ADJ
aiua-9669	96	23	or	or	CCONJ
aiua-9669	96	24	recurrent	recurrent	ADJ
aiua-9669	96	25	pca	pca	NOUN
aiua-9669	96	26	patients	patient	NOUN
aiua-9669	96	27	(	(	PUNCT
aiua-9669	96	28	42	42	NUM
aiua-9669	96	29	)	)	PUNCT
aiua-9669	96	30	.	.	PUNCT
aiua-9669	97	1	interestingly	interestingly	ADV
aiua-9669	97	2	,	,	PUNCT
aiua-9669	97	3	in	in	ADP
aiua-9669	97	4	patients	patient	NOUN
aiua-9669	97	5	treated	treat	VERB
aiua-9669	97	6	with	with	ADP
aiua-9669	97	7	androgen	androgen	NOUN
aiua-9669	97	8	deprivation	deprivation	NOUN
aiua-9669	97	9	therapy	therapy	NOUN
aiua-9669	97	10	(	(	PUNCT
aiua-9669	97	11	adt	adt	NOUN
aiua-9669	97	12	)	)	PUNCT
aiua-9669	97	13	or	or	CCONJ
aiua-9669	97	14	chemotherapy	chemotherapy	NOUN
aiua-9669	97	15	,	,	PUNCT
aiua-9669	97	16	idc	idc	PROPN
aiua-9669	97	17	-	-	PROPN
aiua-9669	97	18	p	p	PROPN
aiua-9669	97	19	was	be	AUX
aiua-9669	97	20	reported	report	VERB
aiua-9669	97	21	in	in	ADP
aiua-9669	97	22	60	60	NUM
aiua-9669	97	23	%	%	NOUN
aiua-9669	97	24	of	of	ADP
aiua-9669	97	25	pca	pca	NOUN
aiua-9669	97	26	indicating	indicate	VERB
aiua-9669	97	27	that	that	SCONJ
aiua-9669	97	28	idc	idc	PROPN
aiua-9669	97	29	-	-	PROPN
aiua-9669	97	30	p	p	PROPN
aiua-9669	97	31	may	may	AUX
aiua-9669	97	32	correlate	correlate	VERB
aiua-9669	97	33	with	with	ADP
aiua-9669	97	34	the	the	DET
aiua-9669	97	35	development	development	NOUN
aiua-9669	97	36	of	of	ADP
aiua-9669	97	37	castration	castration	NOUN
aiua-9669	97	38	-	-	PUNCT
aiua-9669	97	39	resistant	resistant	ADJ
aiua-9669	97	40	prostate	prostate	NOUN
aiua-9669	97	41	cancer	cancer	NOUN
aiua-9669	97	42	.	.	PUNCT
aiua-9669	98	1	95archivio	95archivio	NUM
aiua-9669	98	2	italiano	italiano	PROPN
aiua-9669	98	3	di	di	X
aiua-9669	98	4	urologia	urologia	PROPN
aiua-9669	98	5	e	e	PROPN
aiua-9669	98	6	andrologia	andrologia	NOUN
aiua-9669	98	7	2021	2021	NUM
aiua-9669	98	8	;	;	PUNCT
aiua-9669	98	9	93	93	NUM
aiua-9669	98	10	,	,	PUNCT
aiua-9669	98	11	1	1	NUM
aiua-9669	98	12	significant	significant	ADJ
aiua-9669	98	13	prostate	prostate	NOUN
aiua-9669	98	14	cancer	cancer	NOUN
aiua-9669	98	15	with	with	ADP
aiua-9669	98	16	low	low	ADJ
aiua-9669	98	17	psa	psa	NOUN
aiua-9669	98	18	pca	pca	PROPN
aiua-9669	98	19	with	with	ADP
aiua-9669	98	20	reactive	reactive	ADJ
aiua-9669	98	21	stroma	stroma	NOUN
aiua-9669	98	22	another	another	DET
aiua-9669	98	23	important	important	ADJ
aiua-9669	98	24	overview	overview	NOUN
aiua-9669	98	25	is	be	AUX
aiua-9669	98	26	focused	focus	VERB
aiua-9669	98	27	on	on	ADP
aiua-9669	98	28	pca	pca	PROPN
aiua-9669	98	29	with	with	ADP
aiua-9669	98	30	reactive	reactive	ADJ
aiua-9669	98	31	stroma	stroma	NOUN
aiua-9669	98	32	(	(	PUNCT
aiua-9669	98	33	also	also	ADV
aiua-9669	98	34	called	call	VERB
aiua-9669	98	35	stromogenic	stromogenic	ADJ
aiua-9669	98	36	pca	pca	PROPN
aiua-9669	98	37	)	)	PUNCT
aiua-9669	98	38	,	,	PUNCT
aiua-9669	98	39	that	that	ADV
aiua-9669	98	40	is	is	ADV
aiua-9669	98	41	,	,	PUNCT
aiua-9669	98	42	by	by	ADP
aiua-9669	98	43	definition	definition	NOUN
aiua-9669	98	44	,	,	PUNCT
aiua-9669	98	45	composed	compose	VERB
aiua-9669	98	46	by	by	ADP
aiua-9669	98	47	at	at	ADV
aiua-9669	98	48	least	least	ADV
aiua-9669	98	49	50	50	NUM
aiua-9669	98	50	%	%	NOUN
aiua-9669	98	51	reactive	reactive	ADJ
aiua-9669	98	52	stroma	stroma	NOUN
aiua-9669	98	53	(	(	PUNCT
aiua-9669	98	54	stroma	stroma	ADJ
aiua-9669	98	55	/	/	SYM
aiua-9669	98	56	epithelium	epithelium	NOUN
aiua-9669	98	57	ratio	ratio	NOUN
aiua-9669	98	58	≥	≥	NOUN
aiua-9669	98	59	1	1	NUM
aiua-9669	98	60	)	)	PUNCT
aiua-9669	98	61	.	.	PUNCT
aiua-9669	99	1	the	the	DET
aiua-9669	99	2	prototypic	prototypic	ADJ
aiua-9669	99	3	“	"	PUNCT
aiua-9669	99	4	stromogenic	stromogenic	NOUN
aiua-9669	99	5	”	"	PUNCT
aiua-9669	99	6	carcinoma	carcinoma	NOUN
aiua-9669	99	7	is	be	AUX
aiua-9669	99	8	of	of	ADP
aiua-9669	99	9	the	the	DET
aiua-9669	99	10	classic	classic	ADJ
aiua-9669	99	11	acinar	acinar	NOUN
aiua-9669	99	12	subtype	subtype	NOUN
aiua-9669	99	13	,	,	PUNCT
aiua-9669	99	14	with	with	ADP
aiua-9669	99	15	well	well	ADV
aiua-9669	99	16	-	-	PUNCT
aiua-9669	99	17	formed	form	VERB
aiua-9669	99	18	glands	gland	NOUN
aiua-9669	99	19	surrounded	surround	VERB
aiua-9669	99	20	by	by	ADP
aiua-9669	99	21	an	an	DET
aiua-9669	99	22	evident	evident	ADJ
aiua-9669	99	23	amount	amount	NOUN
aiua-9669	99	24	of	of	ADP
aiua-9669	99	25	stroma	stroma	NOUN
aiua-9669	99	26	.	.	PUNCT
aiua-9669	100	1	this	this	DET
aiua-9669	100	2	pathological	pathological	ADJ
aiua-9669	100	3	feature	feature	NOUN
aiua-9669	100	4	is	be	AUX
aiua-9669	100	5	correlated	correlate	VERB
aiua-9669	100	6	with	with	ADP
aiua-9669	100	7	a	a	DET
aiua-9669	100	8	worse	bad	ADJ
aiua-9669	100	9	prognosis	prognosis	NOUN
aiua-9669	100	10	;	;	PUNCT
aiua-9669	100	11	in	in	ADP
aiua-9669	100	12	samples	sample	NOUN
aiua-9669	100	13	with	with	ADP
aiua-9669	100	14	high	high	ADJ
aiua-9669	100	15	reactive	reactive	ADJ
aiua-9669	100	16	stroma	stroma	NOUN
aiua-9669	100	17	,	,	PUNCT
aiua-9669	100	18	metabolites	metabolite	NOUN
aiua-9669	100	19	and	and	CCONJ
aiua-9669	100	20	genes	gene	NOUN
aiua-9669	100	21	linked	link	VERB
aiua-9669	100	22	to	to	ADP
aiua-9669	100	23	immune	immune	ADJ
aiua-9669	100	24	functions	function	NOUN
aiua-9669	100	25	and	and	CCONJ
aiua-9669	100	26	extracellular	extracellular	ADJ
aiua-9669	100	27	matrix	matrix	NOUN
aiua-9669	100	28	remodeling	remodeling	NOUN
aiua-9669	100	29	are	be	AUX
aiua-9669	100	30	significantly	significantly	ADV
aiua-9669	100	31	upregulated	upregulate	VERB
aiua-9669	100	32	(	(	PUNCT
aiua-9669	100	33	43	43	NUM
aiua-9669	100	34	)	)	PUNCT
aiua-9669	100	35	.	.	PUNCT
aiua-9669	101	1	psa	psa	VERB
aiua-9669	101	2	negative	negative	ADJ
aiua-9669	101	3	prostatic	prostatic	ADJ
aiua-9669	101	4	tumors	tumor	NOUN
aiua-9669	101	5	psa	psa	VERB
aiua-9669	101	6	has	have	AUX
aiua-9669	101	7	been	be	AUX
aiua-9669	101	8	used	use	VERB
aiua-9669	101	9	as	as	ADP
aiua-9669	101	10	serum	serum	NOUN
aiua-9669	101	11	marker	marker	NOUN
aiua-9669	101	12	for	for	ADP
aiua-9669	101	13	pca	pca	NOUN
aiua-9669	101	14	screening	screening	NOUN
aiua-9669	101	15	in	in	ADP
aiua-9669	101	16	the	the	DET
aiua-9669	101	17	male	male	ADJ
aiua-9669	101	18	population	population	NOUN
aiua-9669	101	19	,	,	PUNCT
aiua-9669	101	20	but	but	CCONJ
aiua-9669	101	21	its	its	PRON
aiua-9669	101	22	specificity	specificity	NOUN
aiua-9669	101	23	is	be	AUX
aiua-9669	101	24	low	low	ADJ
aiua-9669	101	25	due	due	ADP
aiua-9669	101	26	to	to	ADP
aiua-9669	101	27	its	its	PRON
aiua-9669	101	28	production	production	NOUN
aiua-9669	101	29	by	by	ADP
aiua-9669	101	30	normal	normal	ADJ
aiua-9669	101	31	epithelial	epithelial	ADJ
aiua-9669	101	32	tissue	tissue	NOUN
aiua-9669	101	33	.	.	PUNCT
aiua-9669	102	1	psa	psa	NOUN
aiua-9669	102	2	antibody	antibody	NOUN
aiua-9669	102	3	is	be	AUX
aiua-9669	102	4	currently	currently	ADV
aiua-9669	102	5	used	use	VERB
aiua-9669	102	6	in	in	ADP
aiua-9669	102	7	immunohistochemistry	immunohistochemistry	NOUN
aiua-9669	102	8	to	to	PART
aiua-9669	102	9	determine	determine	VERB
aiua-9669	102	10	whether	whether	SCONJ
aiua-9669	102	11	tumor	tumor	NOUN
aiua-9669	102	12	masses	masse	NOUN
aiua-9669	102	13	of	of	ADP
aiua-9669	102	14	unknown	unknown	ADJ
aiua-9669	102	15	origin	origin	NOUN
aiua-9669	102	16	can	can	AUX
aiua-9669	102	17	be	be	AUX
aiua-9669	102	18	assigned	assign	VERB
aiua-9669	102	19	to	to	ADP
aiua-9669	102	20	a	a	DET
aiua-9669	102	21	prostate	prostate	NOUN
aiua-9669	102	22	cancer	cancer	NOUN
aiua-9669	102	23	.	.	PUNCT
aiua-9669	103	1	however	however	ADV
aiua-9669	103	2	,	,	PUNCT
aiua-9669	103	3	some	some	DET
aiua-9669	103	4	prostatic	prostatic	ADJ
aiua-9669	103	5	tumors	tumor	NOUN
aiua-9669	103	6	do	do	AUX
aiua-9669	103	7	not	not	PART
aiua-9669	103	8	express	express	VERB
aiua-9669	103	9	psa	psa	NOUN
aiua-9669	103	10	in	in	ADP
aiua-9669	103	11	immunohistochemistry	immunohistochemistry	NOUN
aiua-9669	103	12	and	and	CCONJ
aiua-9669	103	13	do	do	AUX
aiua-9669	103	14	not	not	PART
aiua-9669	103	15	determine	determine	VERB
aiua-9669	103	16	increases	increase	NOUN
aiua-9669	103	17	in	in	ADP
aiua-9669	103	18	psa	psa	NOUN
aiua-9669	103	19	levels	level	NOUN
aiua-9669	103	20	in	in	ADP
aiua-9669	103	21	the	the	DET
aiua-9669	103	22	blood	blood	NOUN
aiua-9669	103	23	(	(	PUNCT
aiua-9669	103	24	34	34	NUM
aiua-9669	103	25	)	)	PUNCT
aiua-9669	103	26	.	.	PUNCT
aiua-9669	104	1	in	in	ADP
aiua-9669	104	2	poorly	poorly	ADV
aiua-9669	104	3	differentiated	differentiate	VERB
aiua-9669	104	4	tumors	tumor	NOUN
aiua-9669	104	5	or	or	CCONJ
aiua-9669	104	6	metastatic	metastatic	ADJ
aiua-9669	104	7	foci	focus	NOUN
aiua-9669	104	8	,	,	PUNCT
aiua-9669	104	9	psa	psa	NOUN
aiua-9669	104	10	expression	expression	NOUN
aiua-9669	104	11	might	might	AUX
aiua-9669	104	12	be	be	AUX
aiua-9669	104	13	decreased	decrease	VERB
aiua-9669	104	14	or	or	CCONJ
aiua-9669	104	15	even	even	ADV
aiua-9669	104	16	lost	lose	VERB
aiua-9669	104	17	.	.	PUNCT
aiua-9669	105	1	pca	pca	PROPN
aiua-9669	105	2	with	with	ADP
aiua-9669	105	3	neuroendocrine	neuroendocrine	ADJ
aiua-9669	105	4	differentiation	differentiation	NOUN
aiua-9669	105	5	often	often	ADV
aiua-9669	105	6	lost	lose	VERB
aiua-9669	105	7	psa	psa	NOUN
aiua-9669	105	8	expression	expression	NOUN
aiua-9669	105	9	(	(	PUNCT
aiua-9669	105	10	44	44	NUM
aiua-9669	105	11	)	)	PUNCT
aiua-9669	105	12	.	.	PUNCT
aiua-9669	106	1	more	more	ADV
aiua-9669	106	2	specific	specific	ADJ
aiua-9669	106	3	markers	marker	NOUN
aiua-9669	106	4	such	such	ADJ
aiua-9669	106	5	as	as	ADP
aiua-9669	106	6	psma	psma	NOUN
aiua-9669	106	7	and	and	CCONJ
aiua-9669	106	8	nkx3.1	nkx3.1	PROPN
aiua-9669	106	9	are	be	AUX
aiua-9669	106	10	now	now	ADV
aiua-9669	106	11	available	available	ADJ
aiua-9669	106	12	to	to	PART
aiua-9669	106	13	overcome	overcome	VERB
aiua-9669	106	14	the	the	DET
aiua-9669	106	15	limited	limited	ADJ
aiua-9669	106	16	sensitivity	sensitivity	NOUN
aiua-9669	106	17	of	of	ADP
aiua-9669	106	18	psa	psa	NOUN
aiua-9669	106	19	(	(	PUNCT
aiua-9669	106	20	figure	figure	NOUN
aiua-9669	106	21	1	1	NUM
aiua-9669	106	22	)	)	PUNCT
aiua-9669	106	23	(	(	PUNCT
aiua-9669	106	24	45	45	NUM
aiua-9669	106	25	)	)	PUNCT
aiua-9669	106	26	.	.	PUNCT
aiua-9669	107	1	moreover	moreover	ADV
aiua-9669	107	2	,	,	PUNCT
aiua-9669	107	3	other	other	ADJ
aiua-9669	107	4	tumor	tumor	NOUN
aiua-9669	107	5	types	type	NOUN
aiua-9669	107	6	,	,	PUNCT
aiua-9669	107	7	although	although	SCONJ
aiua-9669	107	8	rare	rare	ADJ
aiua-9669	107	9	,	,	PUNCT
aiua-9669	107	10	such	such	ADJ
aiua-9669	107	11	as	as	ADP
aiua-9669	107	12	prostatic	prostatic	ADJ
aiua-9669	107	13	stromal	stromal	ADJ
aiua-9669	107	14	and	and	CCONJ
aiua-9669	107	15	smooth	smooth	ADJ
aiua-9669	107	16	muscle	muscle	NOUN
aiua-9669	107	17	tumors	tumor	NOUN
aiua-9669	107	18	,	,	PUNCT
aiua-9669	107	19	both	both	CCONJ
aiua-9669	107	20	benign	benign	ADJ
aiua-9669	107	21	and	and	CCONJ
aiua-9669	107	22	malignant	malignant	ADJ
aiua-9669	107	23	,	,	PUNCT
aiua-9669	107	24	solitary	solitary	ADJ
aiua-9669	107	25	fibrous	fibrous	ADJ
aiua-9669	107	26	,	,	PUNCT
aiua-9669	107	27	neural	neural	ADJ
aiua-9669	107	28	,	,	PUNCT
aiua-9669	107	29	germ	germ	NOUN
aiua-9669	107	30	cell	cell	NOUN
aiua-9669	107	31	,	,	PUNCT
aiua-9669	107	32	hematopoietic	hematopoietic	ADJ
aiua-9669	107	33	and	and	CCONJ
aiua-9669	107	34	melanocytic	melanocytic	ADJ
aiua-9669	107	35	tumors	tumor	NOUN
aiua-9669	107	36	,	,	PUNCT
aiua-9669	107	37	can	can	AUX
aiua-9669	107	38	form	form	VERB
aiua-9669	107	39	a	a	DET
aiua-9669	107	40	palpable	palpable	ADJ
aiua-9669	107	41	mass	mass	NOUN
aiua-9669	107	42	in	in	ADP
aiua-9669	107	43	the	the	DET
aiua-9669	107	44	prostate	prostate	NOUN
aiua-9669	107	45	,	,	PUNCT
aiua-9669	107	46	without	without	ADP
aiua-9669	107	47	giving	give	VERB
aiua-9669	107	48	an	an	DET
aiua-9669	107	49	increase	increase	NOUN
aiua-9669	107	50	of	of	ADP
aiua-9669	107	51	the	the	DET
aiua-9669	107	52	serum	serum	NOUN
aiua-9669	107	53	psa	psa	NOUN
aiua-9669	107	54	(	(	PUNCT
aiua-9669	107	55	46	46	NUM
aiua-9669	107	56	)	)	PUNCT
aiua-9669	107	57	.	.	PUNCT
aiua-9669	108	1	psa	psa	VERB
aiua-9669	108	2	screening	screen	VERB
aiua-9669	108	3	alone	alone	ADV
aiua-9669	108	4	is	be	AUX
aiua-9669	108	5	not	not	PART
aiua-9669	108	6	sufficient	sufficient	ADJ
aiua-9669	108	7	to	to	PART
aiua-9669	108	8	exclude	exclude	VERB
aiua-9669	108	9	a	a	DET
aiua-9669	108	10	prostatic	prostatic	ADJ
aiua-9669	108	11	tumor	tumor	NOUN
aiua-9669	108	12	;	;	PUNCT
aiua-9669	108	13	a	a	DET
aiua-9669	108	14	physical	physical	ADJ
aiua-9669	108	15	inspection	inspection	NOUN
aiua-9669	108	16	with	with	ADP
aiua-9669	108	17	digital	digital	ADJ
aiua-9669	108	18	rectal	rectal	ADJ
aiua-9669	108	19	examination	examination	NOUN
aiua-9669	108	20	is	be	AUX
aiua-9669	108	21	highly	highly	ADV
aiua-9669	108	22	recommended	recommend	VERB
aiua-9669	108	23	and	and	CCONJ
aiua-9669	108	24	should	should	AUX
aiua-9669	108	25	not	not	PART
aiua-9669	108	26	be	be	AUX
aiua-9669	108	27	replaced	replace	VERB
aiua-9669	108	28	by	by	ADP
aiua-9669	108	29	a	a	DET
aiua-9669	108	30	psa	psa	NOUN
aiua-9669	108	31	screening	screen	VERB
aiua-9669	108	32	alone	alone	ADV
aiua-9669	108	33	.	.	PUNCT
aiua-9669	109	1	the	the	DET
aiua-9669	109	2	role	role	NOUN
aiua-9669	109	3	of	of	ADP
aiua-9669	109	4	mpmr	mpmr	NOUN
aiua-9669	109	5	according	accord	VERB
aiua-9669	109	6	to	to	ADP
aiua-9669	109	7	the	the	DET
aiua-9669	109	8	most	most	ADV
aiua-9669	109	9	recent	recent	ADJ
aiua-9669	109	10	update	update	NOUN
aiua-9669	109	11	of	of	ADP
aiua-9669	109	12	the	the	DET
aiua-9669	109	13	european	european	PROPN
aiua-9669	109	14	urology	urology	PROPN
aiua-9669	109	15	association	association	PROPN
aiua-9669	109	16	guidelines	guideline	NOUN
aiua-9669	109	17	,	,	PUNCT
aiua-9669	109	18	the	the	DET
aiua-9669	109	19	introduction	introduction	NOUN
aiua-9669	109	20	of	of	ADP
aiua-9669	109	21	mpmr	mpmr	NOUN
aiua-9669	109	22	in	in	ADP
aiua-9669	109	23	the	the	DET
aiua-9669	109	24	diagnostic	diagnostic	ADJ
aiua-9669	109	25	pathway	pathway	NOUN
aiua-9669	109	26	in	in	ADP
aiua-9669	109	27	all	all	DET
aiua-9669	109	28	patients	patient	NOUN
aiua-9669	109	29	with	with	ADP
aiua-9669	109	30	psa	psa	NOUN
aiua-9669	109	31	elevation	elevation	NOUN
aiua-9669	109	32	leads	lead	VERB
aiua-9669	109	33	to	to	ADP
aiua-9669	109	34	significant	significant	ADJ
aiua-9669	109	35	improvement	improvement	NOUN
aiua-9669	109	36	of	of	ADP
aiua-9669	109	37	clinically	clinically	ADV
aiua-9669	109	38	significant	significant	ADJ
aiua-9669	109	39	pca	pca	NOUN
aiua-9669	109	40	detection	detection	NOUN
aiua-9669	109	41	(	(	PUNCT
aiua-9669	109	42	2	2	NUM
aiua-9669	109	43	)	)	PUNCT
aiua-9669	109	44	.	.	PUNCT
aiua-9669	110	1	the	the	DET
aiua-9669	110	2	lesion	lesion	NOUN
aiua-9669	110	3	detected	detect	VERB
aiua-9669	110	4	by	by	ADP
aiua-9669	110	5	imaging	imaging	NOUN
aiua-9669	110	6	is	be	AUX
aiua-9669	110	7	then	then	ADV
aiua-9669	110	8	targeted	target	VERB
aiua-9669	110	9	by	by	ADP
aiua-9669	110	10	biopsies	biopsy	NOUN
aiua-9669	110	11	under	under	ADP
aiua-9669	110	12	the	the	DET
aiua-9669	110	13	guide	guide	NOUN
aiua-9669	110	14	of	of	ADP
aiua-9669	110	15	mri	mri	NOUN
aiua-9669	110	16	/	/	SYM
aiua-9669	110	17	ultrasound	ultrasound	NOUN
aiua-9669	110	18	fusion	fusion	NOUN
aiua-9669	110	19	technology	technology	NOUN
aiua-9669	110	20	.	.	PUNCT
aiua-9669	111	1	this	this	PRON
aiua-9669	111	2	increases	increase	VERB
aiua-9669	111	3	the	the	DET
aiua-9669	111	4	detection	detection	NOUN
aiua-9669	111	5	of	of	ADP
aiua-9669	111	6	cspca	cspca	NOUN
aiua-9669	111	7	,	,	PUNCT
aiua-9669	111	8	lowering	lower	VERB
aiua-9669	111	9	the	the	DET
aiua-9669	111	10	detection	detection	NOUN
aiua-9669	111	11	of	of	ADP
aiua-9669	111	12	insignificant	insignificant	ADJ
aiua-9669	111	13	disease	disease	NOUN
aiua-9669	111	14	.	.	PUNCT
aiua-9669	112	1	also	also	ADV
aiua-9669	112	2	“	"	PUNCT
aiua-9669	112	3	biopsy	biopsy	VERB
aiua-9669	112	4	naïve	naïve	ADJ
aiua-9669	112	5	”	"	PUNCT
aiua-9669	112	6	patients	patient	NOUN
aiua-9669	112	7	have	have	VERB
aiua-9669	112	8	a	a	DET
aiua-9669	112	9	benefit	benefit	NOUN
aiua-9669	112	10	with	with	ADP
aiua-9669	112	11	a	a	DET
aiua-9669	112	12	mr	mr	PROPN
aiua-9669	112	13	evaluation	evaluation	NOUN
aiua-9669	112	14	.	.	PUNCT
aiua-9669	113	1	however	however	ADV
aiua-9669	113	2	,	,	PUNCT
aiua-9669	113	3	it	it	PRON
aiua-9669	113	4	is	be	AUX
aiua-9669	113	5	of	of	ADP
aiua-9669	113	6	outmost	outmost	NOUN
aiua-9669	113	7	importance	importance	NOUN
aiua-9669	113	8	that	that	SCONJ
aiua-9669	113	9	a	a	DET
aiua-9669	113	10	negative	negative	ADJ
aiua-9669	113	11	mr	mr	PROPN
aiua-9669	113	12	does	do	AUX
aiua-9669	113	13	not	not	PART
aiua-9669	113	14	exclude	exclude	VERB
aiua-9669	113	15	the	the	DET
aiua-9669	113	16	possibility	possibility	NOUN
aiua-9669	113	17	of	of	ADP
aiua-9669	113	18	significant	significant	ADJ
aiua-9669	113	19	pca	pca	NOUN
aiua-9669	113	20	.	.	PUNCT
aiua-9669	114	1	moreover	moreover	ADV
aiua-9669	114	2	,	,	PUNCT
aiua-9669	114	3	deciding	decide	VERB
aiua-9669	114	4	whether	whether	SCONJ
aiua-9669	114	5	or	or	CCONJ
aiua-9669	114	6	not	not	PART
aiua-9669	114	7	is	be	AUX
aiua-9669	114	8	safe	safe	ADJ
aiua-9669	114	9	to	to	PART
aiua-9669	114	10	avoid	avoid	VERB
aiua-9669	114	11	a	a	DET
aiua-9669	114	12	biopsy	biopsy	NOUN
aiua-9669	114	13	in	in	ADP
aiua-9669	114	14	a	a	DET
aiua-9669	114	15	naïve	naïve	ADJ
aiua-9669	114	16	patient	patient	NOUN
aiua-9669	114	17	with	with	ADP
aiua-9669	114	18	negative	negative	ADJ
aiua-9669	114	19	imaging	imaging	NOUN
aiua-9669	114	20	should	should	AUX
aiua-9669	114	21	also	also	ADV
aiua-9669	114	22	rely	rely	VERB
aiua-9669	114	23	on	on	ADP
aiua-9669	114	24	psad	psad	ADJ
aiua-9669	114	25	,	,	PUNCT
aiua-9669	114	26	digital	digital	ADJ
aiua-9669	114	27	rectal	rectal	ADJ
aiua-9669	114	28	evaluations	evaluation	NOUN
aiua-9669	114	29	,	,	PUNCT
aiua-9669	114	30	nomograms	nomogram	NOUN
aiua-9669	114	31	,	,	PUNCT
aiua-9669	114	32	new	new	ADJ
aiua-9669	114	33	biomarkers	biomarker	NOUN
aiua-9669	114	34	and	and	CCONJ
aiua-9669	114	35	family	family	NOUN
aiua-9669	114	36	history	history	NOUN
aiua-9669	114	37	(	(	PUNCT
aiua-9669	114	38	10	10	NUM
aiua-9669	114	39	)	)	PUNCT
aiua-9669	114	40	.	.	PUNCT
aiua-9669	115	1	the	the	DET
aiua-9669	115	2	promis	promis	PROPN
aiua-9669	115	3	study	study	NOUN
aiua-9669	115	4	showed	show	VERB
aiua-9669	115	5	that	that	SCONJ
aiua-9669	115	6	the	the	DET
aiua-9669	115	7	use	use	NOUN
aiua-9669	115	8	of	of	ADP
aiua-9669	115	9	mpmri	mpmri	PROPN
aiua-9669	115	10	reduces	reduce	VERB
aiua-9669	115	11	of	of	ADP
aiua-9669	115	12	a	a	DET
aiua-9669	115	13	5	5	NUM
aiua-9669	115	14	%	%	NOUN
aiua-9669	115	15	the	the	DET
aiua-9669	115	16	detection	detection	NOUN
aiua-9669	115	17	rate	rate	NOUN
aiua-9669	115	18	of	of	ADP
aiua-9669	115	19	indolent	indolent	ADJ
aiua-9669	115	20	cancers	cancer	NOUN
aiua-9669	115	21	lowering	lower	VERB
aiua-9669	115	22	the	the	DET
aiua-9669	115	23	need	need	NOUN
aiua-9669	115	24	of	of	ADP
aiua-9669	115	25	biopsy	biopsy	NOUN
aiua-9669	115	26	in	in	ADP
aiua-9669	115	27	27	27	NUM
aiua-9669	115	28	%	%	NOUN
aiua-9669	115	29	of	of	ADP
aiua-9669	115	30	patients	patient	NOUN
aiua-9669	115	31	(	(	PUNCT
aiua-9669	115	32	47	47	NUM
aiua-9669	115	33	)	)	PUNCT
aiua-9669	115	34	.	.	PUNCT
aiua-9669	116	1	moreover	moreover	ADV
aiua-9669	116	2	,	,	PUNCT
aiua-9669	116	3	the	the	DET
aiua-9669	116	4	application	application	NOUN
aiua-9669	116	5	of	of	ADP
aiua-9669	116	6	mpmr	mpmr	PROPN
aiua-9669	116	7	/	/	SYM
aiua-9669	116	8	trus	trus	NOUN
aiua-9669	116	9	fusion	fusion	NOUN
aiua-9669	116	10	biopsy	biopsy	NOUN
aiua-9669	116	11	technology	technology	NOUN
aiua-9669	116	12	increased	increase	VERB
aiua-9669	116	13	of	of	ADP
aiua-9669	116	14	a	a	DET
aiua-9669	116	15	18	18	NUM
aiua-9669	116	16	%	%	NOUN
aiua-9669	116	17	the	the	DET
aiua-9669	116	18	rate	rate	NOUN
aiua-9669	116	19	of	of	ADP
aiua-9669	116	20	diagnosis	diagnosis	NOUN
aiua-9669	116	21	of	of	ADP
aiua-9669	116	22	cspca	cspca	NOUN
aiua-9669	116	23	compared	compare	VERB
aiua-9669	116	24	to	to	ADP
aiua-9669	116	25	the	the	DET
aiua-9669	116	26	traditional	traditional	ADJ
aiua-9669	116	27	systematic	systematic	ADJ
aiua-9669	116	28	biopsy	biopsy	NOUN
aiua-9669	116	29	.	.	PUNCT
aiua-9669	117	1	the	the	DET
aiua-9669	117	2	need	need	NOUN
aiua-9669	117	3	of	of	ADP
aiua-9669	117	4	systematic	systematic	ADJ
aiua-9669	117	5	biopsy	biopsy	NOUN
aiua-9669	117	6	is	be	AUX
aiua-9669	117	7	underlined	underline	VERB
aiua-9669	117	8	by	by	ADP
aiua-9669	117	9	several	several	ADJ
aiua-9669	117	10	studies	study	NOUN
aiua-9669	117	11	that	that	PRON
aiua-9669	117	12	reported	report	VERB
aiua-9669	117	13	a	a	DET
aiua-9669	117	14	significant	significant	ADJ
aiua-9669	117	15	percentage	percentage	NOUN
aiua-9669	117	16	(	(	PUNCT
aiua-9669	117	17	5	5	NUM
aiua-9669	117	18	%	%	NOUN
aiua-9669	117	19	up	up	ADP
aiua-9669	117	20	to	to	PART
aiua-9669	117	21	16	16	NUM
aiua-9669	117	22	%	%	NOUN
aiua-9669	117	23	)	)	PUNCT
aiua-9669	117	24	of	of	ADP
aiua-9669	117	25	cspca	cspca	NOUN
aiua-9669	117	26	missed	miss	VERB
aiua-9669	117	27	by	by	ADP
aiua-9669	117	28	mr	mr	PROPN
aiua-9669	117	29	-	-	PUNCT
aiua-9669	117	30	guided	guide	VERB
aiua-9669	117	31	biopsy	biopsy	NOUN
aiua-9669	117	32	.	.	PUNCT
aiua-9669	118	1	results	result	NOUN
aiua-9669	118	2	found	find	VERB
aiua-9669	118	3	by	by	ADP
aiua-9669	118	4	rouvière	rouvière	NOUN
aiua-9669	118	5	et	et	PROPN
aiua-9669	118	6	al	al	PROPN
aiua-9669	118	7	.	.	PROPN
aiua-9669	118	8	highlighted	highlight	VERB
aiua-9669	118	9	the	the	DET
aiua-9669	118	10	role	role	NOUN
aiua-9669	118	11	of	of	ADP
aiua-9669	118	12	systematic	systematic	ADJ
aiua-9669	118	13	biopsy	biopsy	NOUN
aiua-9669	118	14	to	to	PART
aiua-9669	118	15	detect	detect	VERB
aiua-9669	118	16	cspca	cspca	NOUN
aiua-9669	118	17	in	in	ADP
aiua-9669	118	18	men	man	NOUN
aiua-9669	118	19	with	with	ADP
aiua-9669	118	20	abnormal	abnormal	ADJ
aiua-9669	118	21	psa	psa	NOUN
aiua-9669	118	22	and	and	CCONJ
aiua-9669	118	23	negative	negative	ADJ
aiua-9669	118	24	imaging	imaging	PROPN
aiua-9669	118	25	/	/	SYM
aiua-9669	118	26	dre	dre	PROPN
aiua-9669	118	27	(	(	PUNCT
aiua-9669	118	28	48	48	NUM
aiua-9669	118	29	)	)	PUNCT
aiua-9669	118	30	.	.	PUNCT
aiua-9669	119	1	they	they	PRON
aiua-9669	119	2	stated	state	VERB
aiua-9669	119	3	that	that	SCONJ
aiua-9669	119	4	the	the	DET
aiua-9669	119	5	mpmr	mpmr	NOUN
aiua-9669	119	6	in	in	ADP
aiua-9669	119	7	biopsy	biopsy	ADJ
aiua-9669	119	8	naïve	naïve	ADJ
aiua-9669	119	9	patients	patient	NOUN
aiua-9669	119	10	can	can	AUX
aiua-9669	119	11	improve	improve	VERB
aiua-9669	119	12	cspca	cspca	NOUN
aiua-9669	119	13	detection	detection	NOUN
aiua-9669	119	14	rate	rate	NOUN
aiua-9669	119	15	using	use	VERB
aiua-9669	119	16	target	target	NOUN
aiua-9669	119	17	biopsy	biopsy	NOUN
aiua-9669	119	18	plus	plus	CCONJ
aiua-9669	119	19	concurrent	concurrent	ADJ
aiua-9669	119	20	systematic	systematic	ADJ
aiua-9669	119	21	biopsy	biopsy	NOUN
aiua-9669	119	22	.	.	PUNCT
aiua-9669	120	1	any	any	DET
aiua-9669	120	2	differences	difference	NOUN
aiua-9669	120	3	in	in	ADP
aiua-9669	120	4	detection	detection	NOUN
aiua-9669	120	5	rate	rate	NOUN
aiua-9669	120	6	of	of	ADP
aiua-9669	120	7	high	high	ADJ
aiua-9669	120	8	grade	grade	NOUN
aiua-9669	120	9	cancers	cancer	NOUN
aiua-9669	120	10	(	(	PUNCT
aiua-9669	120	11	isup	isup	ADJ
aiua-9669	120	12	grade	grade	NOUN
aiua-9669	120	13	≥	≥	NOUN
aiua-9669	120	14	2	2	NUM
aiua-9669	120	15	)	)	PUNCT
aiua-9669	120	16	was	be	AUX
aiua-9669	120	17	observed	observe	VERB
aiua-9669	120	18	between	between	ADP
aiua-9669	120	19	targeted	targeted	ADJ
aiua-9669	120	20	and	and	CCONJ
aiua-9669	120	21	systematic	systematic	ADJ
aiua-9669	120	22	biopsies	biopsy	NOUN
aiua-9669	120	23	,	,	PUNCT
aiua-9669	120	24	but	but	CCONJ
aiua-9669	120	25	they	they	PRON
aiua-9669	120	26	found	find	VERB
aiua-9669	120	27	a	a	DET
aiua-9669	120	28	significant	significant	ADJ
aiua-9669	120	29	improvement	improvement	NOUN
aiua-9669	120	30	(	(	PUNCT
aiua-9669	120	31	plus	plus	CCONJ
aiua-9669	120	32	5	5	NUM
aiua-9669	120	33	%	%	NOUN
aiua-9669	120	34	up	up	ADP
aiua-9669	120	35	to	to	PART
aiua-9669	120	36	7	7	NUM
aiua-9669	120	37	%	%	NOUN
aiua-9669	120	38	)	)	PUNCT
aiua-9669	120	39	using	use	VERB
aiua-9669	120	40	the	the	DET
aiua-9669	120	41	combination	combination	NOUN
aiua-9669	120	42	of	of	ADP
aiua-9669	120	43	both	both	DET
aiua-9669	120	44	techniques	technique	NOUN
aiua-9669	120	45	(	(	PUNCT
aiua-9669	120	46	48	48	NUM
aiua-9669	120	47	)	)	PUNCT
aiua-9669	120	48	.	.	PUNCT
aiua-9669	121	1	are	be	AUX
aiua-9669	121	2	we	we	PRON
aiua-9669	121	3	ready	ready	ADJ
aiua-9669	121	4	to	to	PART
aiua-9669	121	5	avoid	avoid	VERB
aiua-9669	121	6	biopsy	biopsy	NOUN
aiua-9669	121	7	in	in	ADP
aiua-9669	121	8	negative	negative	ADJ
aiua-9669	121	9	mpmr	mpmr	NOUN
aiua-9669	121	10	?	?	PUNCT
aiua-9669	122	1	yes	yes	INTJ
aiua-9669	122	2	,	,	PUNCT
aiua-9669	122	3	since	since	SCONJ
aiua-9669	122	4	the	the	DET
aiua-9669	122	5	benefit	benefit	NOUN
aiua-9669	122	6	is	be	AUX
aiua-9669	122	7	reduced	reduce	VERB
aiua-9669	122	8	in	in	ADP
aiua-9669	122	9	both	both	DET
aiua-9669	122	10	detection	detection	NOUN
aiua-9669	122	11	of	of	ADP
aiua-9669	122	12	indolent	indolent	ADJ
aiua-9669	122	13	disease	disease	NOUN
aiua-9669	122	14	and	and	CCONJ
aiua-9669	122	15	number	number	NOUN
aiua-9669	122	16	of	of	ADP
aiua-9669	122	17	men	man	NOUN
aiua-9669	122	18	undergoing	undergo	VERB
aiua-9669	122	19	biopsy	biopsy	NOUN
aiua-9669	122	20	.	.	PUNCT
aiua-9669	123	1	however	however	ADV
aiua-9669	123	2	,	,	PUNCT
aiua-9669	123	3	from	from	ADP
aiua-9669	123	4	5	5	NUM
aiua-9669	123	5	%	%	NOUN
aiua-9669	123	6	to	to	PART
aiua-9669	123	7	20	20	NUM
aiua-9669	123	8	%	%	NOUN
aiua-9669	123	9	of	of	ADP
aiua-9669	123	10	cspca	cspca	NOUN
aiua-9669	123	11	have	have	VERB
aiua-9669	123	12	negative	negative	ADJ
aiua-9669	123	13	mpmr	mpmr	NOUN
aiua-9669	123	14	imaging	imaging	NOUN
aiua-9669	123	15	(	(	PUNCT
aiua-9669	123	16	49	49	NUM
aiua-9669	123	17	)	)	PUNCT
aiua-9669	123	18	.	.	PUNCT
aiua-9669	124	1	this	this	DET
aiua-9669	124	2	rate	rate	NOUN
aiua-9669	124	3	of	of	ADP
aiua-9669	124	4	undetected	undetected	ADJ
aiua-9669	124	5	cspca	cspca	NOUN
aiua-9669	124	6	should	should	AUX
aiua-9669	124	7	guide	guide	VERB
aiua-9669	124	8	the	the	DET
aiua-9669	124	9	clinician	clinician	NOUN
aiua-9669	124	10	to	to	ADP
aiua-9669	124	11	the	the	DET
aiua-9669	124	12	best	well	ADV
aiua-9669	124	13	tailored	tailor	VERB
aiua-9669	124	14	strategy	strategy	NOUN
aiua-9669	124	15	for	for	ADP
aiua-9669	124	16	the	the	DET
aiua-9669	124	17	single	single	ADJ
aiua-9669	124	18	patient	patient	NOUN
aiua-9669	124	19	balancing	balance	VERB
aiua-9669	124	20	monitoring	monitoring	NOUN
aiua-9669	124	21	versus	versus	ADP
aiua-9669	124	22	early	early	ADJ
aiua-9669	124	23	biopsy	biopsy	NOUN
aiua-9669	124	24	approach	approach	NOUN
aiua-9669	124	25	in	in	ADP
aiua-9669	124	26	terms	term	NOUN
aiua-9669	124	27	of	of	ADP
aiua-9669	124	28	morbidity	morbidity	NOUN
aiua-9669	124	29	of	of	ADP
aiua-9669	124	30	biopsy	biopsy	NOUN
aiua-9669	124	31	and	and	CCONJ
aiua-9669	124	32	delayed	delay	VERB
aiua-9669	124	33	cancer	cancer	NOUN
aiua-9669	124	34	diagnosis	diagnosis	NOUN
aiua-9669	124	35	.	.	PUNCT
aiua-9669	125	1	in	in	ADP
aiua-9669	125	2	patients	patient	NOUN
aiua-9669	125	3	with	with	ADP
aiua-9669	125	4	psa	psa	NOUN
aiua-9669	125	5	below	below	ADP
aiua-9669	125	6	the	the	DET
aiua-9669	125	7	limit	limit	NOUN
aiua-9669	125	8	and	and	CCONJ
aiua-9669	125	9	normal	normal	ADJ
aiua-9669	125	10	dre	dre	NOUN
aiua-9669	125	11	,	,	PUNCT
aiua-9669	125	12	the	the	DET
aiua-9669	125	13	mpmr	mpmr	NOUN
aiua-9669	125	14	is	be	AUX
aiua-9669	125	15	not	not	PART
aiua-9669	125	16	indicated	indicate	VERB
aiua-9669	125	17	and	and	CCONJ
aiua-9669	125	18	not	not	PART
aiua-9669	125	19	supported	support	VERB
aiua-9669	125	20	by	by	ADP
aiua-9669	125	21	guidelines	guideline	NOUN
aiua-9669	125	22	(	(	PUNCT
aiua-9669	125	23	2	2	NUM
aiua-9669	125	24	)	)	PUNCT
aiua-9669	125	25	.	.	PUNCT
aiua-9669	126	1	therefore	therefore	ADV
aiua-9669	126	2	,	,	PUNCT
aiua-9669	126	3	based	base	VERB
aiua-9669	126	4	on	on	ADP
aiua-9669	126	5	available	available	ADJ
aiua-9669	126	6	knowledge	knowledge	NOUN
aiua-9669	126	7	,	,	PUNCT
aiua-9669	126	8	the	the	DET
aiua-9669	126	9	use	use	NOUN
aiua-9669	126	10	of	of	ADP
aiua-9669	126	11	mpmr	mpmr	NOUN
aiua-9669	126	12	as	as	ADP
aiua-9669	126	13	a	a	DET
aiua-9669	126	14	screening	screening	NOUN
aiua-9669	126	15	tool	tool	NOUN
aiua-9669	126	16	in	in	ADP
aiua-9669	126	17	patients	patient	NOUN
aiua-9669	126	18	with	with	ADP
aiua-9669	126	19	normal	normal	ADJ
aiua-9669	126	20	psa	psa	NOUN
aiua-9669	126	21	and	and	CCONJ
aiua-9669	126	22	negative	negative	ADJ
aiua-9669	126	23	dre	dre	PROPN
aiua-9669	126	24	must	must	AUX
aiua-9669	126	25	be	be	AUX
aiua-9669	126	26	discouraged	discourage	VERB
aiua-9669	126	27	.	.	PUNCT
aiua-9669	127	1	the	the	DET
aiua-9669	127	2	negative	negative	ADJ
aiua-9669	127	3	predictive	predictive	ADJ
aiua-9669	127	4	value	value	NOUN
aiua-9669	127	5	(	(	PUNCT
aiua-9669	127	6	npv	npv	NOUN
aiua-9669	127	7	)	)	PUNCT
aiua-9669	127	8	of	of	ADP
aiua-9669	127	9	mpmr	mpmr	NOUN
aiua-9669	127	10	changes	change	VERB
aiua-9669	127	11	significatively	significatively	ADV
aiua-9669	127	12	in	in	ADP
aiua-9669	127	13	relation	relation	NOUN
aiua-9669	127	14	to	to	ADP
aiua-9669	127	15	the	the	DET
aiua-9669	127	16	risk	risk	NOUN
aiua-9669	127	17	of	of	ADP
aiua-9669	127	18	pca	pca	NOUN
aiua-9669	127	19	in	in	ADP
aiua-9669	127	20	a	a	DET
aiua-9669	127	21	population	population	NOUN
aiua-9669	127	22	,	,	PUNCT
aiua-9669	127	23	where	where	SCONJ
aiua-9669	127	24	the	the	DET
aiua-9669	127	25	incidence	incidence	NOUN
aiua-9669	127	26	of	of	ADP
aiua-9669	127	27	cancer	cancer	NOUN
aiua-9669	127	28	is	be	AUX
aiua-9669	127	29	low	low	ADJ
aiua-9669	127	30	(	(	PUNCT
aiua-9669	127	31	normal	normal	ADJ
aiua-9669	127	32	psa	psa	NOUN
aiua-9669	127	33	)	)	PUNCT
aiua-9669	127	34	the	the	DET
aiua-9669	127	35	diagnostic	diagnostic	ADJ
aiua-9669	127	36	performance	performance	NOUN
aiua-9669	127	37	dropped	drop	VERB
aiua-9669	127	38	significatively	significatively	ADV
aiua-9669	127	39	to	to	ADP
aiua-9669	127	40	50	50	NUM
aiua-9669	127	41	%	%	NOUN
aiua-9669	127	42	,	,	PUNCT
aiua-9669	127	43	while	while	SCONJ
aiua-9669	127	44	in	in	ADP
aiua-9669	127	45	high	high	ADJ
aiua-9669	127	46	risk	risk	NOUN
aiua-9669	127	47	is	be	AUX
aiua-9669	127	48	up	up	ADV
aiua-9669	127	49	88	88	NUM
aiua-9669	127	50	%	%	NOUN
aiua-9669	127	51	.	.	PUNCT
aiua-9669	128	1	to	to	PART
aiua-9669	128	2	improve	improve	VERB
aiua-9669	128	3	the	the	DET
aiua-9669	128	4	npv	npv	NOUN
aiua-9669	128	5	of	of	ADP
aiua-9669	128	6	mpmr	mpmr	NOUN
aiua-9669	128	7	in	in	ADP
aiua-9669	128	8	men	man	NOUN
aiua-9669	128	9	with	with	ADP
aiua-9669	128	10	normal	normal	ADJ
aiua-9669	128	11	psa	psa	NOUN
aiua-9669	128	12	,	,	PUNCT
aiua-9669	128	13	other	other	ADJ
aiua-9669	128	14	factors	factor	NOUN
aiua-9669	128	15	such	such	ADJ
aiua-9669	128	16	as	as	ADP
aiua-9669	128	17	genetic	genetic	ADJ
aiua-9669	128	18	,	,	PUNCT
aiua-9669	128	19	psad	psad	ADJ
aiua-9669	128	20	or	or	CCONJ
aiua-9669	128	21	psav	psav	NOUN
aiua-9669	128	22	should	should	AUX
aiua-9669	128	23	be	be	AUX
aiua-9669	128	24	evaluated	evaluate	VERB
aiua-9669	128	25	to	to	PART
aiua-9669	128	26	select	select	VERB
aiua-9669	128	27	those	those	DET
aiua-9669	128	28	men	man	NOUN
aiua-9669	128	29	with	with	ADP
aiua-9669	128	30	higher	high	ADJ
aiua-9669	128	31	risk	risk	NOUN
aiua-9669	128	32	to	to	PART
aiua-9669	128	33	have	have	VERB
aiua-9669	128	34	cancer	cancer	NOUN
aiua-9669	128	35	(	(	PUNCT
aiua-9669	128	36	50	50	NUM
aiua-9669	128	37	)	)	PUNCT
aiua-9669	128	38	.	.	PUNCT
aiua-9669	129	1	a	a	DET
aiua-9669	129	2	recent	recent	ADJ
aiua-9669	129	3	and	and	CCONJ
aiua-9669	129	4	very	very	ADV
aiua-9669	129	5	interesting	interesting	ADJ
aiua-9669	129	6	study	study	NOUN
aiua-9669	129	7	estimated	estimate	VERB
aiua-9669	129	8	the	the	DET
aiua-9669	129	9	risk	risk	NOUN
aiua-9669	129	10	to	to	PART
aiua-9669	129	11	detect	detect	VERB
aiua-9669	129	12	cancer	cancer	NOUN
aiua-9669	129	13	over	over	ADP
aiua-9669	129	14	the	the	DET
aiua-9669	129	15	time	time	NOUN
aiua-9669	129	16	after	after	ADP
aiua-9669	129	17	a	a	DET
aiua-9669	129	18	negative	negative	ADJ
aiua-9669	129	19	mpmr	mpmr	NOUN
aiua-9669	129	20	at	at	ADP
aiua-9669	129	21	baseline	baseline	PROPN
aiua-9669	129	22	(	(	PUNCT
aiua-9669	129	23	17	17	NUM
aiua-9669	129	24	)	)	PUNCT
aiua-9669	129	25	.	.	PUNCT
aiua-9669	130	1	after	after	ADP
aiua-9669	130	2	4	4	NUM
aiua-9669	130	3	years	year	NOUN
aiua-9669	130	4	of	of	ADP
aiua-9669	130	5	follow	follow	NOUN
aiua-9669	130	6	-	-	PUNCT
aiua-9669	130	7	up	up	NOUN
aiua-9669	130	8	,	,	PUNCT
aiua-9669	130	9	they	they	PRON
aiua-9669	130	10	found	find	VERB
aiua-9669	130	11	84	84	NUM
aiua-9669	130	12	%	%	NOUN
aiua-9669	130	13	of	of	ADP
aiua-9669	130	14	patients	patient	NOUN
aiua-9669	130	15	remained	remain	VERB
aiua-9669	130	16	free	free	ADJ
aiua-9669	130	17	of	of	ADP
aiua-9669	130	18	cancer	cancer	NOUN
aiua-9669	130	19	and	and	CCONJ
aiua-9669	130	20	overall	overall	ADJ
aiua-9669	130	21	16	16	NUM
aiua-9669	130	22	%	%	NOUN
aiua-9669	130	23	figure	figure	NOUN
aiua-9669	130	24	1	1	NUM
aiua-9669	130	25	.	.	PUNCT
aiua-9669	130	26	hematoxylin	hematoxylin	PROPN
aiua-9669	130	27	&	&	CCONJ
aiua-9669	130	28	eosin	eosin	PROPN
aiua-9669	130	29	-	-	PUNCT
aiua-9669	130	30	stained	stain	VERB
aiua-9669	130	31	section	section	NOUN
aiua-9669	130	32	of	of	ADP
aiua-9669	130	33	a	a	DET
aiua-9669	130	34	prostate	prostate	NOUN
aiua-9669	130	35	cancer	cancer	NOUN
aiua-9669	130	36	bone	bone	NOUN
aiua-9669	130	37	metastasis	metastasis	NOUN
aiua-9669	130	38	(	(	PUNCT
aiua-9669	130	39	a	a	X
aiua-9669	130	40	)	)	PUNCT
aiua-9669	130	41	with	with	ADP
aiua-9669	130	42	a	a	DET
aiua-9669	130	43	focal	focal	ADJ
aiua-9669	130	44	expression	expression	NOUN
aiua-9669	130	45	of	of	ADP
aiua-9669	130	46	psa	psa	PROPN
aiua-9669	130	47	(	(	PUNCT
aiua-9669	130	48	b	b	NOUN
aiua-9669	130	49	)	)	PUNCT
aiua-9669	130	50	and	and	CCONJ
aiua-9669	130	51	a	a	DET
aiua-9669	130	52	diffuse	diffuse	NOUN
aiua-9669	130	53	and	and	CCONJ
aiua-9669	130	54	strong	strong	ADJ
aiua-9669	130	55	expression	expression	NOUN
aiua-9669	130	56	of	of	ADP
aiua-9669	130	57	psma	psma	NOUN
aiua-9669	130	58	(	(	PUNCT
aiua-9669	130	59	c	c	NOUN
aiua-9669	130	60	)	)	PUNCT
aiua-9669	130	61	and	and	CCONJ
aiua-9669	130	62	nkx	nkx	VERB
aiua-9669	130	63	3.1	3.1	NUM
aiua-9669	130	64	(	(	PUNCT
aiua-9669	130	65	d	d	NOUN
aiua-9669	130	66	)	)	PUNCT
aiua-9669	130	67	.	.	PUNCT
aiua-9669	131	1	archivio	archivio	NOUN
aiua-9669	131	2	italiano	italiano	PROPN
aiua-9669	131	3	di	di	X
aiua-9669	131	4	urologia	urologia	PROPN
aiua-9669	131	5	e	e	PROPN
aiua-9669	131	6	andrologia	andrologia	NOUN
aiua-9669	131	7	2021	2021	NUM
aiua-9669	131	8	;	;	PUNCT
aiua-9669	131	9	93	93	NUM
aiua-9669	131	10	,	,	PUNCT
aiua-9669	131	11	1	1	NUM
aiua-9669	131	12	a.b	a.b	NOUN
aiua-9669	131	13	.	.	PROPN
aiua-9669	131	14	galosi	galosi	PROPN
aiua-9669	131	15	,	,	PUNCT
aiua-9669	131	16	e.	e.	PROPN
aiua-9669	131	17	palagonia	palagonia	PROPN
aiua-9669	131	18	,	,	PUNCT
aiua-9669	131	19	s.	s.	PROPN
aiua-9669	131	20	scarcella	scarcella	PROPN
aiua-9669	131	21	,	,	PUNCT
aiua-9669	131	22	a.	a.	NOUN
aiua-9669	131	23	cimadamore	cimadamore	PROPN
aiua-9669	131	24	,	,	PUNCT
aiua-9669	131	25	v.	v.	ADP
aiua-9669	131	26	lacetera	lacetera	PROPN
aiua-9669	131	27	,	,	PUNCT
aiua-9669	131	28	r.f	r.f	PROPN
aiua-9669	131	29	.	.	PROPN
aiua-9669	131	30	delle	delle	PROPN
aiua-9669	131	31	fave	fave	PROPN
aiua-9669	131	32	,	,	PUNCT
aiua-9669	131	33	a.	a.	NOUN
aiua-9669	131	34	antezza	antezza	NOUN
aiua-9669	131	35	,	,	PUNCT
aiua-9669	131	36	l.	l.	PROPN
aiua-9669	131	37	dell’atti	dell’atti	PROPN
aiua-9669	131	38	96	96	NUM
aiua-9669	131	39	developed	develop	VERB
aiua-9669	131	40	pca	pca	NOUN
aiua-9669	131	41	but	but	CCONJ
aiua-9669	131	42	only	only	ADV
aiua-9669	131	43	4	4	NUM
aiua-9669	131	44	%	%	NOUN
aiua-9669	131	45	cspca	cspca	NOUN
aiua-9669	131	46	.	.	PUNCT
aiua-9669	132	1	although	although	SCONJ
aiua-9669	132	2	of	of	ADP
aiua-9669	132	3	its	its	PRON
aiua-9669	132	4	several	several	ADJ
aiua-9669	132	5	limitations	limitation	NOUN
aiua-9669	132	6	(	(	PUNCT
aiua-9669	132	7	e.g.	e.g.	ADV
aiua-9669	132	8	control	control	NOUN
aiua-9669	132	9	group	group	NOUN
aiua-9669	132	10	,	,	PUNCT
aiua-9669	132	11	highly	highly	ADV
aiua-9669	132	12	selected	select	VERB
aiua-9669	132	13	cases	case	NOUN
aiua-9669	132	14	in	in	ADP
aiua-9669	132	15	referral	referral	ADJ
aiua-9669	132	16	centre	centre	NOUN
aiua-9669	132	17	)	)	PUNCT
aiua-9669	132	18	,	,	PUNCT
aiua-9669	132	19	this	this	DET
aiua-9669	132	20	study	study	NOUN
aiua-9669	132	21	shows	show	VERB
aiua-9669	132	22	that	that	SCONJ
aiua-9669	132	23	a	a	DET
aiua-9669	132	24	negative	negative	ADJ
aiua-9669	132	25	mpmr	mpmr	NOUN
aiua-9669	132	26	predict	predict	VERB
aiua-9669	132	27	a	a	DET
aiua-9669	132	28	lower	low	ADJ
aiua-9669	132	29	risk	risk	NOUN
aiua-9669	132	30	over	over	ADP
aiua-9669	132	31	the	the	DET
aiua-9669	132	32	time	time	NOUN
aiua-9669	132	33	to	to	PART
aiua-9669	132	34	develop	develop	VERB
aiua-9669	132	35	cspca	cspca	NOUN
aiua-9669	132	36	:	:	PUNCT
aiua-9669	132	37	4	4	NUM
aiua-9669	132	38	%	%	NOUN
aiua-9669	132	39	(	(	PUNCT
aiua-9669	132	40	1	1	NUM
aiua-9669	132	41	man	man	NOUN
aiua-9669	132	42	every	every	DET
aiua-9669	132	43	20	20	NUM
aiua-9669	132	44	)	)	PUNCT
aiua-9669	132	45	compared	compare	VERB
aiua-9669	132	46	to	to	ADP
aiua-9669	132	47	8	8	NUM
aiua-9669	132	48	%	%	NOUN
aiua-9669	132	49	of	of	ADP
aiua-9669	132	50	calculated	calculated	ADJ
aiua-9669	132	51	risk	risk	NOUN
aiua-9669	132	52	for	for	SCONJ
aiua-9669	132	53	a	a	DET
aiua-9669	132	54	man	man	NOUN
aiua-9669	132	55	to	to	PART
aiua-9669	132	56	be	be	AUX
aiua-9669	132	57	diagnosed	diagnose	VERB
aiua-9669	132	58	with	with	ADP
aiua-9669	132	59	clinically	clinically	ADV
aiua-9669	132	60	significant	significant	ADJ
aiua-9669	132	61	pca	pca	NOUN
aiua-9669	132	62	throughout	throughout	ADP
aiua-9669	132	63	his	his	PRON
aiua-9669	132	64	lifetime	lifetime	NOUN
aiua-9669	132	65	.	.	PUNCT
aiua-9669	133	1	limits	limit	NOUN
aiua-9669	133	2	of	of	ADP
aiua-9669	133	3	mpmr	mpmr	NOUN
aiua-9669	133	4	despite	despite	SCONJ
aiua-9669	133	5	the	the	DET
aiua-9669	133	6	wide	wide	ADJ
aiua-9669	133	7	acknowledged	acknowledge	VERB
aiua-9669	133	8	improvements	improvement	NOUN
aiua-9669	133	9	cited	cite	VERB
aiua-9669	133	10	in	in	ADP
aiua-9669	133	11	the	the	DET
aiua-9669	133	12	previous	previous	ADJ
aiua-9669	133	13	paragraph	paragraph	NOUN
aiua-9669	133	14	and	and	CCONJ
aiua-9669	133	15	being	be	AUX
aiua-9669	133	16	advocate	advocate	ADJ
aiua-9669	133	17	as	as	ADP
aiua-9669	133	18	the	the	DET
aiua-9669	133	19	reference	reference	NOUN
aiua-9669	133	20	standard	standard	NOUN
aiua-9669	133	21	for	for	ADP
aiua-9669	133	22	prostate	prostate	NOUN
aiua-9669	133	23	radiological	radiological	ADJ
aiua-9669	133	24	imaging	imaging	NOUN
aiua-9669	133	25	,	,	PUNCT
aiua-9669	133	26	mpmr	mpmr	PROPN
aiua-9669	133	27	is	be	AUX
aiua-9669	133	28	not	not	PART
aiua-9669	133	29	exempt	exempt	ADJ
aiua-9669	133	30	from	from	ADP
aiua-9669	133	31	drawbacks	drawback	NOUN
aiua-9669	133	32	.	.	PUNCT
aiua-9669	134	1	according	accord	VERB
aiua-9669	134	2	to	to	ADP
aiua-9669	134	3	quon	quon	PROPN
aiua-9669	134	4	et	et	PROPN
aiua-9669	134	5	al	al	PROPN
aiua-9669	134	6	.	.	PROPN
aiua-9669	134	7	,	,	PUNCT
aiua-9669	134	8	mpmr	mpmr	PROPN
aiua-9669	134	9	missed	miss	VERB
aiua-9669	134	10	up	up	ADP
aiua-9669	134	11	to	to	PART
aiua-9669	134	12	20	20	NUM
aiua-9669	134	13	%	%	NOUN
aiua-9669	134	14	of	of	ADP
aiua-9669	134	15	cspca	cspca	NOUN
aiua-9669	134	16	lesions	lesion	NOUN
aiua-9669	134	17	or	or	CCONJ
aiua-9669	134	18	underestimated	underestimate	VERB
aiua-9669	134	19	its	its	PRON
aiua-9669	134	20	size	size	NOUN
aiua-9669	134	21	(	(	PUNCT
aiua-9669	134	22	51	51	NUM
aiua-9669	134	23	)	)	PUNCT
aiua-9669	134	24	.	.	PUNCT
aiua-9669	135	1	after	after	ADP
aiua-9669	135	2	a	a	DET
aiua-9669	135	3	second	second	ADJ
aiua-9669	135	4	-	-	PUNCT
aiua-9669	135	5	look	look	NOUN
aiua-9669	135	6	of	of	ADP
aiua-9669	135	7	mr	mr	PROPN
aiua-9669	135	8	imaging	imaging	PROPN
aiua-9669	135	9	,	,	PUNCT
aiua-9669	135	10	58	58	NUM
aiua-9669	135	11	%	%	NOUN
aiua-9669	135	12	of	of	ADP
aiua-9669	135	13	the	the	DET
aiua-9669	135	14	missed	miss	VERB
aiua-9669	135	15	lesions	lesion	NOUN
aiua-9669	135	16	were	be	AUX
aiua-9669	135	17	not	not	PART
aiua-9669	135	18	confirmed	confirm	VERB
aiua-9669	135	19	as	as	ADP
aiua-9669	135	20	benign	benign	ADJ
aiua-9669	135	21	findings	finding	NOUN
aiua-9669	135	22	.	.	PUNCT
aiua-9669	136	1	in	in	ADP
aiua-9669	136	2	fact	fact	NOUN
aiua-9669	136	3	,	,	PUNCT
aiua-9669	136	4	this	this	DET
aiua-9669	136	5	technique	technique	NOUN
aiua-9669	136	6	needs	need	VERB
aiua-9669	136	7	further	further	ADJ
aiua-9669	136	8	implementations	implementation	NOUN
aiua-9669	136	9	to	to	PART
aiua-9669	136	10	reduce	reduce	VERB
aiua-9669	136	11	inter	inter	ADJ
aiua-9669	136	12	-	-	ADJ
aiua-9669	136	13	observer	observer	ADJ
aiua-9669	136	14	variability	variability	NOUN
aiua-9669	136	15	and	and	CCONJ
aiua-9669	136	16	to	to	PART
aiua-9669	136	17	reduce	reduce	VERB
aiua-9669	136	18	false	false	ADJ
aiua-9669	136	19	negative	negative	ADJ
aiua-9669	136	20	rates	rate	NOUN
aiua-9669	136	21	.	.	PUNCT
aiua-9669	137	1	the	the	DET
aiua-9669	137	2	radiologist	radiologist	NOUN
aiua-9669	137	3	's	's	PART
aiua-9669	137	4	experience	experience	NOUN
aiua-9669	137	5	is	be	AUX
aiua-9669	137	6	shown	show	VERB
aiua-9669	137	7	to	to	PART
aiua-9669	137	8	be	be	AUX
aiua-9669	137	9	a	a	DET
aiua-9669	137	10	key	key	ADJ
aiua-9669	137	11	factor	factor	NOUN
aiua-9669	137	12	in	in	ADP
aiua-9669	137	13	imaging	imaging	NOUN
aiua-9669	137	14	interpreting	interpreting	NOUN
aiua-9669	137	15	and	and	CCONJ
aiua-9669	137	16	pca	pca	NOUN
aiua-9669	137	17	recognition	recognition	NOUN
aiua-9669	137	18	.	.	PUNCT
aiua-9669	138	1	a	a	DET
aiua-9669	138	2	recent	recent	ADJ
aiua-9669	138	3	study	study	NOUN
aiua-9669	138	4	analysed	analyse	VERB
aiua-9669	138	5	the	the	DET
aiua-9669	138	6	different	different	ADJ
aiua-9669	138	7	reports	report	NOUN
aiua-9669	138	8	of	of	ADP
aiua-9669	138	9	9	9	NUM
aiua-9669	138	10	radiologists	radiologist	NOUN
aiua-9669	138	11	on	on	ADP
aiua-9669	138	12	the	the	DET
aiua-9669	138	13	same	same	ADJ
aiua-9669	138	14	mpmri	mpmri	NOUN
aiua-9669	138	15	by	by	ADP
aiua-9669	138	16	comparing	compare	VERB
aiua-9669	138	17	their	their	PRON
aiua-9669	138	18	experience	experience	NOUN
aiua-9669	138	19	(	(	PUNCT
aiua-9669	138	20	52	52	NUM
aiua-9669	138	21	)	)	PUNCT
aiua-9669	138	22	.	.	PUNCT
aiua-9669	139	1	among	among	ADP
aiua-9669	139	2	pi	pi	NOUN
aiua-9669	139	3	-	-	PUNCT
aiua-9669	139	4	rads	rad	NOUN
aiua-9669	139	5	2	2	NUM
aiua-9669	139	6	results	result	NOUN
aiua-9669	139	7	,	,	PUNCT
aiua-9669	139	8	the	the	DET
aiua-9669	139	9	possibility	possibility	NOUN
aiua-9669	139	10	of	of	ADP
aiua-9669	139	11	finding	find	VERB
aiua-9669	139	12	clinically	clinically	ADV
aiua-9669	139	13	significant	significant	ADJ
aiua-9669	139	14	pca	pca	NOUN
aiua-9669	139	15	in	in	ADP
aiua-9669	139	16	the	the	DET
aiua-9669	139	17	biopsy	biopsy	NOUN
aiua-9669	139	18	ranged	range	VERB
aiua-9669	139	19	from	from	ADP
aiua-9669	139	20	15	15	NUM
aiua-9669	139	21	to	to	PART
aiua-9669	139	22	35	35	NUM
aiua-9669	139	23	%	%	NOUN
aiua-9669	139	24	.	.	PUNCT
aiua-9669	140	1	the	the	DET
aiua-9669	140	2	detection	detection	NOUN
aiua-9669	140	3	of	of	ADP
aiua-9669	140	4	any	any	DET
aiua-9669	140	5	type	type	NOUN
aiua-9669	140	6	of	of	ADP
aiua-9669	140	7	pca	pca	NOUN
aiua-9669	140	8	in	in	ADP
aiua-9669	140	9	pi	pi	NOUN
aiua-9669	140	10	-	-	PUNCT
aiua-9669	140	11	rads	rad	NOUN
aiua-9669	140	12	2	2	NUM
aiua-9669	140	13	ranged	range	VERB
aiua-9669	140	14	from	from	ADP
aiua-9669	140	15	15	15	NUM
aiua-9669	140	16	to	to	PART
aiua-9669	140	17	75	75	NUM
aiua-9669	140	18	%	%	NOUN
aiua-9669	140	19	.	.	PUNCT
aiua-9669	141	1	in	in	ADP
aiua-9669	141	2	2018	2018	NUM
aiua-9669	141	3	johnson	johnson	PROPN
aiua-9669	141	4	et	et	PROPN
aiua-9669	141	5	al	al	PROPN
aiua-9669	141	6	.	.	PROPN
aiua-9669	141	7	analysed	analyse	VERB
aiua-9669	141	8	the	the	DET
aiua-9669	141	9	mpmri	mpmri	PROPN
aiua-9669	141	10	performed	perform	VERB
aiua-9669	141	11	on	on	ADP
aiua-9669	141	12	588	588	NUM
aiua-9669	141	13	patients	patient	NOUN
aiua-9669	141	14	before	before	ADP
aiua-9669	141	15	radical	radical	ADJ
aiua-9669	141	16	prostatectomy	prostatectomy	NOUN
aiua-9669	141	17	,	,	PUNCT
aiua-9669	141	18	using	use	VERB
aiua-9669	141	19	a	a	DET
aiua-9669	141	20	3	3	NUM
aiua-9669	141	21	tesla	tesla	PROPN
aiua-9669	141	22	mri	mri	NOUN
aiua-9669	141	23	in	in	ADP
aiua-9669	141	24	a	a	DET
aiua-9669	141	25	single	single	ADJ
aiua-9669	141	26	institution	institution	NOUN
aiua-9669	141	27	with	with	ADP
aiua-9669	141	28	expert	expert	NOUN
aiua-9669	141	29	radiologists	radiologist	NOUN
aiua-9669	141	30	(	(	PUNCT
aiua-9669	141	31	48	48	NUM
aiua-9669	141	32	)	)	PUNCT
aiua-9669	141	33	.	.	PUNCT
aiua-9669	142	1	overall	overall	ADV
aiua-9669	142	2	,	,	PUNCT
aiua-9669	142	3	the	the	DET
aiua-9669	142	4	mpmri	mpmri	PROPN
aiua-9669	142	5	detected	detect	VERB
aiua-9669	142	6	541	541	NUM
aiua-9669	142	7	out	out	ADP
aiua-9669	142	8	of	of	ADP
aiua-9669	142	9	1213	1213	NUM
aiua-9669	142	10	pathologic	pathologic	ADJ
aiua-9669	142	11	lesions	lesion	NOUN
aiua-9669	142	12	,	,	PUNCT
aiua-9669	142	13	which	which	PRON
aiua-9669	142	14	represent	represent	VERB
aiua-9669	142	15	a	a	DET
aiua-9669	142	16	sensitivity	sensitivity	NOUN
aiua-9669	142	17	of	of	ADP
aiua-9669	142	18	45	45	NUM
aiua-9669	142	19	%	%	NOUN
aiua-9669	142	20	,	,	PUNCT
aiua-9669	142	21	a	a	DET
aiua-9669	142	22	positive	positive	ADJ
aiua-9669	142	23	predictive	predictive	ADJ
aiua-9669	142	24	value	value	NOUN
aiua-9669	142	25	of	of	ADP
aiua-9669	142	26	81	81	NUM
aiua-9669	142	27	%	%	NOUN
aiua-9669	142	28	and	and	CCONJ
aiua-9669	142	29	a	a	DET
aiua-9669	142	30	false	false	ADJ
aiua-9669	142	31	positive	positive	ADJ
aiua-9669	142	32	rate	rate	NOUN
aiua-9669	142	33	of	of	ADP
aiua-9669	142	34	19	19	NUM
aiua-9669	142	35	%	%	NOUN
aiua-9669	142	36	.	.	PUNCT
aiua-9669	143	1	therefore	therefore	ADV
aiua-9669	143	2	larger	large	ADJ
aiua-9669	143	3	(	(	PUNCT
aiua-9669	143	4	>	>	X
aiua-9669	143	5	0.5	0.5	NUM
aiua-9669	143	6	ml	ml	NOUN
aiua-9669	143	7	)	)	PUNCT
aiua-9669	143	8	,	,	PUNCT
aiua-9669	143	9	high	high	ADJ
aiua-9669	143	10	grade	grade	NOUN
aiua-9669	143	11	and	and	CCONJ
aiua-9669	143	12	solitary	solitary	ADJ
aiua-9669	143	13	tumors	tumor	NOUN
aiua-9669	143	14	were	be	AUX
aiua-9669	143	15	more	more	ADV
aiua-9669	143	16	likely	likely	ADJ
aiua-9669	143	17	to	to	PART
aiua-9669	143	18	be	be	AUX
aiua-9669	143	19	detected	detect	VERB
aiua-9669	143	20	.	.	PUNCT
aiua-9669	144	1	comparing	compare	VERB
aiua-9669	144	2	mpmr	mpmr	NOUN
aiua-9669	144	3	and	and	CCONJ
aiua-9669	144	4	surgical	surgical	ADJ
aiua-9669	144	5	specimens	specimen	NOUN
aiua-9669	144	6	,	,	PUNCT
aiua-9669	144	7	90	90	NUM
aiua-9669	144	8	%	%	NOUN
aiua-9669	144	9	of	of	ADP
aiua-9669	144	10	the	the	DET
aiua-9669	144	11	non	non	ADJ
aiua-9669	144	12	-	-	ADJ
aiua-9669	144	13	cspca	cspca	ADJ
aiua-9669	144	14	were	be	AUX
aiua-9669	144	15	missed	miss	VERB
aiua-9669	144	16	,	,	PUNCT
aiua-9669	144	17	but	but	CCONJ
aiua-9669	144	18	also	also	ADV
aiua-9669	144	19	the	the	DET
aiua-9669	144	20	40	40	NUM
aiua-9669	144	21	%	%	NOUN
aiua-9669	144	22	of	of	ADP
aiua-9669	144	23	gleason	gleason	PROPN
aiua-9669	144	24	score	score	VERB
aiua-9669	144	25	3	3	NUM
aiua-9669	144	26	+	+	SYM
aiua-9669	144	27	4	4	NUM
aiua-9669	144	28	,	,	PUNCT
aiua-9669	144	29	the	the	DET
aiua-9669	144	30	26	26	NUM
aiua-9669	144	31	%	%	NOUN
aiua-9669	144	32	of	of	ADP
aiua-9669	144	33	gleason	gleason	PROPN
aiua-9669	144	34	score	score	VERB
aiua-9669	144	35	4	4	NUM
aiua-9669	144	36	+	+	SYM
aiua-9669	144	37	3	3	NUM
aiua-9669	144	38	and	and	CCONJ
aiua-9669	144	39	the	the	DET
aiua-9669	144	40	22	22	NUM
aiua-9669	144	41	%	%	NOUN
aiua-9669	144	42	of	of	ADP
aiua-9669	144	43	gleason	gleason	PROPN
aiua-9669	144	44	score	score	NOUN
aiua-9669	144	45	≥	≥	PROPN
aiua-9669	144	46	8	8	NUM
aiua-9669	144	47	.	.	PUNCT
aiua-9669	145	1	in	in	ADP
aiua-9669	145	2	a	a	DET
aiua-9669	145	3	recently	recently	ADV
aiua-9669	145	4	published	publish	VERB
aiua-9669	145	5	review	review	NOUN
aiua-9669	145	6	,	,	PUNCT
aiua-9669	145	7	chatterjee	chatterjee	PROPN
aiua-9669	145	8	et	et	PROPN
aiua-9669	145	9	al	al	PROPN
aiua-9669	145	10	.	.	PROPN
aiua-9669	145	11	found	find	VERB
aiua-9669	145	12	that	that	SCONJ
aiua-9669	145	13	the	the	DET
aiua-9669	145	14	inter	inter	ADJ
aiua-9669	145	15	-	-	ADJ
aiua-9669	145	16	observer	observer	ADJ
aiua-9669	145	17	variability	variability	NOUN
aiua-9669	145	18	and	and	CCONJ
aiua-9669	145	19	lack	lack	NOUN
aiua-9669	145	20	of	of	ADP
aiua-9669	145	21	standardisation	standardisation	NOUN
aiua-9669	145	22	in	in	ADP
aiua-9669	145	23	reporting	report	VERB
aiua-9669	145	24	radiological	radiological	ADJ
aiua-9669	145	25	findings	finding	NOUN
aiua-9669	145	26	are	be	AUX
aiua-9669	145	27	the	the	DET
aiua-9669	145	28	most	most	ADV
aiua-9669	145	29	important	important	ADJ
aiua-9669	145	30	interpretative	interpretative	ADJ
aiua-9669	145	31	drawbacks	drawback	NOUN
aiua-9669	145	32	(	(	PUNCT
aiua-9669	145	33	53	53	NUM
aiua-9669	145	34	)	)	PUNCT
aiua-9669	145	35	.	.	PUNCT
aiua-9669	146	1	they	they	PRON
aiua-9669	146	2	described	describe	VERB
aiua-9669	146	3	a	a	DET
aiua-9669	146	4	variety	variety	NOUN
aiua-9669	146	5	of	of	ADP
aiua-9669	146	6	interpretative	interpretative	ADJ
aiua-9669	146	7	and	and	CCONJ
aiua-9669	146	8	technical	technical	ADJ
aiua-9669	146	9	pitfalls	pitfall	NOUN
aiua-9669	146	10	that	that	PRON
aiua-9669	146	11	influenced	influence	VERB
aiua-9669	146	12	negatively	negatively	ADV
aiua-9669	146	13	mpmr	mpmr	NOUN
aiua-9669	146	14	performances	performance	NOUN
aiua-9669	146	15	:	:	PUNCT
aiua-9669	146	16	1	1	X
aiua-9669	146	17	)	)	PUNCT
aiua-9669	146	18	different	different	ADJ
aiua-9669	146	19	anatomic	anatomic	ADJ
aiua-9669	146	20	features	feature	NOUN
aiua-9669	146	21	can	can	AUX
aiua-9669	146	22	simulate	simulate	VERB
aiua-9669	146	23	pca	pca	NOUN
aiua-9669	146	24	such	such	ADJ
aiua-9669	146	25	as	as	ADP
aiua-9669	146	26	the	the	DET
aiua-9669	146	27	anterior	anterior	ADJ
aiua-9669	146	28	fibromuscular	fibromuscular	ADJ
aiua-9669	146	29	stroma	stroma	NOUN
aiua-9669	146	30	,	,	PUNCT
aiua-9669	146	31	the	the	DET
aiua-9669	146	32	periprostatic	periprostatic	ADJ
aiua-9669	146	33	venous	venous	ADJ
aiua-9669	146	34	plexus	plexus	NOUN
aiua-9669	146	35	and	and	CCONJ
aiua-9669	146	36	the	the	DET
aiua-9669	146	37	pseudocapsule	pseudocapsule	NOUN
aiua-9669	146	38	of	of	ADP
aiua-9669	146	39	the	the	DET
aiua-9669	146	40	transitional	transitional	ADJ
aiua-9669	146	41	zone	zone	NOUN
aiua-9669	146	42	(	(	PUNCT
aiua-9669	146	43	tz	tz	PROPN
aiua-9669	146	44	)	)	PUNCT
aiua-9669	146	45	;	;	PUNCT
aiua-9669	146	46	2	2	X
aiua-9669	146	47	)	)	PUNCT
aiua-9669	146	48	others	other	NOUN
aiua-9669	146	49	histologic	histologic	ADJ
aiua-9669	146	50	benign	benign	ADJ
aiua-9669	146	51	conditions	condition	NOUN
aiua-9669	146	52	such	such	ADJ
aiua-9669	146	53	as	as	ADP
aiua-9669	146	54	inflammation	inflammation	NOUN
aiua-9669	146	55	and	and	CCONJ
aiua-9669	146	56	prostatitis	prostatitis	NOUN
aiua-9669	146	57	,	,	PUNCT
aiua-9669	146	58	could	could	AUX
aiua-9669	146	59	mimic	mimic	VERB
aiua-9669	146	60	pca	pca	NOUN
aiua-9669	146	61	;	;	PUNCT
aiua-9669	146	62	3	3	X
aiua-9669	146	63	)	)	PUNCT
aiua-9669	146	64	postbiopsy	postbiopsy	NOUN
aiua-9669	146	65	haemorrhage	haemorrhage	NOUN
aiua-9669	146	66	,	,	PUNCT
aiua-9669	146	67	prostatic	prostatic	ADJ
aiua-9669	146	68	calcifications	calcification	NOUN
aiua-9669	146	69	associated	associate	VERB
aiua-9669	146	70	with	with	ADP
aiua-9669	146	71	benign	benign	ADJ
aiua-9669	146	72	prostatic	prostatic	ADJ
aiua-9669	146	73	hyperplasia	hyperplasia	NOUN
aiua-9669	146	74	nodules	nodule	NOUN
aiua-9669	146	75	in	in	ADP
aiua-9669	146	76	the	the	DET
aiua-9669	146	77	transitional	transitional	ADJ
aiua-9669	146	78	zone	zone	NOUN
aiua-9669	146	79	;	;	PUNCT
aiua-9669	146	80	4	4	X
aiua-9669	146	81	)	)	PUNCT
aiua-9669	146	82	technical	technical	ADJ
aiua-9669	146	83	artifacts	artifact	NOUN
aiua-9669	146	84	or	or	CCONJ
aiua-9669	146	85	image	image	NOUN
aiua-9669	146	86	distortion	distortion	NOUN
aiua-9669	146	87	due	due	ADJ
aiua-9669	146	88	to	to	ADP
aiua-9669	146	89	endorectal	endorectal	ADJ
aiua-9669	146	90	coil	coil	NOUN
aiua-9669	146	91	placements	placement	NOUN
aiua-9669	146	92	and	and	CCONJ
aiua-9669	146	93	motion	motion	NOUN
aiua-9669	146	94	artefacts	artefact	NOUN
aiua-9669	146	95	.	.	PUNCT
aiua-9669	147	1	the	the	DET
aiua-9669	147	2	low	low	ADJ
aiua-9669	147	3	-	-	PUNCT
aiua-9669	147	4	intensity	intensity	NOUN
aiua-9669	147	5	t2	t2	NOUN
aiua-9669	147	6	signal	signal	NOUN
aiua-9669	147	7	and	and	CCONJ
aiua-9669	147	8	the	the	DET
aiua-9669	147	9	heterogeneity	heterogeneity	NOUN
aiua-9669	147	10	of	of	ADP
aiua-9669	147	11	enhancement	enhancement	NOUN
aiua-9669	147	12	patterns	pattern	NOUN
aiua-9669	147	13	in	in	ADP
aiua-9669	147	14	the	the	DET
aiua-9669	147	15	peripheral	peripheral	ADJ
aiua-9669	147	16	zone	zone	NOUN
aiua-9669	147	17	are	be	AUX
aiua-9669	147	18	reported	report	VERB
aiua-9669	147	19	to	to	PART
aiua-9669	147	20	reduce	reduce	VERB
aiua-9669	147	21	the	the	DET
aiua-9669	147	22	diagnostic	diagnostic	ADJ
aiua-9669	147	23	yield	yield	NOUN
aiua-9669	147	24	of	of	ADP
aiua-9669	147	25	mpmr	mpmr	NOUN
aiua-9669	147	26	(	(	PUNCT
aiua-9669	147	27	53	53	NUM
aiua-9669	147	28	)	)	PUNCT
aiua-9669	147	29	.	.	PUNCT
aiua-9669	148	1	improvements	improvement	NOUN
aiua-9669	148	2	of	of	ADP
aiua-9669	148	3	mr	mr	PROPN
aiua-9669	148	4	imaging	imaging	PROPN
aiua-9669	148	5	:	:	PUNCT
aiua-9669	148	6	pi	pi	NOUN
aiua-9669	148	7	-	-	PUNCT
aiua-9669	148	8	rads	rad	VERB
aiua-9669	148	9	2.1	2.1	NUM
aiua-9669	148	10	the	the	DET
aiua-9669	148	11	first	first	ADJ
aiua-9669	148	12	version	version	NOUN
aiua-9669	148	13	of	of	ADP
aiua-9669	148	14	the	the	DET
aiua-9669	148	15	prostate	prostate	NOUN
aiua-9669	148	16	imaging	imaging	NOUN
aiua-9669	148	17	reporting	reporting	NOUN
aiua-9669	148	18	and	and	CCONJ
aiua-9669	148	19	data	datum	NOUN
aiua-9669	148	20	system	system	NOUN
aiua-9669	148	21	(	(	PUNCT
aiua-9669	148	22	pi	pi	NOUN
aiua-9669	148	23	-	-	PUNCT
aiua-9669	148	24	rads	rad	NOUN
aiua-9669	148	25	v1	v1	NOUN
aiua-9669	148	26	)	)	PUNCT
aiua-9669	148	27	released	release	VERB
aiua-9669	148	28	in	in	ADP
aiua-9669	148	29	2012	2012	NUM
aiua-9669	148	30	by	by	ADP
aiua-9669	148	31	the	the	DET
aiua-9669	148	32	european	european	PROPN
aiua-9669	148	33	society	society	NOUN
aiua-9669	148	34	of	of	ADP
aiua-9669	148	35	urogenital	urogenital	ADJ
aiua-9669	148	36	radiology	radiology	NOUN
aiua-9669	148	37	and	and	CCONJ
aiua-9669	148	38	then	then	ADV
aiua-9669	148	39	updated	update	VERB
aiua-9669	148	40	to	to	ADP
aiua-9669	148	41	version	version	NOUN
aiua-9669	148	42	2.0	2.0	NUM
aiua-9669	148	43	in	in	ADP
aiua-9669	148	44	2015	2015	NUM
aiua-9669	148	45	has	have	AUX
aiua-9669	148	46	been	be	AUX
aiua-9669	148	47	considered	consider	VERB
aiua-9669	148	48	and	and	CCONJ
aiua-9669	148	49	adopted	adopt	VERB
aiua-9669	148	50	as	as	SCONJ
aiua-9669	148	51	the	the	DET
aiua-9669	148	52	reference	reference	NOUN
aiua-9669	148	53	standard	standard	ADJ
aiua-9669	148	54	tool	tool	NOUN
aiua-9669	148	55	to	to	PART
aiua-9669	148	56	report	report	VERB
aiua-9669	148	57	and	and	CCONJ
aiua-9669	148	58	early	early	ADJ
aiua-9669	148	59	detect	detect	PROPN
aiua-9669	148	60	pca	pca	PROPN
aiua-9669	148	61	.	.	PUNCT
aiua-9669	149	1	the	the	DET
aiua-9669	149	2	most	most	ADV
aiua-9669	149	3	reported	report	VERB
aiua-9669	149	4	limit	limit	NOUN
aiua-9669	149	5	of	of	ADP
aiua-9669	149	6	this	this	DET
aiua-9669	149	7	scoring	scoring	NOUN
aiua-9669	149	8	system	system	NOUN
aiua-9669	149	9	is	be	AUX
aiua-9669	149	10	the	the	DET
aiua-9669	149	11	inter	inter	ADJ
aiua-9669	149	12	-	-	ADJ
aiua-9669	149	13	reader	reader	ADJ
aiua-9669	149	14	concordance	concordance	NOUN
aiua-9669	149	15	ratio	ratio	NOUN
aiua-9669	149	16	(	(	PUNCT
aiua-9669	149	17	moderate	moderate	ADJ
aiua-9669	149	18	)	)	PUNCT
aiua-9669	149	19	,	,	PUNCT
aiua-9669	149	20	which	which	PRON
aiua-9669	149	21	limits	limit	VERB
aiua-9669	149	22	the	the	DET
aiua-9669	149	23	diagnostic	diagnostic	ADJ
aiua-9669	149	24	performance	performance	NOUN
aiua-9669	149	25	of	of	ADP
aiua-9669	149	26	this	this	DET
aiua-9669	149	27	system	system	NOUN
aiua-9669	149	28	.	.	PUNCT
aiua-9669	150	1	moreover	moreover	ADV
aiua-9669	150	2	,	,	PUNCT
aiua-9669	150	3	despite	despite	SCONJ
aiua-9669	150	4	technological	technological	ADJ
aiua-9669	150	5	improvements	improvement	NOUN
aiua-9669	150	6	,	,	PUNCT
aiua-9669	150	7	the	the	DET
aiua-9669	150	8	study	study	NOUN
aiua-9669	150	9	of	of	ADP
aiua-9669	150	10	the	the	DET
aiua-9669	150	11	transition	transition	NOUN
aiua-9669	150	12	zone	zone	NOUN
aiua-9669	150	13	remains	remain	VERB
aiua-9669	150	14	challenging	challenge	VERB
aiua-9669	150	15	if	if	SCONJ
aiua-9669	150	16	compared	compare	VERB
aiua-9669	150	17	to	to	ADP
aiua-9669	150	18	the	the	DET
aiua-9669	150	19	peripheral	peripheral	ADJ
aiua-9669	150	20	zone	zone	NOUN
aiua-9669	150	21	due	due	ADP
aiua-9669	150	22	to	to	ADP
aiua-9669	150	23	the	the	DET
aiua-9669	150	24	presence	presence	NOUN
aiua-9669	150	25	of	of	ADP
aiua-9669	150	26	benign	benign	ADJ
aiua-9669	150	27	hyperplasia	hyperplasia	NOUN
aiua-9669	150	28	as	as	ADP
aiua-9669	150	29	a	a	DET
aiua-9669	150	30	mimic	mimic	NOUN
aiua-9669	150	31	of	of	ADP
aiua-9669	150	32	pca	pca	NOUN
aiua-9669	150	33	(	(	PUNCT
aiua-9669	150	34	2	2	NUM
aiua-9669	150	35	)	)	PUNCT
aiua-9669	150	36	.	.	PUNCT
aiua-9669	151	1	in	in	ADP
aiua-9669	151	2	2019	2019	NUM
aiua-9669	151	3	the	the	DET
aiua-9669	151	4	pi	pi	NOUN
aiua-9669	151	5	-	-	PUNCT
aiua-9669	151	6	rad	rad	NOUN
aiua-9669	151	7	system	system	NOUN
aiua-9669	151	8	was	be	AUX
aiua-9669	151	9	updated	update	VERB
aiua-9669	151	10	to	to	PART
aiua-9669	151	11	version	version	VERB
aiua-9669	151	12	2.1	2.1	NUM
aiua-9669	151	13	with	with	ADP
aiua-9669	151	14	leading	lead	VERB
aiua-9669	151	15	changes	change	NOUN
aiua-9669	151	16	regarding	regard	VERB
aiua-9669	151	17	the	the	DET
aiua-9669	151	18	transition	transition	NOUN
aiua-9669	151	19	zone	zone	NOUN
aiua-9669	151	20	mpmri	mpmri	PROPN
aiua-9669	151	21	conundrum	conundrum	PROPN
aiua-9669	151	22	(	(	PUNCT
aiua-9669	151	23	54	54	NUM
aiua-9669	151	24	)	)	PUNCT
aiua-9669	151	25	.	.	PUNCT
aiua-9669	152	1	the	the	DET
aiua-9669	152	2	most	most	ADV
aiua-9669	152	3	important	important	ADJ
aiua-9669	152	4	ones	one	NOUN
aiua-9669	152	5	are	be	AUX
aiua-9669	152	6	:	:	PUNCT
aiua-9669	152	7	1	1	X
aiua-9669	152	8	)	)	PUNCT
aiua-9669	152	9	the	the	DET
aiua-9669	152	10	definition	definition	NOUN
aiua-9669	152	11	of	of	ADP
aiua-9669	152	12	atypical	atypical	ADJ
aiua-9669	152	13	nodules	nodule	NOUN
aiua-9669	152	14	in	in	ADP
aiua-9669	152	15	the	the	DET
aiua-9669	152	16	tz	tz	NOUN
aiua-9669	152	17	and	and	CCONJ
aiua-9669	152	18	the	the	DET
aiua-9669	152	19	downgrading	downgrading	NOUN
aiua-9669	152	20	to	to	PART
aiua-9669	152	21	category	category	NOUN
aiua-9669	152	22	score	score	VERB
aiua-9669	152	23	1	1	NUM
aiua-9669	152	24	of	of	ADP
aiua-9669	152	25	the	the	DET
aiua-9669	152	26	completely	completely	ADV
aiua-9669	152	27	encapsulated	encapsulate	VERB
aiua-9669	152	28	nodules	nodule	NOUN
aiua-9669	152	29	(	(	PUNCT
aiua-9669	152	30	encapsulated	encapsulate	VERB
aiua-9669	152	31	or	or	CCONJ
aiua-9669	152	32	homogeneous	homogeneous	ADJ
aiua-9669	152	33	circumscribed	circumscribe	VERB
aiua-9669	152	34	defined	define	VERB
aiua-9669	152	35	as	as	ADP
aiua-9669	152	36	pi	pi	NOUN
aiua-9669	152	37	-	-	PUNCT
aiua-9669	152	38	rads	rad	NOUN
aiua-9669	152	39	2	2	NUM
aiua-9669	152	40	in	in	ADP
aiua-9669	152	41	the	the	DET
aiua-9669	152	42	previous	previous	ADJ
aiua-9669	152	43	category	category	NOUN
aiua-9669	152	44	system	system	NOUN
aiua-9669	152	45	)	)	PUNCT
aiua-9669	152	46	;	;	PUNCT
aiua-9669	152	47	2	2	X
aiua-9669	152	48	)	)	PUNCT
aiua-9669	152	49	the	the	DET
aiua-9669	152	50	characterisation	characterisation	NOUN
aiua-9669	152	51	of	of	ADP
aiua-9669	152	52	these	these	DET
aiua-9669	152	53	nodules	nodule	NOUN
aiua-9669	152	54	trough	trough	NOUN
aiua-9669	152	55	diffusion	diffusion	NOUN
aiua-9669	152	56	weighted	weight	VERB
aiua-9669	152	57	imaging	imaging	NOUN
aiua-9669	152	58	(	(	PUNCT
aiua-9669	152	59	dwi	dwi	PROPN
aiua-9669	152	60	)	)	PUNCT
aiua-9669	152	61	features	feature	VERB
aiua-9669	152	62	to	to	PART
aiua-9669	152	63	improve	improve	VERB
aiua-9669	152	64	detection	detection	NOUN
aiua-9669	152	65	and	and	CCONJ
aiua-9669	152	66	localization	localization	NOUN
aiua-9669	152	67	of	of	ADP
aiua-9669	152	68	pi	pi	NOUN
aiua-9669	152	69	-	-	PUNCT
aiua-9669	152	70	rads	rad	NOUN
aiua-9669	152	71	3	3	NUM
aiua-9669	152	72	areas	area	NOUN
aiua-9669	152	73	.	.	PUNCT
aiua-9669	153	1	focus	focus	VERB
aiua-9669	153	2	on	on	ADP
aiua-9669	153	3	pi	pi	NOUN
aiua-9669	153	4	-	-	PUNCT
aiua-9669	153	5	rads	rad	NOUN
aiua-9669	153	6	3	3	NUM
aiua-9669	153	7	lesions	lesion	NOUN
aiua-9669	153	8	in	in	ADP
aiua-9669	153	9	the	the	DET
aiua-9669	153	10	tz	tz	PROPN
aiua-9669	153	11	vs	vs	ADP
aiua-9669	153	12	pz	pz	PROPN
aiua-9669	153	13	mri	mri	NOUN
aiua-9669	153	14	lesions	lesion	NOUN
aiua-9669	153	15	pi	pi	NOUN
aiua-9669	153	16	-	-	PUNCT
aiua-9669	153	17	rads	rad	NOUN
aiua-9669	153	18	3	3	NUM
aiua-9669	153	19	are	be	AUX
aiua-9669	153	20	termed	term	VERB
aiua-9669	153	21	as	as	ADP
aiua-9669	153	22	“	"	PUNCT
aiua-9669	153	23	equivocal	equivocal	ADJ
aiua-9669	153	24	”	"	PUNCT
aiua-9669	153	25	for	for	ADP
aiua-9669	153	26	the	the	DET
aiua-9669	153	27	presence	presence	NOUN
aiua-9669	153	28	of	of	ADP
aiua-9669	153	29	clinically	clinically	ADV
aiua-9669	153	30	cspca	cspca	NOUN
aiua-9669	153	31	.	.	PUNCT
aiua-9669	154	1	pi	pi	NOUN
aiua-9669	154	2	-	-	PUNCT
aiua-9669	154	3	rads	rad	NOUN
aiua-9669	154	4	3	3	NUM
aiua-9669	154	5	represents	represent	VERB
aiua-9669	154	6	a	a	DET
aiua-9669	154	7	“	"	PUNCT
aiua-9669	154	8	grey	grey	ADJ
aiua-9669	154	9	zone	zone	NOUN
aiua-9669	154	10	”	"	PUNCT
aiua-9669	154	11	that	that	PRON
aiua-9669	154	12	needs	need	VERB
aiua-9669	154	13	to	to	PART
aiua-9669	154	14	be	be	AUX
aiua-9669	154	15	further	far	ADV
aiua-9669	154	16	investigated	investigate	VERB
aiua-9669	154	17	to	to	PART
aiua-9669	154	18	solve	solve	VERB
aiua-9669	154	19	the	the	DET
aiua-9669	154	20	issue	issue	NOUN
aiua-9669	154	21	of	of	ADP
aiua-9669	154	22	biopsy	biopsy	NOUN
aiua-9669	154	23	or	or	CCONJ
aiua-9669	154	24	not	not	PART
aiua-9669	154	25	biopsy	biopsy	ADJ
aiua-9669	154	26	.	.	PUNCT
aiua-9669	155	1	they	they	PRON
aiua-9669	155	2	could	could	AUX
aiua-9669	155	3	be	be	AUX
aiua-9669	155	4	malignant	malignant	ADJ
aiua-9669	155	5	lesions	lesion	NOUN
aiua-9669	155	6	but	but	CCONJ
aiua-9669	155	7	mostly	mostly	ADV
aiua-9669	155	8	they	they	PRON
aiua-9669	155	9	are	be	AUX
aiua-9669	155	10	benign	benign	ADJ
aiua-9669	155	11	lesions	lesion	NOUN
aiua-9669	155	12	or	or	CCONJ
aiua-9669	155	13	nonsignificative	nonsignificative	ADJ
aiua-9669	155	14	cancer	cancer	NOUN
aiua-9669	155	15	(	(	PUNCT
aiua-9669	155	16	55	55	NUM
aiua-9669	155	17	)	)	PUNCT
aiua-9669	155	18	.	.	PUNCT
aiua-9669	156	1	the	the	DET
aiua-9669	156	2	pi	pi	NOUN
aiua-9669	156	3	-	-	PUNCT
aiua-9669	156	4	rads	rad	NOUN
aiua-9669	156	5	version	version	NOUN
aiua-9669	156	6	2	2	NUM
aiua-9669	156	7	uses	use	VERB
aiua-9669	156	8	a	a	DET
aiua-9669	156	9	5	5	NUM
aiua-9669	156	10	-	-	PUNCT
aiua-9669	156	11	point	point	NOUN
aiua-9669	156	12	scale	scale	NOUN
aiua-9669	156	13	based	base	VERB
aiua-9669	156	14	on	on	ADP
aiua-9669	156	15	the	the	DET
aiua-9669	156	16	likelihood	likelihood	NOUN
aiua-9669	156	17	(	(	PUNCT
aiua-9669	156	18	probability	probability	NOUN
aiua-9669	156	19	)	)	PUNCT
aiua-9669	156	20	that	that	SCONJ
aiua-9669	156	21	a	a	DET
aiua-9669	156	22	combination	combination	NOUN
aiua-9669	156	23	of	of	ADP
aiua-9669	156	24	mpmr	mpmr	NOUN
aiua-9669	156	25	findings	finding	NOUN
aiua-9669	156	26	on	on	ADP
aiua-9669	156	27	t2	t2	NOUN
aiua-9669	156	28	-	-	PUNCT
aiua-9669	156	29	weighted	weight	VERB
aiua-9669	156	30	imaging	imaging	NOUN
aiua-9669	156	31	(	(	PUNCT
aiua-9669	156	32	t2w	t2w	NOUN
aiua-9669	156	33	)	)	PUNCT
aiua-9669	156	34	,	,	PUNCT
aiua-9669	156	35	diffusion	diffusion	NOUN
aiua-9669	156	36	-	-	PUNCT
aiua-9669	156	37	weighted	weight	VERB
aiua-9669	156	38	imaging	imaging	NOUN
aiua-9669	156	39	(	(	PUNCT
aiua-9669	156	40	dwi	dwi	PROPN
aiua-9669	156	41	)	)	PUNCT
aiua-9669	156	42	,	,	PUNCT
aiua-9669	156	43	and	and	CCONJ
aiua-9669	156	44	dynamic	dynamic	ADJ
aiua-9669	156	45	contrast	contrast	NOUN
aiua-9669	156	46	enhancement	enhancement	NOUN
aiua-9669	156	47	(	(	PUNCT
aiua-9669	156	48	dce	dce	PROPN
aiua-9669	156	49	)	)	PUNCT
aiua-9669	156	50	correlates	correlate	VERB
aiua-9669	156	51	with	with	ADP
aiua-9669	156	52	the	the	DET
aiua-9669	156	53	presence	presence	NOUN
aiua-9669	156	54	of	of	ADP
aiua-9669	156	55	a	a	DET
aiua-9669	156	56	clinically	clinically	ADV
aiua-9669	156	57	significant	significant	ADJ
aiua-9669	156	58	cancer	cancer	NOUN
aiua-9669	156	59	depending	depend	VERB
aiua-9669	156	60	on	on	ADP
aiua-9669	156	61	cancer	cancer	NOUN
aiua-9669	156	62	volume	volume	NOUN
aiua-9669	156	63	(	(	PUNCT
aiua-9669	156	64	>	>	X
aiua-9669	156	65	0.5	0.5	NUM
aiua-9669	156	66	ml	ml	NOUN
aiua-9669	156	67	)	)	PUNCT
aiua-9669	156	68	,	,	PUNCT
aiua-9669	156	69	location	location	NOUN
aiua-9669	156	70	and	and	CCONJ
aiua-9669	156	71	background	background	NOUN
aiua-9669	156	72	tissue	tissue	NOUN
aiua-9669	156	73	within	within	ADP
aiua-9669	156	74	the	the	DET
aiua-9669	156	75	prostate	prostate	NOUN
aiua-9669	156	76	gland	gland	NOUN
aiua-9669	156	77	.	.	PUNCT
aiua-9669	157	1	the	the	DET
aiua-9669	157	2	peripheral	peripheral	ADJ
aiua-9669	157	3	zone	zone	NOUN
aiua-9669	157	4	(	(	PUNCT
aiua-9669	157	5	pz	pz	NOUN
aiua-9669	157	6	)	)	PUNCT
aiua-9669	157	7	of	of	ADP
aiua-9669	157	8	the	the	DET
aiua-9669	157	9	prostate	prostate	NOUN
aiua-9669	157	10	has	have	VERB
aiua-9669	157	11	a	a	DET
aiua-9669	157	12	high	high	ADJ
aiua-9669	157	13	risk	risk	NOUN
aiua-9669	157	14	of	of	ADP
aiua-9669	157	15	develop	develop	VERB
aiua-9669	157	16	prostate	prostate	NOUN
aiua-9669	157	17	cancer	cancer	NOUN
aiua-9669	157	18	compared	compare	VERB
aiua-9669	157	19	to	to	ADP
aiua-9669	157	20	the	the	DET
aiua-9669	157	21	transizion	transizion	NOUN
aiua-9669	157	22	zone	zone	NOUN
aiua-9669	157	23	(	(	PUNCT
aiua-9669	157	24	tz	tz	PROPN
aiua-9669	157	25	)	)	PUNCT
aiua-9669	157	26	.	.	PUNCT
aiua-9669	158	1	therefore	therefore	ADV
aiua-9669	158	2	,	,	PUNCT
aiua-9669	158	3	doubtful	doubtful	ADJ
aiua-9669	158	4	mr	mr	PROPN
aiua-9669	158	5	imaging	imaging	PROPN
aiua-9669	158	6	(	(	PUNCT
aiua-9669	158	7	defined	define	VERB
aiua-9669	158	8	as	as	ADP
aiua-9669	158	9	pirads	pirad	NOUN
aiua-9669	158	10	3	3	NUM
aiua-9669	158	11	)	)	PUNCT
aiua-9669	158	12	has	have	VERB
aiua-9669	158	13	different	different	ADJ
aiua-9669	158	14	diagnostic	diagnostic	ADJ
aiua-9669	158	15	value	value	NOUN
aiua-9669	158	16	taken	take	VERB
aiua-9669	158	17	into	into	ADP
aiua-9669	158	18	account	account	NOUN
aiua-9669	158	19	prostatic	prostatic	ADJ
aiua-9669	158	20	anatomical	anatomical	ADJ
aiua-9669	158	21	zones	zone	NOUN
aiua-9669	158	22	.	.	PUNCT
aiua-9669	159	1	this	this	PRON
aiua-9669	159	2	is	be	AUX
aiua-9669	159	3	supported	support	VERB
aiua-9669	159	4	by	by	ADP
aiua-9669	159	5	yang	yang	PROPN
aiua-9669	159	6	et	et	PROPN
aiua-9669	159	7	al	al	PROPN
aiua-9669	159	8	.	.	PROPN
aiua-9669	159	9	who	who	PRON
aiua-9669	159	10	analyzed	analyze	VERB
aiua-9669	159	11	cancer	cancer	NOUN
aiua-9669	159	12	detection	detection	NOUN
aiua-9669	159	13	rate	rate	NOUN
aiua-9669	159	14	in	in	ADP
aiua-9669	159	15	683	683	NUM
aiua-9669	159	16	patients	patient	NOUN
aiua-9669	159	17	with	with	ADP
aiua-9669	159	18	pi	pi	NOUN
aiua-9669	159	19	-	-	PUNCT
aiua-9669	159	20	rads	rad	NOUN
aiua-9669	159	21	3	3	NUM
aiua-9669	159	22	lesions	lesion	NOUN
aiua-9669	159	23	of	of	ADP
aiua-9669	159	24	the	the	DET
aiua-9669	159	25	pz	pz	NOUN
aiua-9669	159	26	and	and	CCONJ
aiua-9669	159	27	tz	tz	PROPN
aiua-9669	159	28	(	(	PUNCT
aiua-9669	159	29	56	56	NUM
aiua-9669	159	30	)	)	PUNCT
aiua-9669	159	31	.	.	PUNCT
aiua-9669	160	1	they	they	PRON
aiua-9669	160	2	reported	report	VERB
aiua-9669	160	3	37	37	NUM
aiua-9669	160	4	%	%	NOUN
aiua-9669	160	5	cancer	cancer	NOUN
aiua-9669	160	6	detection	detection	NOUN
aiua-9669	160	7	and	and	CCONJ
aiua-9669	160	8	18.7	18.7	NUM
aiua-9669	160	9	%	%	NOUN
aiua-9669	160	10	of	of	ADP
aiua-9669	160	11	cspca	cspca	NOUN
aiua-9669	160	12	in	in	ADP
aiua-9669	160	13	the	the	DET
aiua-9669	160	14	pz	pz	NOUN
aiua-9669	160	15	,	,	PUNCT
aiua-9669	160	16	while	while	SCONJ
aiua-9669	160	17	in	in	ADP
aiua-9669	160	18	the	the	DET
aiua-9669	160	19	tz	tz	NOUN
aiua-9669	160	20	the	the	DET
aiua-9669	160	21	overall	overall	ADJ
aiua-9669	160	22	cancer	cancer	NOUN
aiua-9669	160	23	detection	detection	NOUN
aiua-9669	160	24	was	be	AUX
aiua-9669	160	25	16.4	16.4	NUM
aiua-9669	160	26	%	%	NOUN
aiua-9669	160	27	and	and	CCONJ
aiua-9669	160	28	the	the	DET
aiua-9669	160	29	rate	rate	NOUN
aiua-9669	160	30	of	of	ADP
aiua-9669	160	31	cspca	cspca	NOUN
aiua-9669	160	32	was	be	AUX
aiua-9669	160	33	6.0	6.0	NUM
aiua-9669	160	34	%	%	NOUN
aiua-9669	160	35	.	.	PUNCT
aiua-9669	161	1	furthermore	furthermore	ADV
aiua-9669	161	2	,	,	PUNCT
aiua-9669	161	3	using	use	VERB
aiua-9669	161	4	a	a	DET
aiua-9669	161	5	psad	psad	ADJ
aiua-9669	161	6	greater	great	ADJ
aiua-9669	161	7	than	than	ADP
aiua-9669	161	8	0.15	0.15	NUM
aiua-9669	161	9	and	and	CCONJ
aiua-9669	161	10	age	age	NOUN
aiua-9669	161	11	greater	great	ADJ
aiua-9669	161	12	than	than	ADP
aiua-9669	161	13	68	68	NUM
aiua-9669	161	14	years	year	NOUN
aiua-9669	161	15	,	,	PUNCT
aiua-9669	161	16	they	they	PRON
aiua-9669	161	17	calculated	calculate	VERB
aiua-9669	161	18	that	that	SCONJ
aiua-9669	161	19	24	24	NUM
aiua-9669	161	20	%	%	NOUN
aiua-9669	161	21	of	of	ADP
aiua-9669	161	22	biopsy	biopsy	NOUN
aiua-9669	161	23	could	could	AUX
aiua-9669	161	24	be	be	AUX
aiua-9669	161	25	omitted	omit	VERB
aiua-9669	161	26	by	by	ADP
aiua-9669	161	27	losing	lose	VERB
aiua-9669	161	28	only	only	ADV
aiua-9669	161	29	one	one	NUM
aiua-9669	161	30	cspca	cspca	NOUN
aiua-9669	161	31	,	,	PUNCT
aiua-9669	161	32	with	with	ADP
aiua-9669	161	33	a	a	DET
aiua-9669	161	34	sensitivity	sensitivity	NOUN
aiua-9669	161	35	of	of	ADP
aiua-9669	161	36	80	80	NUM
aiua-9669	161	37	%	%	NOUN
aiua-9669	161	38	and	and	CCONJ
aiua-9669	161	39	a	a	DET
aiua-9669	161	40	negative	negative	ADJ
aiua-9669	161	41	predictive	predictive	ADJ
aiua-9669	161	42	value	value	NOUN
aiua-9669	161	43	of	of	ADP
aiua-9669	161	44	92.3	92.3	NUM
aiua-9669	161	45	%	%	NOUN
aiua-9669	161	46	.	.	PUNCT
aiua-9669	162	1	they	they	PRON
aiua-9669	162	2	conclude	conclude	VERB
aiua-9669	162	3	that	that	SCONJ
aiua-9669	162	4	significant	significant	ADJ
aiua-9669	162	5	cancer	cancer	NOUN
aiua-9669	162	6	is	be	AUX
aiua-9669	162	7	uncommon	uncommon	ADJ
aiua-9669	162	8	in	in	ADP
aiua-9669	162	9	tz	tz	PROPN
aiua-9669	162	10	and	and	CCONJ
aiua-9669	162	11	the	the	DET
aiua-9669	162	12	active	active	ADJ
aiua-9669	162	13	surveillance	surveillance	NOUN
aiua-9669	162	14	is	be	AUX
aiua-9669	162	15	the	the	DET
aiua-9669	162	16	optimal	optimal	ADJ
aiua-9669	162	17	choice	choice	NOUN
aiua-9669	162	18	,	,	PUNCT
aiua-9669	162	19	especially	especially	ADV
aiua-9669	162	20	among	among	ADP
aiua-9669	162	21	patients	patient	NOUN
aiua-9669	162	22	without	without	ADP
aiua-9669	162	23	risk	risk	NOUN
aiua-9669	162	24	factors	factor	NOUN
aiua-9669	162	25	such	such	ADJ
aiua-9669	162	26	as	as	ADP
aiua-9669	162	27	those	those	PRON
aiua-9669	162	28	with	with	ADP
aiua-9669	162	29	low	low	ADJ
aiua-9669	162	30	psad	psad	NOUN
aiua-9669	162	31	.	.	PUNCT
aiua-9669	163	1	many	many	ADJ
aiua-9669	163	2	studies	study	NOUN
aiua-9669	163	3	report	report	VERB
aiua-9669	163	4	that	that	SCONJ
aiua-9669	163	5	mpmr	mpmr	NOUN
aiua-9669	163	6	is	be	AUX
aiua-9669	163	7	very	very	ADV
aiua-9669	163	8	reliable	reliable	ADJ
aiua-9669	163	9	as	as	ADP
aiua-9669	163	10	a	a	DET
aiua-9669	163	11	negative	negative	ADJ
aiua-9669	163	12	predictive	predictive	ADJ
aiua-9669	163	13	value	value	NOUN
aiua-9669	163	14	,	,	PUNCT
aiua-9669	163	15	but	but	CCONJ
aiua-9669	163	16	it	it	PRON
aiua-9669	163	17	depends	depend	VERB
aiua-9669	163	18	on	on	ADP
aiua-9669	163	19	prevalence	prevalence	NOUN
aiua-9669	163	20	of	of	ADP
aiua-9669	163	21	disease	disease	NOUN
aiua-9669	163	22	in	in	ADP
aiua-9669	163	23	the	the	DET
aiua-9669	163	24	population	population	NOUN
aiua-9669	163	25	studied	study	VERB
aiua-9669	163	26	and	and	CCONJ
aiua-9669	163	27	the	the	DET
aiua-9669	163	28	a	a	DET
aiua-9669	163	29	priori	priori	ADJ
aiua-9669	163	30	risk	risk	NOUN
aiua-9669	163	31	of	of	ADP
aiua-9669	163	32	developing	develop	VERB
aiua-9669	163	33	disease	disease	NOUN
aiua-9669	163	34	.	.	PUNCT
aiua-9669	164	1	since	since	SCONJ
aiua-9669	164	2	,	,	PUNCT
aiua-9669	164	3	pi	pi	NOUN
aiua-9669	164	4	-	-	PUNCT
aiua-9669	164	5	rads	rad	NOUN
aiua-9669	164	6	3	3	NUM
aiua-9669	164	7	does	do	AUX
aiua-9669	164	8	not	not	PART
aiua-9669	164	9	identify	identify	VERB
aiua-9669	164	10	the	the	DET
aiua-9669	164	11	same	same	ADJ
aiua-9669	164	12	risk	risk	NOUN
aiua-9669	164	13	of	of	ADP
aiua-9669	164	14	cancer	cancer	NOUN
aiua-9669	164	15	in	in	ADP
aiua-9669	164	16	different	different	ADJ
aiua-9669	164	17	prostate	prostate	NOUN
aiua-9669	164	18	zones	zone	NOUN
aiua-9669	164	19	,	,	PUNCT
aiua-9669	164	20	the	the	DET
aiua-9669	164	21	predictive	predictive	ADJ
aiua-9669	164	22	value	value	NOUN
aiua-9669	164	23	of	of	ADP
aiua-9669	164	24	pi	pi	NOUN
aiua-9669	164	25	-	-	PUNCT
aiua-9669	164	26	rads	rad	NOUN
aiua-9669	164	27	3	3	NUM
aiua-9669	164	28	should	should	AUX
aiua-9669	164	29	be	be	AUX
aiua-9669	164	30	considered	consider	VERB
aiua-9669	164	31	as	as	ADV
aiua-9669	164	32	low	low	ADJ
aiua-9669	164	33	in	in	ADP
aiua-9669	164	34	the	the	DET
aiua-9669	164	35	tz	tz	NOUN
aiua-9669	164	36	respect	respect	NOUN
aiua-9669	164	37	to	to	ADP
aiua-9669	164	38	pz	pz	PROPN
aiua-9669	164	39	.	.	PROPN
aiua-9669	164	40	however	however	ADV
aiua-9669	164	41	,	,	PUNCT
aiua-9669	164	42	the	the	DET
aiua-9669	164	43	estimating	estimating	NOUN
aiua-9669	164	44	of	of	ADP
aiua-9669	164	45	the	the	DET
aiua-9669	164	46	predictive	predictive	ADJ
aiua-9669	164	47	value	value	NOUN
aiua-9669	164	48	of	of	ADP
aiua-9669	164	49	pirads	pirad	NOUN
aiua-9669	164	50	3	3	NUM
aiua-9669	164	51	lesions	lesion	NOUN
aiua-9669	164	52	has	have	VERB
aiua-9669	164	53	methodological	methodological	ADJ
aiua-9669	164	54	bias	bias	NOUN
aiua-9669	164	55	because	because	SCONJ
aiua-9669	164	56	it	it	PRON
aiua-9669	164	57	do	do	AUX
aiua-9669	164	58	not	not	PART
aiua-9669	164	59	represent	represent	VERB
aiua-9669	164	60	the	the	DET
aiua-9669	164	61	primary	primary	ADJ
aiua-9669	164	62	endpoint	endpoint	NOUN
aiua-9669	164	63	of	of	ADP
aiua-9669	164	64	published	publish	VERB
aiua-9669	164	65	studies	study	NOUN
aiua-9669	164	66	,	,	PUNCT
aiua-9669	164	67	97archivio	97archivio	NOUN
aiua-9669	164	68	italiano	italiano	PROPN
aiua-9669	164	69	di	di	PROPN
aiua-9669	164	70	urologia	urologia	PROPN
aiua-9669	164	71	e	e	PROPN
aiua-9669	164	72	andrologia	andrologia	NOUN
aiua-9669	164	73	2021	2021	NUM
aiua-9669	164	74	;	;	PUNCT
aiua-9669	164	75	93	93	NUM
aiua-9669	164	76	,	,	PUNCT
aiua-9669	164	77	1	1	NUM
aiua-9669	164	78	significant	significant	ADJ
aiua-9669	164	79	prostate	prostate	NOUN
aiua-9669	164	80	cancer	cancer	NOUN
aiua-9669	164	81	with	with	ADP
aiua-9669	164	82	low	low	ADJ
aiua-9669	164	83	psa	psa	NOUN
aiua-9669	164	84	as	as	ADP
aiua-9669	164	85	maggi	maggi	PROPN
aiua-9669	164	86	et	et	PROPN
aiua-9669	164	87	al	al	PROPN
aiua-9669	164	88	.	.	PUNCT
aiua-9669	165	1	very	very	ADV
aiua-9669	165	2	recently	recently	ADV
aiua-9669	165	3	underlined	underline	VERB
aiua-9669	165	4	after	after	ADP
aiua-9669	165	5	an	an	DET
aiua-9669	165	6	extensive	extensive	ADJ
aiua-9669	165	7	review	review	NOUN
aiua-9669	165	8	(	(	PUNCT
aiua-9669	165	9	57	57	NUM
aiua-9669	165	10	)	)	PUNCT
aiua-9669	165	11	.	.	PUNCT
aiua-9669	166	1	in	in	ADP
aiua-9669	166	2	28	28	NUM
aiua-9669	166	3	studies	study	NOUN
aiua-9669	166	4	with	with	ADP
aiua-9669	166	5	10.176	10.176	NUM
aiua-9669	166	6	patients	patient	NOUN
aiua-9669	166	7	(	(	PUNCT
aiua-9669	166	8	56.5	56.5	NUM
aiua-9669	166	9	%	%	NOUN
aiua-9669	166	10	with	with	ADP
aiua-9669	166	11	pca	pca	NOUN
aiua-9669	166	12	and	and	CCONJ
aiua-9669	166	13	40.0	40.0	NUM
aiua-9669	166	14	%	%	NOUN
aiua-9669	166	15	with	with	ADP
aiua-9669	166	16	cspca	cspca	NOUN
aiua-9669	166	17	)	)	PUNCT
aiua-9669	166	18	,	,	PUNCT
aiua-9669	166	19	1,759	1,759	NUM
aiua-9669	166	20	men	man	NOUN
aiua-9669	166	21	with	with	ADP
aiua-9669	166	22	targeted	target	VERB
aiua-9669	166	23	biopsies	biopsy	NOUN
aiua-9669	166	24	on	on	ADP
aiua-9669	166	25	pi	pi	NOUN
aiua-9669	166	26	-	-	PUNCT
aiua-9669	166	27	rads	rad	NOUN
aiua-9669	166	28	3	3	NUM
aiua-9669	166	29	lesions	lesion	NOUN
aiua-9669	166	30	were	be	AUX
aiua-9669	166	31	retrieved	retrieve	VERB
aiua-9669	166	32	:	:	PUNCT
aiua-9669	166	33	the	the	DET
aiua-9669	166	34	overall	overall	ADJ
aiua-9669	166	35	rate	rate	NOUN
aiua-9669	166	36	of	of	ADP
aiua-9669	166	37	cspca	cspca	NOUN
aiua-9669	166	38	detection	detection	NOUN
aiua-9669	166	39	was	be	AUX
aiua-9669	166	40	36	36	NUM
aiua-9669	166	41	%	%	NOUN
aiua-9669	166	42	and	and	CCONJ
aiua-9669	166	43	18.5	18.5	NUM
aiua-9669	166	44	%	%	NOUN
aiua-9669	166	45	.	.	PUNCT
aiua-9669	167	1	the	the	DET
aiua-9669	167	2	combination	combination	NOUN
aiua-9669	167	3	technique	technique	NOUN
aiua-9669	167	4	(	(	PUNCT
aiua-9669	167	5	targeted	targeted	ADJ
aiua-9669	167	6	and	and	CCONJ
aiua-9669	167	7	systematic	systematic	ADJ
aiua-9669	167	8	biopsy	biopsy	NOUN
aiua-9669	167	9	)	)	PUNCT
aiua-9669	167	10	has	have	VERB
aiua-9669	167	11	the	the	DET
aiua-9669	167	12	better	well	ADJ
aiua-9669	167	13	detection	detection	NOUN
aiua-9669	167	14	rate	rate	NOUN
aiua-9669	167	15	of	of	ADP
aiua-9669	167	16	37	37	NUM
aiua-9669	167	17	%	%	NOUN
aiua-9669	167	18	versus	versus	ADP
aiua-9669	167	19	the	the	DET
aiua-9669	167	20	24	24	NUM
aiua-9669	167	21	%	%	NOUN
aiua-9669	167	22	of	of	ADP
aiua-9669	167	23	exclusive	exclusive	ADJ
aiua-9669	167	24	targeted	targeted	ADJ
aiua-9669	167	25	biopsy	biopsy	NOUN
aiua-9669	167	26	.	.	PUNCT
aiua-9669	168	1	there	there	PRON
aiua-9669	168	2	is	be	VERB
aiua-9669	168	3	no	no	DET
aiua-9669	168	4	significantly	significantly	ADV
aiua-9669	168	5	relevant	relevant	ADJ
aiua-9669	168	6	difference	difference	NOUN
aiua-9669	168	7	between	between	ADP
aiua-9669	168	8	version	version	NOUN
aiua-9669	168	9	1	1	NUM
aiua-9669	168	10	and	and	CCONJ
aiua-9669	168	11	version	version	NOUN
aiua-9669	168	12	2	2	NUM
aiua-9669	168	13	of	of	ADP
aiua-9669	168	14	pi	pi	NOUN
aiua-9669	168	15	-	-	PUNCT
aiua-9669	168	16	rads	rad	NOUN
aiua-9669	168	17	in	in	ADP
aiua-9669	168	18	the	the	DET
aiua-9669	168	19	detection	detection	NOUN
aiua-9669	168	20	of	of	ADP
aiua-9669	168	21	prostate	prostate	NOUN
aiua-9669	168	22	cancer	cancer	NOUN
aiua-9669	168	23	(	(	PUNCT
aiua-9669	168	24	57	57	NUM
aiua-9669	168	25	)	)	PUNCT
aiua-9669	168	26	.	.	PUNCT
aiua-9669	169	1	however	however	ADV
aiua-9669	169	2	,	,	PUNCT
aiua-9669	169	3	they	they	PRON
aiua-9669	169	4	did	do	AUX
aiua-9669	169	5	not	not	PART
aiua-9669	169	6	differentiate	differentiate	VERB
aiua-9669	169	7	the	the	DET
aiua-9669	169	8	cancer	cancer	NOUN
aiua-9669	169	9	detection	detection	NOUN
aiua-9669	169	10	comparing	compare	VERB
aiua-9669	169	11	prostatic	prostatic	ADJ
aiua-9669	169	12	zones	zone	NOUN
aiua-9669	169	13	.	.	PUNCT
aiua-9669	170	1	byun	byun	NOUN
aiua-9669	170	2	et	et	PROPN
aiua-9669	170	3	al	al	PROPN
aiua-9669	170	4	.	.	PROPN
aiua-9669	170	5	evaluated	evaluate	VERB
aiua-9669	170	6	the	the	DET
aiua-9669	170	7	pi	pi	NOUN
aiua-9669	170	8	-	-	PUNCT
aiua-9669	170	9	rads	rad	NOUN
aiua-9669	170	10	v2.1	v2.1	NUM
aiua-9669	170	11	diagnostic	diagnostic	ADJ
aiua-9669	170	12	performances	performance	NOUN
aiua-9669	170	13	and	and	CCONJ
aiua-9669	170	14	inter	inter	ADJ
aiua-9669	170	15	-	-	ADJ
aiua-9669	170	16	reader	reader	ADJ
aiua-9669	170	17	agreement	agreement	NOUN
aiua-9669	170	18	on	on	ADP
aiua-9669	170	19	the	the	DET
aiua-9669	170	20	pca	pca	NOUN
aiua-9669	170	21	detection	detection	NOUN
aiua-9669	170	22	in	in	ADP
aiua-9669	170	23	the	the	DET
aiua-9669	170	24	tz	tz	NOUN
aiua-9669	170	25	comparing	compare	VERB
aiua-9669	170	26	results	result	NOUN
aiua-9669	170	27	with	with	ADP
aiua-9669	170	28	the	the	DET
aiua-9669	170	29	previous	previous	ADJ
aiua-9669	170	30	version	version	NOUN
aiua-9669	170	31	(	(	PUNCT
aiua-9669	170	32	58	58	NUM
aiua-9669	170	33	)	)	PUNCT
aiua-9669	170	34	.	.	PUNCT
aiua-9669	171	1	their	their	PRON
aiua-9669	171	2	results	result	NOUN
aiua-9669	171	3	demonstrated	demonstrate	VERB
aiua-9669	171	4	that	that	SCONJ
aiua-9669	171	5	the	the	DET
aiua-9669	171	6	last	last	ADJ
aiua-9669	171	7	version	version	NOUN
aiua-9669	171	8	has	have	VERB
aiua-9669	171	9	both	both	CCONJ
aiua-9669	171	10	higher	high	ADJ
aiua-9669	171	11	sensitivity	sensitivity	NOUN
aiua-9669	171	12	and	and	CCONJ
aiua-9669	171	13	specificity	specificity	NOUN
aiua-9669	171	14	for	for	ADP
aiua-9669	171	15	the	the	DET
aiua-9669	171	16	overall	overall	ADJ
aiua-9669	171	17	detection	detection	NOUN
aiua-9669	171	18	of	of	ADP
aiua-9669	171	19	pca	pca	PROPN
aiua-9669	171	20	for	for	ADP
aiua-9669	171	21	category	category	NOUN
aiua-9669	171	22	higher	high	ADJ
aiua-9669	171	23	than	than	ADP
aiua-9669	171	24	3	3	NUM
aiua-9669	171	25	lesions	lesion	NOUN
aiua-9669	171	26	,	,	PUNCT
aiua-9669	171	27	independently	independently	ADV
aiua-9669	171	28	of	of	ADP
aiua-9669	171	29	the	the	DET
aiua-9669	171	30	prostatic	prostatic	ADJ
aiua-9669	171	31	zone	zone	NOUN
aiua-9669	171	32	.	.	PUNCT
aiua-9669	172	1	furthermore	furthermore	ADV
aiua-9669	172	2	,	,	PUNCT
aiua-9669	172	3	they	they	PRON
aiua-9669	172	4	reported	report	VERB
aiua-9669	172	5	a	a	DET
aiua-9669	172	6	reduction	reduction	NOUN
aiua-9669	172	7	of	of	ADP
aiua-9669	172	8	proportion	proportion	NOUN
aiua-9669	172	9	of	of	ADP
aiua-9669	172	10	category	category	NOUN
aiua-9669	172	11	3	3	NUM
aiua-9669	172	12	lesions	lesion	NOUN
aiua-9669	172	13	,	,	PUNCT
aiua-9669	172	14	while	while	SCONJ
aiua-9669	172	15	the	the	DET
aiua-9669	172	16	detection	detection	NOUN
aiua-9669	172	17	rates	rate	NOUN
aiua-9669	172	18	of	of	ADP
aiua-9669	172	19	cspca	cspca	NOUN
aiua-9669	172	20	at	at	ADP
aiua-9669	172	21	this	this	DET
aiua-9669	172	22	cut	cut	VERB
aiua-9669	172	23	-	-	PUNCT
aiua-9669	172	24	off	off	ADP
aiua-9669	172	25	value	value	NOUN
aiua-9669	172	26	significantly	significantly	ADV
aiua-9669	172	27	increased	increase	VERB
aiua-9669	172	28	accordingly	accordingly	ADV
aiua-9669	172	29	with	with	ADP
aiua-9669	172	30	the	the	DET
aiua-9669	172	31	inter	inter	ADJ
aiua-9669	172	32	-	-	ADJ
aiua-9669	172	33	reader	reader	ADJ
aiua-9669	172	34	agreement	agreement	NOUN
aiua-9669	172	35	.	.	PUNCT
aiua-9669	173	1	same	same	ADJ
aiua-9669	173	2	findings	finding	NOUN
aiua-9669	173	3	were	be	AUX
aiua-9669	173	4	confirmed	confirm	VERB
aiua-9669	173	5	by	by	ADP
aiua-9669	173	6	wang	wang	PROPN
aiua-9669	173	7	et	et	PROPN
aiua-9669	173	8	al	al	PROPN
aiua-9669	173	9	.	.	PUNCT
aiua-9669	174	1	that	that	PRON
aiua-9669	174	2	also	also	ADV
aiua-9669	174	3	suggested	suggest	VERB
aiua-9669	174	4	that	that	SCONJ
aiua-9669	174	5	pi	pi	NOUN
aiua-9669	174	6	-	-	PUNCT
aiua-9669	174	7	rads	rad	NOUN
aiua-9669	174	8	version	version	NOUN
aiua-9669	174	9	2.1	2.1	NUM
aiua-9669	174	10	improves	improve	VERB
aiua-9669	174	11	the	the	DET
aiua-9669	174	12	overall	overall	ADJ
aiua-9669	174	13	detection	detection	NOUN
aiua-9669	174	14	rates	rate	NOUN
aiua-9669	174	15	of	of	ADP
aiua-9669	174	16	pca	pca	PROPN
aiua-9669	174	17	,	,	PUNCT
aiua-9669	174	18	specifically	specifically	ADV
aiua-9669	174	19	in	in	ADP
aiua-9669	174	20	the	the	DET
aiua-9669	174	21	tz	tz	NOUN
aiua-9669	174	22	zone	zone	NOUN
aiua-9669	174	23	,	,	PUNCT
aiua-9669	174	24	compared	compare	VERB
aiua-9669	174	25	to	to	ADP
aiua-9669	174	26	v2.0	v2.0	PROPN
aiua-9669	174	27	(	(	PUNCT
aiua-9669	174	28	54	54	NUM
aiua-9669	174	29	)	)	PUNCT
aiua-9669	174	30	.	.	PUNCT
aiua-9669	175	1	recently	recently	ADV
aiua-9669	175	2	,	,	PUNCT
aiua-9669	175	3	several	several	ADJ
aiua-9669	175	4	studies	study	NOUN
aiua-9669	175	5	evaluated	evaluate	VERB
aiua-9669	175	6	the	the	DET
aiua-9669	175	7	role	role	NOUN
aiua-9669	175	8	of	of	ADP
aiua-9669	175	9	psad	psad	ADJ
aiua-9669	175	10	as	as	ADP
aiua-9669	175	11	predictive	predictive	ADJ
aiua-9669	175	12	variable	variable	NOUN
aiua-9669	175	13	to	to	PART
aiua-9669	175	14	predict	predict	VERB
aiua-9669	175	15	cspca	cspca	NOUN
aiua-9669	175	16	in	in	ADP
aiua-9669	175	17	pi	pi	NOUN
aiua-9669	175	18	-	-	PUNCT
aiua-9669	175	19	rads	rad	NOUN
aiua-9669	175	20	3	3	NUM
aiua-9669	175	21	lesions	lesion	NOUN
aiua-9669	175	22	:	:	PUNCT
aiua-9669	175	23	a	a	DET
aiua-9669	175	24	cut	cut	NOUN
aiua-9669	175	25	-	-	PUNCT
aiua-9669	175	26	off	off	NOUN
aiua-9669	175	27	0.15	0.15	NUM
aiua-9669	175	28	ng	ng	NOUN
aiua-9669	175	29	/	/	SYM
aiua-9669	175	30	ml	ml	PROPN
aiua-9669	175	31	/	/	SYM
aiua-9669	175	32	cc	cc	NOUN
aiua-9669	175	33	was	be	AUX
aiua-9669	175	34	the	the	DET
aiua-9669	175	35	most	most	ADV
aiua-9669	175	36	significant	significant	ADJ
aiua-9669	175	37	positive	positive	ADJ
aiua-9669	175	38	predictive	predictive	ADJ
aiua-9669	175	39	value	value	NOUN
aiua-9669	175	40	for	for	ADP
aiua-9669	175	41	detect	detect	NOUN
aiua-9669	175	42	cspca	cspca	NOUN
aiua-9669	175	43	.	.	PUNCT
aiua-9669	176	1	hansen	hansen	PROPN
aiua-9669	176	2	and	and	CCONJ
aiua-9669	176	3	ullrich	ullrich	PROPN
aiua-9669	176	4	et	et	PROPN
aiua-9669	176	5	al	al	PROPN
aiua-9669	176	6	.	.	PROPN
aiua-9669	176	7	confirm	confirm	VERB
aiua-9669	176	8	that	that	SCONJ
aiua-9669	176	9	the	the	DET
aiua-9669	176	10	choice	choice	NOUN
aiua-9669	176	11	to	to	PART
aiua-9669	176	12	execute	execute	VERB
aiua-9669	176	13	biopsies	biopsy	NOUN
aiua-9669	176	14	in	in	ADP
aiua-9669	176	15	the	the	DET
aiua-9669	176	16	group	group	NOUN
aiua-9669	176	17	of	of	ADP
aiua-9669	176	18	pi	pi	NOUN
aiua-9669	176	19	-	-	PUNCT
aiua-9669	176	20	rads	rad	NOUN
aiua-9669	176	21	3	3	NUM
aiua-9669	176	22	with	with	ADP
aiua-9669	176	23	psad	psad	PROPN
aiua-9669	176	24	>	>	X
aiua-9669	176	25	0.15	0.15	NUM
aiua-9669	176	26	ng	ng	PROPN
aiua-9669	176	27	/	/	SYM
aiua-9669	176	28	ml	ml	NOUN
aiua-9669	176	29	/	/	SYM
aiua-9669	176	30	cc	cc	NOUN
aiua-9669	176	31	permit	permit	NOUN
aiua-9669	176	32	to	to	PART
aiua-9669	176	33	avoid	avoid	VERB
aiua-9669	176	34	53.4	53.4	NUM
aiua-9669	176	35	%	%	NOUN
aiua-9669	176	36	of	of	ADP
aiua-9669	176	37	biopsies	biopsy	NOUN
aiua-9669	176	38	in	in	ADP
aiua-9669	176	39	this	this	DET
aiua-9669	176	40	population	population	NOUN
aiua-9669	176	41	of	of	ADP
aiua-9669	176	42	patients	patient	NOUN
aiua-9669	176	43	(	(	PUNCT
aiua-9669	176	44	59	59	NUM
aiua-9669	176	45	,	,	PUNCT
aiua-9669	176	46	60	60	NUM
aiua-9669	176	47	)	)	PUNCT
aiua-9669	176	48	.	.	PUNCT
aiua-9669	177	1	also	also	ADV
aiua-9669	177	2	venderink	venderink	VERB
aiua-9669	177	3	et	et	PROPN
aiua-9669	177	4	al	al	PROPN
aiua-9669	177	5	.	.	PROPN
aiua-9669	177	6	calculated	calculate	VERB
aiua-9669	177	7	that	that	SCONJ
aiua-9669	177	8	42	42	NUM
aiua-9669	177	9	%	%	NOUN
aiua-9669	177	10	patients	patient	NOUN
aiua-9669	177	11	with	with	ADP
aiua-9669	177	12	pi	pi	NOUN
aiua-9669	177	13	-	-	PUNCT
aiua-9669	177	14	rads	rad	NOUN
aiua-9669	177	15	3	3	NUM
aiua-9669	177	16	lesions	lesion	NOUN
aiua-9669	177	17	and	and	CCONJ
aiua-9669	177	18	psad	psad	VERB
aiua-9669	177	19	less	less	ADJ
aiua-9669	177	20	than	than	ADP
aiua-9669	177	21	0.15	0.15	NUM
aiua-9669	177	22	could	could	AUX
aiua-9669	177	23	avoid	avoid	VERB
aiua-9669	177	24	biopsy	biopsy	NOUN
aiua-9669	177	25	with	with	ADP
aiua-9669	177	26	the	the	DET
aiua-9669	177	27	loss	loss	NOUN
aiua-9669	177	28	of	of	ADP
aiua-9669	177	29	only	only	ADV
aiua-9669	177	30	6	6	NUM
aiua-9669	177	31	%	%	NOUN
aiua-9669	177	32	of	of	ADP
aiua-9669	177	33	cs	cs	PROPN
aiua-9669	177	34	pca	pca	PROPN
aiua-9669	177	35	(	(	PUNCT
aiua-9669	177	36	95	95	NUM
aiua-9669	177	37	%	%	NOUN
aiua-9669	177	38	c.i	c.i	NOUN
aiua-9669	177	39	.	.	NOUN
aiua-9669	177	40	2	2	NUM
aiua-9669	177	41	-	-	SYM
aiua-9669	177	42	15	15	NUM
aiua-9669	177	43	)	)	PUNCT
aiua-9669	177	44	(	(	PUNCT
aiua-9669	177	45	61	61	NUM
aiua-9669	177	46	)	)	PUNCT
aiua-9669	177	47	.	.	PUNCT
aiua-9669	178	1	lowering	lower	VERB
aiua-9669	178	2	the	the	DET
aiua-9669	178	3	cut	cut	NOUN
aiua-9669	178	4	-	-	PUNCT
aiua-9669	178	5	off	off	NOUN
aiua-9669	178	6	to	to	ADP
aiua-9669	178	7	0.12	0.12	NUM
aiua-9669	178	8	they	they	PRON
aiua-9669	178	9	spared	spare	VERB
aiua-9669	178	10	26	26	NUM
aiua-9669	178	11	%	%	NOUN
aiua-9669	178	12	of	of	ADP
aiua-9669	178	13	avoidable	avoidable	ADJ
aiua-9669	178	14	biopsies	biopsy	NOUN
aiua-9669	178	15	without	without	ADP
aiua-9669	178	16	losing	lose	VERB
aiua-9669	178	17	any	any	DET
aiua-9669	178	18	cspca	cspca	NOUN
aiua-9669	178	19	(	(	PUNCT
aiua-9669	178	20	61	61	NUM
aiua-9669	178	21	)	)	PUNCT
aiua-9669	178	22	.	.	PUNCT
aiua-9669	179	1	schoots	schoot	NOUN
aiua-9669	179	2	et	et	PROPN
aiua-9669	179	3	al	al	PROPN
aiua-9669	179	4	.	.	PROPN
aiua-9669	179	5	reviewed	review	VERB
aiua-9669	179	6	the	the	DET
aiua-9669	179	7	probability	probability	NOUN
aiua-9669	179	8	of	of	ADP
aiua-9669	179	9	cspca	cspca	NOUN
aiua-9669	179	10	in	in	ADP
aiua-9669	179	11	pi	pi	NOUN
aiua-9669	179	12	-	-	PUNCT
aiua-9669	179	13	rads	rad	NOUN
aiua-9669	179	14	3	3	NUM
aiua-9669	179	15	lesions	lesion	NOUN
aiua-9669	179	16	observed	observe	VERB
aiua-9669	179	17	in	in	ADP
aiua-9669	179	18	biopsy	biopsy	NOUN
aiua-9669	179	19	naïve	naïve	ADJ
aiua-9669	179	20	,	,	PUNCT
aiua-9669	179	21	previous	previous	ADJ
aiua-9669	179	22	negative	negative	ADJ
aiua-9669	179	23	biopsy	biopsy	NOUN
aiua-9669	179	24	,	,	PUNCT
aiua-9669	179	25	and	and	CCONJ
aiua-9669	179	26	active	active	ADJ
aiua-9669	179	27	surveillance	surveillance	NOUN
aiua-9669	179	28	patients	patient	NOUN
aiua-9669	179	29	:	:	PUNCT
aiua-9669	179	30	they	they	PRON
aiua-9669	179	31	retrieved	retrieve	VERB
aiua-9669	179	32	21	21	NUM
aiua-9669	179	33	%	%	NOUN
aiua-9669	179	34	,	,	PUNCT
aiua-9669	179	35	16	16	NUM
aiua-9669	179	36	%	%	NOUN
aiua-9669	179	37	and	and	CCONJ
aiua-9669	179	38	17	17	NUM
aiua-9669	179	39	%	%	NOUN
aiua-9669	179	40	of	of	ADP
aiua-9669	179	41	cspca	cspca	NOUN
aiua-9669	179	42	,	,	PUNCT
aiua-9669	179	43	respectively	respectively	ADV
aiua-9669	179	44	(	(	PUNCT
aiua-9669	179	45	62	62	NUM
aiua-9669	179	46	)	)	PUNCT
aiua-9669	179	47	.	.	PUNCT
aiua-9669	180	1	they	they	PRON
aiua-9669	180	2	focused	focus	VERB
aiua-9669	180	3	on	on	ADP
aiua-9669	180	4	size	size	NOUN
aiua-9669	180	5	of	of	ADP
aiua-9669	180	6	the	the	DET
aiua-9669	180	7	lesion	lesion	NOUN
aiua-9669	180	8	:	:	PUNCT
aiua-9669	180	9	pi	pi	NOUN
aiua-9669	180	10	-	-	PUNCT
aiua-9669	180	11	rads	rad	VERB
aiua-9669	180	12	3	3	NUM
aiua-9669	180	13	lesions	lesion	NOUN
aiua-9669	180	14	in	in	ADP
aiua-9669	180	15	both	both	DET
aiua-9669	180	16	peripheral	peripheral	ADJ
aiua-9669	180	17	zone	zone	NOUN
aiua-9669	180	18	(	(	PUNCT
aiua-9669	180	19	pz	pz	NOUN
aiua-9669	180	20	)	)	PUNCT
aiua-9669	180	21	and	and	CCONJ
aiua-9669	180	22	transition	transition	NOUN
aiua-9669	180	23	zone	zone	NOUN
aiua-9669	180	24	(	(	PUNCT
aiua-9669	180	25	tz	tz	NOUN
aiua-9669	180	26	)	)	PUNCT
aiua-9669	180	27	greater	great	ADJ
aiua-9669	180	28	than	than	ADP
aiua-9669	180	29	10	10	NUM
aiua-9669	180	30	mm	mm	NOUN
aiua-9669	180	31	should	should	AUX
aiua-9669	180	32	be	be	AUX
aiua-9669	180	33	re	re	VERB
aiua-9669	180	34	-	-	VERB
aiua-9669	180	35	classified	classified	ADJ
aiua-9669	180	36	as	as	ADP
aiua-9669	180	37	pi	pi	NOUN
aiua-9669	180	38	-	-	PUNCT
aiua-9669	180	39	rads	rad	NOUN
aiua-9669	180	40	4	4	NUM
aiua-9669	180	41	according	accord	VERB
aiua-9669	180	42	to	to	ADP
aiua-9669	180	43	their	their	PRON
aiua-9669	180	44	results	result	NOUN
aiua-9669	180	45	.	.	PUNCT
aiua-9669	181	1	other	other	ADJ
aiua-9669	181	2	than	than	ADP
aiua-9669	181	3	diameter	diameter	NOUN
aiua-9669	181	4	,	,	PUNCT
aiua-9669	181	5	the	the	DET
aiua-9669	181	6	decision	decision	NOUN
aiua-9669	181	7	to	to	PART
aiua-9669	181	8	proceed	proceed	VERB
aiua-9669	181	9	with	with	ADP
aiua-9669	181	10	the	the	DET
aiua-9669	181	11	biopsy	biopsy	NOUN
aiua-9669	181	12	must	must	AUX
aiua-9669	181	13	include	include	VERB
aiua-9669	181	14	clinical	clinical	ADJ
aiua-9669	181	15	elements	element	NOUN
aiua-9669	181	16	such	such	ADJ
aiua-9669	181	17	as	as	ADP
aiua-9669	181	18	psad	psad	ADJ
aiua-9669	181	19	,	,	PUNCT
aiua-9669	181	20	psav	psav	NOUN
aiua-9669	181	21	and	and	CCONJ
aiua-9669	181	22	previous	previous	ADJ
aiua-9669	181	23	biopsies	biopsy	NOUN
aiua-9669	181	24	.	.	PUNCT
aiua-9669	182	1	the	the	DET
aiua-9669	182	2	risk	risk	NOUN
aiua-9669	182	3	of	of	ADP
aiua-9669	182	4	missing	miss	VERB
aiua-9669	182	5	cspca	cspca	NOUN
aiua-9669	182	6	must	must	AUX
aiua-9669	182	7	be	be	AUX
aiua-9669	182	8	discussed	discuss	VERB
aiua-9669	182	9	with	with	ADP
aiua-9669	182	10	the	the	DET
aiua-9669	182	11	patients	patient	NOUN
aiua-9669	182	12	and	and	CCONJ
aiua-9669	182	13	balanced	balance	VERB
aiua-9669	182	14	against	against	ADP
aiua-9669	182	15	saving	save	VERB
aiua-9669	182	16	biopsies	biopsy	NOUN
aiua-9669	182	17	(	(	PUNCT
aiua-9669	182	18	side	side	NOUN
aiua-9669	182	19	effects	effect	NOUN
aiua-9669	182	20	)	)	PUNCT
aiua-9669	182	21	and	and	CCONJ
aiua-9669	182	22	overdiagnosing	overdiagnosing	NOUN
aiua-9669	182	23	of	of	ADP
aiua-9669	182	24	insignificant	insignificant	ADJ
aiua-9669	182	25	pca	pca	NOUN
aiua-9669	182	26	on	on	ADP
aiua-9669	182	27	an	an	DET
aiua-9669	182	28	individual	individual	ADJ
aiua-9669	182	29	basis	basis	NOUN
aiua-9669	182	30	.	.	PUNCT
aiua-9669	183	1	van	van	PROPN
aiua-9669	183	2	der	der	PROPN
aiua-9669	183	3	sar	sar	PROPN
aiua-9669	183	4	et	et	PROPN
aiua-9669	183	5	al	al	PROPN
aiua-9669	183	6	.	.	PROPN
aiua-9669	183	7	investigated	investigate	VERB
aiua-9669	183	8	retrospectively	retrospectively	ADV
aiua-9669	183	9	outcomes	outcome	NOUN
aiua-9669	183	10	such	such	ADJ
aiua-9669	183	11	as	as	ADP
aiua-9669	183	12	window	window	NOUN
aiua-9669	183	13	of	of	ADP
aiua-9669	183	14	curability	curability	NOUN
aiua-9669	183	15	and	and	CCONJ
aiua-9669	183	16	complication	complication	NOUN
aiua-9669	183	17	and	and	CCONJ
aiua-9669	183	18	costs	cost	NOUN
aiua-9669	183	19	of	of	ADP
aiua-9669	183	20	clinical	clinical	ADJ
aiua-9669	183	21	surveillance	surveillance	NOUN
aiua-9669	183	22	compared	compare	VERB
aiua-9669	183	23	to	to	ADP
aiua-9669	183	24	immediate	immediate	ADJ
aiua-9669	183	25	biopsy	biopsy	NOUN
aiua-9669	183	26	(	(	PUNCT
aiua-9669	183	27	63	63	NUM
aiua-9669	183	28	)	)	PUNCT
aiua-9669	183	29	.	.	PUNCT
aiua-9669	184	1	all	all	DET
aiua-9669	184	2	outcomes	outcome	NOUN
aiua-9669	184	3	were	be	AUX
aiua-9669	184	4	not	not	PART
aiua-9669	184	5	influenced	influence	VERB
aiua-9669	184	6	by	by	ADP
aiua-9669	184	7	both	both	DET
aiua-9669	184	8	strategies	strategy	NOUN
aiua-9669	184	9	as	as	ADV
aiua-9669	184	10	well	well	ADV
aiua-9669	184	11	as	as	ADP
aiua-9669	184	12	the	the	DET
aiua-9669	184	13	risk	risk	NOUN
aiua-9669	184	14	profile	profile	NOUN
aiua-9669	184	15	of	of	ADP
aiua-9669	184	16	the	the	DET
aiua-9669	184	17	cancers	cancer	NOUN
aiua-9669	184	18	appeared	appear	VERB
aiua-9669	184	19	similar	similar	ADJ
aiua-9669	184	20	.	.	PUNCT
aiua-9669	185	1	the	the	DET
aiua-9669	185	2	large	large	ADJ
aiua-9669	185	3	part	part	NOUN
aiua-9669	185	4	of	of	ADP
aiua-9669	185	5	patients	patient	NOUN
aiua-9669	185	6	preferred	prefer	VERB
aiua-9669	185	7	clinical	clinical	ADJ
aiua-9669	185	8	surveillance	surveillance	NOUN
aiua-9669	185	9	(	(	PUNCT
aiua-9669	185	10	57	57	NUM
aiua-9669	185	11	%	%	NOUN
aiua-9669	185	12	)	)	PUNCT
aiua-9669	185	13	compared	compare	VERB
aiua-9669	185	14	to	to	ADP
aiua-9669	185	15	immediate	immediate	ADJ
aiua-9669	185	16	biopsy	biopsy	NOUN
aiua-9669	185	17	(	(	PUNCT
aiua-9669	185	18	43	43	NUM
aiua-9669	185	19	%	%	NOUN
aiua-9669	185	20	)	)	PUNCT
aiua-9669	185	21	.	.	PUNCT
aiua-9669	186	1	frye	frye	PROPN
aiua-9669	186	2	et	et	PROPN
aiua-9669	186	3	al	al	PROPN
aiua-9669	186	4	.	.	PUNCT
aiua-9669	187	1	monitoring	monitor	VERB
aiua-9669	187	2	pi	pi	NOUN
aiua-9669	187	3	-	-	PUNCT
aiua-9669	187	4	rads	rad	NOUN
aiua-9669	187	5	3	3	NUM
aiua-9669	187	6	lesions	lesion	NOUN
aiua-9669	187	7	in	in	ADP
aiua-9669	187	8	active	active	ADJ
aiua-9669	187	9	surveillance	surveillance	NOUN
aiua-9669	187	10	reported	report	VERB
aiua-9669	187	11	a	a	DET
aiua-9669	187	12	rate	rate	NOUN
aiua-9669	187	13	of	of	ADP
aiua-9669	187	14	progression	progression	NOUN
aiua-9669	187	15	of	of	ADP
aiua-9669	187	16	20	20	NUM
aiua-9669	187	17	%	%	NOUN
aiua-9669	187	18	precisely	precisely	ADV
aiua-9669	187	19	on	on	ADP
aiua-9669	187	20	the	the	DET
aiua-9669	187	21	area	area	NOUN
aiua-9669	187	22	of	of	ADP
aiua-9669	187	23	the	the	DET
aiua-9669	187	24	target	target	NOUN
aiua-9669	187	25	lesion	lesion	NOUN
aiua-9669	187	26	pi	pi	NOUN
aiua-9669	187	27	-	-	PUNCT
aiua-9669	187	28	rads	rad	NOUN
aiua-9669	187	29	3	3	NUM
aiua-9669	187	30	compared	compare	VERB
aiua-9669	187	31	to	to	ADP
aiua-9669	187	32	29	29	NUM
aiua-9669	187	33	%	%	NOUN
aiua-9669	187	34	of	of	ADP
aiua-9669	187	35	overall	overall	ADJ
aiua-9669	187	36	progression	progression	NOUN
aiua-9669	187	37	(	(	PUNCT
aiua-9669	187	38	64	64	NUM
aiua-9669	187	39	)	)	PUNCT
aiua-9669	187	40	.	.	PUNCT
aiua-9669	188	1	therefore	therefore	ADV
aiua-9669	188	2	,	,	PUNCT
aiua-9669	188	3	we	we	PRON
aiua-9669	188	4	can	can	AUX
aiua-9669	188	5	assume	assume	VERB
aiua-9669	188	6	that	that	PRON
aiua-9669	188	7	defer	defer	VERB
aiua-9669	188	8	the	the	DET
aiua-9669	188	9	biopsy	biopsy	NOUN
aiua-9669	188	10	in	in	ADP
aiua-9669	188	11	pirads	pirad	NOUN
aiua-9669	188	12	3	3	NUM
aiua-9669	188	13	lesion	lesion	NOUN
aiua-9669	188	14	in	in	ADP
aiua-9669	188	15	the	the	DET
aiua-9669	188	16	tz	tz	NOUN
aiua-9669	188	17	can	can	AUX
aiua-9669	188	18	be	be	AUX
aiua-9669	188	19	a	a	DET
aiua-9669	188	20	safe	safe	ADJ
aiua-9669	188	21	strategy	strategy	NOUN
aiua-9669	188	22	,	,	PUNCT
aiua-9669	188	23	as	as	SCONJ
aiua-9669	188	24	we	we	PRON
aiua-9669	188	25	suggested	suggest	VERB
aiua-9669	188	26	in	in	ADP
aiua-9669	188	27	a	a	DET
aiua-9669	188	28	flow	flow	NOUN
aiua-9669	188	29	-	-	PUNCT
aiua-9669	188	30	chart	chart	NOUN
aiua-9669	188	31	summarized	summarize	VERB
aiua-9669	188	32	in	in	ADP
aiua-9669	188	33	the	the	DET
aiua-9669	188	34	figures	figure	NOUN
aiua-9669	188	35	2	2	NUM
aiua-9669	188	36	,	,	PUNCT
aiua-9669	188	37	3	3	NUM
aiua-9669	188	38	.	.	X
aiua-9669	188	39	figure	figure	NOUN
aiua-9669	188	40	2	2	NUM
aiua-9669	188	41	.	.	PUNCT
aiua-9669	188	42	clinical	clinical	ADJ
aiua-9669	188	43	pathway	pathway	NOUN
aiua-9669	188	44	in	in	ADP
aiua-9669	188	45	biopsy	biopsy	ADJ
aiua-9669	188	46	naïve	naïve	ADJ
aiua-9669	188	47	patient	patient	NOUN
aiua-9669	188	48	with	with	ADP
aiua-9669	188	49	pi	pi	NOUN
aiua-9669	188	50	-	-	PUNCT
aiua-9669	188	51	rads	rad	NOUN
aiua-9669	188	52	3	3	NUM
aiua-9669	188	53	lesions	lesion	NOUN
aiua-9669	188	54	.	.	PUNCT
aiua-9669	189	1	figure	figure	NOUN
aiua-9669	189	2	3	3	NUM
aiua-9669	189	3	.	.	PUNCT
aiua-9669	190	1	clinical	clinical	ADJ
aiua-9669	190	2	pathway	pathway	NOUN
aiua-9669	190	3	in	in	ADP
aiua-9669	190	4	biopsy	biopsy	ADJ
aiua-9669	190	5	negative	negative	ADJ
aiua-9669	190	6	patient	patient	NOUN
aiua-9669	190	7	with	with	ADP
aiua-9669	190	8	pi	pi	NOUN
aiua-9669	190	9	-	-	PUNCT
aiua-9669	190	10	rads	rad	NOUN
aiua-9669	190	11	.	.	PUNCT
aiua-9669	191	1	archivio	archivio	NOUN
aiua-9669	191	2	italiano	italiano	PROPN
aiua-9669	191	3	di	di	X
aiua-9669	191	4	urologia	urologia	PROPN
aiua-9669	191	5	e	e	PROPN
aiua-9669	191	6	andrologia	andrologia	NOUN
aiua-9669	191	7	2021	2021	NUM
aiua-9669	191	8	;	;	PUNCT
aiua-9669	191	9	93	93	NUM
aiua-9669	191	10	,	,	PUNCT
aiua-9669	191	11	1	1	NUM
aiua-9669	191	12	a.b	a.b	NOUN
aiua-9669	191	13	.	.	PROPN
aiua-9669	191	14	galosi	galosi	PROPN
aiua-9669	191	15	,	,	PUNCT
aiua-9669	191	16	e.	e.	PROPN
aiua-9669	191	17	palagonia	palagonia	PROPN
aiua-9669	191	18	,	,	PUNCT
aiua-9669	191	19	s.	s.	PROPN
aiua-9669	191	20	scarcella	scarcella	PROPN
aiua-9669	191	21	,	,	PUNCT
aiua-9669	191	22	a.	a.	NOUN
aiua-9669	191	23	cimadamore	cimadamore	PROPN
aiua-9669	191	24	,	,	PUNCT
aiua-9669	191	25	v.	v.	ADP
aiua-9669	191	26	lacetera	lacetera	PROPN
aiua-9669	191	27	,	,	PUNCT
aiua-9669	191	28	r.f	r.f	PROPN
aiua-9669	191	29	.	.	PROPN
aiua-9669	191	30	delle	delle	PROPN
aiua-9669	191	31	fave	fave	PROPN
aiua-9669	191	32	,	,	PUNCT
aiua-9669	191	33	a.	a.	NOUN
aiua-9669	191	34	antezza	antezza	NOUN
aiua-9669	191	35	,	,	PUNCT
aiua-9669	191	36	l.	l.	PROPN
aiua-9669	191	37	dell’atti	dell’atti	VERB
aiua-9669	191	38	98	98	NUM
aiua-9669	191	39	in	in	ADP
aiua-9669	191	40	conclusion	conclusion	NOUN
aiua-9669	191	41	the	the	DET
aiua-9669	191	42	management	management	NOUN
aiua-9669	191	43	pi	pi	NOUN
aiua-9669	191	44	-	-	PUNCT
aiua-9669	191	45	rads	rad	NOUN
aiua-9669	191	46	3	3	NUM
aiua-9669	191	47	lesion	lesion	NOUN
aiua-9669	191	48	should	should	AUX
aiua-9669	191	49	be	be	AUX
aiua-9669	191	50	based	base	VERB
aiua-9669	191	51	on	on	ADP
aiua-9669	191	52	shared	share	VERB
aiua-9669	191	53	decision	decision	NOUN
aiua-9669	191	54	to	to	ADP
aiua-9669	191	55	immediate	immediate	ADJ
aiua-9669	191	56	biopsy	biopsy	NOUN
aiua-9669	191	57	or	or	CCONJ
aiua-9669	191	58	follow	follow	VERB
aiua-9669	191	59	-	-	PUNCT
aiua-9669	191	60	up	up	NOUN
aiua-9669	191	61	considering	consider	VERB
aiua-9669	191	62	the	the	DET
aiua-9669	191	63	following	follow	VERB
aiua-9669	191	64	points	point	NOUN
aiua-9669	191	65	:	:	PUNCT
aiua-9669	191	66	1	1	NUM
aiua-9669	191	67	)	)	PUNCT
aiua-9669	191	68	estimation	estimation	NOUN
aiua-9669	191	69	of	of	ADP
aiua-9669	191	70	prostate	prostate	NOUN
aiua-9669	191	71	cancer	cancer	NOUN
aiua-9669	191	72	risk	risk	NOUN
aiua-9669	191	73	based	base	VERB
aiua-9669	191	74	on	on	ADP
aiua-9669	191	75	nomograms	nomogram	NOUN
aiua-9669	191	76	and	and	CCONJ
aiua-9669	191	77	risk	risk	NOUN
aiua-9669	191	78	calculators	calculator	NOUN
aiua-9669	191	79	,	,	PUNCT
aiua-9669	191	80	2	2	X
aiua-9669	191	81	)	)	PUNCT
aiua-9669	191	82	use	use	VERB
aiua-9669	191	83	carefully	carefully	ADV
aiua-9669	191	84	mpmr	mpmr	NOUN
aiua-9669	191	85	in	in	ADP
aiua-9669	191	86	patients	patient	NOUN
aiua-9669	191	87	with	with	ADP
aiua-9669	191	88	low	low	ADJ
aiua-9669	191	89	risk	risk	NOUN
aiua-9669	191	90	of	of	ADP
aiua-9669	191	91	cspca	cspca	NOUN
aiua-9669	191	92	and	and	CCONJ
aiua-9669	191	93	normal	normal	ADJ
aiua-9669	191	94	psa	psa	NOUN
aiua-9669	191	95	,	,	PUNCT
aiua-9669	191	96	3	3	X
aiua-9669	191	97	)	)	PUNCT
aiua-9669	191	98	mr	mr	PROPN
aiua-9669	191	99	should	should	AUX
aiua-9669	191	100	be	be	AUX
aiua-9669	191	101	done	do	VERB
aiua-9669	191	102	in	in	ADP
aiua-9669	191	103	quality	quality	NOUN
aiua-9669	191	104	checked	check	VERB
aiua-9669	191	105	centers	center	NOUN
aiua-9669	191	106	(	(	PUNCT
aiua-9669	191	107	controlled	control	VERB
aiua-9669	191	108	incidence	incidence	NOUN
aiua-9669	191	109	of	of	ADP
aiua-9669	191	110	pi	pi	NOUN
aiua-9669	191	111	-	-	PUNCT
aiua-9669	191	112	rads	rad	NOUN
aiua-9669	191	113	3	3	NUM
aiua-9669	191	114	lesions	lesion	NOUN
aiua-9669	191	115	and	and	CCONJ
aiua-9669	191	116	correlation	correlation	NOUN
aiua-9669	191	117	between	between	ADP
aiua-9669	191	118	radiological	radiological	ADJ
aiua-9669	191	119	and	and	CCONJ
aiua-9669	191	120	pathological	pathological	ADJ
aiua-9669	191	121	finding	finding	NOUN
aiua-9669	191	122	)	)	PUNCT
aiua-9669	191	123	,	,	PUNCT
aiua-9669	191	124	3	3	X
aiua-9669	191	125	)	)	PUNCT
aiua-9669	191	126	lower	low	ADJ
aiua-9669	191	127	urinary	urinary	ADJ
aiua-9669	191	128	tract	tract	NOUN
aiua-9669	191	129	symptoms	symptom	NOUN
aiua-9669	191	130	4	4	NUM
aiua-9669	191	131	)	)	PUNCT
aiua-9669	191	132	use	use	NOUN
aiua-9669	191	133	of	of	ADP
aiua-9669	191	134	psad	psad	ADJ
aiua-9669	191	135	,	,	PUNCT
aiua-9669	191	136	anatomical	anatomical	ADJ
aiua-9669	191	137	zone	zone	NOUN
aiua-9669	191	138	(	(	PUNCT
aiua-9669	191	139	tz	tz	PROPN
aiua-9669	191	140	vs	vs	ADP
aiua-9669	191	141	pz	pz	PROPN
aiua-9669	191	142	)	)	PUNCT
aiua-9669	191	143	,	,	PUNCT
aiua-9669	191	144	and	and	CCONJ
aiua-9669	191	145	family	family	NOUN
aiua-9669	191	146	history	history	NOUN
aiua-9669	191	147	.	.	PUNCT
aiua-9669	192	1	all	all	DET
aiua-9669	192	2	those	those	DET
aiua-9669	192	3	factors	factor	NOUN
aiua-9669	192	4	should	should	AUX
aiua-9669	192	5	be	be	AUX
aiua-9669	192	6	taken	take	VERB
aiua-9669	192	7	into	into	ADP
aiua-9669	192	8	account	account	NOUN
aiua-9669	192	9	and	and	CCONJ
aiua-9669	192	10	patient	patient	NOUN
aiua-9669	192	11	should	should	AUX
aiua-9669	192	12	be	be	AUX
aiua-9669	192	13	involved	involve	VERB
aiua-9669	192	14	in	in	ADP
aiua-9669	192	15	the	the	DET
aiua-9669	192	16	final	final	ADJ
aiua-9669	192	17	decision	decision	NOUN
aiua-9669	192	18	to	to	PART
aiua-9669	192	19	perform	perform	VERB
aiua-9669	192	20	a	a	DET
aiua-9669	192	21	fusion	fusion	NOUN
aiua-9669	192	22	prostate	prostate	NOUN
aiua-9669	192	23	biopsy	biopsy	NOUN
aiua-9669	192	24	.	.	PUNCT
aiua-9669	193	1	references	reference	NOUN
aiua-9669	193	2	1	1	NUM
aiua-9669	193	3	.	.	PUNCT
aiua-9669	194	1	cimadamore	cimadamore	NOUN
aiua-9669	194	2	a	a	PRON
aiua-9669	194	3	,	,	PUNCT
aiua-9669	194	4	cheng	cheng	PROPN
aiua-9669	194	5	m	m	PROPN
aiua-9669	194	6	,	,	PUNCT
aiua-9669	194	7	santoni	santoni	PROPN
aiua-9669	194	8	m	m	PROPN
aiua-9669	194	9	,	,	PUNCT
aiua-9669	194	10	et	et	PROPN
aiua-9669	194	11	al	al	PROPN
aiua-9669	194	12	.	.	PUNCT
aiua-9669	195	1	new	new	ADJ
aiua-9669	195	2	prostate	prostate	NOUN
aiua-9669	195	3	cancer	cancer	NOUN
aiua-9669	195	4	targets	target	NOUN
aiua-9669	195	5	for	for	ADP
aiua-9669	195	6	diagnosis	diagnosis	NOUN
aiua-9669	195	7	,	,	PUNCT
aiua-9669	195	8	imaging	imaging	NOUN
aiua-9669	195	9	,	,	PUNCT
aiua-9669	195	10	and	and	CCONJ
aiua-9669	195	11	therapy	therapy	NOUN
aiua-9669	195	12	:	:	PUNCT
aiua-9669	195	13	focus	focus	VERB
aiua-9669	195	14	on	on	ADP
aiua-9669	195	15	prostate	prostate	NOUN
aiua-9669	195	16	-	-	PUNCT
aiua-9669	195	17	specific	specific	ADJ
aiua-9669	195	18	membrane	membrane	NOUN
aiua-9669	195	19	antigen	antigen	NOUN
aiua-9669	195	20	.	.	PUNCT
aiua-9669	196	1	front	front	ADJ
aiua-9669	196	2	oncol	oncol	ADJ
aiua-9669	196	3	.	.	PUNCT
aiua-9669	197	1	2018	2018	NUM
aiua-9669	197	2	;	;	PUNCT
aiua-9669	197	3	8:653	8:653	NUM
aiua-9669	197	4	.	.	NOUN
aiua-9669	198	1	2	2	NUM
aiua-9669	198	2	.	.	NUM
aiua-9669	198	3	mottet	mottet	NOUN
aiua-9669	198	4	n	n	CCONJ
aiua-9669	198	5	,	,	PUNCT
aiua-9669	198	6	bastian	bastian	NOUN
aiua-9669	198	7	p	p	NOUN
aiua-9669	198	8	,	,	PUNCT
aiua-9669	198	9	bellmunt	bellmunt	NOUN
aiua-9669	198	10	j	j	PROPN
aiua-9669	198	11	,	,	PUNCT
aiua-9669	198	12	et	et	PROPN
aiua-9669	198	13	al	al	PROPN
aiua-9669	198	14	.	.	PROPN
aiua-9669	199	1	eau	eau	PROPN
aiua-9669	199	2	eanm	eanm	PROPN
aiua-9669	199	3	estro	estro	PROPN
aiua-9669	199	4	esur	esur	PROPN
aiua-9669	199	5	siog	siog	PROPN
aiua-9669	199	6	:	:	PUNCT
aiua-9669	199	7	guidelines	guideline	NOUN
aiua-9669	199	8	on	on	ADP
aiua-9669	199	9	prostate	prostate	NOUN
aiua-9669	199	10	cancer	cancer	NOUN
aiua-9669	199	11	.	.	PUNCT
aiua-9669	200	1	eur	eur	PROPN
aiua-9669	200	2	assoc	assoc	PROPN
aiua-9669	200	3	urol	urol	PROPN
aiua-9669	200	4	.	.	PUNCT
aiua-9669	200	5	2020	2020	NUM
aiua-9669	200	6	;	;	PUNCT
aiua-9669	200	7	1	1	NUM
aiua-9669	200	8	-	-	SYM
aiua-9669	200	9	182	182	NUM
aiua-9669	200	10	.	.	PUNCT
aiua-9669	201	1	3	3	X
aiua-9669	201	2	.	.	PUNCT
aiua-9669	201	3	lambert	lambert	PROPN
aiua-9669	201	4	e	e	PROPN
aiua-9669	201	5	,	,	PUNCT
aiua-9669	201	6	goossens	goossens	PROPN
aiua-9669	201	7	m	m	PROPN
aiua-9669	201	8	,	,	PUNCT
aiua-9669	201	9	palagonia	palagonia	PROPN
aiua-9669	201	10	e	e	NOUN
aiua-9669	201	11	,	,	PUNCT
aiua-9669	201	12	et	et	PROPN
aiua-9669	201	13	al	al	PROPN
aiua-9669	201	14	.	.	PROPN
aiua-9669	201	15	changes	change	NOUN
aiua-9669	201	16	in	in	ADP
aiua-9669	201	17	serum	serum	NOUN
aiua-9669	201	18	psa	psa	NOUN
aiua-9669	201	19	after	after	ADP
aiua-9669	201	20	endoscopic	endoscopic	ADJ
aiua-9669	201	21	enucleation	enucleation	NOUN
aiua-9669	201	22	of	of	ADP
aiua-9669	201	23	the	the	DET
aiua-9669	201	24	prostate	prostate	NOUN
aiua-9669	201	25	are	be	AUX
aiua-9669	201	26	predictive	predictive	ADJ
aiua-9669	201	27	for	for	ADP
aiua-9669	201	28	the	the	DET
aiua-9669	201	29	future	future	ADJ
aiua-9669	201	30	diagnosis	diagnosis	NOUN
aiua-9669	201	31	of	of	ADP
aiua-9669	201	32	prostate	prostate	NOUN
aiua-9669	201	33	cancer	cancer	NOUN
aiua-9669	201	34	.	.	PUNCT
aiua-9669	202	1	world	world	PROPN
aiua-9669	202	2	j	j	PROPN
aiua-9669	202	3	urol	urol	PROPN
aiua-9669	202	4	.	.	PUNCT
aiua-9669	203	1	2020	2020	NUM
aiua-9669	203	2	sep	sep	PROPN
aiua-9669	203	3	30	30	NUM
aiua-9669	203	4	.	.	PUNCT
aiua-9669	204	1	doi	doi	NOUN
aiua-9669	204	2	:	:	PUNCT
aiua-9669	204	3	10.1007	10.1007	NUM
aiua-9669	204	4	/	/	SYM
aiua-9669	204	5	s00345	s00345	PROPN
aiua-9669	204	6	-	-	PUNCT
aiua-9669	204	7	020	020	NUM
aiua-9669	204	8	-	-	PUNCT
aiua-9669	204	9	03444	03444	NUM
aiua-9669	204	10	-	-	PUNCT
aiua-9669	204	11	0	0	NUM
aiua-9669	204	12	.	.	PUNCT
aiua-9669	205	1	epub	epub	NOUN
aiua-9669	205	2	ahead	ahead	ADV
aiua-9669	205	3	of	of	ADP
aiua-9669	205	4	print	print	NOUN
aiua-9669	205	5	.	.	PUNCT
aiua-9669	206	1	4	4	X
aiua-9669	206	2	.	.	X
aiua-9669	206	3	thompson	thompson	PROPN
aiua-9669	207	1	i	i	PRON
aiua-9669	207	2	m	m	PROPN
aiua-9669	207	3	,	,	PUNCT
aiua-9669	207	4	pauler	pauler	ADJ
aiua-9669	207	5	dk	dk	PROPN
aiua-9669	207	6	,	,	PUNCT
aiua-9669	207	7	goodman	goodman	PROPN
aiua-9669	207	8	pj	pj	PROPN
aiua-9669	207	9	,	,	PUNCT
aiua-9669	207	10	et	et	PROPN
aiua-9669	207	11	al	al	PROPN
aiua-9669	207	12	.	.	PUNCT
aiua-9669	208	1	prevalence	prevalence	NOUN
aiua-9669	208	2	of	of	ADP
aiua-9669	208	3	prostate	prostate	NOUN
aiua-9669	208	4	cancer	cancer	NOUN
aiua-9669	208	5	among	among	ADP
aiua-9669	208	6	men	man	NOUN
aiua-9669	208	7	with	with	ADP
aiua-9669	208	8	a	a	DET
aiua-9669	208	9	prostate	prostate	NOUN
aiua-9669	208	10	-	-	PUNCT
aiua-9669	208	11	specific	specific	ADJ
aiua-9669	208	12	antigen	antigen	NOUN
aiua-9669	208	13	level	level	NOUN
aiua-9669	208	14	<	<	X
aiua-9669	208	15	or	or	CCONJ
aiua-9669	208	16	=	=	SYM
aiua-9669	208	17	4.0	4.0	NUM
aiua-9669	208	18	ng	ng	NOUN
aiua-9669	208	19	per	per	ADP
aiua-9669	208	20	milliliter	milliliter	NOUN
aiua-9669	208	21	.	.	PUNCT
aiua-9669	209	1	n	n	PROPN
aiua-9669	209	2	engl	engl	PROPN
aiua-9669	209	3	j	j	PROPN
aiua-9669	209	4	med	med	PROPN
aiua-9669	209	5	.	.	PUNCT
aiua-9669	209	6	2004	2004	NUM
aiua-9669	209	7	;	;	PUNCT
aiua-9669	210	1	350:2239	350:2239	NUM
aiua-9669	210	2	-	-	SYM
aiua-9669	210	3	46	46	NUM
aiua-9669	210	4	.	.	PUNCT
aiua-9669	211	1	5	5	NUM
aiua-9669	211	2	.	.	X
aiua-9669	211	3	maselli	maselli	PROPN
aiua-9669	211	4	g	g	PROPN
aiua-9669	211	5	,	,	PUNCT
aiua-9669	211	6	tucci	tucci	PROPN
aiua-9669	211	7	g	g	NOUN
aiua-9669	211	8	,	,	PUNCT
aiua-9669	211	9	mazzaferro	mazzaferro	NOUN
aiua-9669	211	10	d	d	NOUN
aiua-9669	211	11	,	,	PUNCT
aiua-9669	211	12	et	et	PROPN
aiua-9669	211	13	al	al	PROPN
aiua-9669	211	14	.	.	PROPN
aiua-9669	211	15	prolonged	prolong	VERB
aiua-9669	211	16	antibiotic	antibiotic	ADJ
aiua-9669	211	17	therapy	therapy	NOUN
aiua-9669	211	18	increases	increase	VERB
aiua-9669	211	19	risk	risk	NOUN
aiua-9669	211	20	of	of	ADP
aiua-9669	211	21	infection	infection	NOUN
aiua-9669	211	22	after	after	ADP
aiua-9669	211	23	transrectal	transrectal	ADJ
aiua-9669	211	24	prostate	prostate	NOUN
aiua-9669	211	25	biopsy	biopsy	NOUN
aiua-9669	211	26	:	:	PUNCT
aiua-9669	211	27	a	a	DET
aiua-9669	211	28	case	case	NOUN
aiua-9669	211	29	report	report	NOUN
aiua-9669	211	30	after	after	ADP
aiua-9669	211	31	pancreasectomy	pancreasectomy	NOUN
aiua-9669	211	32	and	and	CCONJ
aiua-9669	211	33	review	review	NOUN
aiua-9669	211	34	of	of	ADP
aiua-9669	211	35	the	the	DET
aiua-9669	211	36	literature	literature	NOUN
aiua-9669	211	37	.	.	PUNCT
aiua-9669	212	1	arch	arch	PROPN
aiua-9669	212	2	ital	ital	PROPN
aiua-9669	212	3	urol	urol	PROPN
aiua-9669	212	4	androl	androl	PROPN
aiua-9669	212	5	.	.	PROPN
aiua-9669	212	6	2014	2014	NUM
aiua-9669	212	7	;	;	PUNCT
aiua-9669	212	8	86:387	86:387	NUM
aiua-9669	212	9	-	-	SYM
aiua-9669	212	10	8	8	NUM
aiua-9669	212	11	.	.	NOUN
aiua-9669	212	12	6	6	NUM
aiua-9669	212	13	.	.	X
aiua-9669	213	1	halpern	halpern	PROPN
aiua-9669	213	2	ja	ja	PROPN
aiua-9669	213	3	,	,	PUNCT
aiua-9669	213	4	oromendia	oromendia	PROPN
aiua-9669	213	5	c	c	NOUN
aiua-9669	213	6	,	,	PUNCT
aiua-9669	213	7	shoag	shoag	PROPN
aiua-9669	213	8	je	je	PROPN
aiua-9669	213	9	,	,	PUNCT
aiua-9669	213	10	et	et	PROPN
aiua-9669	213	11	al	al	PROPN
aiua-9669	213	12	.	.	PUNCT
aiua-9669	213	13	use	use	NOUN
aiua-9669	213	14	of	of	ADP
aiua-9669	213	15	digital	digital	ADJ
aiua-9669	213	16	rectal	rectal	ADJ
aiua-9669	213	17	examination	examination	NOUN
aiua-9669	213	18	as	as	ADP
aiua-9669	213	19	an	an	DET
aiua-9669	213	20	adjunct	adjunct	ADJ
aiua-9669	213	21	to	to	PART
aiua-9669	213	22	prostate	prostate	VERB
aiua-9669	213	23	specific	specific	ADJ
aiua-9669	213	24	antigen	antigen	NOUN
aiua-9669	213	25	in	in	ADP
aiua-9669	213	26	the	the	DET
aiua-9669	213	27	detection	detection	NOUN
aiua-9669	213	28	of	of	ADP
aiua-9669	213	29	clinically	clinically	ADV
aiua-9669	213	30	significant	significant	ADJ
aiua-9669	213	31	prostate	prostate	NOUN
aiua-9669	213	32	cancer	cancer	NOUN
aiua-9669	213	33	.	.	PUNCT
aiua-9669	214	1	j	j	PROPN
aiua-9669	214	2	urol	urol	PROPN
aiua-9669	214	3	.	.	PROPN
aiua-9669	214	4	2018	2018	NUM
aiua-9669	214	5	;	;	PUNCT
aiua-9669	214	6	199:947	199:947	NUM
aiua-9669	214	7	-	-	SYM
aiua-9669	214	8	53	53	NUM
aiua-9669	214	9	.	.	PUNCT
aiua-9669	215	1	7	7	X
aiua-9669	215	2	.	.	X
aiua-9669	215	3	vickers	vickers	PROPN
aiua-9669	215	4	aj	aj	PROPN
aiua-9669	215	5	,	,	PUNCT
aiua-9669	215	6	ulmert	ulmert	PROPN
aiua-9669	215	7	d	d	NOUN
aiua-9669	215	8	,	,	PUNCT
aiua-9669	215	9	sjoberg	sjoberg	PROPN
aiua-9669	215	10	dd	dd	PROPN
aiua-9669	215	11	,	,	PUNCT
aiua-9669	215	12	et	et	PROPN
aiua-9669	215	13	al	al	PROPN
aiua-9669	215	14	.	.	PROPN
aiua-9669	215	15	strategy	strategy	NOUN
aiua-9669	215	16	for	for	ADP
aiua-9669	215	17	detection	detection	NOUN
aiua-9669	215	18	of	of	ADP
aiua-9669	215	19	prostate	prostate	NOUN
aiua-9669	215	20	cancer	cancer	NOUN
aiua-9669	215	21	based	base	VERB
aiua-9669	215	22	on	on	ADP
aiua-9669	215	23	relation	relation	NOUN
aiua-9669	215	24	between	between	ADP
aiua-9669	215	25	prostate	prostate	NOUN
aiua-9669	215	26	specific	specific	ADJ
aiua-9669	215	27	antigen	antigen	NOUN
aiua-9669	215	28	at	at	ADP
aiua-9669	215	29	age	age	NOUN
aiua-9669	215	30	40	40	NUM
aiua-9669	215	31	-	-	SYM
aiua-9669	215	32	55	55	NUM
aiua-9669	215	33	and	and	CCONJ
aiua-9669	215	34	long	long	ADJ
aiua-9669	215	35	term	term	NOUN
aiua-9669	215	36	risk	risk	NOUN
aiua-9669	215	37	of	of	ADP
aiua-9669	215	38	metastasis	metastasis	NOUN
aiua-9669	215	39	:	:	PUNCT
aiua-9669	215	40	case	case	NOUN
aiua-9669	215	41	-	-	PUNCT
aiua-9669	215	42	control	control	NOUN
aiua-9669	215	43	study	study	NOUN
aiua-9669	215	44	.	.	PUNCT
aiua-9669	216	1	bmj	bmj	PROPN
aiua-9669	216	2	.	.	PUNCT
aiua-9669	216	3	2013	2013	NUM
aiua-9669	216	4	;	;	PUNCT
aiua-9669	216	5	346	346	NUM
aiua-9669	216	6	:	:	PUNCT
aiua-9669	216	7	f2023	f2023	PROPN
aiua-9669	216	8	.	.	PROPN
aiua-9669	216	9	8	8	NUM
aiua-9669	216	10	.	.	PUNCT
aiua-9669	217	1	carter	carter	PROPN
aiua-9669	217	2	hb	hb	PROPN
aiua-9669	217	3	,	,	PUNCT
aiua-9669	217	4	ferrucci	ferrucci	PROPN
aiua-9669	217	5	l	l	PROPN
aiua-9669	217	6	,	,	PUNCT
aiua-9669	217	7	kettermann	kettermann	PROPN
aiua-9669	217	8	a	a	PROPN
aiua-9669	217	9	,	,	PUNCT
aiua-9669	217	10	et	et	PROPN
aiua-9669	217	11	al	al	PROPN
aiua-9669	217	12	.	.	PUNCT
aiua-9669	217	13	detection	detection	NOUN
aiua-9669	217	14	of	of	ADP
aiua-9669	217	15	lifethreatening	lifethreatene	VERB
aiua-9669	217	16	prostate	prostate	NOUN
aiua-9669	217	17	cancer	cancer	NOUN
aiua-9669	217	18	with	with	ADP
aiua-9669	217	19	prostate	prostate	NOUN
aiua-9669	217	20	-	-	PUNCT
aiua-9669	217	21	specific	specific	ADJ
aiua-9669	217	22	antigen	antigen	ADJ
aiua-9669	217	23	velocity	velocity	NOUN
aiua-9669	217	24	during	during	ADP
aiua-9669	217	25	a	a	DET
aiua-9669	217	26	window	window	NOUN
aiua-9669	217	27	of	of	ADP
aiua-9669	217	28	curability	curability	NOUN
aiua-9669	217	29	.	.	PUNCT
aiua-9669	218	1	j	j	PROPN
aiua-9669	218	2	natl	natl	PROPN
aiua-9669	218	3	cancer	cancer	PROPN
aiua-9669	218	4	inst	inst	PROPN
aiua-9669	218	5	.	.	PUNCT
aiua-9669	219	1	2006	2006	NUM
aiua-9669	219	2	;	;	PUNCT
aiua-9669	220	1	98:15217	98:15217	NUM
aiua-9669	220	2	.	.	NOUN
aiua-9669	221	1	9	9	X
aiua-9669	221	2	.	.	X
aiua-9669	221	3	vickers	vickers	PROPN
aiua-9669	221	4	aj	aj	PROPN
aiua-9669	221	5	,	,	PUNCT
aiua-9669	221	6	till	till	SCONJ
aiua-9669	221	7	c	c	PRON
aiua-9669	221	8	,	,	PUNCT
aiua-9669	221	9	tangen	tangen	PROPN
aiua-9669	221	10	cm	cm	PROPN
aiua-9669	221	11	,	,	PUNCT
aiua-9669	221	12	et	et	PROPN
aiua-9669	221	13	al	al	PROPN
aiua-9669	221	14	.	.	PUNCT
aiua-9669	222	1	an	an	DET
aiua-9669	222	2	empirical	empirical	ADJ
aiua-9669	222	3	evaluation	evaluation	NOUN
aiua-9669	222	4	of	of	ADP
aiua-9669	222	5	guidelines	guideline	NOUN
aiua-9669	222	6	on	on	ADP
aiua-9669	222	7	prostate	prostate	NOUN
aiua-9669	222	8	-	-	PUNCT
aiua-9669	222	9	specific	specific	ADJ
aiua-9669	222	10	antigen	antigen	ADJ
aiua-9669	222	11	velocity	velocity	NOUN
aiua-9669	222	12	in	in	ADP
aiua-9669	222	13	prostate	prostate	NOUN
aiua-9669	222	14	cancer	cancer	NOUN
aiua-9669	222	15	detection	detection	NOUN
aiua-9669	222	16	.	.	PUNCT
aiua-9669	223	1	2011	2011	NUM
aiua-9669	223	2	;	;	PUNCT
aiua-9669	223	3	103:0	103:0	NUM
aiua-9669	223	4	-	-	SYM
aiua-9669	223	5	7	7	NUM
aiua-9669	223	6	.	.	NOUN
aiua-9669	223	7	10	10	NUM
aiua-9669	223	8	.	.	PUNCT
aiua-9669	224	1	fandella	fandella	PROPN
aiua-9669	224	2	a	a	PRON
aiua-9669	224	3	,	,	PUNCT
aiua-9669	224	4	scattoni	scattoni	ADJ
aiua-9669	224	5	v	v	NOUN
aiua-9669	224	6	,	,	PUNCT
aiua-9669	224	7	galosi	galosi	NOUN
aiua-9669	224	8	a	a	NOUN
aiua-9669	224	9	,	,	PUNCT
aiua-9669	224	10	et	et	PROPN
aiua-9669	224	11	al	al	PROPN
aiua-9669	224	12	.	.	PUNCT
aiua-9669	225	1	italian	italian	ADJ
aiua-9669	225	2	prostate	prostate	NOUN
aiua-9669	225	3	biopsies	biopsy	NOUN
aiua-9669	225	4	group	group	NOUN
aiua-9669	225	5	:	:	PUNCT
aiua-9669	225	6	2016	2016	NUM
aiua-9669	225	7	updated	update	VERB
aiua-9669	225	8	guidelines	guideline	NOUN
aiua-9669	225	9	insights	insight	NOUN
aiua-9669	225	10	.	.	PUNCT
aiua-9669	226	1	anticancer	anticancer	NOUN
aiua-9669	226	2	res	re	NOUN
aiua-9669	226	3	.	.	PROPN
aiua-9669	226	4	2017	2017	NUM
aiua-9669	226	5	;	;	PUNCT
aiua-9669	226	6	37:413	37:413	NUM
aiua-9669	226	7	-	-	SYM
aiua-9669	226	8	24	24	NUM
aiua-9669	226	9	.	.	PUNCT
aiua-9669	227	1	11	11	NUM
aiua-9669	227	2	.	.	PUNCT
aiua-9669	228	1	martino	martino	PROPN
aiua-9669	228	2	p	p	PROPN
aiua-9669	228	3	,	,	PUNCT
aiua-9669	228	4	galosi	galosi	PROPN
aiua-9669	228	5	ab	ab	PROPN
aiua-9669	228	6	,	,	PUNCT
aiua-9669	228	7	bitelli	bitelli	PROPN
aiua-9669	228	8	m	m	PROPN
aiua-9669	228	9	,	,	PUNCT
aiua-9669	228	10	et	et	PROPN
aiua-9669	228	11	al	al	PROPN
aiua-9669	228	12	.	.	PROPN
aiua-9669	228	13	practical	practical	ADJ
aiua-9669	228	14	recommendations	recommendation	NOUN
aiua-9669	228	15	for	for	ADP
aiua-9669	228	16	performing	perform	VERB
aiua-9669	228	17	ultrasound	ultrasound	NOUN
aiua-9669	228	18	scanning	scanning	NOUN
aiua-9669	228	19	in	in	ADP
aiua-9669	228	20	the	the	DET
aiua-9669	228	21	urological	urological	ADJ
aiua-9669	228	22	and	and	CCONJ
aiua-9669	228	23	andrological	andrological	ADJ
aiua-9669	228	24	fields	field	NOUN
aiua-9669	228	25	.	.	PUNCT
aiua-9669	229	1	arch	arch	ADJ
aiua-9669	229	2	ital	ital	PROPN
aiua-9669	229	3	urol	urol	PROPN
aiua-9669	229	4	androl	androl	PROPN
aiua-9669	229	5	.	.	PROPN
aiua-9669	229	6	2014	2014	NUM
aiua-9669	229	7	;	;	PUNCT
aiua-9669	229	8	86:56	86:56	NUM
aiua-9669	229	9	-	-	SYM
aiua-9669	229	10	78	78	NUM
aiua-9669	229	11	.	.	PUNCT
aiua-9669	230	1	12	12	NUM
aiua-9669	230	2	.	.	PUNCT
aiua-9669	231	1	pagniez	pagniez	PROPN
aiua-9669	231	2	ma	ma	PROPN
aiua-9669	231	3	,	,	PUNCT
aiua-9669	231	4	kasivisvanathan	kasivisvanathan	NOUN
aiua-9669	231	5	v	v	NOUN
aiua-9669	231	6	,	,	PUNCT
aiua-9669	231	7	puech	puech	NOUN
aiua-9669	231	8	p	p	NOUN
aiua-9669	231	9	,	,	PUNCT
aiua-9669	231	10	et	et	PROPN
aiua-9669	231	11	al	al	PROPN
aiua-9669	231	12	.	.	PUNCT
aiua-9669	232	1	predictive	predictive	ADJ
aiua-9669	232	2	factors	factor	NOUN
aiua-9669	232	3	of	of	ADP
aiua-9669	232	4	missed	miss	VERB
aiua-9669	232	5	clinically	clinically	ADV
aiua-9669	232	6	significant	significant	ADJ
aiua-9669	232	7	prostate	prostate	NOUN
aiua-9669	232	8	cancers	cancer	NOUN
aiua-9669	232	9	in	in	ADP
aiua-9669	232	10	men	man	NOUN
aiua-9669	232	11	with	with	ADP
aiua-9669	232	12	negative	negative	ADJ
aiua-9669	232	13	magnetic	magnetic	ADJ
aiua-9669	232	14	resonance	resonance	NOUN
aiua-9669	232	15	imaging	imaging	NOUN
aiua-9669	232	16	:	:	PUNCT
aiua-9669	232	17	a	a	DET
aiua-9669	232	18	systematic	systematic	ADJ
aiua-9669	232	19	review	review	NOUN
aiua-9669	232	20	and	and	CCONJ
aiua-9669	232	21	metaanalysis	metaanalysis	NOUN
aiua-9669	232	22	.	.	PUNCT
aiua-9669	233	1	j	j	PROPN
aiua-9669	233	2	urol	urol	PROPN
aiua-9669	233	3	.	.	PUNCT
aiua-9669	234	1	2020	2020	NUM
aiua-9669	234	2	;	;	PUNCT
aiua-9669	234	3	204:24	204:24	NUM
aiua-9669	234	4	-	-	SYM
aiua-9669	234	5	32	32	NUM
aiua-9669	234	6	.	.	PUNCT
aiua-9669	235	1	13	13	NUM
aiua-9669	235	2	.	.	PUNCT
aiua-9669	236	1	roscigno	roscigno	PROPN
aiua-9669	236	2	m	m	PROPN
aiua-9669	236	3	,	,	PUNCT
aiua-9669	236	4	stabile	stabile	VERB
aiua-9669	236	5	a	a	PRON
aiua-9669	236	6	,	,	PUNCT
aiua-9669	236	7	lughezzani	lughezzani	ADJ
aiua-9669	236	8	g	g	PROPN
aiua-9669	236	9	,	,	PUNCT
aiua-9669	236	10	et	et	PROPN
aiua-9669	236	11	al	al	PROPN
aiua-9669	236	12	.	.	PUNCT
aiua-9669	237	1	the	the	DET
aiua-9669	237	2	use	use	NOUN
aiua-9669	237	3	of	of	ADP
aiua-9669	237	4	multiparametric	multiparametric	ADJ
aiua-9669	237	5	magnetic	magnetic	ADJ
aiua-9669	237	6	resonance	resonance	NOUN
aiua-9669	237	7	imaging	imaging	NOUN
aiua-9669	237	8	for	for	ADP
aiua-9669	237	9	follow	follow	NOUN
aiua-9669	237	10	-	-	PUNCT
aiua-9669	237	11	up	up	NOUN
aiua-9669	237	12	of	of	ADP
aiua-9669	237	13	patients	patient	NOUN
aiua-9669	237	14	included	include	VERB
aiua-9669	237	15	in	in	ADP
aiua-9669	237	16	active	active	ADJ
aiua-9669	237	17	surveillance	surveillance	NOUN
aiua-9669	237	18	protocol	protocol	NOUN
aiua-9669	237	19	.	.	PUNCT
aiua-9669	238	1	can	can	AUX
aiua-9669	238	2	psa	psa	VERB
aiua-9669	238	3	density	density	NOUN
aiua-9669	238	4	discriminate	discriminate	VERB
aiua-9669	238	5	patients	patient	NOUN
aiua-9669	238	6	at	at	ADP
aiua-9669	238	7	different	different	ADJ
aiua-9669	238	8	risk	risk	NOUN
aiua-9669	238	9	of	of	ADP
aiua-9669	238	10	reclassification	reclassification	NOUN
aiua-9669	238	11	?	?	PUNCT
aiua-9669	239	1	clin	clin	PROPN
aiua-9669	239	2	genitourin	genitourin	NOUN
aiua-9669	239	3	cancer	cancer	NOUN
aiua-9669	239	4	.	.	PUNCT
aiua-9669	240	1	2020	2020	NUM
aiua-9669	240	2	;	;	PUNCT
aiua-9669	240	3	18	18	NUM
aiua-9669	240	4	:	:	PUNCT
aiua-9669	240	5	e698	e698	PROPN
aiua-9669	240	6	-	-	PUNCT
aiua-9669	240	7	704	704	NUM
aiua-9669	240	8	.	.	PUNCT
aiua-9669	241	1	14	14	NUM
aiua-9669	241	2	.	.	PUNCT
aiua-9669	242	1	bhat	bhat	PROPN
aiua-9669	242	2	nr	nr	PROPN
aiua-9669	242	3	,	,	PUNCT
aiua-9669	242	4	vetter	vetter	PROPN
aiua-9669	242	5	jm	jm	PROPN
aiua-9669	242	6	,	,	PUNCT
aiua-9669	242	7	andriole	andriole	PROPN
aiua-9669	242	8	gl	gl	PROPN
aiua-9669	242	9	,	,	PUNCT
aiua-9669	242	10	et	et	PROPN
aiua-9669	242	11	al	al	PROPN
aiua-9669	242	12	.	.	PUNCT
aiua-9669	242	13	magnetic	magnetic	ADJ
aiua-9669	242	14	resonance	resonance	NOUN
aiua-9669	242	15	imaging	imaging	NOUN
aiua-9669	242	16	-	-	PUNCT
aiua-9669	242	17	defined	define	VERB
aiua-9669	242	18	prostate	prostate	NOUN
aiua-9669	242	19	-	-	PUNCT
aiua-9669	242	20	specific	specific	ADJ
aiua-9669	242	21	antigen	antigen	NOUN
aiua-9669	242	22	density	density	NOUN
aiua-9669	242	23	significantly	significantly	ADV
aiua-9669	242	24	improves	improve	VERB
aiua-9669	242	25	the	the	DET
aiua-9669	242	26	risk	risk	NOUN
aiua-9669	242	27	prediction	prediction	NOUN
aiua-9669	242	28	for	for	ADP
aiua-9669	242	29	clinically	clinically	ADV
aiua-9669	242	30	significant	significant	ADJ
aiua-9669	242	31	prostate	prostate	NOUN
aiua-9669	242	32	cancer	cancer	NOUN
aiua-9669	242	33	on	on	ADP
aiua-9669	242	34	biopsy	biopsy	NOUN
aiua-9669	242	35	.	.	PUNCT
aiua-9669	243	1	urology	urology	NOUN
aiua-9669	243	2	.	.	PUNCT
aiua-9669	244	1	2019	2019	NUM
aiua-9669	244	2	;	;	PUNCT
aiua-9669	244	3	126:152	126:152	NUM
aiua-9669	244	4	-	-	SYM
aiua-9669	244	5	7	7	NUM
aiua-9669	244	6	.	.	NOUN
aiua-9669	244	7	15	15	NUM
aiua-9669	244	8	.	.	PUNCT
aiua-9669	245	1	moldovan	moldovan	PROPN
aiua-9669	245	2	pc	pc	PROPN
aiua-9669	245	3	,	,	PUNCT
aiua-9669	245	4	van	van	PROPN
aiua-9669	245	5	den	den	PROPN
aiua-9669	245	6	broeck	broeck	PROPN
aiua-9669	245	7	t	t	PROPN
aiua-9669	245	8	,	,	PUNCT
aiua-9669	245	9	sylvester	sylvester	ADJ
aiua-9669	245	10	r	r	NOUN
aiua-9669	245	11	,	,	PUNCT
aiua-9669	245	12	et	et	PROPN
aiua-9669	245	13	al	al	PROPN
aiua-9669	245	14	.	.	PUNCT
aiua-9669	246	1	what	what	PRON
aiua-9669	246	2	is	be	AUX
aiua-9669	246	3	the	the	DET
aiua-9669	246	4	negative	negative	ADJ
aiua-9669	246	5	predictive	predictive	ADJ
aiua-9669	246	6	value	value	NOUN
aiua-9669	246	7	of	of	ADP
aiua-9669	246	8	multiparametric	multiparametric	ADJ
aiua-9669	246	9	magnetic	magnetic	ADJ
aiua-9669	246	10	resonance	resonance	NOUN
aiua-9669	246	11	imaging	imaging	NOUN
aiua-9669	246	12	in	in	ADP
aiua-9669	246	13	excluding	exclude	VERB
aiua-9669	246	14	prostate	prostate	NOUN
aiua-9669	246	15	cancer	cancer	NOUN
aiua-9669	246	16	at	at	ADP
aiua-9669	246	17	biopsy	biopsy	NOUN
aiua-9669	246	18	?	?	PUNCT
aiua-9669	247	1	a	a	DET
aiua-9669	247	2	systematic	systematic	ADJ
aiua-9669	247	3	review	review	NOUN
aiua-9669	247	4	and	and	CCONJ
aiua-9669	247	5	meta	meta	NOUN
aiua-9669	247	6	-	-	PUNCT
aiua-9669	247	7	analysis	analysis	NOUN
aiua-9669	247	8	from	from	ADP
aiua-9669	247	9	the	the	DET
aiua-9669	247	10	european	european	PROPN
aiua-9669	247	11	association	association	PROPN
aiua-9669	247	12	of	of	ADP
aiua-9669	247	13	urology	urology	NOUN
aiua-9669	247	14	prostate	prostate	NOUN
aiua-9669	247	15	cancer	cancer	NOUN
aiua-9669	247	16	guidelines	guideline	NOUN
aiua-9669	247	17	panel	panel	NOUN
aiua-9669	247	18	.	.	PUNCT
aiua-9669	248	1	eur	eur	PROPN
aiua-9669	248	2	urol	urol	PROPN
aiua-9669	248	3	.	.	PUNCT
aiua-9669	248	4	2017	2017	NUM
aiua-9669	248	5	;	;	PUNCT
aiua-9669	248	6	72:250	72:250	NUM
aiua-9669	248	7	-	-	SYM
aiua-9669	248	8	66	66	NUM
aiua-9669	248	9	.	.	PUNCT
aiua-9669	249	1	16	16	NUM
aiua-9669	249	2	.	.	PUNCT
aiua-9669	250	1	poyet	poyet	NOUN
aiua-9669	251	1	c	c	X
aiua-9669	251	2	,	,	PUNCT
aiua-9669	251	3	nieboer	nieboer	NOUN
aiua-9669	251	4	d	d	NOUN
aiua-9669	251	5	,	,	PUNCT
aiua-9669	251	6	bhindi	bhindi	PROPN
aiua-9669	251	7	b	b	PROPN
aiua-9669	251	8	,	,	PUNCT
aiua-9669	251	9	et	et	PROPN
aiua-9669	251	10	al	al	PROPN
aiua-9669	251	11	.	.	PROPN
aiua-9669	251	12	prostate	prostate	NOUN
aiua-9669	251	13	cancer	cancer	NOUN
aiua-9669	251	14	risk	risk	NOUN
aiua-9669	251	15	prediction	prediction	NOUN
aiua-9669	251	16	using	use	VERB
aiua-9669	251	17	the	the	DET
aiua-9669	251	18	novel	novel	ADJ
aiua-9669	251	19	versions	version	NOUN
aiua-9669	251	20	of	of	ADP
aiua-9669	251	21	the	the	DET
aiua-9669	251	22	european	european	ADJ
aiua-9669	251	23	randomised	randomised	ADJ
aiua-9669	251	24	study	study	NOUN
aiua-9669	251	25	for	for	ADP
aiua-9669	251	26	screening	screening	NOUN
aiua-9669	251	27	of	of	ADP
aiua-9669	251	28	prostate	prostate	NOUN
aiua-9669	251	29	cancer	cancer	NOUN
aiua-9669	251	30	(	(	PUNCT
aiua-9669	251	31	erspc	erspc	NOUN
aiua-9669	251	32	)	)	PUNCT
aiua-9669	251	33	and	and	CCONJ
aiua-9669	251	34	prostate	prostate	NOUN
aiua-9669	251	35	cancer	cancer	NOUN
aiua-9669	251	36	prevention	prevention	NOUN
aiua-9669	251	37	trial	trial	NOUN
aiua-9669	251	38	(	(	PUNCT
aiua-9669	251	39	pcpt	pcpt	NOUN
aiua-9669	251	40	)	)	PUNCT
aiua-9669	251	41	risk	risk	NOUN
aiua-9669	251	42	calculators	calculator	NOUN
aiua-9669	251	43	:	:	PUNCT
aiua-9669	251	44	independent	independent	ADJ
aiua-9669	251	45	validation	validation	NOUN
aiua-9669	251	46	and	and	CCONJ
aiua-9669	251	47	comparison	comparison	NOUN
aiua-9669	251	48	in	in	ADP
aiua-9669	251	49	a	a	DET
aiua-9669	251	50	contemporary	contemporary	ADJ
aiua-9669	251	51	european	european	ADJ
aiua-9669	251	52	cohort	cohort	NOUN
aiua-9669	251	53	.	.	PUNCT
aiua-9669	252	1	bju	bju	NOUN
aiua-9669	252	2	int	int	PROPN
aiua-9669	252	3	.	.	PUNCT
aiua-9669	253	1	2016	2016	NUM
aiua-9669	253	2	;	;	PUNCT
aiua-9669	253	3	117:401	117:401	NUM
aiua-9669	253	4	-	-	SYM
aiua-9669	253	5	8	8	NUM
aiua-9669	253	6	.	.	PUNCT
aiua-9669	254	1	17	17	NUM
aiua-9669	254	2	.	.	PUNCT
aiua-9669	255	1	panebianco	panebianco	PROPN
aiua-9669	255	2	v	v	NOUN
aiua-9669	255	3	,	,	PUNCT
aiua-9669	255	4	barchetti	barchetti	NOUN
aiua-9669	255	5	g	g	NOUN
aiua-9669	255	6	,	,	PUNCT
aiua-9669	255	7	simone	simone	NOUN
aiua-9669	255	8	g	g	NOUN
aiua-9669	255	9	,	,	PUNCT
aiua-9669	255	10	et	et	PROPN
aiua-9669	255	11	al	al	PROPN
aiua-9669	255	12	.	.	PROPN
aiua-9669	256	1	negative	negative	ADJ
aiua-9669	256	2	multiparametric	multiparametric	ADJ
aiua-9669	256	3	magnetic	magnetic	ADJ
aiua-9669	256	4	resonance	resonance	NOUN
aiua-9669	256	5	imaging	imaging	NOUN
aiua-9669	256	6	for	for	ADP
aiua-9669	256	7	prostate	prostate	NOUN
aiua-9669	256	8	cancer	cancer	NOUN
aiua-9669	256	9	:	:	PUNCT
aiua-9669	256	10	what	what	PRON
aiua-9669	256	11	’s	’	VERB
aiua-9669	256	12	next	next	ADJ
aiua-9669	256	13	?	?	PUNCT
aiua-9669	257	1	eur	eur	NOUN
aiua-9669	257	2	urol	urol	ADJ
aiua-9669	257	3	2018	2018	NUM
aiua-9669	257	4	;	;	PUNCT
aiua-9669	257	5	74:48	74:48	NUM
aiua-9669	257	6	-	-	SYM
aiua-9669	257	7	54	54	NUM
aiua-9669	257	8	.	.	PUNCT
aiua-9669	257	9	18	18	NUM
aiua-9669	257	10	.	.	PUNCT
aiua-9669	258	1	andreoiu	andreoiu	PROPN
aiua-9669	258	2	m	m	PROPN
aiua-9669	258	3	,	,	PUNCT
aiua-9669	258	4	cheng	cheng	PROPN
aiua-9669	258	5	l.	l.	PROPN
aiua-9669	258	6	multifocal	multifocal	ADJ
aiua-9669	258	7	prostate	prostate	NOUN
aiua-9669	258	8	cancer	cancer	NOUN
aiua-9669	258	9	:	:	PUNCT
aiua-9669	258	10	biologic	biologic	NOUN
aiua-9669	258	11	,	,	PUNCT
aiua-9669	258	12	prognostic	prognostic	NOUN
aiua-9669	258	13	,	,	PUNCT
aiua-9669	258	14	and	and	CCONJ
aiua-9669	258	15	therapeutic	therapeutic	ADJ
aiua-9669	258	16	implications	implication	NOUN
aiua-9669	258	17	.	.	PUNCT
aiua-9669	259	1	hum	hum	PROPN
aiua-9669	259	2	pathol	pathol	PROPN
aiua-9669	259	3	2010	2010	NUM
aiua-9669	259	4	;	;	PUNCT
aiua-9669	259	5	41:781	41:781	NUM
aiua-9669	259	6	-	-	SYM
aiua-9669	259	7	93	93	NUM
aiua-9669	259	8	19	19	NUM
aiua-9669	259	9	.	.	PUNCT
aiua-9669	260	1	giri	giri	PROPN
aiua-9669	260	2	vn	vn	PROPN
aiua-9669	260	3	,	,	PUNCT
aiua-9669	260	4	knudsen	knudsen	PROPN
aiua-9669	260	5	ke	ke	PROPN
aiua-9669	260	6	,	,	PUNCT
aiua-9669	260	7	kelly	kelly	PROPN
aiua-9669	260	8	wk	wk	PROPN
aiua-9669	260	9	,	,	PUNCT
aiua-9669	260	10	et	et	PROPN
aiua-9669	260	11	al	al	PROPN
aiua-9669	260	12	.	.	PUNCT
aiua-9669	261	1	implementation	implementation	NOUN
aiua-9669	261	2	of	of	ADP
aiua-9669	261	3	germline	germline	NOUN
aiua-9669	261	4	testing	testing	NOUN
aiua-9669	261	5	for	for	ADP
aiua-9669	261	6	prostate	prostate	NOUN
aiua-9669	261	7	cancer	cancer	NOUN
aiua-9669	261	8	:	:	PUNCT
aiua-9669	261	9	philadelphia	philadelphia	PROPN
aiua-9669	261	10	prostate	prostate	NOUN
aiua-9669	261	11	cancer	cancer	NOUN
aiua-9669	261	12	consensus	consensus	NOUN
aiua-9669	261	13	conference	conference	NOUN
aiua-9669	261	14	2019	2019	NUM
aiua-9669	261	15	.	.	PUNCT
aiua-9669	262	1	j	j	PROPN
aiua-9669	262	2	clin	clin	PROPN
aiua-9669	262	3	oncol	oncol	PROPN
aiua-9669	262	4	.	.	PUNCT
aiua-9669	263	1	2020	2020	NUM
aiua-9669	263	2	;	;	PUNCT
aiua-9669	263	3	38:2798	38:2798	NUM
aiua-9669	263	4	-	-	SYM
aiua-9669	263	5	811	811	NUM
aiua-9669	263	6	.	.	PUNCT
aiua-9669	264	1	20	20	NUM
aiua-9669	264	2	.	.	PUNCT
aiua-9669	264	3	zhen	zhen	PROPN
aiua-9669	264	4	jt	jt	PROPN
aiua-9669	264	5	,	,	PUNCT
aiua-9669	264	6	syed	syed	PROPN
aiua-9669	264	7	j	j	PROPN
aiua-9669	264	8	,	,	PUNCT
aiua-9669	264	9	nguyen	nguyen	PROPN
aiua-9669	264	10	ka	ka	PROPN
aiua-9669	264	11	,	,	PUNCT
aiua-9669	264	12	et	et	PROPN
aiua-9669	264	13	al	al	PROPN
aiua-9669	264	14	.	.	PUNCT
aiua-9669	265	1	genetic	genetic	ADJ
aiua-9669	265	2	testing	testing	NOUN
aiua-9669	265	3	for	for	ADP
aiua-9669	265	4	hereditary	hereditary	ADJ
aiua-9669	265	5	prostate	prostate	NOUN
aiua-9669	265	6	cancer	cancer	NOUN
aiua-9669	265	7	:	:	PUNCT
aiua-9669	265	8	current	current	ADJ
aiua-9669	265	9	status	status	NOUN
aiua-9669	265	10	and	and	CCONJ
aiua-9669	265	11	limitations	limitation	NOUN
aiua-9669	265	12	.	.	PUNCT
aiua-9669	266	1	cancer	cancer	NOUN
aiua-9669	266	2	.	.	PUNCT
aiua-9669	267	1	2018	2018	NUM
aiua-9669	267	2	;	;	PUNCT
aiua-9669	267	3	124:3105	124:3105	NUM
aiua-9669	267	4	-	-	SYM
aiua-9669	267	5	17	17	NUM
aiua-9669	267	6	.	.	PUNCT
aiua-9669	268	1	21	21	NUM
aiua-9669	268	2	.	.	PUNCT
aiua-9669	269	1	oh	oh	NUM
aiua-9669	269	2	m	m	NOUN
aiua-9669	269	3	,	,	PUNCT
aiua-9669	269	4	alkhushaym	alkhushaym	PROPN
aiua-9669	269	5	n	n	CCONJ
aiua-9669	269	6	,	,	PUNCT
aiua-9669	269	7	fallatah	fallatah	PROPN
aiua-9669	269	8	s	s	PROPN
aiua-9669	269	9	,	,	PUNCT
aiua-9669	269	10	et	et	PROPN
aiua-9669	269	11	al	al	PROPN
aiua-9669	269	12	.	.	PUNCT
aiua-9669	270	1	the	the	DET
aiua-9669	270	2	association	association	PROPN
aiua-9669	270	3	of	of	ADP
aiua-9669	270	4	brca1	brca1	PROPN
aiua-9669	270	5	and	and	CCONJ
aiua-9669	270	6	brca2	brca2	NOUN
aiua-9669	270	7	mutations	mutation	NOUN
aiua-9669	270	8	with	with	ADP
aiua-9669	270	9	prostate	prostate	NOUN
aiua-9669	270	10	cancer	cancer	NOUN
aiua-9669	270	11	risk	risk	NOUN
aiua-9669	270	12	,	,	PUNCT
aiua-9669	270	13	frequency	frequency	NOUN
aiua-9669	270	14	,	,	PUNCT
aiua-9669	270	15	and	and	CCONJ
aiua-9669	270	16	mortality	mortality	NOUN
aiua-9669	270	17	:	:	PUNCT
aiua-9669	270	18	a	a	DET
aiua-9669	270	19	meta	meta	ADJ
aiua-9669	270	20	-	-	PUNCT
aiua-9669	270	21	analysis	analysis	NOUN
aiua-9669	270	22	.	.	PUNCT
aiua-9669	271	1	prostate	prostate	NOUN
aiua-9669	271	2	.	.	PUNCT
aiua-9669	272	1	2019	2019	NUM
aiua-9669	272	2	;	;	PUNCT
aiua-9669	272	3	79:880	79:880	NUM
aiua-9669	272	4	-	-	SYM
aiua-9669	272	5	95	95	NUM
aiua-9669	272	6	.	.	PUNCT
aiua-9669	273	1	22	22	NUM
aiua-9669	273	2	.	.	PUNCT
aiua-9669	274	1	castro	castro	PROPN
aiua-9669	274	2	e	e	PROPN
aiua-9669	274	3	,	,	PUNCT
aiua-9669	274	4	eeles	eele	VERB
aiua-9669	274	5	r.	r.	VERB
aiua-9669	274	6	the	the	DET
aiua-9669	274	7	role	role	NOUN
aiua-9669	274	8	of	of	ADP
aiua-9669	274	9	brca1	brca1	PROPN
aiua-9669	274	10	and	and	CCONJ
aiua-9669	274	11	brca2	brca2	PROPN
aiua-9669	274	12	in	in	ADP
aiua-9669	274	13	prostate	prostate	NOUN
aiua-9669	274	14	cancer	cancer	NOUN
aiua-9669	274	15	.	.	PUNCT
aiua-9669	275	1	asian	asian	PROPN
aiua-9669	275	2	j	j	PROPN
aiua-9669	275	3	androl	androl	PROPN
aiua-9669	275	4	.	.	PROPN
aiua-9669	275	5	2012	2012	NUM
aiua-9669	275	6	;	;	PUNCT
aiua-9669	275	7	14:409	14:409	NUM
aiua-9669	275	8	-	-	SYM
aiua-9669	275	9	14	14	NUM
aiua-9669	275	10	.	.	PUNCT
aiua-9669	276	1	23	23	NUM
aiua-9669	276	2	.	.	PUNCT
aiua-9669	277	1	raymond	raymond	PROPN
aiua-9669	277	2	vm	vm	PROPN
aiua-9669	277	3	,	,	PUNCT
aiua-9669	277	4	mukherjee	mukherjee	PROPN
aiua-9669	277	5	b	b	PROPN
aiua-9669	277	6	,	,	PUNCT
aiua-9669	277	7	wang	wang	PROPN
aiua-9669	277	8	f	f	PROPN
aiua-9669	277	9	,	,	PUNCT
aiua-9669	277	10	et	et	PROPN
aiua-9669	277	11	al	al	PROPN
aiua-9669	277	12	.	.	PROPN
aiua-9669	277	13	elevated	elevated	ADJ
aiua-9669	277	14	risk	risk	NOUN
aiua-9669	277	15	of	of	ADP
aiua-9669	277	16	prostate	prostate	NOUN
aiua-9669	277	17	cancer	cancer	NOUN
aiua-9669	277	18	among	among	ADP
aiua-9669	277	19	men	man	NOUN
aiua-9669	277	20	with	with	ADP
aiua-9669	277	21	lynch	lynch	PROPN
aiua-9669	277	22	syndrome	syndrome	PROPN
aiua-9669	277	23	.	.	PUNCT
aiua-9669	278	1	j	j	PROPN
aiua-9669	278	2	clin	clin	PROPN
aiua-9669	278	3	oncol	oncol	PROPN
aiua-9669	278	4	.	.	PUNCT
aiua-9669	279	1	2013	2013	NUM
aiua-9669	279	2	;	;	PUNCT
aiua-9669	279	3	31:1713	31:1713	NUM
aiua-9669	279	4	-	-	SYM
aiua-9669	279	5	8	8	NUM
aiua-9669	279	6	.	.	NUM
aiua-9669	280	1	24	24	NUM
aiua-9669	280	2	.	.	PUNCT
aiua-9669	281	1	ostrander	ostrander	PROPN
aiua-9669	281	2	ea	ea	PROPN
aiua-9669	281	3	,	,	PUNCT
aiua-9669	281	4	stanford	stanford	PROPN
aiua-9669	281	5	jl	jl	PROPN
aiua-9669	281	6	.	.	PUNCT
aiua-9669	282	1	genetics	genetic	NOUN
aiua-9669	282	2	of	of	ADP
aiua-9669	282	3	prostate	prostate	NOUN
aiua-9669	282	4	cancer	cancer	NOUN
aiua-9669	282	5	:	:	PUNCT
aiua-9669	282	6	too	too	ADV
aiua-9669	282	7	many	many	ADJ
aiua-9669	282	8	loci	locus	NOUN
aiua-9669	282	9	,	,	PUNCT
aiua-9669	282	10	too	too	ADV
aiua-9669	282	11	few	few	ADJ
aiua-9669	282	12	genes	gene	NOUN
aiua-9669	282	13	.	.	PUNCT
aiua-9669	283	1	am	be	AUX
aiua-9669	283	2	j	j	PROPN
aiua-9669	283	3	hum	hum	PROPN
aiua-9669	283	4	genet	genet	PROPN
aiua-9669	283	5	.	.	PUNCT
aiua-9669	284	1	2000	2000	NUM
aiua-9669	284	2	;	;	PUNCT
aiua-9669	284	3	67:1367	67:1367	X
aiua-9669	284	4	-	-	SYM
aiua-9669	284	5	75	75	NUM
aiua-9669	284	6	.	.	PUNCT
aiua-9669	285	1	25	25	NUM
aiua-9669	285	2	.	.	PUNCT
aiua-9669	286	1	carroll	carroll	PROPN
aiua-9669	286	2	pr	pr	PROPN
aiua-9669	286	3	,	,	PUNCT
aiua-9669	286	4	parsons	parsons	PROPN
aiua-9669	286	5	jk	jk	PROPN
aiua-9669	286	6	,	,	PUNCT
aiua-9669	286	7	andriole	andriole	PROPN
aiua-9669	286	8	g	g	PROPN
aiua-9669	286	9	,	,	PUNCT
aiua-9669	286	10	et	et	PROPN
aiua-9669	286	11	al	al	PROPN
aiua-9669	286	12	.	.	PROPN
aiua-9669	286	13	prostate	prostate	NOUN
aiua-9669	286	14	cancer	cancer	NOUN
aiua-9669	286	15	early	early	ADJ
aiua-9669	286	16	detection	detection	NOUN
aiua-9669	286	17	,	,	PUNCT
aiua-9669	286	18	version	version	NOUN
aiua-9669	286	19	2.2015	2.2015	NUM
aiua-9669	286	20	:	:	PUNCT
aiua-9669	286	21	clinical	clinical	ADJ
aiua-9669	286	22	practice	practice	NOUN
aiua-9669	286	23	guidelines	guideline	NOUN
aiua-9669	286	24	in	in	ADP
aiua-9669	286	25	oncology	oncology	NOUN
aiua-9669	286	26	.	.	PUNCT
aiua-9669	287	1	j	j	PROPN
aiua-9669	287	2	natl	natl	PROPN
aiua-9669	287	3	compr	compr	PROPN
aiua-9669	287	4	cancer	cancer	NOUN
aiua-9669	287	5	netw	netw	NOUN
aiua-9669	287	6	.	.	PUNCT
aiua-9669	288	1	2015	2015	NUM
aiua-9669	288	2	;	;	PUNCT
aiua-9669	288	3	13:1534	13:1534	NUM
aiua-9669	288	4	-	-	SYM
aiua-9669	288	5	61	61	NUM
aiua-9669	288	6	.	.	NOUN
aiua-9669	289	1	26	26	NUM
aiua-9669	289	2	.	.	PUNCT
aiua-9669	290	1	gasparrini	gasparrini	PROPN
aiua-9669	290	2	s	s	PROPN
aiua-9669	290	3	,	,	PUNCT
aiua-9669	290	4	cimadamore	cimadamore	VERB
aiua-9669	290	5	a	a	PRON
aiua-9669	290	6	,	,	PUNCT
aiua-9669	290	7	mazzucchelli	mazzucchelli	NOUN
aiua-9669	290	8	r	r	NOUN
aiua-9669	290	9	,	,	PUNCT
aiua-9669	290	10	et	et	PROPN
aiua-9669	290	11	al	al	PROPN
aiua-9669	290	12	.	.	PUNCT
aiua-9669	290	13	pathology	pathology	PROPN
aiua-9669	290	14	and	and	CCONJ
aiua-9669	290	15	molecular	molecular	ADJ
aiua-9669	290	16	updates	update	NOUN
aiua-9669	290	17	in	in	ADP
aiua-9669	290	18	tumors	tumor	NOUN
aiua-9669	290	19	of	of	ADP
aiua-9669	290	20	the	the	DET
aiua-9669	290	21	prostate	prostate	NOUN
aiua-9669	290	22	:	:	PUNCT
aiua-9669	290	23	towards	towards	ADP
aiua-9669	290	24	a	a	DET
aiua-9669	290	25	personalized	personalized	ADJ
aiua-9669	290	26	approach	approach	NOUN
aiua-9669	290	27	.	.	PUNCT
aiua-9669	291	1	expert	expert	NOUN
aiua-9669	291	2	rev	rev	VERB
aiua-9669	291	3	mol	mol	ADP
aiua-9669	291	4	diagn	diagn	PROPN
aiua-9669	291	5	.	.	PUNCT
aiua-9669	292	1	2017	2017	NUM
aiua-9669	292	2	;	;	PUNCT
aiua-9669	292	3	17:781	17:781	NUM
aiua-9669	292	4	-	-	SYM
aiua-9669	292	5	9	9	NUM
aiua-9669	292	6	.	.	NOUN
aiua-9669	292	7	27	27	NUM
aiua-9669	292	8	.	.	PUNCT
aiua-9669	293	1	dell’atti	dell’atti	VERB
aiua-9669	293	2	l	l	NOUN
aiua-9669	293	3	,	,	PUNCT
aiua-9669	293	4	galosi	galosi	PROPN
aiua-9669	293	5	ab	ab	PROPN
aiua-9669	293	6	.	.	PUNCT
aiua-9669	293	7	safety	safety	NOUN
aiua-9669	293	8	of	of	ADP
aiua-9669	293	9	transrectal	transrectal	ADJ
aiua-9669	293	10	ultrasound	ultrasound	NOUN
aiua-9669	293	11	-	-	PUNCT
aiua-9669	293	12	guided	guide	VERB
aiua-9669	293	13	prostate	prostate	NOUN
aiua-9669	293	14	biopsy	biopsy	NOUN
aiua-9669	293	15	in	in	ADP
aiua-9669	293	16	patients	patient	NOUN
aiua-9669	293	17	affected	affect	VERB
aiua-9669	293	18	by	by	ADP
aiua-9669	293	19	crohn	crohn	PROPN
aiua-9669	293	20	’s	’s	PART
aiua-9669	293	21	disease	disease	PROPN
aiua-9669	293	22	.	.	PUNCT
aiua-9669	294	1	arch	arch	PROPN
aiua-9669	294	2	ital	ital	PROPN
aiua-9669	294	3	urol	urol	PROPN
aiua-9669	294	4	androl	androl	PROPN
aiua-9669	294	5	.	.	PROPN
aiua-9669	294	6	2017	2017	NUM
aiua-9669	294	7	;	;	PUNCT
aiua-9669	294	8	89:106	89:106	NUM
aiua-9669	294	9	-	-	SYM
aiua-9669	294	10	9	9	NUM
aiua-9669	294	11	.	.	NOUN
aiua-9669	294	12	28	28	NUM
aiua-9669	294	13	.	.	PUNCT
aiua-9669	295	1	oon	oon	PROPN
aiua-9669	295	2	sf	sf	PROPN
aiua-9669	295	3	,	,	PUNCT
aiua-9669	295	4	watson	watson	PROPN
aiua-9669	295	5	rw	rw	PROPN
aiua-9669	295	6	,	,	PUNCT
aiua-9669	295	7	o’leary	o’leary	PROPN
aiua-9669	295	8	jj	jj	PROPN
aiua-9669	295	9	,	,	PUNCT
aiua-9669	295	10	fitzpatrick	fitzpatrick	PROPN
aiua-9669	295	11	jm	jm	PROPN
aiua-9669	295	12	.	.	PROPN
aiua-9669	295	13	epstein	epstein	PROPN
aiua-9669	295	14	criteria	criteria	PROPN
aiua-9669	295	15	for	for	ADP
aiua-9669	295	16	insignificant	insignificant	ADJ
aiua-9669	295	17	prostate	prostate	NOUN
aiua-9669	295	18	cancer	cancer	NOUN
aiua-9669	295	19	.	.	PUNCT
aiua-9669	296	1	bju	bju	NOUN
aiua-9669	296	2	int	int	PROPN
aiua-9669	296	3	.	.	PUNCT
aiua-9669	297	1	2011	2011	NUM
aiua-9669	297	2	;	;	PUNCT
aiua-9669	298	1	108:518	108:518	NOUN
aiua-9669	298	2	-	-	SYM
aiua-9669	298	3	25	25	NUM
aiua-9669	298	4	.	.	PUNCT
aiua-9669	298	5	29	29	NUM
aiua-9669	298	6	.	.	PUNCT
aiua-9669	299	1	mazzucchelli	mazzucchelli	PROPN
aiua-9669	299	2	r	r	PROPN
aiua-9669	299	3	,	,	PUNCT
aiua-9669	299	4	galosi	galosi	PROPN
aiua-9669	299	5	ab	ab	PROPN
aiua-9669	299	6	,	,	PUNCT
aiua-9669	299	7	lopez	lopez	PROPN
aiua-9669	299	8	-	-	PUNCT
aiua-9669	299	9	beltran	beltran	PROPN
aiua-9669	299	10	a	a	PROPN
aiua-9669	299	11	,	,	PUNCT
aiua-9669	299	12	et	et	PROPN
aiua-9669	299	13	al	al	PROPN
aiua-9669	299	14	.	.	PUNCT
aiua-9669	299	15	pathological	pathological	ADJ
aiua-9669	299	16	issues	issue	NOUN
aiua-9669	299	17	in	in	ADP
aiua-9669	299	18	biopsy	biopsy	NOUN
aiua-9669	299	19	specimens	specimen	NOUN
aiua-9669	299	20	of	of	ADP
aiua-9669	299	21	men	man	NOUN
aiua-9669	299	22	with	with	ADP
aiua-9669	299	23	prostate	prostate	NOUN
aiua-9669	299	24	cancer	cancer	NOUN
aiua-9669	299	25	eligible	eligible	ADJ
aiua-9669	299	26	for	for	ADP
aiua-9669	299	27	active	active	ADJ
aiua-9669	299	28	surveillance	surveillance	NOUN
aiua-9669	299	29	.	.	PUNCT
aiua-9669	300	1	arch	arch	PROPN
aiua-9669	300	2	ital	ital	PROPN
aiua-9669	300	3	di	di	PROPN
aiua-9669	300	4	urol	urol	PROPN
aiua-9669	300	5	androl	androl	PROPN
aiua-9669	300	6	.	.	PROPN
aiua-9669	300	7	2014	2014	NUM
aiua-9669	300	8	;	;	PUNCT
aiua-9669	300	9	86:314	86:314	NUM
aiua-9669	300	10	-	-	SYM
aiua-9669	300	11	8	8	NUM
aiua-9669	300	12	.	.	PUNCT
aiua-9669	301	1	99archivio	99archivio	NUM
aiua-9669	301	2	italiano	italiano	PROPN
aiua-9669	301	3	di	di	PROPN
aiua-9669	301	4	urologia	urologia	PROPN
aiua-9669	301	5	e	e	PROPN
aiua-9669	301	6	andrologia	andrologia	NOUN
aiua-9669	301	7	2021	2021	NUM
aiua-9669	301	8	;	;	PUNCT
aiua-9669	301	9	93	93	NUM
aiua-9669	301	10	,	,	PUNCT
aiua-9669	301	11	1	1	NUM
aiua-9669	301	12	significant	significant	ADJ
aiua-9669	301	13	prostate	prostate	NOUN
aiua-9669	301	14	cancer	cancer	NOUN
aiua-9669	301	15	with	with	ADP
aiua-9669	301	16	low	low	ADJ
aiua-9669	301	17	psa	psa	NOUN
aiua-9669	301	18	30	30	NUM
aiua-9669	301	19	.	.	PUNCT
aiua-9669	302	1	epstein	epstein	PROPN
aiua-9669	302	2	ji	ji	PROPN
aiua-9669	302	3	,	,	PUNCT
aiua-9669	302	4	egevad	egevad	PROPN
aiua-9669	302	5	l	l	PROPN
aiua-9669	302	6	,	,	PUNCT
aiua-9669	302	7	amin	amin	NOUN
aiua-9669	302	8	mb	mb	PROPN
aiua-9669	302	9	,	,	PUNCT
aiua-9669	302	10	et	et	PROPN
aiua-9669	302	11	al	al	PROPN
aiua-9669	302	12	.	.	PUNCT
aiua-9669	303	1	the	the	DET
aiua-9669	303	2	2014	2014	NUM
aiua-9669	303	3	international	international	ADJ
aiua-9669	303	4	society	society	NOUN
aiua-9669	303	5	of	of	ADP
aiua-9669	303	6	urological	urological	ADJ
aiua-9669	303	7	pathology	pathology	NOUN
aiua-9669	303	8	(	(	PUNCT
aiua-9669	303	9	isup	isup	NOUN
aiua-9669	303	10	)	)	PUNCT
aiua-9669	303	11	consensus	consensus	NOUN
aiua-9669	303	12	conference	conference	NOUN
aiua-9669	303	13	on	on	ADP
aiua-9669	303	14	gleason	gleason	PROPN
aiua-9669	303	15	grading	grade	VERB
aiua-9669	303	16	of	of	ADP
aiua-9669	303	17	prostatic	prostatic	ADJ
aiua-9669	303	18	carcinoma	carcinoma	NOUN
aiua-9669	303	19	:	:	PUNCT
aiua-9669	303	20	definition	definition	NOUN
aiua-9669	303	21	of	of	ADP
aiua-9669	303	22	grading	grade	VERB
aiua-9669	303	23	patterns	pattern	NOUN
aiua-9669	303	24	and	and	CCONJ
aiua-9669	303	25	proposal	proposal	NOUN
aiua-9669	303	26	for	for	ADP
aiua-9669	303	27	a	a	DET
aiua-9669	303	28	new	new	ADJ
aiua-9669	303	29	grading	grade	VERB
aiua-9669	303	30	system	system	NOUN
aiua-9669	303	31	.	.	PUNCT
aiua-9669	303	32	am	be	AUX
aiua-9669	303	33	j	j	PROPN
aiua-9669	303	34	surg	surg	PROPN
aiua-9669	303	35	pathol	pathol	NOUN
aiua-9669	303	36	.	.	PUNCT
aiua-9669	304	1	2016	2016	NUM
aiua-9669	304	2	;	;	PUNCT
aiua-9669	304	3	40:244	40:244	NUM
aiua-9669	304	4	-	-	SYM
aiua-9669	304	5	52	52	NUM
aiua-9669	304	6	.	.	PUNCT
aiua-9669	305	1	31	31	NUM
aiua-9669	305	2	.	.	PUNCT
aiua-9669	306	1	matoso	matoso	PROPN
aiua-9669	306	2	a	a	PROPN
aiua-9669	306	3	,	,	PUNCT
aiua-9669	306	4	epstein	epstein	PROPN
aiua-9669	306	5	ji	ji	PROPN
aiua-9669	306	6	.	.	PUNCT
aiua-9669	306	7	defining	define	VERB
aiua-9669	306	8	clinically	clinically	ADV
aiua-9669	306	9	significant	significant	ADJ
aiua-9669	306	10	prostate	prostate	NOUN
aiua-9669	306	11	cancer	cancer	NOUN
aiua-9669	306	12	on	on	ADP
aiua-9669	306	13	the	the	DET
aiua-9669	306	14	basis	basis	NOUN
aiua-9669	306	15	of	of	ADP
aiua-9669	306	16	pathological	pathological	ADJ
aiua-9669	306	17	findings	finding	NOUN
aiua-9669	306	18	.	.	PUNCT
aiua-9669	307	1	histopathology	histopathology	NOUN
aiua-9669	307	2	.	.	PUNCT
aiua-9669	308	1	2019	2019	NUM
aiua-9669	308	2	;	;	PUNCT
aiua-9669	308	3	74:135	74:135	NUM
aiua-9669	308	4	-	-	SYM
aiua-9669	308	5	45	45	NUM
aiua-9669	308	6	.	.	PUNCT
aiua-9669	309	1	32	32	NUM
aiua-9669	309	2	.	.	PUNCT
aiua-9669	310	1	lacetera	lacetera	NOUN
aiua-9669	310	2	v	v	PROPN
aiua-9669	310	3	,	,	PUNCT
aiua-9669	310	4	cervelli	cervelli	PROPN
aiua-9669	310	5	b	b	PROPN
aiua-9669	310	6	,	,	PUNCT
aiua-9669	310	7	cicetti	cicetti	VERB
aiua-9669	310	8	a	a	PRON
aiua-9669	310	9	,	,	PUNCT
aiua-9669	310	10	et	et	PROPN
aiua-9669	310	11	al	al	PROPN
aiua-9669	310	12	.	.	PUNCT
aiua-9669	311	1	mri	mri	PROPN
aiua-9669	311	2	/	/	SYM
aiua-9669	311	3	us	us	PROPN
aiua-9669	311	4	fusion	fusion	NOUN
aiua-9669	311	5	prostate	prostate	NOUN
aiua-9669	311	6	biopsy	biopsy	NOUN
aiua-9669	311	7	:	:	PUNCT
aiua-9669	311	8	our	our	PRON
aiua-9669	311	9	initial	initial	ADJ
aiua-9669	311	10	experience	experience	NOUN
aiua-9669	311	11	.	.	PUNCT
aiua-9669	312	1	arch	arch	PROPN
aiua-9669	312	2	ital	ital	PROPN
aiua-9669	312	3	di	di	PROPN
aiua-9669	312	4	urol	urol	PROPN
aiua-9669	312	5	androl	androl	PROPN
aiua-9669	312	6	.	.	PROPN
aiua-9669	312	7	2016	2016	NUM
aiua-9669	312	8	;	;	PUNCT
aiua-9669	312	9	88:296	88:296	NUM
aiua-9669	312	10	-	-	SYM
aiua-9669	312	11	9	9	NUM
aiua-9669	312	12	.	.	NOUN
aiua-9669	312	13	33	33	NUM
aiua-9669	312	14	.	.	PUNCT
aiua-9669	313	1	galosi	galosi	PROPN
aiua-9669	313	2	ab	ab	PROPN
aiua-9669	313	3	,	,	PUNCT
aiua-9669	313	4	maselli	maselli	PROPN
aiua-9669	313	5	g	g	PROPN
aiua-9669	313	6	,	,	PUNCT
aiua-9669	313	7	sbrollini	sbrollini	PROPN
aiua-9669	313	8	g	g	PROPN
aiua-9669	313	9	,	,	PUNCT
aiua-9669	313	10	et	et	PROPN
aiua-9669	313	11	al	al	PROPN
aiua-9669	313	12	.	.	PROPN
aiua-9669	313	13	cognitive	cognitive	ADJ
aiua-9669	313	14	zonal	zonal	ADJ
aiua-9669	313	15	fusion	fusion	NOUN
aiua-9669	313	16	biopsy	biopsy	NOUN
aiua-9669	313	17	of	of	ADP
aiua-9669	313	18	the	the	DET
aiua-9669	313	19	prostate	prostate	NOUN
aiua-9669	313	20	:	:	PUNCT
aiua-9669	313	21	original	original	ADJ
aiua-9669	313	22	technique	technique	NOUN
aiua-9669	313	23	between	between	ADP
aiua-9669	313	24	target	target	NOUN
aiua-9669	313	25	and	and	CCONJ
aiua-9669	313	26	saturation	saturation	NOUN
aiua-9669	313	27	.	.	PUNCT
aiua-9669	314	1	arch	arch	ADJ
aiua-9669	314	2	ital	ital	PROPN
aiua-9669	314	3	urol	urol	PROPN
aiua-9669	314	4	androl	androl	PROPN
aiua-9669	314	5	.	.	PROPN
aiua-9669	314	6	2016	2016	NUM
aiua-9669	314	7	;	;	PUNCT
aiua-9669	314	8	88:292	88:292	NUM
aiua-9669	314	9	-	-	SYM
aiua-9669	314	10	5	5	NUM
aiua-9669	314	11	.	.	NOUN
aiua-9669	314	12	34	34	NUM
aiua-9669	314	13	.	.	PUNCT
aiua-9669	315	1	cimadamore	cimadamore	VERB
aiua-9669	315	2	a	a	PRON
aiua-9669	315	3	,	,	PUNCT
aiua-9669	315	4	scarpelli	scarpelli	PROPN
aiua-9669	315	5	m	m	PROPN
aiua-9669	315	6	,	,	PUNCT
aiua-9669	315	7	raspollini	raspollini	PROPN
aiua-9669	315	8	mr	mr	PROPN
aiua-9669	315	9	,	,	PUNCT
aiua-9669	315	10	et	et	PROPN
aiua-9669	315	11	al	al	PROPN
aiua-9669	315	12	.	.	PROPN
aiua-9669	315	13	prostate	prostate	NOUN
aiua-9669	315	14	cancer	cancer	NOUN
aiua-9669	315	15	pathology	pathology	NOUN
aiua-9669	315	16	:	:	PUNCT
aiua-9669	315	17	what	what	PRON
aiua-9669	315	18	has	have	AUX
aiua-9669	315	19	changed	change	VERB
aiua-9669	315	20	in	in	ADP
aiua-9669	315	21	the	the	DET
aiua-9669	315	22	last	last	ADJ
aiua-9669	315	23	5	5	NUM
aiua-9669	315	24	years	year	NOUN
aiua-9669	315	25	.	.	PUNCT
aiua-9669	316	1	urologia	urologia	PROPN
aiua-9669	316	2	.	.	PUNCT
aiua-9669	317	1	2020	2020	NUM
aiua-9669	317	2	;	;	PUNCT
aiua-9669	317	3	87:3	87:3	NUM
aiua-9669	317	4	-	-	SYM
aiua-9669	317	5	10	10	NUM
aiua-9669	317	6	.	.	PUNCT
aiua-9669	317	7	35	35	NUM
aiua-9669	317	8	.	.	PUNCT
aiua-9669	318	1	montironi	montironi	PROPN
aiua-9669	318	2	r	r	NOUN
aiua-9669	318	3	,	,	PUNCT
aiua-9669	318	4	santoni	santoni	NOUN
aiua-9669	318	5	m	m	PROPN
aiua-9669	318	6	,	,	PUNCT
aiua-9669	318	7	mazzucchelli	mazzucchelli	NOUN
aiua-9669	318	8	r	r	NOUN
aiua-9669	318	9	,	,	PUNCT
aiua-9669	318	10	et	et	PROPN
aiua-9669	318	11	al	al	PROPN
aiua-9669	318	12	.	.	PROPN
aiua-9669	318	13	prostate	prostate	NOUN
aiua-9669	318	14	cancer	cancer	NOUN
aiua-9669	318	15	:	:	PUNCT
aiua-9669	318	16	from	from	ADP
aiua-9669	318	17	gleason	gleason	PROPN
aiua-9669	318	18	scoring	score	VERB
aiua-9669	318	19	to	to	ADP
aiua-9669	318	20	prognostic	prognostic	ADJ
aiua-9669	318	21	grade	grade	NOUN
aiua-9669	318	22	grouping	grouping	NOUN
aiua-9669	318	23	.	.	PUNCT
aiua-9669	319	1	expert	expert	NOUN
aiua-9669	319	2	rev	rev	PROPN
aiua-9669	319	3	anticancer	anticancer	NOUN
aiua-9669	319	4	ther	ther	ADV
aiua-9669	319	5	.	.	PUNCT
aiua-9669	320	1	2016	2016	NUM
aiua-9669	320	2	;	;	PUNCT
aiua-9669	320	3	16:433	16:433	NUM
aiua-9669	320	4	-	-	SYM
aiua-9669	320	5	40	40	NUM
aiua-9669	320	6	.	.	PUNCT
aiua-9669	321	1	36	36	NUM
aiua-9669	321	2	.	.	PUNCT
aiua-9669	322	1	magi	magi	NOUN
aiua-9669	322	2	-	-	PUNCT
aiua-9669	322	3	galluzzi	galluzzi	NOUN
aiua-9669	322	4	c	c	NOUN
aiua-9669	322	5	,	,	PUNCT
aiua-9669	322	6	montironi	montironi	X
aiua-9669	322	7	r	r	NOUN
aiua-9669	322	8	,	,	PUNCT
aiua-9669	322	9	epstein	epstein	PROPN
aiua-9669	322	10	ji	ji	PROPN
aiua-9669	322	11	.	.	PROPN
aiua-9669	323	1	contemporary	contemporary	PROPN
aiua-9669	323	2	gleason	gleason	PROPN
aiua-9669	323	3	grading	grading	NOUN
aiua-9669	323	4	and	and	CCONJ
aiua-9669	323	5	novel	novel	ADJ
aiua-9669	323	6	grade	grade	NOUN
aiua-9669	323	7	groups	group	NOUN
aiua-9669	323	8	in	in	ADP
aiua-9669	323	9	clinical	clinical	ADJ
aiua-9669	323	10	practice	practice	NOUN
aiua-9669	323	11	.	.	PUNCT
aiua-9669	324	1	curr	curr	PROPN
aiua-9669	324	2	opin	opin	PROPN
aiua-9669	324	3	urol	urol	PROPN
aiua-9669	324	4	.	.	PROPN
aiua-9669	324	5	2016	2016	NUM
aiua-9669	324	6	;	;	PUNCT
aiua-9669	324	7	26:488	26:488	NUM
aiua-9669	324	8	-	-	SYM
aiua-9669	324	9	92	92	NUM
aiua-9669	324	10	.	.	PUNCT
aiua-9669	325	1	37	37	NUM
aiua-9669	325	2	.	.	PUNCT
aiua-9669	326	1	kamoun	kamoun	PROPN
aiua-9669	326	2	a	a	PRON
aiua-9669	326	3	,	,	PUNCT
aiua-9669	326	4	cancel	cancel	VERB
aiua-9669	326	5	-	-	PUNCT
aiua-9669	326	6	tassin	tassin	NOUN
aiua-9669	326	7	g	g	NOUN
aiua-9669	326	8	,	,	PUNCT
aiua-9669	326	9	fromont	fromont	NOUN
aiua-9669	326	10	g	g	PROPN
aiua-9669	326	11	,	,	PUNCT
aiua-9669	326	12	et	et	PROPN
aiua-9669	326	13	al	al	PROPN
aiua-9669	326	14	.	.	PROPN
aiua-9669	327	1	comprehensive	comprehensive	ADJ
aiua-9669	327	2	molecular	molecular	ADJ
aiua-9669	327	3	classification	classification	NOUN
aiua-9669	327	4	of	of	ADP
aiua-9669	327	5	localized	localized	ADJ
aiua-9669	327	6	prostate	prostate	NOUN
aiua-9669	327	7	adenocarcinoma	adenocarcinoma	NOUN
aiua-9669	327	8	reveals	reveal	VERB
aiua-9669	327	9	a	a	DET
aiua-9669	327	10	tumour	tumour	ADJ
aiua-9669	327	11	subtype	subtype	NOUN
aiua-9669	327	12	predictive	predictive	NOUN
aiua-9669	327	13	of	of	ADP
aiua-9669	327	14	non	non	ADJ
aiua-9669	327	15	-	-	ADJ
aiua-9669	327	16	aggressive	aggressive	ADJ
aiua-9669	327	17	disease	disease	NOUN
aiua-9669	327	18	.	.	PUNCT
aiua-9669	328	1	ann	ann	PROPN
aiua-9669	328	2	oncol	oncol	PROPN
aiua-9669	328	3	.	.	PUNCT
aiua-9669	329	1	2018	2018	NUM
aiua-9669	329	2	;	;	PUNCT
aiua-9669	329	3	29:1814	29:1814	X
aiua-9669	329	4	-	-	SYM
aiua-9669	329	5	21	21	NUM
aiua-9669	329	6	.	.	PUNCT
aiua-9669	330	1	38	38	NUM
aiua-9669	330	2	.	.	PUNCT
aiua-9669	331	1	sauter	sauter	PROPN
aiua-9669	331	2	g	g	PROPN
aiua-9669	331	3	,	,	PUNCT
aiua-9669	331	4	steurer	steurer	PROPN
aiua-9669	331	5	s	s	PROPN
aiua-9669	331	6	,	,	PUNCT
aiua-9669	331	7	clauditz	clauditz	NOUN
aiua-9669	331	8	ts	ts	PROPN
aiua-9669	331	9	,	,	PUNCT
aiua-9669	331	10	et	et	PROPN
aiua-9669	331	11	al	al	PROPN
aiua-9669	331	12	.	.	PROPN
aiua-9669	332	1	clinical	clinical	ADJ
aiua-9669	332	2	utility	utility	NOUN
aiua-9669	332	3	of	of	ADP
aiua-9669	332	4	quantitative	quantitative	ADJ
aiua-9669	332	5	gleason	gleason	PROPN
aiua-9669	332	6	grading	grade	VERB
aiua-9669	332	7	in	in	ADP
aiua-9669	332	8	prostate	prostate	NOUN
aiua-9669	332	9	biopsies	biopsy	NOUN
aiua-9669	332	10	and	and	CCONJ
aiua-9669	332	11	prostatectomy	prostatectomy	ADP
aiua-9669	332	12	specimens	specimen	NOUN
aiua-9669	332	13	.	.	PUNCT
aiua-9669	333	1	eur	eur	PROPN
aiua-9669	333	2	urol	urol	PROPN
aiua-9669	333	3	.	.	PUNCT
aiua-9669	334	1	2016	2016	NUM
aiua-9669	334	2	;	;	PUNCT
aiua-9669	334	3	69:592	69:592	NUM
aiua-9669	334	4	-	-	SYM
aiua-9669	334	5	8	8	NUM
aiua-9669	334	6	.	.	NOUN
aiua-9669	334	7	39	39	NUM
aiua-9669	334	8	.	.	PUNCT
aiua-9669	335	1	hollemans	holleman	NOUN
aiua-9669	335	2	e	e	PROPN
aiua-9669	335	3	,	,	PUNCT
aiua-9669	335	4	verhoef	verhoef	NOUN
aiua-9669	335	5	ei	ei	PROPN
aiua-9669	335	6	,	,	PUNCT
aiua-9669	335	7	bangma	bangma	PROPN
aiua-9669	335	8	ch	ch	PROPN
aiua-9669	335	9	,	,	PUNCT
aiua-9669	335	10	et	et	PROPN
aiua-9669	335	11	al	al	PROPN
aiua-9669	335	12	.	.	PUNCT
aiua-9669	336	1	large	large	ADJ
aiua-9669	336	2	cribriform	cribriform	NOUN
aiua-9669	336	3	growth	growth	NOUN
aiua-9669	336	4	pattern	pattern	NOUN
aiua-9669	336	5	identifies	identify	VERB
aiua-9669	336	6	isup	isup	ADJ
aiua-9669	336	7	grade	grade	NOUN
aiua-9669	336	8	2	2	NUM
aiua-9669	336	9	prostate	prostate	NOUN
aiua-9669	336	10	cancer	cancer	NOUN
aiua-9669	336	11	at	at	ADP
aiua-9669	336	12	high	high	ADJ
aiua-9669	336	13	risk	risk	NOUN
aiua-9669	336	14	for	for	ADP
aiua-9669	336	15	recurrence	recurrence	NOUN
aiua-9669	336	16	and	and	CCONJ
aiua-9669	336	17	metastasis	metastasis	NOUN
aiua-9669	336	18	.	.	PUNCT
aiua-9669	337	1	mod	mod	PROPN
aiua-9669	337	2	pathol	pathol	PROPN
aiua-9669	337	3	.	.	PUNCT
aiua-9669	338	1	2019	2019	NUM
aiua-9669	338	2	;	;	PUNCT
aiua-9669	338	3	32:139	32:139	NUM
aiua-9669	338	4	-	-	SYM
aiua-9669	338	5	46	46	NUM
aiua-9669	338	6	.	.	PUNCT
aiua-9669	338	7	40	40	NUM
aiua-9669	338	8	.	.	PUNCT
aiua-9669	339	1	roberts	roberts	PROPN
aiua-9669	339	2	ja	ja	PROPN
aiua-9669	339	3	,	,	PUNCT
aiua-9669	339	4	zhou	zhou	PROPN
aiua-9669	339	5	m	m	PROPN
aiua-9669	339	6	,	,	PUNCT
aiua-9669	339	7	park	park	PROPN
aiua-9669	339	8	yw	yw	PROPN
aiua-9669	339	9	,	,	PUNCT
aiua-9669	339	10	ro	ro	PROPN
aiua-9669	339	11	jy	jy	PROPN
aiua-9669	339	12	.	.	PUNCT
aiua-9669	339	13	intraductal	intraductal	ADJ
aiua-9669	339	14	carcinoma	carcinoma	NOUN
aiua-9669	339	15	of	of	ADP
aiua-9669	339	16	prostate	prostate	NOUN
aiua-9669	339	17	:	:	PUNCT
aiua-9669	339	18	a	a	DET
aiua-9669	339	19	comprehensive	comprehensive	ADJ
aiua-9669	339	20	and	and	CCONJ
aiua-9669	339	21	concise	concise	ADJ
aiua-9669	339	22	review	review	NOUN
aiua-9669	339	23	.	.	PUNCT
aiua-9669	340	1	korean	korean	PROPN
aiua-9669	340	2	j	j	PROPN
aiua-9669	340	3	pathol	pathol	PROPN
aiua-9669	340	4	.	.	PUNCT
aiua-9669	341	1	2013	2013	NUM
aiua-9669	341	2	;	;	PUNCT
aiua-9669	341	3	47:307	47:307	NUM
aiua-9669	341	4	-	-	SYM
aiua-9669	341	5	15	15	NUM
aiua-9669	341	6	.	.	NOUN
aiua-9669	341	7	41	41	NUM
aiua-9669	341	8	.	.	PUNCT
aiua-9669	342	1	zong	zong	PROPN
aiua-9669	342	2	y	y	PROPN
aiua-9669	342	3	,	,	PUNCT
aiua-9669	342	4	montironi	montironi	X
aiua-9669	342	5	r	r	NOUN
aiua-9669	342	6	,	,	PUNCT
aiua-9669	342	7	massari	massari	PROPN
aiua-9669	342	8	f	f	PROPN
aiua-9669	342	9	,	,	PUNCT
aiua-9669	342	10	et	et	PROPN
aiua-9669	342	11	al	al	PROPN
aiua-9669	342	12	.	.	PUNCT
aiua-9669	342	13	intraductal	intraductal	ADJ
aiua-9669	342	14	carcinoma	carcinoma	NOUN
aiua-9669	342	15	of	of	ADP
aiua-9669	342	16	the	the	DET
aiua-9669	342	17	prostate	prostate	NOUN
aiua-9669	342	18	:	:	PUNCT
aiua-9669	342	19	pathogenesis	pathogenesis	NOUN
aiua-9669	342	20	and	and	CCONJ
aiua-9669	342	21	molecular	molecular	ADJ
aiua-9669	342	22	perspectives	perspective	NOUN
aiua-9669	342	23	.	.	PUNCT
aiua-9669	343	1	eur	eur	PROPN
aiua-9669	343	2	urol	urol	ADJ
aiua-9669	343	3	focus	focus	NOUN
aiua-9669	343	4	2020	2020	NUM
aiua-9669	343	5	:	:	PUNCT
aiua-9669	343	6	s2405	s2405	PROPN
aiua-9669	343	7	-	-	PUNCT
aiua-9669	343	8	4569(20)30291	4569(20)30291	NUM
aiua-9669	343	9	-	-	PUNCT
aiua-9669	343	10	1	1	NUM
aiua-9669	343	11	42	42	NUM
aiua-9669	343	12	.	.	PUNCT
aiua-9669	344	1	porter	porter	PROPN
aiua-9669	344	2	lh	lh	PROPN
aiua-9669	344	3	,	,	PUNCT
aiua-9669	344	4	lawrence	lawrence	PROPN
aiua-9669	344	5	mg	mg	PROPN
aiua-9669	344	6	,	,	PUNCT
aiua-9669	344	7	ilic	ilic	PROPN
aiua-9669	344	8	d	d	PROPN
aiua-9669	344	9	,	,	PUNCT
aiua-9669	344	10	et	et	PROPN
aiua-9669	344	11	al	al	PROPN
aiua-9669	344	12	.	.	PUNCT
aiua-9669	345	1	systematic	systematic	PROPN
aiua-9669	345	2	review	review	NOUN
aiua-9669	345	3	links	link	VERB
aiua-9669	345	4	the	the	DET
aiua-9669	345	5	prevalence	prevalence	NOUN
aiua-9669	345	6	of	of	ADP
aiua-9669	345	7	intraductal	intraductal	ADJ
aiua-9669	345	8	carcinoma	carcinoma	NOUN
aiua-9669	345	9	of	of	ADP
aiua-9669	345	10	the	the	DET
aiua-9669	345	11	prostate	prostate	NOUN
aiua-9669	345	12	to	to	PART
aiua-9669	345	13	prostate	prostate	NOUN
aiua-9669	345	14	cancer	cancer	NOUN
aiua-9669	345	15	risk	risk	NOUN
aiua-9669	345	16	categories	category	NOUN
aiua-9669	345	17	.	.	PUNCT
aiua-9669	346	1	eur	eur	PROPN
aiua-9669	346	2	urol	urol	PROPN
aiua-9669	346	3	.	.	PROPN
aiua-9669	347	1	2017	2017	NUM
aiua-9669	347	2	;	;	PUNCT
aiua-9669	347	3	72:492	72:492	NUM
aiua-9669	347	4	-	-	SYM
aiua-9669	347	5	5	5	NUM
aiua-9669	347	6	.	.	NOUN
aiua-9669	347	7	43	43	NUM
aiua-9669	347	8	.	.	PUNCT
aiua-9669	348	1	silva	silva	PROPN
aiua-9669	348	2	mm	mm	PROPN
aiua-9669	348	3	da	da	PROPN
aiua-9669	348	4	j	j	PROPN
aiua-9669	348	5	,	,	PUNCT
aiua-9669	348	6	matheus	matheus	PROPN
aiua-9669	348	7	we	we	PRON
aiua-9669	348	8	,	,	PUNCT
aiua-9669	348	9	garcia	garcia	PROPN
aiua-9669	348	10	pv	pv	AUX
aiua-9669	348	11	,	,	PUNCT
aiua-9669	348	12	et	et	PROPN
aiua-9669	348	13	al	al	PROPN
aiua-9669	348	14	.	.	PUNCT
aiua-9669	348	15	characterization	characterization	NOUN
aiua-9669	348	16	of	of	ADP
aiua-9669	348	17	reactive	reactive	ADJ
aiua-9669	348	18	stroma	stroma	NOUN
aiua-9669	348	19	in	in	ADP
aiua-9669	348	20	prostate	prostate	NOUN
aiua-9669	348	21	cancer	cancer	NOUN
aiua-9669	348	22	:	:	PUNCT
aiua-9669	348	23	involvement	involvement	NOUN
aiua-9669	348	24	of	of	ADP
aiua-9669	348	25	growth	growth	NOUN
aiua-9669	348	26	factors	factor	NOUN
aiua-9669	348	27	,	,	PUNCT
aiua-9669	348	28	metalloproteinase	metalloproteinase	NOUN
aiua-9669	348	29	matrix	matrix	NOUN
aiua-9669	348	30	,	,	PUNCT
aiua-9669	348	31	sexual	sexual	ADJ
aiua-9669	348	32	hormones	hormone	NOUN
aiua-9669	348	33	receptors	receptor	NOUN
aiua-9669	348	34	and	and	CCONJ
aiua-9669	348	35	prostatic	prostatic	ADJ
aiua-9669	348	36	stem	stem	NOUN
aiua-9669	348	37	cells	cell	NOUN
aiua-9669	348	38	.	.	PUNCT
aiua-9669	349	1	int	int	PROPN
aiua-9669	349	2	braz	braz	PROPN
aiua-9669	349	3	j	j	PROPN
aiua-9669	349	4	urol	urol	PROPN
aiua-9669	349	5	.	.	PUNCT
aiua-9669	350	1	2015	2015	NUM
aiua-9669	350	2	;	;	PUNCT
aiua-9669	350	3	41:849	41:849	NUM
aiua-9669	350	4	-	-	SYM
aiua-9669	350	5	58	58	NUM
aiua-9669	350	6	.	.	PUNCT
aiua-9669	351	1	44	44	NUM
aiua-9669	351	2	.	.	PUNCT
aiua-9669	352	1	wang	wang	PROPN
aiua-9669	352	2	w	w	PROPN
aiua-9669	352	3	,	,	PUNCT
aiua-9669	352	4	epstein	epstein	PROPN
aiua-9669	352	5	ji	ji	PROPN
aiua-9669	352	6	.	.	PROPN
aiua-9669	352	7	small	small	ADJ
aiua-9669	352	8	cell	cell	NOUN
aiua-9669	352	9	carcinoma	carcinoma	NOUN
aiua-9669	352	10	of	of	ADP
aiua-9669	352	11	the	the	DET
aiua-9669	352	12	prostate	prostate	NOUN
aiua-9669	352	13	.	.	PUNCT
aiua-9669	353	1	a	a	DET
aiua-9669	353	2	morphologic	morphologic	ADJ
aiua-9669	353	3	and	and	CCONJ
aiua-9669	353	4	immunohistochemical	immunohistochemical	ADJ
aiua-9669	353	5	study	study	NOUN
aiua-9669	353	6	of	of	ADP
aiua-9669	353	7	95	95	NUM
aiua-9669	353	8	cases	case	NOUN
aiua-9669	353	9	.	.	PUNCT
aiua-9669	354	1	am	be	AUX
aiua-9669	354	2	j	j	PROPN
aiua-9669	354	3	surg	surg	PROPN
aiua-9669	354	4	pathol	pathol	NOUN
aiua-9669	354	5	.	.	PUNCT
aiua-9669	355	1	2008	2008	NUM
aiua-9669	355	2	;	;	PUNCT
aiua-9669	355	3	32:65	32:65	NUM
aiua-9669	355	4	-	-	SYM
aiua-9669	355	5	71	71	NUM
aiua-9669	355	6	.	.	PUNCT
aiua-9669	356	1	45	45	NUM
aiua-9669	356	2	.	.	PUNCT
aiua-9669	356	3	abouhashem	abouhashem	PROPN
aiua-9669	356	4	ns	ns	PROPN
aiua-9669	356	5	,	,	PUNCT
aiua-9669	356	6	salah	salah	PROPN
aiua-9669	356	7	s.	s.	PROPN
aiua-9669	356	8	differential	differential	PROPN
aiua-9669	356	9	expression	expression	NOUN
aiua-9669	356	10	of	of	ADP
aiua-9669	356	11	nkx	nkx	NOUN
aiua-9669	356	12	3.1	3.1	NUM
aiua-9669	356	13	and	and	CCONJ
aiua-9669	356	14	hoxb	hoxb	PROPN
aiua-9669	356	15	13	13	NUM
aiua-9669	356	16	in	in	ADP
aiua-9669	356	17	bone	bone	NOUN
aiua-9669	356	18	metastases	metastasis	NOUN
aiua-9669	356	19	originating	originate	VERB
aiua-9669	356	20	from	from	ADP
aiua-9669	356	21	prostatic	prostatic	ADJ
aiua-9669	356	22	carcinoma	carcinoma	NOUN
aiua-9669	356	23	among	among	ADP
aiua-9669	356	24	the	the	DET
aiua-9669	356	25	egyptian	egyptian	ADJ
aiua-9669	356	26	males	male	NOUN
aiua-9669	356	27	.	.	PUNCT
aiua-9669	357	1	pathol	pathol	VERB
aiua-9669	357	2	res	re	NOUN
aiua-9669	357	3	pract	pract	NOUN
aiua-9669	357	4	.	.	PUNCT
aiua-9669	358	1	2020	2020	NUM
aiua-9669	358	2	;	;	PUNCT
aiua-9669	358	3	216:153221	216:153221	NUM
aiua-9669	358	4	.	.	NOUN
aiua-9669	358	5	46	46	NUM
aiua-9669	358	6	.	.	PUNCT
aiua-9669	358	7	paner	paner	PROPN
aiua-9669	358	8	gp	gp	PROPN
aiua-9669	358	9	,	,	PUNCT
aiua-9669	358	10	aron	aron	PROPN
aiua-9669	358	11	m	m	PROPN
aiua-9669	358	12	,	,	PUNCT
aiua-9669	358	13	hansel	hansel	PROPN
aiua-9669	358	14	de	de	PROPN
aiua-9669	358	15	,	,	PUNCT
aiua-9669	358	16	amin	amin	NOUN
aiua-9669	358	17	mb	mb	PROPN
aiua-9669	358	18	.	.	PROPN
aiua-9669	358	19	non	non	ADJ
aiua-9669	358	20	-	-	ADJ
aiua-9669	358	21	epithelial	epithelial	ADJ
aiua-9669	358	22	neoplasms	neoplasm	NOUN
aiua-9669	358	23	of	of	ADP
aiua-9669	358	24	the	the	DET
aiua-9669	358	25	prostate	prostate	NOUN
aiua-9669	358	26	.	.	PUNCT
aiua-9669	359	1	histopathology	histopathology	NOUN
aiua-9669	359	2	.	.	PUNCT
aiua-9669	360	1	2012	2012	NUM
aiua-9669	360	2	;	;	PUNCT
aiua-9669	360	3	60:166	60:166	NUM
aiua-9669	360	4	-	-	SYM
aiua-9669	360	5	86	86	NUM
aiua-9669	360	6	.	.	PUNCT
aiua-9669	361	1	47	47	NUM
aiua-9669	361	2	.	.	PUNCT
aiua-9669	362	1	ahmed	ahmed	PROPN
aiua-9669	362	2	hu	hu	PROPN
aiua-9669	362	3	,	,	PUNCT
aiua-9669	362	4	el	el	PROPN
aiua-9669	362	5	-	-	PUNCT
aiua-9669	362	6	shater	shater	NOUN
aiua-9669	362	7	bosaily	bosaily	ADV
aiua-9669	362	8	a	a	X
aiua-9669	362	9	,	,	PUNCT
aiua-9669	362	10	et	et	PROPN
aiua-9669	362	11	al	al	PROPN
aiua-9669	362	12	.	.	PUNCT
aiua-9669	363	1	diagnostic	diagnostic	ADJ
aiua-9669	363	2	accuracy	accuracy	NOUN
aiua-9669	363	3	of	of	ADP
aiua-9669	363	4	multi	multi	ADJ
aiua-9669	363	5	-	-	ADJ
aiua-9669	363	6	parametric	parametric	ADJ
aiua-9669	363	7	mri	mri	NOUN
aiua-9669	363	8	and	and	CCONJ
aiua-9669	363	9	trus	trus	NOUN
aiua-9669	363	10	biopsy	biopsy	NOUN
aiua-9669	363	11	in	in	ADP
aiua-9669	363	12	prostate	prostate	NOUN
aiua-9669	363	13	cancer	cancer	NOUN
aiua-9669	363	14	(	(	PUNCT
aiua-9669	363	15	promis	promis	PROPN
aiua-9669	363	16	):	):	PUNCT
aiua-9669	363	17	a	a	DET
aiua-9669	363	18	paired	pair	VERB
aiua-9669	363	19	validating	validate	VERB
aiua-9669	363	20	confirmatory	confirmatory	ADJ
aiua-9669	363	21	study	study	NOUN
aiua-9669	363	22	.	.	PUNCT
aiua-9669	364	1	lancet	lancet	PROPN
aiua-9669	364	2	.	.	PUNCT
aiua-9669	365	1	2017	2017	NUM
aiua-9669	365	2	;	;	PUNCT
aiua-9669	365	3	389:815	389:815	NOUN
aiua-9669	365	4	-	-	SYM
aiua-9669	365	5	22	22	NUM
aiua-9669	365	6	.	.	PUNCT
aiua-9669	366	1	48	48	NUM
aiua-9669	366	2	.	.	PUNCT
aiua-9669	367	1	rouvière	rouvière	NOUN
aiua-9669	367	2	o	o	PROPN
aiua-9669	367	3	,	,	PUNCT
aiua-9669	367	4	puech	puech	NOUN
aiua-9669	367	5	p	p	NOUN
aiua-9669	367	6	,	,	PUNCT
aiua-9669	367	7	renard	renard	NOUN
aiua-9669	367	8	-	-	PUNCT
aiua-9669	367	9	penna	penna	NOUN
aiua-9669	367	10	r	r	PROPN
aiua-9669	367	11	,	,	PUNCT
aiua-9669	367	12	claudon	claudon	PROPN
aiua-9669	367	13	m	m	PROPN
aiua-9669	367	14	,	,	PUNCT
aiua-9669	367	15	roy	roy	PROPN
aiua-9669	367	16	c	c	PROPN
aiua-9669	367	17	,	,	PUNCT
aiua-9669	367	18	mège	mège	NOUN
aiua-9669	367	19	-	-	PUNCT
aiua-9669	367	20	lechevallier	lechevallier	NOUN
aiua-9669	367	21	f	f	NOUN
aiua-9669	367	22	,	,	PUNCT
aiua-9669	367	23	et	et	PROPN
aiua-9669	367	24	al	al	PROPN
aiua-9669	367	25	.	.	PUNCT
aiua-9669	367	26	use	use	NOUN
aiua-9669	367	27	of	of	ADP
aiua-9669	367	28	prostate	prostate	NOUN
aiua-9669	367	29	systematic	systematic	ADJ
aiua-9669	367	30	and	and	CCONJ
aiua-9669	367	31	targeted	target	VERB
aiua-9669	367	32	biopsy	biopsy	NOUN
aiua-9669	367	33	on	on	ADP
aiua-9669	367	34	the	the	DET
aiua-9669	367	35	basis	basis	NOUN
aiua-9669	367	36	of	of	ADP
aiua-9669	367	37	multiparametric	multiparametric	ADJ
aiua-9669	367	38	mri	mri	NOUN
aiua-9669	367	39	in	in	ADP
aiua-9669	367	40	biopsy	biopsy	ADJ
aiua-9669	367	41	-	-	PUNCT
aiua-9669	367	42	naive	naive	ADJ
aiua-9669	367	43	patients	patient	NOUN
aiua-9669	367	44	(	(	PUNCT
aiua-9669	367	45	mri	mri	NOUN
aiua-9669	367	46	-	-	PUNCT
aiua-9669	367	47	first	first	ADV
aiua-9669	367	48	):	):	PUNCT
aiua-9669	367	49	a	a	DET
aiua-9669	367	50	prospective	prospective	ADJ
aiua-9669	367	51	,	,	PUNCT
aiua-9669	367	52	multicentre	multicentre	NOUN
aiua-9669	367	53	,	,	PUNCT
aiua-9669	367	54	paired	pair	VERB
aiua-9669	367	55	diagnostic	diagnostic	ADJ
aiua-9669	367	56	study	study	NOUN
aiua-9669	367	57	.	.	PUNCT
aiua-9669	368	1	lancet	lancet	PROPN
aiua-9669	368	2	oncol	oncol	PROPN
aiua-9669	368	3	.	.	PUNCT
aiua-9669	369	1	2019	2019	NUM
aiua-9669	369	2	;	;	PUNCT
aiua-9669	369	3	20:100	20:100	NUM
aiua-9669	369	4	-	-	SYM
aiua-9669	369	5	9	9	NUM
aiua-9669	369	6	.	.	NUM
aiua-9669	369	7	49	49	NUM
aiua-9669	369	8	.	.	PUNCT
aiua-9669	370	1	johnson	johnson	PROPN
aiua-9669	370	2	dc	dc	PROPN
aiua-9669	370	3	,	,	PUNCT
aiua-9669	370	4	raman	raman	PROPN
aiua-9669	370	5	ss	ss	PROPN
aiua-9669	370	6	,	,	PUNCT
aiua-9669	370	7	mirak	mirak	PROPN
aiua-9669	370	8	sa	sa	PROPN
aiua-9669	370	9	,	,	PUNCT
aiua-9669	370	10	kwan	kwan	PROPN
aiua-9669	370	11	l	l	PROPN
aiua-9669	370	12	,	,	PUNCT
aiua-9669	370	13	bajgiran	bajgiran	NOUN
aiua-9669	370	14	am	be	AUX
aiua-9669	370	15	,	,	PUNCT
aiua-9669	370	16	hsu	hsu	PROPN
aiua-9669	370	17	w	w	PROPN
aiua-9669	370	18	,	,	PUNCT
aiua-9669	370	19	et	et	PROPN
aiua-9669	370	20	al	al	PROPN
aiua-9669	370	21	.	.	PUNCT
aiua-9669	371	1	detection	detection	NOUN
aiua-9669	371	2	of	of	ADP
aiua-9669	371	3	individual	individual	ADJ
aiua-9669	371	4	prostate	prostate	NOUN
aiua-9669	371	5	cancer	cancer	NOUN
aiua-9669	371	6	foci	focus	NOUN
aiua-9669	371	7	via	via	ADP
aiua-9669	371	8	multiparametric	multiparametric	ADJ
aiua-9669	371	9	magnetic	magnetic	ADJ
aiua-9669	371	10	resonance	resonance	NOUN
aiua-9669	371	11	imaging	imaging	NOUN
aiua-9669	371	12	.	.	PUNCT
aiua-9669	372	1	eur	eur	PROPN
aiua-9669	372	2	urol	urol	PROPN
aiua-9669	372	3	.	.	PROPN
aiua-9669	373	1	2019	2019	NUM
aiua-9669	373	2	;	;	PUNCT
aiua-9669	373	3	75:712	75:712	NUM
aiua-9669	373	4	-	-	SYM
aiua-9669	373	5	20	20	NUM
aiua-9669	373	6	50	50	NUM
aiua-9669	373	7	.	.	PUNCT
aiua-9669	374	1	galosi	galosi	PROPN
aiua-9669	374	2	ab	ab	PROPN
aiua-9669	374	3	,	,	PUNCT
aiua-9669	374	4	dell’atti	dell’atti	ADJ
aiua-9669	374	5	l	l	NOUN
aiua-9669	374	6	,	,	PUNCT
aiua-9669	374	7	bertaccini	bertaccini	VERB
aiua-9669	374	8	a	a	PRON
aiua-9669	374	9	,	,	PUNCT
aiua-9669	374	10	gion	gion	NOUN
aiua-9669	374	11	m	m	PROPN
aiua-9669	374	12	,	,	PUNCT
aiua-9669	374	13	francavilla	francavilla	PROPN
aiua-9669	374	14	s	s	NOUN
aiua-9669	374	15	,	,	PUNCT
aiua-9669	374	16	ferretti	ferretti	PROPN
aiua-9669	374	17	s	s	PROPN
aiua-9669	374	18	,	,	PUNCT
aiua-9669	374	19	et	et	PROPN
aiua-9669	374	20	al	al	PROPN
aiua-9669	374	21	.	.	PROPN
aiua-9669	375	1	clinical	clinical	ADJ
aiua-9669	375	2	evaluation	evaluation	NOUN
aiua-9669	375	3	of	of	ADP
aiua-9669	375	4	the	the	DET
aiua-9669	375	5	ixip	ixip	NOUN
aiua-9669	375	6	index	index	NOUN
aiua-9669	375	7	to	to	PART
aiua-9669	375	8	reduce	reduce	VERB
aiua-9669	375	9	prostate	prostate	NOUN
aiua-9669	375	10	re	re	NOUN
aiua-9669	375	11	-	-	NOUN
aiua-9669	375	12	biopsies	biopsy	NOUN
aiua-9669	375	13	.	.	PUNCT
aiua-9669	376	1	cancer	cancer	NOUN
aiua-9669	376	2	treat	treat	VERB
aiua-9669	376	3	res	re	NOUN
aiua-9669	376	4	commun	commun	PROPN
aiua-9669	376	5	.	.	PUNCT
aiua-9669	377	1	2018	2018	NUM
aiua-9669	377	2	;	;	PUNCT
aiua-9669	377	3	16:59	16:59	NUM
aiua-9669	377	4	-	-	SYM
aiua-9669	377	5	63	63	NUM
aiua-9669	377	6	.	.	PUNCT
aiua-9669	378	1	51	51	NUM
aiua-9669	378	2	.	.	PUNCT
aiua-9669	379	1	quon	quon	PROPN
aiua-9669	379	2	js	js	PROPN
aiua-9669	379	3	,	,	PUNCT
aiua-9669	379	4	moosavi	moosavi	PROPN
aiua-9669	379	5	b	b	PROPN
aiua-9669	379	6	,	,	PUNCT
aiua-9669	379	7	khanna	khanna	PROPN
aiua-9669	379	8	m	m	PROPN
aiua-9669	379	9	,	,	PUNCT
aiua-9669	379	10	flood	flood	PROPN
aiua-9669	379	11	ta	ta	PROPN
aiua-9669	379	12	,	,	PUNCT
aiua-9669	379	13	lim	lim	PROPN
aiua-9669	379	14	cs	cs	PROPN
aiua-9669	379	15	,	,	PUNCT
aiua-9669	379	16	schieda	schieda	NOUN
aiua-9669	379	17	n.	n.	NOUN
aiua-9669	379	18	false	false	ADJ
aiua-9669	379	19	positive	positive	ADJ
aiua-9669	379	20	and	and	CCONJ
aiua-9669	379	21	false	false	ADJ
aiua-9669	379	22	negative	negative	ADJ
aiua-9669	379	23	diagnoses	diagnosis	NOUN
aiua-9669	379	24	of	of	ADP
aiua-9669	379	25	prostate	prostate	NOUN
aiua-9669	379	26	cancer	cancer	NOUN
aiua-9669	379	27	at	at	ADP
aiua-9669	379	28	multi	multi	ADJ
aiua-9669	379	29	-	-	ADJ
aiua-9669	379	30	parametric	parametric	ADJ
aiua-9669	379	31	prostate	prostate	NOUN
aiua-9669	379	32	mri	mri	NOUN
aiua-9669	379	33	in	in	ADP
aiua-9669	379	34	active	active	ADJ
aiua-9669	379	35	surveillance	surveillance	NOUN
aiua-9669	379	36	.	.	PUNCT
aiua-9669	380	1	insights	insight	NOUN
aiua-9669	380	2	imaging	image	VERB
aiua-9669	380	3	.	.	PUNCT
aiua-9669	381	1	2015	2015	NUM
aiua-9669	381	2	;	;	PUNCT
aiua-9669	381	3	6:449	6:449	X
aiua-9669	381	4	-	-	SYM
aiua-9669	381	5	63	63	NUM
aiua-9669	381	6	.	.	PUNCT
aiua-9669	382	1	52	52	NUM
aiua-9669	382	2	.	.	PUNCT
aiua-9669	382	3	sonn	sonn	PROPN
aiua-9669	382	4	ga	ga	PROPN
aiua-9669	382	5	,	,	PUNCT
aiua-9669	382	6	fan	fan	PROPN
aiua-9669	382	7	re	re	PROPN
aiua-9669	382	8	,	,	PUNCT
aiua-9669	382	9	ghanouni	ghanouni	PROPN
aiua-9669	382	10	p	p	X
aiua-9669	382	11	,	,	PUNCT
aiua-9669	382	12	wang	wang	PROPN
aiua-9669	382	13	nn	nn	PROPN
aiua-9669	382	14	,	,	PUNCT
aiua-9669	382	15	brooks	brooks	PROPN
aiua-9669	382	16	jd	jd	PROPN
aiua-9669	382	17	,	,	PUNCT
aiua-9669	382	18	loening	loene	VERB
aiua-9669	382	19	am	am	NOUN
aiua-9669	382	20	,	,	PUNCT
aiua-9669	382	21	et	et	PROPN
aiua-9669	382	22	al	al	PROPN
aiua-9669	382	23	.	.	PROPN
aiua-9669	382	24	prostate	prostate	PROPN
aiua-9669	382	25	magnetic	magnetic	ADJ
aiua-9669	382	26	resonance	resonance	NOUN
aiua-9669	382	27	imaging	imaging	NOUN
aiua-9669	382	28	interpretation	interpretation	NOUN
aiua-9669	382	29	varies	vary	VERB
aiua-9669	382	30	substantially	substantially	ADV
aiua-9669	382	31	across	across	ADP
aiua-9669	382	32	radiologists	radiologist	NOUN
aiua-9669	382	33	.	.	PUNCT
aiua-9669	383	1	eur	eur	PROPN
aiua-9669	383	2	urol	urol	ADJ
aiua-9669	383	3	focus	focus	NOUN
aiua-9669	383	4	.	.	PUNCT
aiua-9669	384	1	2019	2019	NUM
aiua-9669	384	2	;	;	PUNCT
aiua-9669	384	3	5:592	5:592	X
aiua-9669	384	4	-	-	SYM
aiua-9669	384	5	9	9	NUM
aiua-9669	384	6	.	.	X
aiua-9669	385	1	53	53	NUM
aiua-9669	385	2	.	.	PUNCT
aiua-9669	386	1	chatterjee	chatterjee	PROPN
aiua-9669	386	2	a	a	PROPN
aiua-9669	386	3	,	,	PUNCT
aiua-9669	386	4	thomas	thomas	PROPN
aiua-9669	386	5	s	s	PROPN
aiua-9669	386	6	,	,	PUNCT
aiua-9669	386	7	oto	oto	PROPN
aiua-9669	386	8	a.	a.	NOUN
aiua-9669	386	9	prostate	prostate	NOUN
aiua-9669	386	10	mr	mr	PROPN
aiua-9669	386	11	:	:	PUNCT
aiua-9669	386	12	pitfalls	pitfall	NOUN
aiua-9669	386	13	and	and	CCONJ
aiua-9669	386	14	benign	benign	ADJ
aiua-9669	386	15	lesions	lesion	NOUN
aiua-9669	386	16	.	.	PUNCT
aiua-9669	387	1	abdom	abdom	NOUN
aiua-9669	387	2	radiol	radiol	NOUN
aiua-9669	387	3	2020	2020	NUM
aiua-9669	387	4	;	;	PUNCT
aiua-9669	387	5	45:2154	45:2154	NOUN
aiua-9669	387	6	-	-	SYM
aiua-9669	387	7	64	64	NUM
aiua-9669	387	8	.	.	PUNCT
aiua-9669	388	1	54	54	NUM
aiua-9669	388	2	.	.	PUNCT
aiua-9669	389	1	wang	wang	PROPN
aiua-9669	389	2	z	z	PROPN
aiua-9669	389	3	,	,	PUNCT
aiua-9669	389	4	zhao	zhao	PROPN
aiua-9669	389	5	w	w	PROPN
aiua-9669	389	6	,	,	PUNCT
aiua-9669	389	7	shen	shen	PROPN
aiua-9669	389	8	j	j	PROPN
aiua-9669	389	9	,	,	PUNCT
aiua-9669	389	10	jiang	jiang	PROPN
aiua-9669	389	11	z	z	PROPN
aiua-9669	389	12	,	,	PUNCT
aiua-9669	389	13	yang	yang	PROPN
aiua-9669	389	14	s	s	PROPN
aiua-9669	389	15	,	,	PUNCT
aiua-9669	389	16	tan	tan	PROPN
aiua-9669	389	17	s	s	PART
aiua-9669	389	18	,	,	PUNCT
aiua-9669	389	19	et	et	PROPN
aiua-9669	389	20	al	al	PROPN
aiua-9669	389	21	.	.	PROPN
aiua-9669	390	1	pi	pi	NOUN
aiua-9669	390	2	-	-	PUNCT
aiua-9669	390	3	rads	rad	NOUN
aiua-9669	390	4	version	version	NOUN
aiua-9669	390	5	2.1	2.1	NUM
aiua-9669	390	6	scoring	scoring	NOUN
aiua-9669	390	7	system	system	NOUN
aiua-9669	390	8	is	be	AUX
aiua-9669	390	9	superior	superior	ADJ
aiua-9669	390	10	in	in	ADP
aiua-9669	390	11	detecting	detect	VERB
aiua-9669	390	12	transition	transition	NOUN
aiua-9669	390	13	zone	zone	NOUN
aiua-9669	390	14	prostate	prostate	NOUN
aiua-9669	390	15	cancer	cancer	NOUN
aiua-9669	390	16	:	:	PUNCT
aiua-9669	390	17	a	a	DET
aiua-9669	390	18	diagnostic	diagnostic	ADJ
aiua-9669	390	19	study	study	NOUN
aiua-9669	390	20	.	.	PUNCT
aiua-9669	391	1	abdom	abdom	NOUN
aiua-9669	391	2	radiol	radiol	NOUN
aiua-9669	391	3	.	.	PUNCT
aiua-9669	392	1	2020	2020	NUM
aiua-9669	392	2	;	;	PUNCT
aiua-9669	392	3	45:41424149	45:41424149	NUM
aiua-9669	392	4	.	.	PUNCT
aiua-9669	393	1	55	55	NUM
aiua-9669	393	2	.	.	PUNCT
aiua-9669	394	1	weinreb	weinreb	PROPN
aiua-9669	394	2	jc	jc	PROPN
aiua-9669	394	3	,	,	PUNCT
aiua-9669	394	4	barentsz	barentsz	VERB
aiua-9669	394	5	jo	jo	PROPN
aiua-9669	394	6	,	,	PUNCT
aiua-9669	394	7	choyke	choyke	PROPN
aiua-9669	394	8	pl	pl	PROPN
aiua-9669	394	9	,	,	PUNCT
aiua-9669	394	10	cornud	cornud	PROPN
aiua-9669	394	11	f	f	PROPN
aiua-9669	394	12	,	,	PUNCT
aiua-9669	394	13	haider	haider	PROPN
aiua-9669	394	14	ma	ma	PROPN
aiua-9669	394	15	,	,	PUNCT
aiua-9669	394	16	macura	macura	PROPN
aiua-9669	394	17	kj	kj	PROPN
aiua-9669	394	18	,	,	PUNCT
aiua-9669	394	19	et	et	PROPN
aiua-9669	394	20	al	al	PROPN
aiua-9669	394	21	.	.	PROPN
aiua-9669	395	1	pi	pi	NOUN
aiua-9669	395	2	-	-	PUNCT
aiua-9669	395	3	rads	rad	NOUN
aiua-9669	395	4	prostate	prostate	NOUN
aiua-9669	395	5	imaging	imaging	NOUN
aiua-9669	395	6	reporting	reporting	NOUN
aiua-9669	395	7	and	and	CCONJ
aiua-9669	395	8	data	datum	NOUN
aiua-9669	395	9	system	system	NOUN
aiua-9669	395	10	:	:	PUNCT
aiua-9669	395	11	2015	2015	NUM
aiua-9669	395	12	,	,	PUNCT
aiua-9669	395	13	version	version	NOUN
aiua-9669	395	14	2	2	NUM
aiua-9669	395	15	.	.	PUNCT
aiua-9669	395	16	eur	eur	PROPN
aiua-9669	395	17	urol	urol	PROPN
aiua-9669	395	18	.	.	PUNCT
aiua-9669	395	19	2016	2016	NUM
aiua-9669	395	20	;	;	PUNCT
aiua-9669	395	21	69:16	69:16	NUM
aiua-9669	395	22	-	-	SYM
aiua-9669	395	23	40	40	NUM
aiua-9669	395	24	.	.	PUNCT
aiua-9669	396	1	56	56	NUM
aiua-9669	396	2	.	.	PUNCT
aiua-9669	397	1	yang	yang	PROPN
aiua-9669	397	2	s	s	PROPN
aiua-9669	397	3	,	,	PUNCT
aiua-9669	397	4	zhao	zhao	PROPN
aiua-9669	397	5	w	w	PROPN
aiua-9669	397	6	,	,	PUNCT
aiua-9669	397	7	tan	tan	PROPN
aiua-9669	397	8	s	s	PART
aiua-9669	397	9	,	,	PUNCT
aiua-9669	397	10	zhang	zhang	PROPN
aiua-9669	397	11	y	y	PROPN
aiua-9669	397	12	,	,	PUNCT
aiua-9669	397	13	wei	wei	PROPN
aiua-9669	397	14	c	c	PROPN
aiua-9669	397	15	,	,	PUNCT
aiua-9669	397	16	chen	chen	PROPN
aiua-9669	397	17	t	t	PROPN
aiua-9669	397	18	,	,	PUNCT
aiua-9669	397	19	et	et	PROPN
aiua-9669	397	20	al	al	PROPN
aiua-9669	397	21	.	.	PUNCT
aiua-9669	398	1	combining	combine	VERB
aiua-9669	398	2	clinical	clinical	ADJ
aiua-9669	398	3	and	and	CCONJ
aiua-9669	398	4	mri	mri	NOUN
aiua-9669	398	5	data	datum	NOUN
aiua-9669	398	6	to	to	PART
aiua-9669	398	7	manage	manage	VERB
aiua-9669	398	8	pi	pi	NOUN
aiua-9669	398	9	-	-	PUNCT
aiua-9669	398	10	rads	rad	NOUN
aiua-9669	398	11	3	3	NUM
aiua-9669	398	12	lesions	lesion	NOUN
aiua-9669	398	13	and	and	CCONJ
aiua-9669	398	14	reduce	reduce	VERB
aiua-9669	398	15	excessive	excessive	ADJ
aiua-9669	398	16	biopsy	biopsy	NOUN
aiua-9669	398	17	.	.	PUNCT
aiua-9669	399	1	transl	transl	PROPN
aiua-9669	399	2	androl	androl	PROPN
aiua-9669	399	3	urol	urol	PROPN
aiua-9669	399	4	.	.	PUNCT
aiua-9669	400	1	2020	2020	NUM
aiua-9669	400	2	;	;	PUNCT
aiua-9669	400	3	9:1252	9:1252	NUM
aiua-9669	400	4	-	-	SYM
aiua-9669	400	5	61	61	NUM
aiua-9669	400	6	.	.	PUNCT
aiua-9669	401	1	57	57	NUM
aiua-9669	401	2	.	.	PUNCT
aiua-9669	402	1	maggi	maggi	PROPN
aiua-9669	402	2	m	m	PROPN
aiua-9669	402	3	,	,	PUNCT
aiua-9669	402	4	panebianco	panebianco	ADJ
aiua-9669	402	5	v	v	NOUN
aiua-9669	402	6	,	,	PUNCT
aiua-9669	402	7	mosca	mosca	PROPN
aiua-9669	402	8	a	a	PRON
aiua-9669	402	9	,	,	PUNCT
aiua-9669	402	10	salciccia	salciccia	PROPN
aiua-9669	402	11	s	s	PART
aiua-9669	402	12	,	,	PUNCT
aiua-9669	402	13	gentilucci	gentilucci	NOUN
aiua-9669	402	14	a	a	PRON
aiua-9669	402	15	,	,	PUNCT
aiua-9669	402	16	di	di	PROPN
aiua-9669	402	17	pierro	pierro	PROPN
aiua-9669	402	18	g	g	PROPN
aiua-9669	402	19	,	,	PUNCT
aiua-9669	402	20	et	et	PROPN
aiua-9669	402	21	al	al	PROPN
aiua-9669	402	22	.	.	PROPN
aiua-9669	402	23	prostate	prostate	NOUN
aiua-9669	402	24	imaging	imaging	NOUN
aiua-9669	402	25	reporting	reporting	NOUN
aiua-9669	402	26	and	and	CCONJ
aiua-9669	402	27	data	datum	NOUN
aiua-9669	402	28	system	system	NOUN
aiua-9669	402	29	3	3	NUM
aiua-9669	402	30	category	category	NOUN
aiua-9669	402	31	cases	case	NOUN
aiua-9669	402	32	at	at	ADP
aiua-9669	402	33	multiparametric	multiparametric	ADJ
aiua-9669	402	34	magnetic	magnetic	ADJ
aiua-9669	402	35	resonance	resonance	NOUN
aiua-9669	402	36	for	for	ADP
aiua-9669	402	37	prostate	prostate	NOUN
aiua-9669	402	38	cancer	cancer	NOUN
aiua-9669	402	39	:	:	PUNCT
aiua-9669	402	40	a	a	DET
aiua-9669	402	41	systematic	systematic	ADJ
aiua-9669	402	42	review	review	NOUN
aiua-9669	402	43	and	and	CCONJ
aiua-9669	402	44	meta	meta	ADJ
aiua-9669	402	45	-	-	PUNCT
aiua-9669	402	46	analysis	analysis	NOUN
aiua-9669	402	47	.	.	PUNCT
aiua-9669	403	1	eur	eur	PROPN
aiua-9669	403	2	urol	urol	ADJ
aiua-9669	403	3	focus	focus	NOUN
aiua-9669	403	4	.	.	PUNCT
aiua-9669	404	1	2020	2020	NUM
aiua-9669	404	2	;	;	PUNCT
aiua-9669	404	3	6:463	6:463	NUM
aiua-9669	404	4	-	-	SYM
aiua-9669	404	5	78	78	NUM
aiua-9669	404	6	.	.	PUNCT
aiua-9669	405	1	58	58	NUM
aiua-9669	405	2	.	.	PUNCT
aiua-9669	406	1	byun	byun	PROPN
aiua-9669	406	2	j	j	PROPN
aiua-9669	406	3	,	,	PUNCT
aiua-9669	406	4	park	park	PROPN
aiua-9669	406	5	kj	kj	PROPN
aiua-9669	406	6	,	,	PUNCT
aiua-9669	406	7	kim	kim	PROPN
aiua-9669	406	8	m	m	PROPN
aiua-9669	406	9	hyun	hyun	PROPN
aiua-9669	406	10	,	,	PUNCT
aiua-9669	406	11	kim	kim	PROPN
aiua-9669	406	12	jk	jk	PROPN
aiua-9669	406	13	.	.	PUNCT
aiua-9669	407	1	direct	direct	ADJ
aiua-9669	407	2	comparison	comparison	NOUN
aiua-9669	407	3	of	of	ADP
aiua-9669	407	4	pirads	pirad	NOUN
aiua-9669	407	5	version	version	PROPN
aiua-9669	407	6	2	2	NUM
aiua-9669	407	7	and	and	CCONJ
aiua-9669	407	8	2.1	2.1	NUM
aiua-9669	407	9	in	in	ADP
aiua-9669	407	10	transition	transition	NOUN
aiua-9669	407	11	zone	zone	NOUN
aiua-9669	407	12	lesions	lesion	NOUN
aiua-9669	407	13	for	for	ADP
aiua-9669	407	14	detection	detection	NOUN
aiua-9669	407	15	of	of	ADP
aiua-9669	407	16	prostate	prostate	NOUN
aiua-9669	407	17	cancer	cancer	NOUN
aiua-9669	407	18	:	:	PUNCT
aiua-9669	407	19	preliminary	preliminary	ADJ
aiua-9669	407	20	experience	experience	NOUN
aiua-9669	407	21	.	.	PUNCT
aiua-9669	408	1	j	j	PROPN
aiua-9669	408	2	magn	magn	PROPN
aiua-9669	408	3	reson	reson	PROPN
aiua-9669	408	4	imaging	imaging	PROPN
aiua-9669	408	5	.	.	PUNCT
aiua-9669	409	1	2020	2020	NUM
aiua-9669	409	2	;	;	PUNCT
aiua-9669	409	3	52:577	52:577	NUM
aiua-9669	409	4	-	-	SYM
aiua-9669	409	5	86	86	NUM
aiua-9669	409	6	.	.	PUNCT
aiua-9669	410	1	59	59	NUM
aiua-9669	410	2	.	.	PUNCT
aiua-9669	411	1	hansen	hansen	PROPN
aiua-9669	411	2	nl	nl	PROPN
aiua-9669	411	3	,	,	PUNCT
aiua-9669	411	4	kesch	kesch	PROPN
aiua-9669	411	5	c	c	NOUN
aiua-9669	411	6	,	,	PUNCT
aiua-9669	411	7	barrett	barrett	PROPN
aiua-9669	411	8	t	t	PROPN
aiua-9669	411	9	,	,	PUNCT
aiua-9669	411	10	koo	koo	PROPN
aiua-9669	411	11	b	b	PROPN
aiua-9669	411	12	,	,	PUNCT
aiua-9669	411	13	radtke	radtke	ADJ
aiua-9669	411	14	jp	jp	NOUN
aiua-9669	411	15	,	,	PUNCT
aiua-9669	411	16	bonekamp	bonekamp	PROPN
aiua-9669	411	17	d	d	PROPN
aiua-9669	411	18	,	,	PUNCT
aiua-9669	411	19	et	et	PROPN
aiua-9669	411	20	al	al	PROPN
aiua-9669	411	21	.	.	PROPN
aiua-9669	412	1	multicentre	multicentre	PROPN
aiua-9669	412	2	evaluation	evaluation	NOUN
aiua-9669	412	3	of	of	ADP
aiua-9669	412	4	targeted	target	VERB
aiua-9669	412	5	and	and	CCONJ
aiua-9669	412	6	systematic	systematic	ADJ
aiua-9669	412	7	biopsies	biopsy	NOUN
aiua-9669	412	8	using	use	VERB
aiua-9669	412	9	magnetic	magnetic	ADJ
aiua-9669	412	10	resonance	resonance	NOUN
aiua-9669	412	11	and	and	CCONJ
aiua-9669	412	12	ultrasound	ultrasound	NOUN
aiua-9669	412	13	image	image	NOUN
aiua-9669	412	14	-	-	PUNCT
aiua-9669	412	15	fusion	fusion	NOUN
aiua-9669	412	16	guided	guide	VERB
aiua-9669	412	17	transperineal	transperineal	NOUN
aiua-9669	412	18	prostate	prostate	NOUN
aiua-9669	412	19	biopsy	biopsy	NOUN
aiua-9669	412	20	in	in	ADP
aiua-9669	412	21	patients	patient	NOUN
aiua-9669	412	22	with	with	ADP
aiua-9669	412	23	a	a	DET
aiua-9669	412	24	previous	previous	ADJ
aiua-9669	412	25	negative	negative	ADJ
aiua-9669	412	26	biopsy	biopsy	NOUN
aiua-9669	412	27	.	.	PUNCT
aiua-9669	413	1	bju	bju	NOUN
aiua-9669	413	2	int	int	PROPN
aiua-9669	413	3	.	.	PUNCT
aiua-9669	414	1	2017	2017	NUM
aiua-9669	414	2	;	;	PUNCT
aiua-9669	415	1	120:631	120:631	NUM
aiua-9669	415	2	-	-	SYM
aiua-9669	415	3	8	8	NUM
aiua-9669	415	4	.	.	PUNCT
aiua-9669	415	5	60	60	NUM
aiua-9669	415	6	.	.	PUNCT
aiua-9669	416	1	ullrich	ullrich	PROPN
aiua-9669	416	2	t	t	PROPN
aiua-9669	416	3	,	,	PUNCT
aiua-9669	416	4	quentin	quentin	PROPN
aiua-9669	416	5	m	m	PROPN
aiua-9669	416	6	,	,	PUNCT
aiua-9669	416	7	arsov	arsov	PROPN
aiua-9669	416	8	c	c	PROPN
aiua-9669	416	9	,	,	PUNCT
aiua-9669	416	10	schmaltz	schmaltz	PROPN
aiua-9669	416	11	ak	ak	PROPN
aiua-9669	416	12	,	,	PUNCT
aiua-9669	416	13	tschischka	tschischka	PROPN
aiua-9669	416	14	a	a	PRON
aiua-9669	416	15	,	,	PUNCT
aiua-9669	416	16	laqua	laqua	PROPN
aiua-9669	416	17	n	n	CCONJ
aiua-9669	416	18	,	,	PUNCT
aiua-9669	416	19	et	et	PROPN
aiua-9669	416	20	al	al	PROPN
aiua-9669	416	21	.	.	PUNCT
aiua-9669	417	1	risk	risk	NOUN
aiua-9669	417	2	stratification	stratification	NOUN
aiua-9669	417	3	of	of	ADP
aiua-9669	417	4	equivocal	equivocal	ADJ
aiua-9669	417	5	lesions	lesion	NOUN
aiua-9669	417	6	on	on	ADP
aiua-9669	417	7	multiparametric	multiparametric	ADJ
aiua-9669	417	8	magnetic	magnetic	ADJ
aiua-9669	417	9	resonance	resonance	NOUN
aiua-9669	417	10	imaging	imaging	NOUN
aiua-9669	417	11	of	of	ADP
aiua-9669	417	12	the	the	DET
aiua-9669	417	13	prostate	prostate	NOUN
aiua-9669	417	14	.	.	PUNCT
aiua-9669	418	1	j	j	PROPN
aiua-9669	418	2	urol	urol	PROPN
aiua-9669	418	3	.	.	PROPN
aiua-9669	418	4	2018	2018	NUM
aiua-9669	418	5	;	;	PUNCT
aiua-9669	418	6	199:691	199:691	NUM
aiua-9669	418	7	-	-	SYM
aiua-9669	418	8	8	8	NUM
aiua-9669	418	9	.	.	NOUN
aiua-9669	418	10	61	61	NUM
aiua-9669	418	11	.	.	PUNCT
aiua-9669	419	1	venderink	venderink	PROPN
aiua-9669	419	2	w	w	PROPN
aiua-9669	419	3	,	,	PUNCT
aiua-9669	419	4	van	van	PROPN
aiua-9669	419	5	luijtelaar	luijtelaar	PROPN
aiua-9669	419	6	a	a	PRON
aiua-9669	419	7	,	,	PUNCT
aiua-9669	419	8	bomers	bomers	PROPN
aiua-9669	419	9	jgr	jgr	PROPN
aiua-9669	419	10	,	,	PUNCT
aiua-9669	419	11	van	van	PROPN
aiua-9669	419	12	der	der	NOUN
aiua-9669	419	13	leest	lee	ADJ
aiua-9669	419	14	m	m	PROPN
aiua-9669	419	15	,	,	PUNCT
aiua-9669	419	16	hulsbergen	hulsbergen	PROPN
aiua-9669	419	17	-	-	PUNCT
aiua-9669	419	18	van	van	PROPN
aiua-9669	419	19	de	de	X
aiua-9669	419	20	kaa	kaa	PROPN
aiua-9669	419	21	c	c	PROPN
aiua-9669	419	22	,	,	PUNCT
aiua-9669	419	23	barentsz	barentsz	VERB
aiua-9669	419	24	jo	jo	PROPN
aiua-9669	419	25	,	,	PUNCT
aiua-9669	420	1	et	et	PROPN
aiua-9669	420	2	al	al	PROPN
aiua-9669	420	3	.	.	PROPN
aiua-9669	420	4	results	result	NOUN
aiua-9669	420	5	of	of	ADP
aiua-9669	420	6	targeted	target	VERB
aiua-9669	420	7	biopsy	biopsy	NOUN
aiua-9669	420	8	in	in	ADP
aiua-9669	420	9	men	man	NOUN
aiua-9669	420	10	with	with	ADP
aiua-9669	420	11	magnetic	magnetic	ADJ
aiua-9669	420	12	resonance	resonance	NOUN
aiua-9669	420	13	imaging	imaging	NOUN
aiua-9669	420	14	lesions	lesion	NOUN
aiua-9669	420	15	classified	classify	VERB
aiua-9669	420	16	archivio	archivio	NOUN
aiua-9669	420	17	italiano	italiano	X
aiua-9669	420	18	di	di	X
aiua-9669	420	19	urologia	urologia	PROPN
aiua-9669	420	20	e	e	PROPN
aiua-9669	420	21	andrologia	andrologia	NOUN
aiua-9669	420	22	2021	2021	NUM
aiua-9669	420	23	;	;	PUNCT
aiua-9669	420	24	93	93	NUM
aiua-9669	420	25	,	,	PUNCT
aiua-9669	420	26	1	1	NUM
aiua-9669	420	27	a.b	a.b	NOUN
aiua-9669	420	28	.	.	PROPN
aiua-9669	420	29	galosi	galosi	PROPN
aiua-9669	420	30	,	,	PUNCT
aiua-9669	420	31	e.	e.	PROPN
aiua-9669	420	32	palagonia	palagonia	PROPN
aiua-9669	420	33	,	,	PUNCT
aiua-9669	420	34	s.	s.	PROPN
aiua-9669	420	35	scarcella	scarcella	PROPN
aiua-9669	420	36	,	,	PUNCT
aiua-9669	420	37	a.	a.	NOUN
aiua-9669	420	38	cimadamore	cimadamore	PROPN
aiua-9669	420	39	,	,	PUNCT
aiua-9669	420	40	v.	v.	ADP
aiua-9669	420	41	lacetera	lacetera	PROPN
aiua-9669	420	42	,	,	PUNCT
aiua-9669	420	43	r.f	r.f	PROPN
aiua-9669	420	44	.	.	PROPN
aiua-9669	420	45	delle	delle	PROPN
aiua-9669	420	46	fave	fave	PROPN
aiua-9669	420	47	,	,	PUNCT
aiua-9669	420	48	a.	a.	NOUN
aiua-9669	420	49	antezza	antezza	PROPN
aiua-9669	420	50	,	,	PUNCT
aiua-9669	420	51	l.	l.	PROPN
aiua-9669	420	52	dell’atti	dell’atti	VERB
aiua-9669	420	53	100	100	NUM
aiua-9669	420	54	equivocal	equivocal	ADJ
aiua-9669	420	55	,	,	PUNCT
aiua-9669	420	56	likely	likely	ADJ
aiua-9669	420	57	or	or	CCONJ
aiua-9669	420	58	highly	highly	ADV
aiua-9669	420	59	likely	likely	ADJ
aiua-9669	420	60	to	to	PART
aiua-9669	420	61	be	be	AUX
aiua-9669	420	62	clinically	clinically	ADV
aiua-9669	420	63	significant	significant	ADJ
aiua-9669	420	64	prostate	prostate	NOUN
aiua-9669	420	65	cancer	cancer	NOUN
aiua-9669	420	66	.	.	PUNCT
aiua-9669	421	1	eur	eur	PROPN
aiua-9669	421	2	urol	urol	PROPN
aiua-9669	421	3	.	.	PUNCT
aiua-9669	421	4	2018	2018	NUM
aiua-9669	421	5	;	;	PUNCT
aiua-9669	421	6	73:353	73:353	NUM
aiua-9669	421	7	-	-	SYM
aiua-9669	421	8	60	60	NUM
aiua-9669	421	9	.	.	PUNCT
aiua-9669	422	1	62	62	NUM
aiua-9669	422	2	.	.	PUNCT
aiua-9669	422	3	schoots	schoot	VERB
aiua-9669	422	4	ig	ig	PROPN
aiua-9669	422	5	.	.	PUNCT
aiua-9669	422	6	mri	mri	NOUN
aiua-9669	422	7	in	in	ADP
aiua-9669	422	8	early	early	ADJ
aiua-9669	422	9	prostate	prostate	NOUN
aiua-9669	422	10	cancer	cancer	NOUN
aiua-9669	422	11	detection	detection	NOUN
aiua-9669	422	12	:	:	PUNCT
aiua-9669	422	13	how	how	SCONJ
aiua-9669	422	14	to	to	PART
aiua-9669	422	15	manage	manage	VERB
aiua-9669	422	16	indeterminate	indeterminate	ADJ
aiua-9669	422	17	or	or	CCONJ
aiua-9669	422	18	equivocal	equivocal	ADJ
aiua-9669	422	19	pi	pi	NOUN
aiua-9669	422	20	-	-	PUNCT
aiua-9669	422	21	rads	rad	NOUN
aiua-9669	422	22	3	3	NUM
aiua-9669	422	23	lesions	lesion	NOUN
aiua-9669	422	24	?	?	PUNCT
aiua-9669	423	1	transl	transl	PROPN
aiua-9669	423	2	androl	androl	PROPN
aiua-9669	423	3	urol	urol	PROPN
aiua-9669	423	4	.	.	PROPN
aiua-9669	423	5	2018	2018	NUM
aiua-9669	423	6	;	;	PUNCT
aiua-9669	423	7	7:70	7:70	NUM
aiua-9669	423	8	-	-	SYM
aiua-9669	423	9	82	82	NUM
aiua-9669	423	10	.	.	PUNCT
aiua-9669	423	11	63	63	NUM
aiua-9669	423	12	.	.	PUNCT
aiua-9669	424	1	van	van	PROPN
aiua-9669	424	2	der	der	PROPN
aiua-9669	424	3	sar	sar	PROPN
aiua-9669	424	4	eca	eca	PROPN
aiua-9669	424	5	,	,	PUNCT
aiua-9669	424	6	kasivisvanathan	kasivisvanathan	ADV
aiua-9669	424	7	v	v	PROPN
aiua-9669	424	8	,	,	PUNCT
aiua-9669	424	9	brizmohun	brizmohun	PROPN
aiua-9669	424	10	m	m	PROPN
aiua-9669	424	11	,	,	PUNCT
aiua-9669	424	12	freeman	freeman	PROPN
aiua-9669	424	13	a	a	PROPN
aiua-9669	424	14	,	,	PUNCT
aiua-9669	424	15	punwani	punwani	PROPN
aiua-9669	424	16	s	s	PROPN
aiua-9669	424	17	,	,	PUNCT
aiua-9669	424	18	hamoudi	hamoudi	ADJ
aiua-9669	424	19	r	r	NOUN
aiua-9669	424	20	,	,	PUNCT
aiua-9669	424	21	et	et	PROPN
aiua-9669	424	22	al	al	PROPN
aiua-9669	424	23	.	.	PUNCT
aiua-9669	424	24	management	management	NOUN
aiua-9669	424	25	of	of	ADP
aiua-9669	424	26	radiologically	radiologically	ADV
aiua-9669	424	27	indeterminate	indeterminate	ADJ
aiua-9669	424	28	magnetic	magnetic	ADJ
aiua-9669	424	29	resonance	resonance	NOUN
aiua-9669	424	30	imaging	imaging	NOUN
aiua-9669	424	31	signals	signal	NOUN
aiua-9669	424	32	in	in	ADP
aiua-9669	424	33	men	man	NOUN
aiua-9669	424	34	at	at	ADP
aiua-9669	424	35	risk	risk	NOUN
aiua-9669	424	36	of	of	ADP
aiua-9669	424	37	prostate	prostate	NOUN
aiua-9669	424	38	cancer	cancer	NOUN
aiua-9669	424	39	.	.	PUNCT
aiua-9669	425	1	eur	eur	PROPN
aiua-9669	425	2	urol	urol	PROPN
aiua-9669	425	3	focus	focus	NOUN
aiua-9669	425	4	.	.	PUNCT
aiua-9669	426	1	2019	2019	NUM
aiua-9669	426	2	;	;	PUNCT
aiua-9669	426	3	5:62	5:62	NUM
aiua-9669	426	4	-	-	SYM
aiua-9669	426	5	8	8	NUM
aiua-9669	426	6	.	.	NOUN
aiua-9669	426	7	64	64	NUM
aiua-9669	426	8	.	.	PUNCT
aiua-9669	427	1	frye	frye	PROPN
aiua-9669	427	2	tp	tp	PROPN
aiua-9669	427	3	,	,	PUNCT
aiua-9669	427	4	george	george	PROPN
aiua-9669	427	5	ak	ak	PROPN
aiua-9669	427	6	,	,	PUNCT
aiua-9669	427	7	kilchevsky	kilchevsky	PROPN
aiua-9669	427	8	a	a	NOUN
aiua-9669	427	9	,	,	PUNCT
aiua-9669	427	10	maruf	maruf	PROPN
aiua-9669	427	11	m	m	PROPN
aiua-9669	427	12	,	,	PUNCT
aiua-9669	427	13	siddiqui	siddiqui	NOUN
aiua-9669	427	14	mm	mm	PROPN
aiua-9669	427	15	,	,	PUNCT
aiua-9669	427	16	kongnyuy	kongnyuy	PROPN
aiua-9669	427	17	m	m	PROPN
aiua-9669	427	18	,	,	PUNCT
aiua-9669	427	19	et	et	PROPN
aiua-9669	427	20	al	al	PROPN
aiua-9669	427	21	.	.	PUNCT
aiua-9669	427	22	magnetic	magnetic	ADJ
aiua-9669	427	23	resonance	resonance	NOUN
aiua-9669	427	24	imaging	imaging	NOUN
aiua-9669	427	25	-	-	PUNCT
aiua-9669	427	26	transrectal	transrectal	ADJ
aiua-9669	427	27	ultrasound	ultrasound	NOUN
aiua-9669	427	28	guided	guide	VERB
aiua-9669	427	29	fusion	fusion	NOUN
aiua-9669	427	30	biopsy	biopsy	NOUN
aiua-9669	427	31	to	to	PART
aiua-9669	427	32	detect	detect	VERB
aiua-9669	427	33	progression	progression	NOUN
aiua-9669	427	34	in	in	ADP
aiua-9669	427	35	patients	patient	NOUN
aiua-9669	427	36	with	with	ADP
aiua-9669	427	37	existing	exist	VERB
aiua-9669	427	38	lesions	lesion	NOUN
aiua-9669	427	39	on	on	ADP
aiua-9669	427	40	active	active	ADJ
aiua-9669	427	41	surveillance	surveillance	NOUN
aiua-9669	427	42	for	for	ADP
aiua-9669	427	43	low	low	ADJ
aiua-9669	427	44	and	and	CCONJ
aiua-9669	427	45	intermediate	intermediate	ADJ
aiua-9669	427	46	risk	risk	NOUN
aiua-9669	427	47	prostate	prostate	NOUN
aiua-9669	427	48	cancer	cancer	NOUN
aiua-9669	427	49	.	.	PUNCT
aiua-9669	428	1	j	j	PROPN
aiua-9669	428	2	urol	urol	PROPN
aiua-9669	428	3	.	.	PROPN
aiua-9669	428	4	2017	2017	NUM
aiua-9669	428	5	;	;	PUNCT
aiua-9669	428	6	197:640	197:640	NUM
aiua-9669	428	7	-	-	SYM
aiua-9669	428	8	6	6	NUM
aiua-9669	428	9	.	.	PUNCT
aiua-9669	429	1	correspondence	correspondence	NOUN
aiua-9669	429	2	andrea	andrea	PROPN
aiua-9669	429	3	b.	b.	PROPN
aiua-9669	429	4	galosi	galosi	PROPN
aiua-9669	429	5	,	,	PUNCT
aiua-9669	429	6	md	md	PROPN
aiua-9669	429	7	(	(	PUNCT
aiua-9669	429	8	corresponding	correspond	VERB
aiua-9669	429	9	author	author	NOUN
aiua-9669	429	10	)	)	PUNCT
aiua-9669	429	11	a.b.galosi@univpm.it	a.b.galosi@univpm.it	PROPN
aiua-9669	429	12	department	department	NOUN
aiua-9669	429	13	of	of	ADP
aiua-9669	429	14	clinical	clinical	ADJ
aiua-9669	429	15	sciences	science	NOUN
aiua-9669	429	16	,	,	PUNCT
aiua-9669	429	17	politecnica	politecnica	NOUN
aiua-9669	429	18	delle	delle	PROPN
aiua-9669	429	19	marche	marche	PROPN
aiua-9669	429	20	university	university	PROPN
aiua-9669	429	21	via	via	ADP
aiua-9669	429	22	conca	conca	PROPN
aiua-9669	429	23	71	71	NUM
aiua-9669	429	24	,	,	PUNCT
aiua-9669	429	25	60126	60126	NUM
aiua-9669	429	26	ancona	ancona	NOUN
aiua-9669	429	27	,	,	PUNCT
aiua-9669	429	28	italy	italy	PROPN
aiua-9669	429	29	erika	erika	PROPN
aiua-9669	429	30	palagonia	palagonia	PROPN
aiua-9669	429	31	,	,	PUNCT
aiua-9669	429	32	md	md	PROPN
aiua-9669	429	33	erika.palagonia@gmail.com	erika.palagonia@gmail.com	X
aiua-9669	429	34	simone	simone	NOUN
aiua-9669	429	35	scarcella	scarcella	PROPN
aiua-9669	429	36	,	,	PUNCT
aiua-9669	429	37	md	md	PROPN
aiua-9669	429	38	simoscarc@gmail.com	simoscarc@gmail.com	PROPN
aiua-9669	430	1	rocco	rocco	PROPN
aiua-9669	430	2	f.	f.	PROPN
aiua-9669	430	3	delle	delle	PROPN
aiua-9669	430	4	fave	fave	PROPN
aiua-9669	430	5	,	,	PUNCT
aiua-9669	430	6	md	md	PROPN
aiua-9669	430	7	checcoboss90@gmail.com	checcoboss90@gmail.com	PROPN
aiua-9669	430	8	angelo	angelo	PROPN
aiua-9669	430	9	antezza	antezza	PROPN
aiua-9669	430	10	,	,	PUNCT
aiua-9669	430	11	md	md	PROPN
aiua-9669	430	12	angelo.antezza@yahoo.it	angelo.antezza@yahoo.it	PROPN
aiua-9669	430	13	lucio	lucio	PROPN
aiua-9669	430	14	dell’atti	dell’atti	PROPN
aiua-9669	430	15	,	,	PUNCT
aiua-9669	430	16	md	md	PROPN
aiua-9669	430	17	dellatti@hotmail.com	dellatti@hotmail.com	PROPN
aiua-9669	431	1	division	division	NOUN
aiua-9669	431	2	of	of	ADP
aiua-9669	431	3	urology	urology	NOUN
aiua-9669	431	4	,	,	PUNCT
aiua-9669	431	5	school	school	NOUN
aiua-9669	431	6	of	of	ADP
aiua-9669	431	7	medicine	medicine	NOUN
aiua-9669	431	8	,	,	PUNCT
aiua-9669	431	9	università	università	PROPN
aiua-9669	431	10	politecnica	politecnica	PROPN
aiua-9669	431	11	delle	delle	PROPN
aiua-9669	431	12	marche	marche	PROPN
aiua-9669	431	13	,	,	PUNCT
aiua-9669	431	14	ancona	ancona	PROPN
aiua-9669	431	15	(	(	PUNCT
aiua-9669	431	16	italy	italy	PROPN
aiua-9669	431	17	)	)	PUNCT
aiua-9669	431	18	alessia	alessia	PROPN
aiua-9669	431	19	cimadamore	cimadamore	PROPN
aiua-9669	431	20	,	,	PUNCT
aiua-9669	431	21	md	md	PROPN
aiua-9669	431	22	a.cimadamore@staff.univpm.it	a.cimadamore@staff.univpm.it	DET
aiua-9669	431	23	division	division	NOUN
aiua-9669	431	24	of	of	ADP
aiua-9669	431	25	pathology	pathology	NOUN
aiua-9669	431	26	,	,	PUNCT
aiua-9669	431	27	school	school	NOUN
aiua-9669	431	28	of	of	ADP
aiua-9669	431	29	medicine	medicine	NOUN
aiua-9669	431	30	,	,	PUNCT
aiua-9669	431	31	università	università	PROPN
aiua-9669	431	32	politecnica	politecnica	PROPN
aiua-9669	431	33	delle	delle	PROPN
aiua-9669	431	34	marche	marche	PROPN
aiua-9669	431	35	,	,	PUNCT
aiua-9669	431	36	ancona	ancona	PROPN
aiua-9669	431	37	(	(	PUNCT
aiua-9669	431	38	italy	italy	PROPN
aiua-9669	431	39	)	)	PUNCT
aiua-9669	431	40	vito	vito	PROPN
aiua-9669	431	41	lacetera	lacetera	PROPN
aiua-9669	431	42	,	,	PUNCT
aiua-9669	431	43	md	md	PROPN
aiua-9669	431	44	vito.lacetera@gmail.com	vito.lacetera@gmail.com	X
aiua-9669	431	45	division	division	NOUN
aiua-9669	431	46	of	of	ADP
aiua-9669	431	47	urology	urology	NOUN
aiua-9669	431	48	,	,	PUNCT
aiua-9669	431	49	azienda	azienda	PROPN
aiua-9669	431	50	ospedaliera	ospedaliera	NOUN
aiua-9669	431	51	marche	marche	PROPN
aiua-9669	431	52	nord	nord	PROPN
aiua-9669	431	53	,	,	PUNCT
aiua-9669	431	54	pesaro	pesaro	PROPN
aiua-9669	431	55	(	(	PUNCT
aiua-9669	431	56	italy	italy	PROPN
aiua-9669	431	57	)	)	PUNCT